false
Q2
--12-31
0001289340
0001289340
2024-01-01
2024-06-30
0001289340
2024-07-31
0001289340
2024-06-30
0001289340
2023-12-31
0001289340
2024-04-01
2024-06-30
0001289340
2023-04-01
2023-06-30
0001289340
2023-01-01
2023-06-30
0001289340
STXS:SystemsMember
2024-04-01
2024-06-30
0001289340
STXS:SystemsMember
2023-04-01
2023-06-30
0001289340
STXS:SystemsMember
2024-01-01
2024-06-30
0001289340
STXS:SystemsMember
2023-01-01
2023-06-30
0001289340
STXS:DisposablesServiceAndAccessoriesMember
2024-04-01
2024-06-30
0001289340
STXS:DisposablesServiceAndAccessoriesMember
2023-04-01
2023-06-30
0001289340
STXS:DisposablesServiceAndAccessoriesMember
2024-01-01
2024-06-30
0001289340
STXS:DisposablesServiceAndAccessoriesMember
2023-01-01
2023-06-30
0001289340
STXS:ConvertiblePreferredStockSeriesAMember
2023-03-31
0001289340
STXS:ConvertiblePreferredStockSeriesBMember
2023-03-31
0001289340
us-gaap:CommonStockMember
2023-03-31
0001289340
us-gaap:AdditionalPaidInCapitalMember
2023-03-31
0001289340
us-gaap:TreasuryStockCommonMember
2023-03-31
0001289340
us-gaap:RetainedEarningsMember
2023-03-31
0001289340
2023-03-31
0001289340
STXS:ConvertiblePreferredStockSeriesAMember
2024-03-31
0001289340
STXS:ConvertiblePreferredStockSeriesBMember
2024-03-31
0001289340
us-gaap:CommonStockMember
2024-03-31
0001289340
us-gaap:AdditionalPaidInCapitalMember
2024-03-31
0001289340
us-gaap:TreasuryStockCommonMember
2024-03-31
0001289340
us-gaap:RetainedEarningsMember
2024-03-31
0001289340
2024-03-31
0001289340
STXS:ConvertiblePreferredStockSeriesAMember
2022-12-31
0001289340
STXS:ConvertiblePreferredStockSeriesBMember
2022-12-31
0001289340
us-gaap:CommonStockMember
2022-12-31
0001289340
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001289340
us-gaap:TreasuryStockCommonMember
2022-12-31
0001289340
us-gaap:RetainedEarningsMember
2022-12-31
0001289340
2022-12-31
0001289340
STXS:ConvertiblePreferredStockSeriesAMember
2023-12-31
0001289340
STXS:ConvertiblePreferredStockSeriesBMember
2023-12-31
0001289340
us-gaap:CommonStockMember
2023-12-31
0001289340
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0001289340
us-gaap:TreasuryStockCommonMember
2023-12-31
0001289340
us-gaap:RetainedEarningsMember
2023-12-31
0001289340
STXS:ConvertiblePreferredStockSeriesAMember
2023-04-01
2023-06-30
0001289340
STXS:ConvertiblePreferredStockSeriesBMember
2023-04-01
2023-06-30
0001289340
us-gaap:CommonStockMember
2023-04-01
2023-06-30
0001289340
us-gaap:AdditionalPaidInCapitalMember
2023-04-01
2023-06-30
0001289340
us-gaap:TreasuryStockCommonMember
2023-04-01
2023-06-30
0001289340
us-gaap:RetainedEarningsMember
2023-04-01
2023-06-30
0001289340
STXS:ConvertiblePreferredStockSeriesAMember
2024-04-01
2024-06-30
0001289340
STXS:ConvertiblePreferredStockSeriesBMember
2024-04-01
2024-06-30
0001289340
us-gaap:CommonStockMember
2024-04-01
2024-06-30
0001289340
us-gaap:AdditionalPaidInCapitalMember
2024-04-01
2024-06-30
0001289340
us-gaap:TreasuryStockCommonMember
2024-04-01
2024-06-30
0001289340
us-gaap:RetainedEarningsMember
2024-04-01
2024-06-30
0001289340
STXS:ConvertiblePreferredStockSeriesAMember
2023-01-01
2023-06-30
0001289340
STXS:ConvertiblePreferredStockSeriesBMember
2023-01-01
2023-06-30
0001289340
us-gaap:CommonStockMember
2023-01-01
2023-06-30
0001289340
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-06-30
0001289340
us-gaap:TreasuryStockCommonMember
2023-01-01
2023-06-30
0001289340
us-gaap:RetainedEarningsMember
2023-01-01
2023-06-30
0001289340
STXS:ConvertiblePreferredStockSeriesAMember
2024-01-01
2024-06-30
0001289340
STXS:ConvertiblePreferredStockSeriesBMember
2024-01-01
2024-06-30
0001289340
us-gaap:CommonStockMember
2024-01-01
2024-06-30
0001289340
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-06-30
0001289340
us-gaap:TreasuryStockCommonMember
2024-01-01
2024-06-30
0001289340
us-gaap:RetainedEarningsMember
2024-01-01
2024-06-30
0001289340
STXS:ConvertiblePreferredStockSeriesAMember
2023-06-30
0001289340
STXS:ConvertiblePreferredStockSeriesBMember
2023-06-30
0001289340
us-gaap:CommonStockMember
2023-06-30
0001289340
us-gaap:AdditionalPaidInCapitalMember
2023-06-30
0001289340
us-gaap:TreasuryStockCommonMember
2023-06-30
0001289340
us-gaap:RetainedEarningsMember
2023-06-30
0001289340
2023-06-30
0001289340
STXS:ConvertiblePreferredStockSeriesAMember
2024-06-30
0001289340
STXS:ConvertiblePreferredStockSeriesBMember
2024-06-30
0001289340
us-gaap:CommonStockMember
2024-06-30
0001289340
us-gaap:AdditionalPaidInCapitalMember
2024-06-30
0001289340
us-gaap:TreasuryStockCommonMember
2024-06-30
0001289340
us-gaap:RetainedEarningsMember
2024-06-30
0001289340
us-gaap:OtherCurrentAssetsMember
srt:MaximumMember
2024-06-30
0001289340
us-gaap:OtherCurrentAssetsMember
srt:MaximumMember
2023-12-31
0001289340
2023-01-01
2023-12-31
0001289340
STXS:RevenueFromSystemDeliveryAndInstallationMember
us-gaap:ProductConcentrationRiskMember
2024-01-01
2024-06-30
0001289340
STXS:RevenueFromSystemDeliveryAndInstallationMember
us-gaap:ProductConcentrationRiskMember
2023-01-01
2023-06-30
0001289340
STXS:DisposableRevenueMember
us-gaap:ProductConcentrationRiskMember
2024-01-01
2024-06-30
0001289340
STXS:DisposableRevenueMember
us-gaap:ProductConcentrationRiskMember
2023-01-01
2023-06-30
0001289340
STXS:RoyaltyRevenueMember
us-gaap:ProductConcentrationRiskMember
2024-01-01
2024-06-30
0001289340
STXS:RoyaltyRevenueMember
us-gaap:ProductConcentrationRiskMember
2023-01-01
2023-06-30
0001289340
STXS:OtherRecurringRevenueMember
us-gaap:ProductConcentrationRiskMember
2024-01-01
2024-06-30
0001289340
STXS:OtherRecurringRevenueMember
us-gaap:ProductConcentrationRiskMember
2023-01-01
2023-06-30
0001289340
STXS:StockOptionsandStockAppreciationRightsMember
2024-01-01
2024-06-30
0001289340
STXS:StockOptionsandStockAppreciationRightsMember
2024-06-30
0001289340
STXS:SeriesAConvertiblePreferredStockMember
2024-01-01
2024-06-30
0001289340
us-gaap:RestrictedStockMember
2024-01-01
2024-06-30
0001289340
STXS:UnearnedRestrictedSharesMember
2024-01-01
2024-06-30
0001289340
STXS:CustomerDepositsMember
2024-06-30
0001289340
STXS:CustomerDepositsMember
2023-12-31
0001289340
STXS:ProductShippedRevenueDeferredMember
2024-06-30
0001289340
STXS:ProductShippedRevenueDeferredMember
2023-12-31
0001289340
STXS:DeferredServiceAndLicenseFeesMember
2024-06-30
0001289340
STXS:DeferredServiceAndLicenseFeesMember
2023-12-31
0001289340
us-gaap:CashMember
2024-06-30
0001289340
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel2Member
2024-06-30
0001289340
us-gaap:FairValueInputsLevel2Member
2024-06-30
0001289340
us-gaap:CashMember
2023-12-31
0001289340
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel2Member
2023-12-31
0001289340
us-gaap:FairValueInputsLevel2Member
2023-12-31
0001289340
us-gaap:EquipmentMember
2024-06-30
0001289340
us-gaap:EquipmentMember
2023-12-31
0001289340
us-gaap:LeaseholdImprovementsMember
2024-06-30
0001289340
us-gaap:LeaseholdImprovementsMember
2023-12-31
0001289340
STXS:OfficeLeaseAgreementMember
STXS:GlobeBuildingCompanyMember
2021-03-01
0001289340
STXS:OfficeLeaseAgreementMember
STXS:GlobeBuildingCompanyMember
2021-03-01
2021-03-01
0001289340
STXS:OfficeLeaseAgreementMember
STXS:GlobeBuildingCompanyMember
STXS:TwoThousandTwentyTwoMember
2021-03-01
2021-03-01
0001289340
STXS:OfficeLeaseAgreementMember
STXS:GlobeBuildingCompanyMember
STXS:TwoThousandThirtyOneMember
2021-03-01
2021-03-01
0001289340
STXS:SeriesAConvertiblePreferredStockMember
2016-09-01
2016-09-30
0001289340
STXS:SeriesAConvertiblePreferredStockMember
2016-09-30
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
2021-02-23
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
srt:MaximumMember
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
2024-01-01
2024-06-30
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
2023-01-01
2023-06-30
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
2024-06-30
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
2023-06-30
0001289340
STXS:TwoThousandTwelveStockIncentivePlanMember
2024-01-01
2024-06-30
0001289340
STXS:StockAwardPlansMember
2024-06-30
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
us-gaap:ShareBasedCompensationAwardTrancheOneMember
2021-02-23
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
us-gaap:ShareBasedCompensationAwardTrancheOneMember
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
us-gaap:ShareBasedCompensationAwardTrancheTwoMember
2021-02-23
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
us-gaap:ShareBasedCompensationAwardTrancheTwoMember
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
us-gaap:ShareBasedCompensationAwardTrancheThreeMember
2021-02-23
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
us-gaap:ShareBasedCompensationAwardTrancheThreeMember
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
STXS:ShareBasedCompensationAwardTrancheFourMember
2021-02-23
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
STXS:ShareBasedCompensationAwardTrancheFourMember
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
STXS:ShareBasedCompensationAwardTrancheFiveMember
2021-02-23
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
STXS:ShareBasedCompensationAwardTrancheFiveMember
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
STXS:ShareBasedCompensationAwardTrancheSixMember
2021-02-23
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
STXS:ShareBasedCompensationAwardTrancheSixMember
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
STXS:ShareBasedCompensationAwardTrancheSevenMember
2021-02-23
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
STXS:ShareBasedCompensationAwardTrancheSevenMember
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
STXS:ShareBasedCompensationAwardTrancheEightMember
2021-02-23
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
STXS:ShareBasedCompensationAwardTrancheEightMember
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
STXS:ShareBasedCompensationAwardTrancheNineMember
2021-02-23
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
STXS:ShareBasedCompensationAwardTrancheNineMember
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
STXS:ShareBasedCompensationAwardTrancheTenMember
2021-02-23
2021-02-23
0001289340
STXS:PerformanceShareUnitAwardAgreementMember
STXS:Mr.FischelMember
STXS:ShareBasedCompensationAwardTrancheTenMember
2021-02-23
0001289340
us-gaap:StockOptionMember
us-gaap:StockAppreciationRightsSARSMember
2023-12-31
0001289340
us-gaap:StockAppreciationRightsSARSMember
us-gaap:StockOptionMember
srt:MinimumMember
2023-12-31
0001289340
us-gaap:StockAppreciationRightsSARSMember
us-gaap:StockOptionMember
srt:MaximumMember
2023-12-31
0001289340
us-gaap:StockAppreciationRightsSARSMember
us-gaap:StockOptionMember
2024-01-01
2024-06-30
0001289340
us-gaap:StockAppreciationRightsSARSMember
us-gaap:StockOptionMember
srt:MinimumMember
2024-01-01
2024-06-30
0001289340
us-gaap:StockAppreciationRightsSARSMember
us-gaap:StockOptionMember
srt:MaximumMember
2024-01-01
2024-06-30
0001289340
us-gaap:StockAppreciationRightsSARSMember
us-gaap:StockOptionMember
2024-06-30
0001289340
us-gaap:StockAppreciationRightsSARSMember
us-gaap:StockOptionMember
srt:MinimumMember
2024-06-30
0001289340
us-gaap:StockAppreciationRightsSARSMember
us-gaap:StockOptionMember
srt:MaximumMember
2024-06-30
0001289340
us-gaap:RestrictedStockUnitsRSUMember
2023-12-31
0001289340
us-gaap:RestrictedStockUnitsRSUMember
2024-01-01
2024-06-30
0001289340
us-gaap:RestrictedStockUnitsRSUMember
2024-06-30
0001289340
2024-02-01
2024-02-29
0001289340
us-gaap:LetterOfCreditMember
2021-04-30
0001289340
us-gaap:SubsequentEventMember
us-gaap:CommonStockMember
STXS:SharePurchaseAgreementMember
2024-07-31
2024-07-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
utr:sqft
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
10-Q
(MARK
ONE)
☒ |
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
FOR
THE QUARTERLY PERIOD ENDED JUNE 30, 2024
OR
☐ |
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
FOR
THE TRANSITION PERIOD FROM TO
COMMISSION
FILE NUMBER 001-36159
STEREOTAXIS,
INC.
(Exact
name of the Registrant as Specified in its Charter)
delaware |
|
94-3120386 |
(State
or Other Jurisdiction of
Incorporation
or Organization) |
|
(I.R.S.
Employer
Identification
Number) |
710
North Tucker Boulevard, Suite 110
St.
Louis, MO 63101
(Address
of Principal Executive Offices including Zip Code)
(314)
678-6100
(Registrant’s
Telephone Number, Including Area Code)
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common
Stock, par value $0.001 per share |
|
STXS |
|
NYSE
American LLC |
Securities
registered pursuant to Section 12(g) of the Act: None
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T “See 232.405 of this Chapter” during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”,
“smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large
accelerated filer ☐ |
Accelerated
Filer ☐ |
Non-accelerated
filer ☒ |
Smaller
reporting company ☒ |
Emerging
growth company ☐ |
|
|
|
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒
The
number of outstanding shares of the registrant’s common stock on July 31, 2024, was 84,656,254.
STEREOTAXIS,
INC.
INDEX
TO FORM 10-Q
ITEM
1. FINANCIAL STATEMENTS
STEREOTAXIS,
INC.
BALANCE
SHEETS
(in thousands, except share amounts) | |
June 30, 2024 | | |
December 31, 2023 | |
| |
(Unaudited) | | |
| |
Assets | |
| | | |
| | |
Current assets: | |
| | | |
| | |
Cash and cash equivalents | |
$ | 14,683 | | |
$ | 19,818 | |
Restricted cash - current | |
| 481 | | |
| 525 | |
Accounts receivable, net of allowance of $640 and $672 at 2024 and 2023, respectively | |
| 2,782 | | |
| 3,822 | |
Inventories, net | |
| 9,284 | | |
| 8,426 | |
Prepaid expenses and other current assets | |
| 842 | | |
| 676 | |
Total current assets | |
| 28,072 | | |
| 33,267 | |
Property and equipment, net | |
| 3,059 | | |
| 3,304 | |
Restricted cash | |
| - | | |
| 219 | |
Operating lease right-of-use assets | |
| 4,767 | | |
| 4,982 | |
Prepaid and other non-current assets | |
| 116 | | |
| 137 | |
Total assets | |
$ | 36,014 | | |
$ | 41,909 | |
| |
| | | |
| | |
Liabilities and stockholders’ equity | |
| | | |
| | |
Current liabilities: | |
| | | |
| | |
Accounts payable | |
$ | 4,146 | | |
$ | 3,190 | |
Accrued liabilities | |
| 2,698 | | |
| 2,972 | |
Deferred revenue | |
| 4,950 | | |
| 6,657 | |
Current portion of operating lease liabilities | |
| 458 | | |
| 428 | |
Total current liabilities | |
| 12,252 | | |
| 13,247 | |
Long-term deferred revenue | |
| 2,121 | | |
| 1,637 | |
Operating lease liabilities | |
| 4,823 | | |
| 5,062 | |
Other liabilities | |
| 54 | | |
| 43 | |
Total liabilities | |
| 19,250 | | |
| 19,989 | |
| |
| | | |
| | |
Series A - Convertible preferred stock: | |
| | | |
| | |
Convertible preferred stock, Series A, par value $0.001;
10,000,000 shares authorized, 21,683
and 22,358
shares outstanding at 2024 and 2023, respectively | |
| 5,408 | | |
| 5,577 | |
| |
| | | |
| | |
Stockholders’ equity: | |
| | | |
| | |
Common stock, par value $0.001; 300,000,000 shares authorized, 82,990,159 and 80,949,697 shares issued at 2024 and 2023, respectively | |
| 83 | | |
| 81 | |
Additional paid in capital | |
| 559,499 | | |
| 554,148 | |
Treasury stock, 4,015 shares at 2024 and 2023 | |
| (206 | ) | |
| (206 | ) |
Accumulated deficit | |
| (548,020 | ) | |
| (537,680 | ) |
Total stockholders’ equity | |
| 11,356 | | |
| 16,343 | |
Total liabilities and stockholders’ equity | |
$ | 36,014 | | |
$ | 41,909 | |
See
accompanying notes.
STEREOTAXIS,
INC.
STATEMENTS
OF OPERATIONS
(Unaudited)
(in thousands, except share and per share amounts) | |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
(in thousands, except share and per share amounts) | |
2024 | | |
2023 | | |
2024 | | |
2023 | |
Revenue: | |
| | | |
| | | |
| | | |
| | |
Systems | |
$ | 240 | | |
$ | 3,313 | | |
$ | 2,852 | | |
$ | 5,134 | |
Disposables, service and accessories | |
| 4,262 | | |
| 4,546 | | |
| 8,530 | | |
| 9,273 | |
Total revenue | |
| 4,502 | | |
| 7,859 | | |
| 11,382 | | |
| 14,407 | |
| |
| | | |
| | | |
| | | |
| | |
Cost of revenue: | |
| | | |
| | | |
| | | |
| | |
Systems | |
| 187 | | |
| 2,703 | | |
| 2,087 | | |
| 4,400 | |
Disposables, service and accessories | |
| 1,002 | | |
| 969 | | |
| 2,016 | | |
| 1,944 | |
Total cost of revenue | |
| 1,189 | | |
| 3,672 | | |
| 4,103 | | |
| 6,344 | |
| |
| | | |
| | | |
| | | |
| | |
Gross margin | |
| 3,313 | | |
| 4,187 | | |
| 7,279 | | |
| 8,063 | |
| |
| | | |
| | | |
| | | |
| | |
Operating expenses: | |
| | | |
| | | |
| | | |
| | |
Research and development | |
| 2,273 | | |
| 2,647 | | |
| 4,516 | | |
| 5,393 | |
Sales and marketing | |
| 3,301 | | |
| 3,340 | | |
| 6,304 | | |
| 6,488 | |
General and administrative | |
| 3,760 | | |
| 3,477 | | |
| 7,226 | | |
| 7,078 | |
Total operating expenses | |
| 9,334 | | |
| 9,464 | | |
| 18,046 | | |
| 18,959 | |
Operating loss | |
| (6,021 | ) | |
| (5,277 | ) | |
| (10,767 | ) | |
| (10,896 | ) |
| |
| | | |
| | | |
| | | |
| | |
Other income (expense) | |
| (3 | ) | |
| 27 | | |
| (3 | ) | |
| 27 | |
Interest income, net | |
| 191 | | |
| 293 | | |
| 430 | | |
| 565 | |
Net loss | |
$ | (5,833 | ) | |
$ | (4,957 | ) | |
$ | (10,340 | ) | |
$ | (10,304 | ) |
| |
| | | |
| | | |
| | | |
| | |
Cumulative dividend on convertible preferred stock | |
| (325 | ) | |
| (335 | ) | |
| (656 | ) | |
| (666 | ) |
Net loss attributable to common stockholders | |
$ | (6,158 | ) | |
$ | (5,292 | ) | |
$ | (10,996 | ) | |
$ | (10,970 | ) |
| |
| | | |
| | | |
| | | |
| | |
Net loss per share attributable to common stockholders: | |
| | | |
| | | |
| | | |
| | |
Basic | |
$ | (0.07 | ) | |
$ | (0.07 | ) | |
$ | (0.13 | ) | |
$ | (0.14 | ) |
Diluted | |
$ | (0.07 | ) | |
$ | (0.07 | ) | |
$ | (0.13 | ) | |
$ | (0.14 | ) |
| |
| | | |
| | | |
| | | |
| | |
Weighted average number of common shares and equivalents: | |
| | | |
| | | |
| | | |
| | |
Basic | |
| 84,570,738 | | |
| 81,049,211 | | |
| 84,025,335 | | |
| 78,787,652 | |
Diluted | |
| 84,570,738 | | |
| 81,049,211 | | |
| 84,025,335 | | |
| 78,787,652 | |
See
accompanying notes.
STEREOTAXIS,
INC.
STATEMENTS
OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY
(Unaudited)
Three
Months Ended June 30, 2023
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Amount | | |
Amount | | |
Amount | | |
Amount | |
(in
thousands, except share amounts) | |
Convertible
Preferred Stock
Series A (Mezzanine) | | |
Convertible
Preferred
Stock Series B | | |
Common
Stock | | |
Additional
Paid-In Capital | | |
Treasury
Stock | | |
Accumulated
Deficit | | |
Total
Stockholders’ Equity (Deficit) | |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Amount | | |
Amount | | |
Amount | | |
Amount | |
Balance
at March 31, 2023 | |
| 22,383 | | |
$ | 5,583 | | |
| 5,610,121 | | |
$ | 6 | | |
| 75,059,499 | | |
$ | 75 | | |
$ | 546,149 | | |
$ | (206 | ) | |
$ | (522,314 | ) | |
$ | 23,710 | |
Stock
issued for the exercise of stock options | |
| | | |
| | | |
| | | |
| | | |
| 196 | | |
| | | |
| (52 | ) | |
| | | |
| | | |
| (52 | ) |
Stock-based
compensation | |
| | | |
| | | |
| | | |
| | | |
| - | | |
| | | |
| 2,660 | | |
| | | |
| | | |
| 2,660 | |
Components
of net loss | |
| | | |
| - | | |
| | | |
| - | | |
| | | |
| | | |
| | | |
| - | | |
| (4,957 | ) | |
| (4,957 | ) |
Employee
stock purchase plan | |
| | | |
| | | |
| | | |
| | | |
| 12,770 | | |
| | | |
| 25 | | |
| | | |
| | | |
| 25 | |
Preferred
stock conversion | |
| | | |
| | | |
| (5,610,121 | ) | |
| (6 | ) | |
| 5,610,121 | | |
| 6 | | |
| | | |
| | | |
| | | |
| - | |
Balance
at June 30, 2023 | |
| 22,383 | | |
$ | 5,583 | | |
| - | | |
$ | - | | |
| 80,682,586 | | |
$ | 81 | | |
$ | 548,782 | | |
$ | (206 | ) | |
$ | (527,271 | ) | |
$ | 21,386 | |
Three
Months Ended June 30, 2024
(in
thousands, except share amounts) | |
Convertible
Preferred Stock
Series A (Mezzanine) | | |
Convertible
Preferred
Stock Series B | | |
Common
Stock | | |
Additional
Paid-In Capital | | |
Treasury
Stock | | |
Accumulated
Deficit | | |
Total
Stockholders’ Equity (Deficit) | |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Amount | | |
Amount | | |
Amount | | |
Amount | |
Balance
at March 31, 2024 | |
| 21,908 | | |
$ | 5,464 | | |
| - | | |
$ | - | | |
| 82,132,777 | | |
$ | 82 | | |
$ | 556,878 | | |
$ | (206 | ) | |
$ | (542,187 | ) | |
$ | 14,567 | |
Stock
issued for the exercise of stock options | |
| | | |
| | | |
| | | |
| | | |
| 2,213 | | |
| | | |
| 4 | | |
| | | |
| | | |
| 4 | |
Stock-based
compensation | |
| | | |
| | | |
| | | |
| | | |
| 342,901 | | |
| | | |
| 2,538 | | |
| | | |
| | | |
| 2,538 | |
Components
of net loss | |
| | | |
| | | |
| | | |
| - | | |
| | | |
| | | |
| | | |
| - | | |
| (5,833 | ) | |
| (5,833 | ) |
Employee
stock purchase plan | |
| | | |
| | | |
| | | |
| | | |
| 9,634 | | |
| | | |
| 24 | | |
| | | |
| | | |
| 24 | |
Preferred
stock conversion | |
| (225 | ) | |
| (56 | ) | |
| | | |
| | | |
| 502,634 | | |
| 1 | | |
| 55 | | |
| | | |
| | | |
| 56 | |
Balance
at June 30, 2024 | |
| 21,683 | | |
$ | 5,408 | | |
| - | | |
$ | - | | |
| 82,990,159 | | |
$ | 83 | | |
$ | 559,499 | | |
$ | (206 | ) | |
$ | (548,020 | ) | |
$ | 11,356 | |
See
accompanying notes.
STEREOTAXIS,
INC.
STATEMENTS
OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY
(Unaudited)
Six
Months Ended June 30, 2023
(in thousands, except share amounts) | |
Convertible Preferred Stock
Series A (Mezzanine) | | |
Convertible Preferred
Stock Series B | | |
Common Stock | | |
Additional Paid-In Capital | | |
Treasury Stock | | |
Accumulated Deficit | | |
Total Stockholders’ Equity (Deficit) | |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Amount | | |
Amount | | |
Amount | | |
Amount | |
Balance at December 31, 2022 | |
| 22,383 | | |
$ | 5,583 | | |
| 5,610,121 | | |
$ | 6 | | |
| 74,874,459 | | |
$ | 75 | | |
$ | 543,438 | | |
$ | (206 | ) | |
$ | (516,967 | ) | |
$ | 26,346 | |
Stock issued for the exercise of stock options | |
| | | |
| | | |
| | | |
| | | |
| 29,384 | | |
| | | |
| (18 | ) | |
| | | |
| | | |
| (18 | ) |
Stock-based compensation | |
| | | |
| | | |
| | | |
| | | |
| 144,054 | | |
| | | |
| 5,314 | | |
| | | |
| | | |
| 5,314 | |
Components of net loss | |
| | | |
| - | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| - | | |
| (10,304 | ) | |
| (10,304 | ) |
Employee stock purchase plan | |
| | | |
| | | |
| | | |
| | | |
| 24,568 | | |
| | | |
| 48 | | |
| | | |
| | | |
| 48 | |
Preferred stock conversion | |
| | | |
| | | |
| (5,610,121 | ) | |
| (6 | ) | |
| 5,610,121 | | |
| 6 | | |
| | | |
| | | |
| | | |
| - | |
Balance at June 30, 2023 | |
| 22,383 | | |
$ | 5,583 | | |
| - | | |
$ | - | | |
| 80,682,586 | | |
$ | 81 | | |
$ | 548,782 | | |
$ | (206 | ) | |
$ | (527,271 | ) | |
$ | 21,386 | |
Six
Months Ended June 30, 2024
(in thousands, except share amounts) | |
Convertible Preferred Stock
Series A (Mezzanine) | | |
Convertible Preferred
Stock Series B | | |
Common Stock | | |
Additional Paid-In Capital | | |
Treasury Stock | | |
Accumulated Deficit | | |
Total Stockholders’ Equity (Deficit) | |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Amount | | |
Amount | | |
Amount | | |
Amount | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance at December 31, 2023 | |
| 22,358 | | |
$ | 5,577 | | |
| - | | |
$ | - | | |
| 80,949,697 | | |
$ | 81 | | |
$ | 554,148 | | |
$ | (206 | ) | |
$ | (537,680 | ) | |
$ | 16,343 | |
Balance | |
| 22,358 | | |
$ | 5,577 | | |
| - | | |
$ | - | | |
| 80,949,697 | | |
$ | 81 | | |
$ | 554,148 | | |
$ | (206 | ) | |
$ | (537,680 | ) | |
$ | 16,343 | |
Stock issued for the exercise of stock options | |
| | | |
| | | |
| | | |
| | | |
| 11,763 | | |
| | | |
| 12 | | |
| | | |
| | | |
| 12 | |
Stock-based compensation | |
| | | |
| | | |
| | | |
| | | |
| 504,375 | | |
| | | |
| 5,127 | | |
| | | |
| | | |
| 5,127 | |
Components of net loss | |
| | | |
| | | |
| | | |
| - | | |
| | | |
| | | |
| | | |
| - | | |
| (10,340 | ) | |
| (10,340 | ) |
Employee stock purchase plan | |
| | | |
| | | |
| | | |
| | | |
| 23,022 | | |
| | | |
| 46 | | |
| | | |
| | | |
| 46 | |
Preferred stock conversion | |
| (675 | ) | |
| (169 | ) | |
| | | |
| | | |
| 1,501,302 | | |
| 2 | | |
| 166 | | |
| | | |
| | | |
| 168 | |
Balance at June 30, 2024 | |
| 21,683 | | |
$ | 5,408 | | |
| - | | |
$ | - | | |
| 82,990,159 | | |
$ | 83 | | |
$ | 559,499 | | |
$ | (206 | ) | |
$ | (548,020 | ) | |
$ | 11,356 | |
Balance | |
| 21,683 | | |
$ | 5,408 | | |
| - | | |
$ | - | | |
| 82,990,159 | | |
$ | 83 | | |
$ | 559,499 | | |
$ | (206 | ) | |
$ | (548,020 | ) | |
$ | 11,356 | |
See
accompanying notes.
STEREOTAXIS,
INC.
STATEMENTS
OF CASH FLOWS
(Unaudited)
(in thousands) | |
2024 | | |
2023 | |
| |
Six Months Ended June 30, | |
(in thousands) | |
2024 | | |
2023 | |
Cash flows from operating activities | |
| | | |
| | |
Net loss | |
$ | (10,340 | ) | |
$ | (10,304 | ) |
Adjustments to reconcile net loss to cash used in operating activities: | |
| | | |
| | |
Depreciation | |
| 276 | | |
| 310 | |
Non-cash lease expense | |
| 6 | | |
| 16 | |
Stock-based compensation | |
| 5,127 | | |
| 5,314 | |
Accretion and short-term investment discount | |
| - | | |
| (287 | ) |
Changes in operating assets and liabilities: | |
| | | |
| | |
Accounts receivable | |
| 1,040 | | |
| (1,555 | ) |
Inventories | |
| (858 | ) | |
| 173 | |
Prepaid expenses and other current assets | |
| (166 | ) | |
| 217 | |
Other assets | |
| 21 | | |
| 54 | |
Accounts payable | |
| 946 | | |
| (143 | ) |
Accrued liabilities | |
| (274 | ) | |
| (386 | ) |
Deferred revenue | |
| (1,223 | ) | |
| 866 | |
Other liabilities | |
| 11 | | |
| (8 | ) |
Net cash used in operating activities | |
| (5,434 | ) | |
| (5,733 | ) |
Cash flows from investing activities | |
| | | |
| | |
Purchase of property and equipment | |
| (22 | ) | |
| (356 | ) |
Proceeds from maturity of short-term investments | |
| - | | |
| 20,131 | |
Net cash (used in) provided by investing activities | |
| (22 | ) | |
| 19,775 | |
Cash flows from financing activities | |
| | | |
| | |
Proceeds from issuance of stock, net of issuance costs | |
| 58 | | |
| 30 | |
Net cash provided by financing activities | |
| 58 | | |
| 30 | |
Net (decrease) increase in cash, cash equivalents, and restricted
cash | |
| (5,398 | ) | |
| 14,072 | |
Cash, cash equivalents, and restricted cash at beginning of period | |
| 20,562 | | |
| 9,855 | |
Cash, cash equivalents, and restricted cash at end of period | |
$ | 15,164 | | |
$ | 23,927 | |
| |
| | | |
| | |
Supplemental disclosure of cash flow information: | |
| | | |
| | |
Purchase of property and equipment included in accounts payable | |
$ | 10 | | |
$ | 17 | |
| |
| | | |
| | |
Reconciliation of cash, cash equivalents, and restricted cash to balance sheet as of June 30th: | |
| | | |
| | |
Cash and cash equivalents | |
$ | 14,683 | | |
$ | 22,877 | |
Restricted cash - current | |
| 481 | | |
| 569 | |
Restricted cash | |
| - | | |
| 481 | |
Total cash, cash equivalents, and restricted cash | |
$ | 15,164 | | |
$ | 23,927 | |
See
accompanying notes.
STEREOTAXIS,
INC.
NOTES
TO FINANCIAL STATEMENTS
(Unaudited)
Notes
to Financial Statements
In
this report, “Stereotaxis”, the “Company”, “Registrant”, “we”, “us”, and
“our” refer to Stereotaxis, Inc. and its wholly owned subsidiaries. Genesis RMN®, Niobe®, Navigant®,
Odyssey®, Odyssey Cinema™, Vdrive®, Vdrive Duo™, V-CAS™, V-Loop™, V-Sono™,
QuikCAS™, Cardiodrive®, and MAGiC ™ are trademarks of Stereotaxis, Inc. All other trademarks that appear in
this report are the property of their respective owners.
1.
Description of Business
Stereotaxis
designs, manufactures and markets robotic systems, instruments and information systems for the interventional laboratory. Our proprietary
robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled
magnetic fields to directly control the tip of flexible interventional catheters or devices. Direct control of the tip of an interventional
device, in contrast to all manual hand-held devices that are controlled from their handle, can improve the precision, stability, reach
and safety of these devices during procedures.
Our
primary clinical focus has been electrophysiology, specifically cardiac ablation procedures for the treatment of arrhythmias. Cardiac
ablation has become a well-accepted therapy for arrhythmias and a multi-billion-dollar medical device market with expectations for substantial
long-term growth. Our product strategy is to expand the clinical focus of our technology to several additional endovascular indications
including coronary, neuro, and peripheral interventions.
There
is substantial real-world evidence and clinical literature for Robotic Magnetic Navigation in electrophysiology. Hundreds of electrophysiologists
at over one hundred hospitals globally have treated over 100,000 arrhythmia patients with our robotic technology. Clinical use of our
technology has been documented in over 500 clinical publications. Robotic Magnetic Navigation is designed to enable physicians to complete
more complex interventional procedures with greater success and safety by providing image-guided delivery of catheters through the blood
vessels and chambers of the heart to treatment sites. This is achieved using externally applied computer-controlled magnetic fields that
govern the motion of the working tip of the catheter, resulting in improved navigation. The more flexible atraumatic design of catheters
driven using magnetic fields may reduce the risk of patient harm and other adverse events. Performing the procedure from a control cockpit
enables physicians to complete procedures in a safe location protected from x-ray exposure, with greater ergonomics, and improved efficiency.
We believe these benefits can be applicable in other endovascular indications where navigation through complex vasculature is often challenging
or unsuccessful and generates significant x-ray exposure, and we are investing in research and development in these areas.
Our
primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through our strategic
relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties,
we offer our customers x-ray systems and other accessory devices.
The
Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided
delivery of catheters through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied
magnetic fields that govern the motion of the working tip of the catheter, resulting in improved navigation, efficient procedures, and
reduced x-ray exposure.
The
Odyssey Solution consolidates lab information onto one large integrated display, enabling physicians to view and control all the
key information in the operating room. This is designed to improve lab layout and procedure efficiency. The system also features a remote
viewing and recording capability called Odyssey Cinema, which is an innovative solution that delivers synchronized content for
optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store
and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local
area network and over the global Odyssey Network providing physicians with a tool for clinical collaboration, remote consultation, and
training.
We
have arrangements with fluoroscopy system manufacturers to provide such systems in a bundled purchase offer for hospitals establishing
robotic interventional operating rooms. These are single-plane, full-power x-ray systems and include the c-arm and powered table. The
combination of RMN Systems with our partnered x-ray systems reduces the cost of acquisition, the ongoing cost of ownership, and the complexity
of installation of a robotic electrophysiology practice.
We
promote our full suite of products in a typical hospital implementation, subject to regulatory approvals or clearances. This implementation
requires a hospital to agree to an upfront capital payment and recurring payments. The upfront capital payment typically includes equipment
and installation charges. The recurring payments typically include disposable costs for each procedure, equipment service costs beyond
the warranty period, and ongoing software updates. In hospitals where our full suite of products has not been implemented, equipment
upgrade or expansion can be implemented upon purchasing of the necessary upgrade or expansion.
We
have received regulatory clearances and approvals necessary for us to market the Genesis RMN System in the U.S. and Europe, and
we are in the process of obtaining necessary registrations for extending our markets in other countries. The Niobe System, our
prior generation robotic magnetic navigation system, the Odyssey Solution, Cardiodrive, e-Contact, and various disposable
interventional devices have received regulatory clearances and approvals in the U.S., Europe, Canada, China, Japan and various other
countries. We have regulatory clearances and approvals that allow us to market the Vdrive and Vdrive Duo Systems with the V-CAS device
in the U.S., Canada and Europe. We are pursuing regulatory approvals for the Stereotaxis MAGiC catheter, a robotically-navigated magnetic
ablation catheter designed to perform minimally invasive cardiac ablation procedures, in various global geographies. Approval processes
can be lengthy and uncertain, submissions may require revised or additional non-clinical and clinical data, and regulatory applications
could be denied.
We
have strategic relationships with technology leaders and innovators in the global interventional market. Through these strategic relationships
we provide compatibility between our robotic magnetic navigation system, x-ray systems, and digital imaging and 3D catheter location
sensing technology, as well as disposable interventional devices. The maintenance of these strategic relationships, or the establishment
of equivalent alternatives, is critical to our commercialization efforts. There are no guarantees that any existing strategic relationships
will continue, and efforts are ongoing to ensure the availability of compatible systems and devices and/or equivalent alternatives. We
cannot provide assurance as to the timeline of the ongoing availability of such compatible systems or our ability to obtain equivalent
alternatives on competitive terms or at all.
2.
Summary of Significant Accounting Policies
Basis
of Presentation
The
accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with U.S. generally accepted accounting
principles (“GAAP”) for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include
all the disclosures required by GAAP for complete financial statements. In the opinion of management, they include all adjustments, consisting
only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results
for the six-month period ended June 30, 2024, are not necessarily indicative of the results that may be expected for the year ending
December 31, 2024, or for future operating periods.
These
interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included
in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission
(SEC) on March 8, 2024.
Risks
and Uncertainties
Future
results of operations could be materially adversely impacted by macroeconomic and geopolitical factors. The Company continues to experience
difficulties with periodic worldwide supply chain disruptions, including shortages and inflationary pressures, and logistics delays which
make it difficult for us to source parts and ship our products. We have generally been able to conduct normal business activities albeit
in a more deliberate manner than prior to the pandemic, including taking action to increase inventory levels and engaging in discussions
with our vendors on contractual obligations, but we cannot guarantee that they will not be impacted more severely in the future. Our
suppliers and contract manufacturers have experienced, and may continue to experience, similar difficulties. If our manufacturing operations
or supply chains are materially interrupted, it may not be possible for us to timely manufacture or service our products at required
levels, or at all. Changes in economic conditions and supply chain constraints could lead to higher inflation than previously experienced
or expected, which could, in turn, lead to an increase in costs. We may be unable to raise the prices of our products sufficiently to
keep up with the rate of inflation. A material reduction or interruption in any of our manufacturing processes or a substantial increase
in costs would have a material adverse effect on our business, operating results, and financial condition.
Many
of our hospital customers, for whom the purchase of our system involves a significant capital purchase which may be part of a larger
construction project at the customer site (typically the construction of a new building), may themselves be under economic pressures.
Hospitals continue to experience challenges with staffing and cost pressures as supply chain constraints and inflation drive up operating
costs. This may cause delays or cancellations of current purchase orders and other commitments and may exacerbate the long and variable
sales and installation cycles for our robotic magnetic navigation systems. Our hospital customers have also experienced challenges in
sourcing supplies, such as catheters, needed to perform procedures. Such shortages have, and may continue to, put pressure on procedures
and our disposable revenue.
Any
disruption to the capital markets could negatively impact our ability to raise capital. If the capital markets are disrupted for an extended
period of time and we need to raise additional capital, such capital may not be available on acceptable terms, or at all. Disruptions
to the capital markets and other financing sources could also negatively impact our hospital customers’ ability to raise capital
or otherwise obtain financing to fund their operations and capital projects. Such could result in delayed spending on current projects,
a longer sales cycle for new projects where a large capital commitment is required, and decreased demand for our disposable products
as well as an increased risk of customer defaults or delays in payments for our system installations, service contracts and disposable
products.
In
addition to the aforementioned macroeconomic factors, the COVID-19 pandemic negatively affected, and any resurgence of a variant of COVID-19
or any similar occurrences may in the future negatively affect demand for both our systems and our disposable products. In the past,
we have experienced business disruptions, including travel restrictions on us and our third-party distributors, which negatively affected
our complex sales, marketing, installation, distribution and service network relating to our products and services. We also experienced
reductions in demand for our disposable products as our healthcare customers (physicians and hospitals) re-prioritized the treatment
of patients and diverted resources away from non-coronavirus areas, leading to the performance of fewer procedures in which our disposable
products are used. Significant decreases to our capital or recurring revenues could have a material adverse effect on our business, operating
results, and financial condition. While we cannot reliably estimate the ultimate duration of the impact or the severity of ongoing periodic
resurgences of pandemic-related issues, we continue to anticipate periodic disruptions to our manufacturing operations, supply chains,
procedures volumes, service activities, and capital system orders and placements, any of which could have a material adverse effect on
our business, financial condition, results of operations, or cash flows. The impact has varied widely over time by individual geography.
Concentration
of Credit Risk
Financial
instruments that potentially subject the Company to concentration of credit risk consist of cash, cash equivalents and marketable securities.
Our investments may include, at any time, a diversified portfolio of cash equivalents and short- and long-term investments in a variety
of high-quality securities, including money market funds, U.S. treasury and U.S. government agency securities, corporate notes and bonds,
commercial paper, non-U.S. government agency securities, and municipal notes. The Company’s exposure to any individual corporate
entity is limited by policy. Deposits may exceed federally insured limits, and the Company is exposed to credit risk on deposits in the
event of default by the financial institutions to the extent account balances exceed the amount insured by the Federal Deposit Insurance
Corporation (FDIC). The Company closely monitors events involving limited liquidity, defaults, non-performance or other adverse developments
that affect financial institutions or other companies in the financial services industry or the financial services industry generally,
including Silicon Valley Bank. On March 10, 2023, Silicon Valley Bank (“SVB”), where the Company maintained accounts with
a cash balance of less than 6% of the Company’s total cash, cash equivalents and marketable securities, was closed by the California
Department of Financial Protection and Innovation and the FDIC was appointed as receiver. On March 12, 2023, the U.S. Department of the
Treasury, Federal Reserve Board, and FDIC released a joint statement announcing that the FDIC would complete its resolution of SVB in
a manner that fully protected all depositors at SVB and that depositors would have access to all of their money starting March 13, 2023.
On March 26, 2023, it was announced that First-Citizens Bank & Trust Company would assume all of SVB’s deposits and loans as
of March 27, 2023. During the periods presented, the Company has not experienced any losses on its deposits of cash, cash equivalents
or marketable securities.
Cash
and Cash Equivalents
Cash
and cash equivalents include cash on hand, money market instruments, and other highly liquid investments with original maturities of
three months or less from the date of purchase. Accrued interest receivable on money market instruments, included in other current assets,
was less than $0.1 million as of June 30, 2024, and December 31, 2023.
Restricted
Cash
Restricted
cash primarily consists of cash that the Company is obligated to maintain in accordance with contractual obligations. The Company’s
restricted cash was $0.5 million and $0.7 million as of June 30, 2024, and December 31, 2023, respectively.
Investments
Our
investments may include, at any time, a diversified portfolio of cash equivalents and short-and long-term investments in a variety of
high-quality securities, including money market funds, U.S. treasury and U.S. government agency securities, corporate notes and bonds,
commercial paper, non-U.S. government agency securities, and municipal notes. As of June 30, 2024, and December 31, 2023, the Company
had no short-term investments.
Amortized
cost of U.S. treasury securities and marketable debt securities are based on the Company’s purchase price adjusted for accrual
of discount, or amortization of premium, and recognition of impairment charges, if any. The amortized cost of securities the Company
purchases at a discount or premium will equal the face or par value at maturity or the call date, if applicable. Stated interest on investments
is reported as income when earned and is adjusted for amortization or accretion of any premium or discount.
The
Company segments its portfolio based on the underlying risk profiles of the securities and has a zero-loss expectation for U.S. treasury
and U.S. government agency securities. The Company regularly reviews the securities using the probability of default method and analyzes
the unrealized loss positions and evaluates the current expected credit loss by considering factors such as credit ratings, issuer-specific
factors, current economic conditions, and reasonable and supportable forecasts. The Company did not have any material expected credit
losses on investments or material expected credit losses on accrued interest related to investments during the six months ended June
30, 2024, or year ended December 31, 2023.
Fair
Value Measurements
Financial
instruments consist of cash and cash equivalents, restricted cash, investments, accounts receivable, and accounts payable.
The
Company measures certain financial assets and liabilities at fair value on a recurring basis. General accounting principles for fair
value measurement establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value.
The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level
1”) and the lowest priority to unobservable inputs (“Level 3”). The three levels of the fair value hierarchy are described
below:
Level
1: |
|
Values
are based on unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets
or liabilities. |
|
|
|
Level
2: |
|
Values
are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets
that are not active, or other model-based valuation techniques for which all significant assumptions are observable in the market. |
|
|
|
Level
3: |
|
Values
are generated from model-based techniques that use significant assumptions not observable in the market. |
As
of June 30, 2024, and December 31, 2023, financial assets classified as Level 2 consisted of money market funds. The Company reviews
trading activity and pricing for these investments as of the measurement date. When sufficient quoted pricing for identical securities
is not available, the Company uses market pricing and other observable market inputs for similar securities. These inputs either represent
quoted prices for similar assets in active markets or have been derived from observable market data. This approach results in the Level
2 classification of these securities within the fair value hierarchy.
Accounts
Receivable, Contract Assets, and Allowance for Credit Losses
Accounts
receivable primarily include amounts due from hospitals and distributors for acquisition of magnetic systems, associated disposable device
sales and service contracts, net of allowances for expected credit losses. Credit is granted on a limited basis, with balances due generally
within 30 days of billing. Contract assets primarily represent the difference between the revenue that was earned but not billed on service
contracts and revenue from system contracts that was recognized based on the relative selling price of the related performance obligations
and the contractual billing terms in the arrangements. The Company reports accounts receivable and contract assets net of an allowance
for expected credit losses in accordance with Accounting Standards Codification Topic 326, Financial Instruments – Credit Losses
(“ASC 326”). The provision for credit loss is based upon management’s assessment of historical and expected net collections
considering business and economic conditions and other collection indicators. We assess collectability by reviewing the accounts receivable
aging schedule on an aggregated basis where similar characteristics exist and on an individual basis when we identify specific customers
with known disputes or collectability issues. Amounts deemed uncollectible are recorded as an allowance for expected credit losses.
Revenue
and Costs of Revenue
The
Company accounts for revenue in accordance with Accounting Standards Codification Topic 606 (“ASC 606”), Revenue from
Contracts with Customers.
We
generate revenue from the initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices,
from royalties paid to the Company on the sale of various devices as provided by co-development and co-placement arrangements, and from
other recurring revenue including ongoing software updates and service contracts.
We
account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights
of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We
record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that
are remitted to government authorities.
For
contracts containing multiple products and services, the Company accounts for individual products and services as separate performance
obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package,
and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes
revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.
For
arrangements with multiple performance obligations, revenue is allocated to each performance obligation based on its relative standalone
selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services.
If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market
conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market
conditions. The Company regularly reviews standalone selling prices and updates these estimates if necessary.
Our
revenue recognition policy affects the following revenue streams in our business as follows:
Systems:
Contracts
related to the sale of systems typically contain separate obligations for the delivery of system(s), installation, service-type
warranty, and an implied obligation to provide software enhancements if and when available for one year following installation.
Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs
that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from
service-type warranties and the implied obligation to deliver software enhancements if and when available is included in Other
Recurring Revenue and is recognized ratably typically over the first year following installation of the system as the customer
receives the service-type warranty and right to software updates throughout the period. The Company’s system contracts
generally do not provide a right of return. Systems may be covered by a one-year assurance-type warranty in lieu of a service-type
warranty. Assurance-type warranty costs were less than $0.1
million for the six months ended June 30, 2024, and 2023. Revenue from system delivery and installation represented 25%
and 36%
of revenue for the six months ended June 30, 2024, and 2023, respectively.
Disposables:
Revenue
from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment,
but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type
warranty that provides for the return of defective products. Warranty costs were not material for the six months ended June 30, 2024,
and 2023. Disposable revenue represented 28% and 22% of revenue for the six months ended June 30, 2024, and 2023, respectively.
Royalty:
The
Company receives royalties on the sale of various devices as provided by co-development and co-placement arrangements with various manufacturers.
Royalty revenue represented less than 1% of revenue for the six months ended June 30, 2024, and 2023.
Other
Recurring Revenue:
Other
recurring revenue includes revenue from product maintenance plans, service-type warranties, other post warranty maintenance, and the
implied obligation to provide software enhancements if and when available for a specified period, typically one year following installation
of our systems. Revenue from services and software enhancements, service-type warranties, and the implied obligation to provide software
enhancements are deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed
on a time-and-materials basis is recognized when performed. Other recurring revenue represented 47% and 41% of revenue for the six months
ended June 30, 2024, and 2023, respectively.
The
following table summarizes the Company’s revenue for systems, disposables, and service and accessories for the six months ended
June 30, 2024, and 2023 (in thousands):
Schedule of Revenue Disaggregated by Type
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
Systems | |
$ | 240 | | |
$ | 3,313 | | |
$ | 2,852 | | |
$ | 5,134 | |
Disposables, service and accessories | |
| 4,262 | | |
| 4,546 | | |
| 8,530 | | |
| 9,273 | |
Total revenue | |
$ | 4,502 | | |
$ | 7,859 | | |
$ | 11,382 | | |
$ | 14,407 | |
Transaction
price allocated to remaining performance obligations relates to amounts allocated to products and services for which the revenue has
not yet been recognized. A significant portion of this amount relates to the Company’s systems contracts and obligations that will
be recognized as revenue in future periods. These obligations are generally satisfied within two years after contract inception but may
occasionally extend longer. Transaction price representing revenue to be earned on remaining performance obligations on system contracts
was approximately $15.3 million as of June 30, 2024. Performance obligations arising from contracts for disposables and service are generally
expected to be satisfied within one year after entering into the contract.
The
following table summarizes the Company’s contract assets and liabilities (in thousands):
Summary of Contract Assets and Liabilities
| |
June 30, 2024 | | |
December 31, 2023 | |
Contract Assets - unbilled receivables | |
$ | 116 | | |
$ | 72 | |
| |
| | | |
| | |
Customer deposits | |
$ | 1,845 | | |
$ | 2,105 | |
Product shipped, revenue deferred | |
| 1,371 | | |
| 1,413 | |
Deferred service and license fees | |
| 3,855 | | |
| 4,776 | |
Total deferred revenue | |
$ | 7,071 | | |
$ | 8,294 | |
Less: Long-term deferred revenue | |
| (2,121 | ) | |
| (1,637 | ) |
Total current deferred revenue | |
$ | 4,950 | | |
$ | 6,657 | |
The
Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference
between the revenue that was earned but not billed on service contracts and revenue from system contracts that was recognized based on
the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Customer deposits
primarily relate to future system sales but can also include deposits on disposable sales. Deferred revenue is primarily related to service
contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system
contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally
recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance
obligations are satisfied. The Company did not have any impairment losses on its contract assets for the periods presented.
Revenue
recognized for the six months ended June 30, 2024, and 2023, that was included in the deferred revenue balance at the beginning of each
reporting period was $4.3 million.
Assets
Recognized from the Costs to Obtain a Contract with a Customer
The
Company has determined that sales incentive programs for the Company’s sales team meet the requirements to be capitalized as the
Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction.
The costs capitalized as contract acquisition costs included in prepaid expenses and other assets, in the Company’s balance sheet
were $0.1 million as of June 30, 2024, and December 31, 2023. The Company did not incur any impairment losses during any of the periods
presented.
Costs
of systems revenue include direct product costs, installation labor and other costs including estimated assurance-type warranty costs,
and initial training costs, when applicable. These costs are recognized at the time of sale. Costs of disposable revenue include direct
product costs and estimated warranty costs and are recognized at the time of sale. Cost of revenue from services and license fees are
recognized when incurred.
Leasing
Arrangements
A
lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or equipment
for a period of time in exchange for consideration. The Company accounts for leases in accordance with Accounting Standards Update No.
2016-02 “Leases” (Topic 842) and all subsequent ASUs that modified Topic 842 (“ASC 842”). The Company determines
if an arrangement contains a lease at inception.
The
Company leases its facilities under operating leases. In accordance with ASC 842, operating lease agreements are recognized on the balance
sheet as a right-of-use (“ROU”) asset and a corresponding lease liability. These leases generally do not have significant
rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. Further, the leases do not contain
contingent rent provisions. Many of our leases include both lease (i.e., fixed payments including rent, taxes, and insurance costs) and
non-lease components (i.e., common-area or other maintenance costs) which are accounted for as a single lease component as we have elected
the practical expedient to group lease and non-lease components for all leases.
The
Company’s lease agreements often include one or more options to renew at the Company’s discretion. If at lease inception,
the Company considers the exercising of a renewal option to be reasonably certain, the Company will include the extended term in the
calculation of the ROU asset and lease liability. The Company elected not to include short-term leases (i.e., leases with initial terms
of twelve months or less) on the balance sheet.
The
calculated amounts of the ROU assets and lease liabilities are impacted by the length of the lease term and the discount rate used to
calculate the present value of the minimum lease payments. ASC 842 requires the use of the discount rate implicit in the lease whenever
this rate is readily determinable. As this rate is rarely determinable, the Company utilizes its incremental borrowing rate at lease
inception.
Stock-Based
Compensation
The
Company accounts for its grants of stock options, non-qualified stock options, stock appreciation rights, restricted shares, restricted
stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based
payments. These accounting principles require the determination of the fair value of the stock-based compensation at the grant date and
the recognition of the related expense over the period in which the stock-based compensation vests.
For
time-based awards, the Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation
rights at the date of grant. The weighted average assumptions and fair value for options granted during the six months ended June 30,
2024, were 1) expected dividend rate of 0%; 2) expected volatility of 76% based on the Company’s historical volatility; 3) risk-free
interest rate based on the Treasury yield on the date of grant; and 4) expected term of 6.25 years. The resulting compensation expense
is recognized over the requisite service period, which is generally four years. Restricted shares and units granted to employees and
non-employee directors are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense
over the service period, which is generally four years except for grants to directors which are generally earned over a period of six
months. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting
period and is subject to adjustment based on the actual achievement of objectives.
For
market-based awards, stock-based compensation expense is recognized over the minimum service period regardless of whether or not the
market target is probable of being achieved. The fair value of such awards is estimated on the grant date using Monte Carlo simulations.
Shares
purchased by employees under the 2022 Employee Stock Purchase Plans are considered to be non-compensatory.
Net
Loss per Common Share
Basic
earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common
shares outstanding during the period. In periods where there is net income, we apply the two-class method to calculate basic and diluted
net income (loss) per share of common stock, as our convertible preferred stock is a participating security. The two-class method is
an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available
to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as
our convertible preferred stock does not contractually participate in our losses. We compute diluted net income (loss) per common share
using net income (loss) as the “control number” in determining whether potential common shares are dilutive, after giving
consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding
during the period and potential issuance of stock upon the conversion of our convertible preferred stock issued and outstanding during
the period, except where the effect of such securities would be antidilutive.
The
following table sets forth the computation of basic and diluted EPS (in thousands except for share and per share amounts):
Schedule of Computation of Basic and Diluted Earnings Per Share
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
Net loss | |
$ | (5,833 | ) | |
$ | (4,957 | ) | |
$ | (10,340 | ) | |
$ | (10,304 | ) |
Cumulative dividend on convertible preferred stock | |
| (325 | ) | |
| (335 | ) | |
| (656 | ) | |
| (666 | ) |
Net loss attributable to common stockholders | |
$ | (6,158 | ) | |
$ | (5,292 | ) | |
$ | (10,996 | ) | |
$ | (10,970 | ) |
| |
| | | |
| | | |
| | | |
| | |
Weighted average number of common shares and equivalents: | |
| 84,570,738 | | |
| 81,049,211 | | |
| 84,025,335 | | |
| 78,787,652 | |
Basic EPS | |
$ | (0.07 | ) | |
$ | (0.07 | ) | |
$ | (0.13 | ) | |
$ | (0.14 | ) |
Diluted EPS | |
$ | (0.07 | ) | |
$ | (0.07 | ) | |
$ | (0.13 | ) | |
$ | (0.14 | ) |
The
Company did not include any portion of unearned restricted shares, outstanding options, stock appreciation rights, warrants or convertible
preferred stock in the calculation of diluted loss per common share because all such securities are anti-dilutive for all periods presented.
The application of the two-class method of computing earnings per share under general accounting principles for participating securities
is not applicable during these periods because those securities do not contractually participate in its losses.
As
of June 30, 2024, the Company had 4,103,847 shares of common stock issuable upon the exercise of outstanding options and stock appreciation
rights at a weighted average exercise price of $3.77 per share, 48,882,491 shares of our common stock issuable upon conversion of our
Series A Convertible Preferred Stock and 1,399,157 shares of unvested restricted share units. The Company had no unearned restricted
shares outstanding as of June 30, 2024.
Recently
Issued Accounting Pronouncements
In
June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial
Instruments” and also issued subsequent amendments to the initial guidance under ASU 2018-19, ASU 2019-04 and ASU 2019-05. The
standard modifies the measurement approach for credit losses on financial instruments, including trade receivables, from an incurred
loss method to a current expected credit loss method, otherwise known as “CECL.” The standard requires the measurement of
expected credit losses to be based on relevant information, including historical experience, current conditions and a forecast that is
supportable. The Company adopted the standard in the first quarter of 2023. The impact to the Company’s financial results was immaterial.
In
December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”),
which requires enhanced income tax disclosures, primarily related to the effective tax rate reconciliation and income taxes paid. The
Company does not expect a significant impact on its income tax disclosures upon adoption of the ASU which will be effective in the Company’s
year ending December 31, 2025.
3.
Financial Instruments
The
following tables summarize the Company’s cash and fair value by significant category reported as cash and cash equivalents and
restricted cash as of June 30, 2024, and December 31, 2023:
Schedule of Cash and Cash Equivalents, Restricted Cash and Investments
| |
June 30, 2024 | |
| |
Valuation | | |
Reported as: | |
(in thousands) | |
Amortized Cost | | |
Gross Unrealized Gains | | |
Gross Unrealized Losses | | |
Fair Value | | |
Cash and Cash Equivalents | | |
Restricted Cash- current | | |
Short-term Investments | | |
Restricted Cash | |
Cash | |
$ | 1,726 | | |
$ | - | | |
$ | - | | |
$ | 1,726 | | |
$ | 1,726 | | |
$ | - | | |
$ | - | | |
$ | - | |
Level 2 | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Money market funds | |
| 13,438 | | |
| - | | |
| - | | |
| 13,438 | | |
| 12,957 | | |
| 481 | | |
| - | | |
| - | |
Subtotal | |
| 13,438 | | |
| - | | |
| - | | |
| 13,438 | | |
| 12,957 | | |
| 481 | | |
| - | | |
| - | |
Total assets measured at fair value | |
$ | 15,164 | | |
$ | - | | |
$ | - | | |
$ | 15,164 | | |
$ | 14,683 | | |
$ | 481 | | |
$ | - | | |
$ | - | |
| |
December 31, 2023 | |
| |
Valuation | | |
Reported as: | |
(in thousands) | |
Amortized Cost | | |
Gross Unrealized Gains | | |
Gross Unrealized Losses | | |
Fair Value | | |
Cash and Cash Equivalents | | |
Restricted Cash- current | | |
Short-term Investments | | |
Restricted Cash | |
Cash | |
$ | 2,122 | | |
$ | - | | |
$ | - | | |
$ | 2,122 | | |
$ | 2,122 | | |
$ | - | | |
$ | - | | |
$ | - | |
Level 2 | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Money market funds | |
| 18,440 | | |
| - | | |
| - | | |
| 18,440 | | |
| 17,696 | | |
| 525 | | |
| - | | |
| 219 | |
Subtotal | |
| 18,440 | | |
| - | | |
| - | | |
| 18,440 | | |
| 17,696 | | |
| 525 | | |
| - | | |
| 219 | |
Total assets measured at fair value | |
$ | 20,562 | | |
$ | - | | |
$ | - | | |
$ | 20,562 | | |
$ | 19,818 | | |
$ | 525 | | |
$ | - | | |
$ | 219 | |
Interest
income was approximately $0.4 million and $1.1 million during the six months ended June 30, 2024, and the year ended December 31, 2023,
respectively.
As
of June 30, 2024, and December 31, 2023, the Company did not have any financial assets classified as Level 1 or Level 3 nor did the Company
have financial liabilities valued at fair value on a recurring basis.
4.
Inventories
Inventories
consist of the following (in thousands):
Schedule
of Inventories
| |
June 30, 2024 | | |
December 31, 2023 | |
Raw materials | |
$ | 6,064 | | |
$ | 5,918 | |
Work in process | |
| 1,112 | | |
| 1,034 | |
Finished goods | |
| 4,111 | | |
| 3,413 | |
Reserve for excess and obsolescence | |
| (2,003 | ) | |
| (1,939 | ) |
Total inventory | |
$ | 9,284 | | |
$ | 8,426 | |
The
reserve for excess and obsolescence primarily includes Niobe Systems and related raw materials and spare parts.
5.
Prepaid Expenses and Other Assets
Prepaid
expenses and other assets consist of the following (in thousands):
Schedule
of Prepaid Expenses and Other Assets
| |
June 30, 2024 | | |
December 31, 2023 | |
Prepaid expenses | |
$ | 297 | | |
$ | 181 | |
Prepaid commissions | |
| 97 | | |
| 110 | |
Deposits | |
| 467 | | |
| 424 | |
Other assets | |
| 97 | | |
| 98 | |
Total prepaid expenses and other assets | |
| 958 | | |
| 813 | |
Less: Noncurrent prepaid expenses and other assets | |
| (116 | ) | |
| (137 | ) |
Total current prepaid expenses and other assets | |
$ | 842 | | |
$ | 676 | |
6.
Property and Equipment
Property
and Equipment consist of the following (in thousands):
Schedule
of Property and Equipment
| |
June 30, 2024 | | |
December 31, 2023 | |
Equipment | |
$ | 4,288 | | |
$ | 4,269 | |
Leasehold improvements | |
| 2,911 | | |
| 2,911 | |
Gross property and equipment | |
| 7,199 | | |
| 7,180 | |
Less: Accumulated depreciation | |
| (4,140 | ) | |
| (3,876 | ) |
Net property and equipment | |
$ | 3,059 | | |
$ | 3,304 | |
The
Company had less than $0.1 million of property and equipment additions during the six months ended June 30, 2024, and the year ended
December 31, 2023. The additions in the current year period were for purchases
of equipment and the additions in the prior year period were associated with the buildout of the new leased space in St. Louis, Missouri.
7.
Leases
On
March 1, 2021, the Company entered into an office lease agreement (the “Lease”) with Globe Building Company (the “Landlord”),
under which the Company leases executive office space and manufacturing facilities of approximately 43,100 square feet of rentable space
located at 710 N. Tucker Boulevard, St. Louis, Missouri (the “Premises”) that serves as the Company’s principal executive
and administrative offices and manufacturing facility. Lease payments commenced on January 1, 2022, and the lease has a term of ten years,
with two renewal options of five years each. The minimum annual rent under the terms of the Lease ranges from approximately $0.8 million
in 2022 to $1.0 million in 2031.
As
of June 30, 2024, the weighted average discount rate for operating leases was 9% and the weighted average remaining lease term for operating
lease term is 7.49 years.
The
following table represents lease costs and other lease information (in thousands):
Schedule
of Lease Costs and Other Lease Information
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
Operating lease cost | |
$ | 227 | | |
$ | 227 | | |
$ | 454 | | |
$ | 454 | |
Short-term lease cost | |
| 5 | | |
| 4 | | |
| 8 | | |
| 8 | |
Total net lease cost | |
$ | 232 | | |
$ | 231 | | |
$ | 462 | | |
$ | 462 | |
| |
| | | |
| | | |
| | | |
| | |
Cash paid within operating cash flows | |
$ | 253 | | |
$ | 245 | | |
$ | 510 | | |
$ | 486 | |
Variable
lease costs consist primarily of taxes, insurance, and common area or other maintenance costs for our leased facilities and equipment
which are paid based on actual costs incurred.
Future
minimum payments for operating leases with initial or remaining terms of one year or more as of June 30, 2024, were as follows (in thousands):
Schedule
of Future Minimum Operating Lease Payments
| | |
June 30, 2024 | |
2024 | | |
$ | 449 | |
2025 | | |
| 919 | |
2026 | | |
| 935 | |
2027 | | |
| 956 | |
2028 | | |
| 976 | |
2029 and thereafter | | |
| 3,054 | |
Total lease payments | | |
| 7,289 | |
Less: Interest | | |
| (2,008 | ) |
Present value of lease liabilities | | |
$ | 5,281 | |
8.
Accrued Liabilities
Accrued
liabilities consist of the following (in thousands):
Schedule
of Accrued Liabilities
| |
June 30, 2024 | | |
December 31, 2023 | |
Accrued salaries, bonus, and benefits | |
$ | 1,230 | | |
$ | 1,222 | |
Accrued licenses and maintenance fees | |
| - | | |
| 484 | |
Accrued warranties | |
| 83 | | |
| 107 | |
Accrued professional services | |
| 176 | | |
| 138 | |
Accrued investigational sites | |
| 101 | | |
| - | |
Deferred contract obligation | |
| 1,045 | | |
| 1,045 | |
Other | |
| 117 | | |
| 19 | |
Total accrued liabilities | |
| 2,752 | | |
| 3,015 | |
Less: Long term accrued liabilities | |
| (54 | ) | |
| (43 | ) |
Total current accrued liabilities | |
$ | 2,698 | | |
$ | 2,972 | |
The
Company reversed an aged accrued regulatory fee of approximately $0.5 million during the three-month period ended June 30, 2024. The
release was recognized as a reduction of research and development expenses within the Statement of Operations.
9.
Convertible Preferred Stock and Stockholders’ Equity
The
holders of common stock are entitled to one vote for each share held and to receive dividends when and as declared by the Board of Directors
out of funds legally available for dividends, subject to the prior rights or preferences applicable to any preferred stock as may then
be outstanding. No dividends have been declared or paid as of June 30, 2024, and the Company does not presently intend to pay any cash
dividends in the foreseeable future.
Series
A Convertible Preferred Stock and Warrants
In
September 2016, the Company issued (i) 24,000 shares of Series A Convertible Preferred Stock (the “Series A Preferred Stock”),
par value $0.001 per share, with a stated value of $1,000 per share, which are convertible into shares of the Company’s common
stock at an initial conversion rate of $0.65 per share, subject to adjustment for events such as stock splits, combinations and the like
as provided in the certificate of designations covering such Series A Preferred Stock, and (ii) (the SPA Warrants) to purchase an aggregate
of 36,923,078 shares of common stock. The shares of Series A Preferred Stock are entitled to vote on an as-converted basis with the common
stock, subject to specified beneficial ownership issuance limitations. The Series A Preferred Stock bear dividends at a rate of six percent
(6%) per annum, which are cumulative and accrue daily from the date of issuance on the $1,000 stated value. Such dividends will not be
paid in cash except in connection with any liquidation, dissolution or winding up of the Company or any redemption of the Series A Preferred
Stock. Each holder of convertible preferred shares has the right to require us to redeem such holder’s shares of Series A Preferred
Stock upon the occurrence of specified events, which include certain business combinations, the sale of all or substantially all of the
Company’s assets, or the sale of more than 50% of the outstanding shares of the Company’s common stock. In addition, the
Company has the right to redeem the Series A Preferred Stock in the event of a defined change of control. The Series A Preferred Stock
ranks senior to our common stock as to distributions and payments upon the liquidation, dissolution, and winding up of the Company. Since
the Series A Preferred Stock are subject to conditions for redemption that are outside the Company’s control, the Series A Preferred
Stock are presently reported in the mezzanine section of the balance sheet.
2021
CEO Performance Award Unit Grant
On
February 23, 2021, the Company`s Board of Directors, upon recommendation of the Compensation Committee, approved the grant of the CEO
Performance Award to the Company’s Chief Executive Officer. The CEO Performance award is a 10-year performance award of up to 13,000,000
shares, tied to the achievement of market capitalization milestones and subject to minimum service requirements.
As
detailed in the table below, the CEO Performance Award consists of ten vesting tranches. The first market capitalization milestone is
$1.0 billion, and each of the remaining nine market capitalization milestones are in additional $500 million increments, up to $5.5 billion.
Summary
of Performance Award And Market Capitalization Milestones
Tranche # | | |
No. of Shares Subject to PSU | | |
Market Capitalization Milestones(1) | |
1 | | |
| 1,000,000 | | |
$ | 1,000,000,000 | |
2 | | |
| 1,500,000 | | |
$ | 1,500,000,000 | |
3 | | |
| 1,500,000 | | |
$ | 2,000,000,000 | |
4 | | |
| 2,000,000 | | |
$ | 2,500,000,000 | |
5 | | |
| 1,000,000 | | |
$ | 3,000,000,000 | |
6 | | |
| 1,000,000 | | |
$ | 3,500,000,000 | |
7 | | |
| 1,000,000 | | |
$ | 4,000,000,000 | |
8 | | |
| 2,000,000 | | |
$ | 4,500,000,000 | |
9 | | |
| 1,000,000 | | |
$ | 5,000,000,000 | |
10 | | |
| 1,000,000 | | |
$ | 5,500,000,000 | |
Total: | | |
| 13,000,000 | | |
| | |
Each
tranche represents a portion of the PSUs covering the number of shares outlined in the table above. Each tranche vests upon (i) satisfaction
of the market capitalization milestones and (ii) continued employment as CEO of the Company from the grant date through December 31,
2030. Absent an earlier termination, the PSUs will expire on December 31, 2030. If our CEO ceases employment as CEO of the Company for
any reason including death, disability, termination for cause or without cause (as defined in the award agreement), or if he voluntary
terminates after service as CEO for at least five years, the remaining service period will be waived and he will retain any PSUs that
have vested through the date of termination.
The
Company received Shareholder approval at its annual meeting on May 20, 2021, for shares to be issued under the award.
The
market capitalization requirement is considered a market condition under FASB Accounting Standards Codification Topic 718 “Compensation
– Stock Compensation” and is estimated on the grant date using Monte Carlo simulations. Recognition of stock-based compensation
expense of all the tranches commenced on February 23, 2021, the date of grant, as the probability of meeting the ten market capitalization
milestones is not considered in determining the timing of expense recognition. The expense will be recognized on an accelerated basis
through 2030. Key assumptions for estimating the performance-based awards fair value at the date of grant included share price on grant
date, volatility of the Company’s common stock price, risk free interest rate, and grant term.
Total
stock-based compensation recorded as operating expense for the CEO Performance Award was $3.6 million and $3.5 million for the six months
ended June 30, 2024, and 2023. As of June 30, 2024, and 2023, the Company had approximately $33.4 million and $40.6 million, respectively,
of total unrecognized stock-based compensation expense remaining under the CEO Performance Award assuming the grantee’s continued
employment as CEO of the Company, or in a similar capacity, through 2030. As of June 30, 2024, none of the performance milestones established
by the 2021 CEO Incentive Program have been achieved, and no awards have been earned.
Stock
Award Plans
In
February 2022, the Compensation Committee of the Board of Directors adopted the 2022 Stock Incentive Plan (the “Plan”) which
was subsequently approved by the Company’s shareholders. This plan replaced the 2012 Stock Incentive Plan which expired on May
19, 2022. The 2022 Stock Incentive Plan allows for the grant of incentive stock options, non-qualified stock options, stock appreciation
rights, restricted shares and restricted share units to employees, non-employee directors, and third-party consultants.
At
June 30, 2024, the Company had 5,633,730 remaining shares of the Company’s common stock to provide for current and future grants
under its various equity plans.
At
June 30, 2024, the total compensation cost related to options and non-vested stock granted to employees and non-employees under the Company’s
stock award plans but not yet recognized was approximately $3.6 million, excluding compensation not yet recognized related to the CEO
Performance Award discussed above. This cost will be amortized over a period of up to four years over the underlying estimated service
periods and will be adjusted for subsequent changes in actual forfeitures and anticipated vesting periods.
A
summary of the option and stock appreciation rights activity for the six-month period ended June 30, 2024, is as follows:
Summary
of Option and Stock Appreciation Rights Activity
| |
Number of Options/SARs | | |
Range of Exercise Price | | |
Weighted Average Exercise Price per Share | |
Outstanding, December 31, 2023 | |
| 3,650,115 | | |
| $0.74 - $9.87 | | |
$ | 3.93 | |
Granted | |
| 716,500 | | |
| $2.45 - $3.01 | | |
$ | 3.00 | |
Exercised | |
| (11,763 | ) | |
| $0.74 - $2.57 | | |
$ | 1.02 | |
Forfeited | |
| (251,005 | ) | |
| $0.74 - $9.20 | | |
$ | 3.99 | |
Outstanding, June 30, 2024 | |
| 4,103,847 | | |
| $0.74 - $9.87 | | |
$ | 3.77 | |
A
summary of the restricted stock unit activity for the six-month period ended June 30, 2024, is as follows:
Schedule
of Restricted Stock Unit Activity
| |
Number of Restricted Stock Units | | |
Weighted Average Grant Date Fair Value per Unit | |
Outstanding, December 31, 2023 | |
| 1,502,131 | | |
$ | 3.94 | |
Granted | |
| 389,610 | | |
$ | 1.54 | |
Vested | |
| (492,584 | ) | |
$ | 3.03 | |
Outstanding, June 30, 2024 | |
| 1,399,157 | | |
$ | 3.60 | |
10.
Product Warranty Provisions
The
Company’s standard policy is to warrant all capital systems against defects in material or workmanship for one year following
installation with an assurance or a service-type warranty. The Company’s estimate of costs to service the warranty obligations is based on historical experience and
current product performance trends. A regular review of warranty obligations is performed to determine the adequacy of the reserve
and adjustments are made to the estimated warranty liability as appropriate.
Accrued
assurance-type warranty, which is included in other accrued liabilities, consists of the following (in thousands):
Schedule
of Accrued Warranty
| |
June 30, 2024 | | |
December 31, 2023 | |
Warranty accrual, beginning of the fiscal period | |
$ | 107 | | |
$ | 163 | |
Accrual adjustment for product warranty | |
| (8 | ) | |
| 547 | |
Payments made | |
| (16 | ) | |
| (603 | ) |
Warranty accrual, end of the fiscal period | |
$ | 83 | | |
$ | 107 | |
11.
Commitments and Contingencies
The
Company at times becomes a party to claims in the ordinary course of business. Management believes that the ultimate resolution of pending
or threatened proceedings will not have a material effect on the financial position, results of operations or liquidity of the Company.
In February 2024, a vendor filed financing statements under the Uniform Commercial Code (“UCC”) on underlying inventory for
approximately $0.6 million. We believe the financing statements were filed without merit, and we are fully contesting the propriety
of such actions.
In
April 2021, the Company entered into a letter of credit pursuant to the Lease agreement totaling approximately $1.8 million to be delivered
in four equal installments of which the first was delivered in April 2021, the second was delivered in July 2021, the third was delivered
in October 2021, and the fourth was delivered in January 2022. The amount available under this letter of credit automatically reduces
by one fortieth at the end of each month during the lease term.
12.
Subsequent Events
On
July 31, 2024, the Company completed its previously announced acquisition of all the shares of capital stock of Access Point Technologies
EP, Inc., a Minnesota corporation (“APT”), from APT Holding Company, Inc., a Minnesota corporation, pursuant to that certain
Share Purchase Agreement, dated May 11, 2024.
APT,
based in Rogers, Minnesota, designs, manufactures, and commercializes a portfolio of differentiated high-quality diagnostic catheters
used during cardiac ablation procedures that are commercially available across key global geographies.
At
closing, the Company issued 1,486,620 shares of its common stock.
ITEM
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The
following discussion and analysis should be read in conjunction with our financial statements and notes thereto included in this Quarterly
Report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2023. Operating results are not necessarily
indicative of results that may occur in future periods.
This
report includes various forward-looking statements that are subject to risks and uncertainties, many of which are beyond our
control. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of
various factors, including those set forth in “Part II - Item 1A. Risk Factors” included in this Quarterly Report on
Form 10-Q and in Part I, Item 1A, “Risk Factors,” included in our Annual Report on Form 10-K for the year ended December
31,2023, as well as various impacts related to our previously announced acquisition of Access Point Technologies, Inc.
(“APT”). Forward-looking statements discuss matters that are not historical facts. Forward-looking statements include,
but are not limited to, discussions regarding our operating strategy, sales and marketing strategy, regulatory strategy, industry,
economic conditions, financial condition, liquidity, capital resources, results of operations, the on-going impact of the
coronavirus (“COVID -19”) pandemic and our response to it or any impact of a similar pandemic, and
statements relating to our recent acquisition of APT including any benefits expected from the acquisition, potential strategic
implications as a result of the acquisition, and the potential for achievement of the regulatory and commercial milestones that
would trigger contingent payments in the transaction. Such statements include, but are not limited to, statements preceded by,
followed by, or that otherwise include the words “believe”, “expects”, “anticipates”,
“intends”, “estimates”, “projects”, “can”, “could”, “may”,
“would”, or similar expressions. For those statements, we claim the protection of the safe harbor for forward-looking
statements contained in the Private Securities Litigation Reform Act of 1995. You should not unduly rely on these forward-looking
statements, which speak only as of the date on which they are made. They give our expectations regarding the future but are not
guarantees. We undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new
information, future events or otherwise, unless required by law.
Overview
Stereotaxis
designs, manufactures and markets robotic systems, instruments and information systems for the interventional laboratory. Our proprietary
robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled
magnetic fields to directly control the tip of flexible interventional catheters or devices. Direct control of the tip of an interventional
device, in contrast to all manual hand-held devices that are controlled from their handle, can improve the precision, stability, reach
and safety of these devices during procedures.
Our
primary clinical focus has been electrophysiology, specifically cardiac ablation procedures for the treatment of arrhythmias. Cardiac
ablation has become a well-accepted therapy for arrhythmias and a multi-billion-dollar medical device market with expectations for substantial
long-term growth. Our product strategy is to expand the clinical focus of our technology to several additional endovascular indications
including coronary, neuro, and peripheral interventions.
There
is substantial real-world evidence and clinical literature for Robotic Magnetic Navigation in electrophysiology. Hundreds of electrophysiologists
at over one hundred hospitals globally have treated over 100,000 arrhythmia patients with our robotic technology. Clinical use of our
technology has been documented in over 500 clinical publications. Robotic Magnetic Navigation is designed to enable physicians to complete
more complex interventional procedures with greater success and safety by providing image-guided delivery of catheters through the blood
vessels and chambers of the heart to treatment sites. This is achieved using externally applied computer-controlled magnetic fields that
govern the motion of the working tip of the catheter, resulting in improved navigation. The more flexible atraumatic design of catheters
driven using magnetic fields may reduce the risk of patient harm and other adverse events. Performing the procedure from a control cockpit
enables physicians to complete procedures in a safe location protected from x-ray exposure, with greater ergonomics, and improved efficiency.
We believe these benefits can be applicable in other endovascular indications where navigation through complex vasculature is often challenging
or unsuccessful and generates significant x-ray exposure, and we are investing in research and development in these areas.
Our
primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through our strategic
relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties,
we offer our customers magnetically compatible x-ray systems and other accessory devices.
The
Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided
delivery of catheters through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied
magnetic fields that govern the motion of the working tip of the catheter, resulting in improved navigation, efficient procedures, and
reduced x-ray exposure.
The
Odyssey Solution consolidates lab information onto one large integrated display, enabling physicians to view and control all the
key information in the operating room. This is designed to improve lab layout and procedure efficiency. The system also features a remote
viewing and recording capability called Odyssey Cinema, which is an innovative solution that delivers synchronized content for
optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store
and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local
area network and over the global Odyssey Network providing physicians with a tool for clinical collaboration, remote consultation, and
training.
We
have arrangements with fluoroscopy system manufacturers to provide such systems in a bundled purchase offer for hospitals establishing
robotic interventional operating rooms. These are single-plane, full-power x-ray systems and include the c-arm and powered table. The
combination of RMN Systems with our partnered x-ray systems reduces the cost of acquisition, the ongoing cost of ownership, and the complexity
of installation of a robotic electrophysiology practice.
We
promote our full suite of products in a typical hospital implementation, subject to regulatory approvals or clearances. This implementation
requires a hospital to agree to an upfront capital payment and recurring payments. The upfront capital payment typically includes equipment
and installation charges. The recurring payments typically include disposable costs for each procedure, equipment service costs beyond
the warranty period, and ongoing software updates. In hospitals where our full suite of products has not been implemented, equipment
upgrade or expansion can be implemented upon purchasing of the necessary upgrade or expansion.
We
have received regulatory clearances and approvals necessary for us to market the Genesis RMN System in the U.S. and Europe, and
we are in the process of obtaining necessary registrations for extending our markets in other countries. The Niobe System, our
prior generation robotic magnetic navigation system, the Odyssey Solution, Cardiodrive, e-Contact, and various disposable
interventional devices have received regulatory clearances and approvals in the U.S., Europe, Canada, China, Japan and various other
countries. We have regulatory clearances and approvals that allow us to market the Vdrive and Vdrive Duo Systems with the
V-CAS device in the U.S., Canada and Europe. We are pursuing regulatory approvals for the Stereotaxis MAGiC catheter, a robotically-navigated
magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures, in various global geographies. Approval
processes can be lengthy and uncertain, submissions may require revised or additional non-clinical and clinical data, and regulatory
applications could be denied.
We
have strategic relationships with technology leaders and innovators in the global interventional market. Through these strategic relationships
we provide compatibility between our robotic magnetic navigation system, x-ray systems, and digital imaging and 3D catheter location
sensing technology, as well as disposable interventional devices. The maintenance of these strategic relationships, or the establishment
of equivalent alternatives, is critical to our commercialization efforts. There are no guarantees that any existing strategic relationships
will continue, and efforts are ongoing to ensure the availability of compatible systems and devices and/or equivalent alternatives. We
cannot provide assurance as to the timeline of the ongoing availability of such compatible systems or our ability to obtain equivalent
alternatives on competitive terms or at all.
Corporate
Developments
On
July 31, 2024, the Company completed its previously announced acquisition of all the shares of capital stock of Access Point Technologies
EP, Inc., a Minnesota corporation (“APT”), from APT Holding Company, Inc., a Minnesota corporation, pursuant to that certain
Share Purchase Agreement, dated May 11, 2024. All consideration is payable in Stereotaxis common stock.
APT,
based in Rogers, Minnesota, designs, manufactures, and commercializes a portfolio of differentiated high-quality diagnostic catheters
used during cardiac ablation procedures that are commercially available across key global geographies. The acquisition provides Stereotaxis with high-quality catheter development and manufacturing capabilities which will further advance
the Company’s goals of advancing the treatment of complex arrhythmias and the broad adoption of robotics within endovascular surgery.
The transaction consideration included an upfront payment of 1,486,620 shares of Company common stock issued at closing, as well as additional
contingent payments of Company common stock based upon the achievement of specified product revenue and regulatory approval milestones
through September 30, 2029.
Risks
and Uncertainties
Future
results of operations could be materially adversely impacted by macroeconomic and geopolitical factors. The Company continues to experience
difficulties with periodic worldwide supply chain disruptions, including shortages and inflationary pressures, and logistics delays which
make it difficult for us to source parts and ship our products. We have generally been able to conduct normal business activities albeit
in a more deliberate manner than prior to the pandemic, including taking action to increase inventory levels and engaging in discussions
with our vendors on contractual obligations, but we cannot guarantee that they will not be impacted more severely in the future. Our
suppliers and contract manufacturers have experienced, and may continue to experience, similar difficulties. If our manufacturing operations
or supply chains are materially interrupted, it may not be possible for us to timely manufacture or service our products at required
levels, or at all. Changes in economic conditions and supply chain constraints could lead to higher inflation than previously experienced
or expected, which could, in turn, lead to an increase in costs. We may be unable to raise the prices of our products sufficiently to
keep up with the rate of inflation. A material reduction or interruption in any of our manufacturing processes or a substantial increase
in costs would have a material adverse effect on our business, operating results, and financial condition.
Many
of our hospital customers, for whom the purchase of our system involves a significant capital purchase which may be part of a larger
construction project at the customer site (typically the construction of a new building), may themselves be under economic pressures.
Hospitals continue to experience challenges with staffing and cost pressures as supply chain constraints and inflation drive up operating
costs. This may cause delays or cancellations of current purchase orders and other commitments and may exacerbate the long and variable
sales and installation cycles for our robotic magnetic navigation systems. Our hospital customers have also experienced challenges in
sourcing supplies, such as catheters, needed to perform procedures. Such shortages have, and may continue to, put pressure on procedures
and our disposable revenue.
Any
disruption to the capital markets could negatively impact our ability to raise capital. If the capital markets are disrupted for an extended
period of time and we need to raise additional capital, such capital may not be available on acceptable terms, or at all. Disruptions
to the capital markets and other financing sources could also negatively impact our hospital customers’ ability to raise capital
or otherwise obtain financing to fund their operations and capital projects. Such could result in delayed spending on current projects,
a longer sales cycle for new projects where a large capital commitment is required, and decreased demand for our disposable products
as well as an increased risk of customer defaults or delays in payments for our system installations, service contracts and disposable
products.
In
addition to the aforementioned macroeconomic factors, the COVID-19 pandemic negatively affected, and any resurgence of a variant of COVID-19
or any similar occurrences may in the future negatively affect demand for both our systems and our disposable products. In the past,
we have experienced business disruptions, including travel restrictions on us and our third-party distributors, which negatively affected
our complex sales, marketing, installation, distribution and service network relating to our products and services. We also experienced
reductions in demand for our disposable products as our healthcare customers (physicians and hospitals) re-prioritized the treatment
of patients and diverted resources away from non-coronavirus areas, leading to the performance of fewer procedures in which our disposable
products are used. Significant decreases to our capital or recurring revenues could have a material adverse effect on our business, operating
results, and financial condition. While we cannot reliably estimate the ultimate duration of the impact or the severity of ongoing periodic
resurgences of pandemic-related issues, we continue to anticipate periodic disruptions to our manufacturing operations, supply chains,
procedures volumes, service activities, and capital system orders and placements, any of which could have a material adverse effect on
our business, financial condition, results of operations, or cash flows. The impact has varied widely over time by individual geography.
Concentration
of Credit Risk
Financial
instruments that potentially subject the Company to concentration of credit risk consist of cash, cash equivalents and marketable securities.
Our investments may include, at any time, a diversified portfolio of cash equivalents and short- and long-term investments in a variety
of high-quality securities, including money market funds, U.S. treasury and U.S. government agency securities, corporate notes and bonds,
commercial paper, non-U.S. government agency securities, and municipal notes. The Company’s exposure to any individual corporate
entity is limited by policy. Deposits may exceed federally insured limits, and the Company is exposed to credit risk on deposits in the
event of default by the financial institutions to the extent account balances exceed the amount insured by the Federal Deposit Insurance
Corporation (FDIC). The Company closely monitors events involving limited liquidity, defaults, non-performance or other adverse developments
that affect financial institutions or other companies in the financial services industry or the financial services industry generally,
including Silicon Valley Bank. On March 10, 2023, Silicon Valley Bank (“SVB”), where the Company maintained accounts with
a cash balance of less than 6% of the Company’s total cash, cash equivalents and marketable securities, was closed by the California
Department of Financial Protection and Innovation and the FDIC was appointed as receiver. On March 12, 2023, the U.S. Department of the
Treasury, Federal Reserve Board, and FDIC released a joint statement announcing that the FDIC would complete its resolution of SVB in
a manner that fully protected all depositors at SVB and that depositors would have access to all of their money starting March 13, 2023.
On March 26, 2023, it was announced that First-Citizens Bank & Trust Company would assume all of SVB’s deposits and loans as
of March 27, 2023. During the periods presented, the Company has not experienced any losses on its deposits of cash, cash equivalents
or marketable securities.
Critical
Accounting Policies and Estimates
Our
discussion and analysis of our financial condition and results of operations are based on our financial statements, which have been prepared
in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates
and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures. We review our
estimates and judgments on an on-going basis. We base our estimates and judgments on historical experience and on various other assumptions
that we believe to be reasonable under the circumstances. Actual results may differ from these estimates. We believe the following accounting
policies are critical to the judgments and estimates we use in preparing our financial statements. For a complete listing of our critical
accounting policies, please refer to our Annual Report on Form 10-K for the year ended December 31, 2023.
Revenue
Recognition
We
generate revenue from the initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices,
from royalties paid to the Company on the sale of various devices as provided by co-development and co-placement arrangements, and from
other recurring revenue including ongoing software updates and service contracts.
In
accordance with Accounting Standards Codification Topic 606 (“ASC 606”), “Revenue from Contracts with Customers,”
we account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights
of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We
record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that
are remitted to government authorities.
For
contracts containing multiple products and services the Company accounts for individual products and services as separate performance
obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package,
and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes
revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.
For
arrangements with multiple performance obligations, revenue is allocated to each performance obligation based on its relative standalone
selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services.
If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market
conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market
conditions. The Company regularly reviews standalone selling prices and updates these estimates as necessary.
Systems:
Contracts
related to the sale of systems typically contain separate obligations for the delivery of system(s), installation, service-type
warranty, and an implied obligation to provide software enhancements if and when available for one year following installation.
Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs
that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from
service-type warranties and the implied obligation to deliver software enhancements if and when available is included in Other
Recurring Revenue and is recognized ratably typically over the first year following installation of the system as the customer
receives the service-type warranty and right to software updates throughout the period. The Company’s system contracts
generally do not provide a right of return. Systems may be covered by a one-year assurance-type warranty in lieu of a service-type warranty. Assurance-type warranty costs were less than $0.1 million for the six months ended June 30, 2024,
and 2023.
Disposables:
Revenue
from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment,
but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type
warranty that provides for the return of defective products. Warranty costs were not material for the six months ended June 30, 2024,
and 2023.
Royalty:
The
Company receives royalties on the sale of various devices as provided by co-development and co-placement arrangements with various manufacturers.
Other
Recurring Revenue:
Other
recurring revenue includes revenue from product maintenance plans, service-type warranties, other post warranty maintenance, and the
implied obligation to provide software enhancements if and when available for a specified period, typically one year following installation
of our systems. Revenue from services and software enhancements, service-type warranties, and the implied obligation to provide software
enhancements are deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed
on a time-and-materials basis is recognized when performed.
The
Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference
between the revenue that was recognized based on the relative selling price of the related performance obligations and the contractual
billing terms in the arrangements. Customer deposits primarily relate to future system sales but can also include deposits on disposable
sales. Deferred revenue is primarily related to service contracts, for which the service fees are billed up-front, generally quarterly
or annually, and for amounts billed in advance for system contracts for which some performance obligations remain outstanding. For service
contracts, the associated deferred revenue is generally recognized ratably over the service period. For system contracts, the associated
deferred revenue is recognized when the remaining performance obligations are satisfied. See Note 2 for additional detail on deferred
revenue. The Company did not have any impairment losses on its contract assets for the periods presented.
Assets
Recognized from the Costs to Obtain a Contract with a Customer
The
Company has determined that sales incentive programs for the Company’s sales team meet the requirements to be capitalized as the
Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction.
The costs capitalized as contract acquisition costs included in prepaid expenses and other assets in the Company’s balance sheets
were $0.1 million as of June 30, 2024, and December 31, 2023. The Company did not incur any impairment losses during any of the periods
presented.
Cost
of Contracts
Costs
of systems revenue include direct product costs, installation labor and other costs including estimated assurance-type warranty costs
and initial training costs, when applicable. These costs are recognized at the time of sale. Costs of disposable revenue include direct
product costs and estimated warranty costs and are recognized at the time of sale. Cost of revenue from services and license fees are
recognized when incurred.
Stock-Based
Compensation
Stock
compensation expense, which is a non-cash charge, results from stock option, non-qualified stock options, stock appreciation rights,
and restricted share grants made to employees, non-employee directors, and third-party consultants at the fair value of the grants. For
time-based awards, the fair value of options and stock appreciation rights granted was determined using the Black-Scholes valuation method
which gives consideration to the estimated value of the underlying stock at the date of grant, the exercise price of the option, the
expected dividend yield and volatility of the underlying stock, the expected life of the option and the corresponding risk-free interest
rate. The fair value of the grants of restricted shares and units was determined based on the closing price of our stock on the date
of grant. Stock compensation expense for options, stock appreciation rights and for time-based restricted share grants and units is amortized
on a straight-line basis over the vesting period of the underlying issue, generally over four years except for grants to non-employee
directors which are generally earned over a period of six months. Stock compensation expense for performance-based restricted shares,
if any, is amortized on a straight-line basis over the anticipated vesting period and is subject to adjustment based on the actual achievement
of objectives. Compensation expense is recognized only for those options expected to vest, net of actual forfeitures. Estimates of the
expected life of options have been based on the average of the vesting and expiration periods, which is the simplified method under general
accounting principles for share-based payments. Estimates of volatility utilized in calculating stock-based compensation have been prepared
based on historical data. Actual experience to date has been consistent with these estimates.
For
market-based awards, stock-based compensation expense is recognized over the minimum service period regardless of whether or not the
market target is probable of being achieved. The fair value of such awards is estimated on the grant date using Monte Carlo simulations.
The
amount of compensation expense to be recorded in future periods may increase if we make additional grants of options, stock appreciation
rights or restricted shares. The amount of expense to be recorded in future periods may decrease if the requisite service periods are
not completed.
Results
of Operations
Comparison
of the Three Months Ended June 30, 2024 and 2023
Revenue.
Revenue decreased from $7.9 million for the three months ended June 30, 2023, to $4.5 million for the three months ended June 30, 2024,
a decrease of 43%. Revenue from the sales of systems decreased to $0.2 million for the three months ended June 30, 2024, from $3.3 million
for the three months ended June 30, 2023, driven by decreased system sales volumes in the current year period. Revenue from sales of
disposable interventional devices, service, and accessories decreased to approximately $4.3 million for the three months ended June 30,
2024, from $4.6 million for the three months ended June 30, 2023, a decrease of approximately 6%. The decrease was primarily driven by
decreased service revenue in the current year period.
Cost
of Revenue. Cost of revenue decreased from $3.7 million for the three months ended June 30, 2023, to $1.2 million for the three months
ended June 30, 2024, a decrease of approximately 68%. As a percentage of our total revenue, overall gross margin increased to 74% for
the three months ended June 30, 2024, from 53% for the three months ended June 30, 2023, primarily due to changes in product mix. Cost
of revenue for systems sold decreased from $2.7 million for the three months ended June 30, 2023, to $0.2 million for the three months
ended June 30, 2024, driven by decreased system sales volumes in the current year period. Gross margin for systems was $0.6 million for
the three months ended June 30, 2023, compared to less than $0.1 million for the three months ended June 30, 2024. Cost of revenue for
disposables, service, and accessories remained consistent at $1.0 million for the three months ended June 30, 2023, and 2024. Gross margin
for disposables, service, and accessories was 76% for the three months ended June 30, 2024, compared to 79% for the three months ended
June 30, 2023. The decrease was driven primarily by decreased service revenue in the current year period.
Research
and Development Expenses. Research and development expenses decreased from $2.6 million for the three months ended June 30,
2023, to $2.3 million for the three months ended June 30, 2024, a decrease of approximately 14%. This decrease was primarily driven
by the reversal of an accrued regulatory license fee of approximately $0.5 million and decreased headcount costs offset slightly by
project timing, including regulatory fees, in the current year period.
Sales
and Marketing Expenses. Sales and marketing expenses remained consistent at $3.3 million for the three months ended June 30, 2023,
and 2024.
General
and Administrative Expenses. General and administrative expenses include finance, information systems, legal, and general management.
General and administrative expenses increased from $3.5 million for the three months ended June 30, 2023, to $3.8 million for the three
months ended June 30, 2024, an increase of approximately 8%. This increase was primarily driven by higher administrative expenses and
professional service fees in the current period.
Interest
Income (Expense). Net interest income was approximately $0.3 million for the three months ended June 30, 2023, compared to $0.2 million
for the three months ended June 30, 2024. The decrease was driven by lower invested balances in the current year period.
Comparison
of the Six Months Ended June 30, 2024 and 2023
Revenue.
Revenue decreased from $14.4 million for the six months ended June 30, 2023, to $11.4 million for the six months ended June 30, 2024,
a decrease of approximately 21%. Revenue from the sales of systems decreased from $5.1 million for the six months ended June 30, 2023,
to $2.9 million for the six months ended June 30, 2024, driven by decreased system sales volumes in the current year period. Revenue
from sales of disposable interventional devices, service and accessories decreased to $8.5 million for the six months ended June 30,
2024, from $9.3 million for the six months ended June 30, 2023, a decrease of approximately 8%. The decrease was primarily driven by
decreased service revenue in the current year period.
Cost
of Revenue. Cost of revenue decreased from $6.3 million for the six months ended June 30, 2023, to $4.1 million for the six months
ended June 30, 2024, a decrease of approximately 35%. As a percentage of our total revenue, overall gross margin increased to 64% for
the six months ended June 30, 2024, from 56% for the six months ended June 30, 2023, primarily due to changes in product mix. Cost of
revenue for systems sold decreased from $4.4 million for the six months ended June 30, 2023, to $2.1 million for the six months ended
June 30, 2024, driven by decreased system sales volumes in the current year period. Gross margin for systems was $0.7 million for the
six months ended June 30, 2023, compared to $0.8 million for the six months ended June 30, 2024. Cost of revenue for disposables, service,
and accessories increased from $1.9 million for the six months ended June 30, 2023, to $2.0 million for the six months ended June 30,
2024, driven by higher expenses incurred under service contracts in the current period. Gross margin for disposables, service and accessories
was 79% for the six months ended June 30, 2023, compared to 76% for the six months ended June 30, 2024. The decrease was driven primarily
by decreased service revenue in the current year period.
Research
and Development Expenses. Research and development expenses decreased from $5.4 million for the six months ended June 30, 2023,
compared to $4.5 million for the six months ended June 30, 2024, a decrease of 16%. This decrease was primarily driven by the
reversal of an accrued regulatory license fee of approximately $0.5 million and decreased headcount costs in the current year
period.
Sales
and Marketing Expenses. Sales and marketing expenses decreased from $6.5 million for the six months ended June 30, 2023, to $6.3
million for the six months ended June 30, 2024, a decrease of approximately 3%. This decrease was primarily due to lower headcount expenses
in the current year period.
General
and Administrative Expenses. General and administrative expenses include finance, information systems, legal, and general management.
General and administrative expenses increased from $7.1 million for the six months ended June 30, 2023, to $7.2 million for the six months
ended June 30, 2024, an increase of approximately 2%. This increase was primarily driven by higher administrative expenses and professional
service fees in the current period.
Interest
Income (Expense). Net interest income was approximately $0.6 million for the six months ended June 30, 2023, compared to $0.4 million
for the six months ended June 30, 2024. The decrease was driven by lower invested balances in the current year period.
Liquidity
and Capital Resources
Liquidity
refers to the liquid financial assets available to fund our business operations and pay for near-term obligations. These liquid financial
assets consist of cash, cash equivalents, and investments.
As
of June 30, 2024, we had $15.2 million of cash and cash equivalents, inclusive of restricted cash. We had working capital of $15.8 million
as of June 30, 2024, compared to $20.0 million as of December 31, 2023.
The
following table summarizes our cash flow by operating, investing and financing activities for the six months ended June 30, 2024, and
2023 (in thousands):
| |
Six Months Ended June 30, | |
| |
2024 | | |
2023 | |
Cash flow used in operating activities | |
$ | (5,434 | ) | |
$ | (5,733 | ) |
Cash flow (used in) provided by investing activities | |
| (22 | ) | |
| 19,775 | |
Cash flow provided by financing activities | |
| 58 | | |
| 30 | |
Net
cash used in operating activities. We used approximately $5.4 million and $5.7 million of cash for operating activities during the
six months ended June 30, 2024, and 2023, respectively. The decrease in cash used in operating activities was driven by changes in working capital.
Net
cash (used in) provided by investing activities. We used less than $0.1 million and generated approximately $19.8
million of cash during the six months ended June 30, 2024, and 2023, respectively. The cash used during the six months ended June
30, 2024, was for the purchase of equipment. The cash generated during the six months ended June 30, 2023, was from proceeds
received from the maturity of short-term investments.
Net
cash provided by financing activities. We generated less than $0.1 million of cash from financing
activities during the six months ended June 30, 2024, and 2023. The cash generated in both periods was driven by the proceeds from issuance
of stock from the exercise of options, net of issuance costs, and from our employee stock purchase program.
Capital
Resources
As
of June 30, 2024, the Company did not have any debt.
Off-Balance
Sheet Arrangements
We
do not currently have, nor have we ever had, any relationships with unconsolidated entities or financial partnerships, such as entities
often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating
off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not engage in trading activities
involving non-exchange traded contracts. As a result, we are not materially exposed to any financing, liquidity, market, or credit risk
that could have arisen if we had engaged in these relationships.
ITEM
3. [RESERVED]
None.
ITEM
4. CONTROLS AND PROCEDURES
Disclosure
Controls and Procedures: The Company’s management, with the participation of the Company’s Chief Executive Officer and
Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined
in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end
of the period covered by this report. Any controls and procedures, no matter how well designed and operated, can provide only reasonable
assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit
relationship of possible controls and procedures. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial
Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective.
Changes
In Internal Control Over Financial Reporting: The Company’s management, with the participation of the Company’s Chief
Executive Officer and Chief Financial Officer, also conducted an evaluation of the Company’s internal control over financial reporting
to determine whether any changes occurred during the period covered by this report that have materially affected, or are reasonably likely
to materially affect, the Company’s internal control over financial reporting. Based on that evaluation, there has been no such
change during the period covered by this report.
PART
II – OTHER INFORMATION
ITEM
1. LEGAL PROCEEDINGS
None.
ITEM
1A. RISK FACTORS
Risks
Related to our Recently Completed Acquisition of APT
We
may be unable to successfully integrate APT into our business and may fail to realize any or all of the anticipated benefits of the acquisition,
or those benefits may take longer to realize than expected.
Prior
to the completion of our acquisition of APT, both companies previously operated independently and manufactured different products. The
success of the acquisition will depend, in part, on our ability to (i) successfully integrate APT’s businesses into Stereotaxis,
(ii) successfully manufacture, commercialize, develop and sell APT’s catheters and related products, and (iii) realize the anticipated
benefits, including synergies, cost savings, innovation opportunities and operational efficiencies, from the acquisition, all in a manner
that does not materially disrupt existing customer, supplier and employee relations. If we are unable to achieve these objectives within
the anticipated time frame, or at all, the anticipated benefits may not be realized fully or at all, or may take longer to realize than
expected, and the value of our common stock may decline.
The
integration of APT into our business may result in material challenges, including, without limitation:
|
● |
the
diversion of management’s attention from ongoing business concerns; |
|
● |
developing
and managing internal financial and disclosure processes at APT, which has been a private company not subject to SEC reporting obligations; |
|
● |
managing
a more complex combined business; |
|
● |
expanding
operations to manufacture APT’s catheter products and overcoming our lack of manufacturing experience related to such products; |
|
● |
maintaining
employee morale, retaining key APT employees and the possibility that the integration process and organizational changes may adversely
impact the ability to maintain employee relationships; |
|
● |
transitioning
and maintaining business and operational relationships of APT, including suppliers, collaboration partners, employees and other counterparties; |
|
● |
risks
related to APT’s existing customer contracts and disputes with customers; |
|
● |
the
integration process not proceeding as expected, including due to a possibility of faulty assumptions or expectations regarding the
integration process or APT’s operations; |
|
● |
risks
related to litigation, disputes, investigations or other events that could increase our expenses, result in liability or require
that we take other action; |
|
● |
consolidating
corporate, administrative and compliance infrastructures and eliminating duplicative operations; |
|
● |
coordinating
geographically separate locations; |
|
● |
unanticipated
issues in integrating information technology, communications and other systems; and |
|
● |
unforeseen
expenses, costs, liabilities or delays associated with the acquisition or the integration. |
Many
of these factors are outside of our control, and any one of them could result in delays, increased costs, decreases in the amount of
expected cost savings or synergies and diversion of management’s time and energy, which could materially affect our financial position,
results of operations and cash flows.
Our
future results may be adversely impacted if we do not effectively manage APT’s catheter manufacturing business following the completion
of the acquisition.
As
a result of the acquisition, we will be managing APT’s ongoing business of manufacturing, commercializing, development and
sales of APT’s catheters and related products and services. The manufacturing process of catheters is complex, highly
technical, and our prior experience in this field is dated. The process can be subject to periodic worldwide supply chain
disruptions, including labor shortages and inflationary pressures, and logistics delays which make it difficult for us to source
parts and ship our products. We may require a higher level of overhead than currently anticipated. Our ability to successfully
manage this new aspect of our business will depend, in part, upon management’s ability to design and implement strategic
initiatives that address not only the integration of APT into us, but also the increased scope of the combined business with its
associated increased costs and complexity. There can be no assurances that we will be successful in manufacturing catheter products
or that we will realize the expected operating efficiencies, cost savings and other benefits anticipated from the
acquisition.
The
issuance of the Earnout Consideration will result in dilution to our stockholders and may adversely affect us, including the market price
of our securities.
At
the closing of the acquisition of APT on July 31, 2024, we issued 1,486,620 shares (the “Upfront Stock Consideration”) to
the APT Holding Company, Inc. (the “Seller”). In addition, the Purchase Agreement requires us to issue additional shares
(the “Additional Earnout Shares”) to the Seller upon achievement of the revenue and regulatory approval milestones. We are
required to file a resale registration statement relating to the Upfront Stock Consideration and Additional Earnout Shares and anticipate
it will cover an aggregate of approximately 6.1 million shares, which includes an estimated 4,613,380
Additional Earnout Shares. However, the actual number of Additional Earnout Shares issued to the Seller could be materially greater
or less than the number we currently estimate, depending whether and to what extent the
future revenue milestones are met and/or regulatory approvals are obtained, as well as the
actual average closing price of our Common Stock calculated pursuant to a formula near the time such milestones are achieved. If such
Additional Earnout Shares are issued under the Purchase Agreement, there will be significant additional dilution to the Company’s
stockholders, and even in the event that the Additional Earnout Shares are not issued, the potential for the issuance of such shares
may negatively affect the trading price of our Common Stock in anticipation of such dilution. Sales of a substantial number of shares
comprising the Upfront Stock Consideration or any Additional Earnout Shares in the public market, or the perception that such sales may
occur, could adversely affect the market price of our securities.
Under
certain circumstances, we may take certain actions to achieve the milestones under the Purchase Agreement that we would not have undertaken
if we had not completed the acquisition, which may have an adverse effect on the historical business of Stereotaxis.
During the revenue earnout periods under our
Purchase Agreement, which end on September 30, 2029, we agreed to operate APT and its business in a commercially reasonable manner as
conducted prior to the closing, taken as a whole, including maintaining relationships with customers, suppliers, independent contractors,
governmental entities, and others having business dealings with it consistent with APT’s practice prior to the closing. We agreed not to take any action during the revenue earnout periods which has as its intended purpose the diminution of the earnout consideration.
While
we retain the sole authority to operate and control APT’s business and its operations, including without limitation, any and all decisions relating
various aspects of their and our combined business, we may nevertheless take certain actions related to the milestones that we would
not have undertaken if we had not completed the acquisition.
ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
None.
ITEM
3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM
4. [RESERVED]
None.
ITEM
5. OTHER INFORMATION
None.
ITEM
6. EXHIBITS
Number |
|
Description |
|
|
|
2.1†# |
|
Share Purchase Agreement, dated as of May 11, 2024, by and among the Company, Access Point Technologies EP, Inc. and APT Holding Company, Inc., as seller. filed herewith. |
|
|
|
2.2 |
|
Amendment No. 1 to Share Purchase Agreement, dated as of July 31, 2024, by and among the Company, Access Point Technologies EP, Inc. and APT Holding Company, Inc., as seller. filed herewith. |
|
|
|
2.3# |
|
Form of Voting and Support Agreement (included as Exhibit B to the Securities Purchase Agreement filed as Exhibit 2.1). |
|
|
|
3.1 |
|
Restated Articles of Incorporation of the Registrant, incorporated by reference to Exhibit 3.1 of the Registrant’s Form 10-Q (File No. 000-50884) for the fiscal quarter ended September 30, 2004. |
|
|
|
3.2 |
|
Certificate of Amendment to Amended and Restated Certificate of Incorporation, incorporated by reference to Exhibit 3.1 of the Registrant’s Form 8-K (File No. 000-50884) filed on July 10, 2012. |
|
|
|
3.3 |
|
Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock, incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K (File No. 001-36159) filed on September 30, 2016. |
|
|
|
3.4 |
|
Restated Bylaws of the Registrant, incorporated by reference to Exhibit 3.2 of the Registrant’s Form 10-Q (File No. 000-50884) for the fiscal quarter ended September 30, 2004. |
|
|
|
31.1 |
|
Rule 13a-14(a)/15d-14(a) Certification (pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, executed by Chief Executive Officer). |
|
|
|
31.2 |
|
Rule 13a-14(a)/15d-14(a) Certification (pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, executed by Chief Financial Officer). |
|
|
|
32.1 |
|
Section 1350 Certification (pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Chief Executive Officer). |
|
|
|
32.2 |
|
Section 1350 Certification (pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Chief Financial Officer). |
|
|
|
101.INS |
|
Inline
XBRL Instance Document. |
|
|
|
101.SCH |
|
Inline
XBRL Taxonomy Extension Schema Document. |
|
|
|
101.CAL |
|
Inline
XBRL Taxonomy Extension Calculation Linkbase Document. |
|
|
|
101.DEF |
|
Inline
XBRL Taxonomy Extension Definition Linkbase Document. |
|
|
|
101.LAB |
|
Inline
XBRL Taxonomy Extension Label Linkbase Document. |
|
|
|
101.PRE |
|
Inline
XBRL Taxonomy Extension Presentation Linkbase Document. |
|
|
|
104 |
|
Cover
Page Interactive Data File (embedded within the Inline XBRL document) |
# This filing excludes certain schedules and exhibits pursuant to Item 601(a)(5) of Regulation S-K, which the registrant agrees to furnish
supplementally to the Securities and Exchange Commission upon request; provided, however, that the registrant may request confidential
treatment for any schedules or exhibits so furnished.
†As permitted by Regulation S-K, Item 601(b)(2)(ii) of the Securities Exchange
Act of 1934, as amended, certain confidential portions of this exhibit have been redacted from the publicly filed document.
STEREOTAXIS,
INC.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
|
STEREOTAXIS,
INC. (Registrant) |
|
|
|
Date:
August 14, 2024 |
By: |
/s/
David L. Fischel |
|
|
David
L. Fischel |
|
|
Chief
Executive Officer |
|
|
|
Date:
August 14, 2024 |
By: |
/s/
Kimberly R. Peery |
|
|
Kimberly
R. Peery |
|
|
Chief
Financial Officer |
Exhibit
2.1
EXECUTION VERSION
CERTAIN
CONFIDENTIAL PORTIONS HAVE BEEN REDACTED FROM THIS EXHIBIT BECAUSE THEY ARE BOTH (i) NOT MATERIAL AND (ii) A TYPE THAT THE REGISTRANT
TREATS AS PRIVATE OR CONFIDENTIAL. INFORMATION THAT HAS BEEN OMITTED HAS BEEN IDENTIFIED IN THIS DOCUMENT WITH A PLACEHOLDER IDENTIFIED
BY THE MARK “[***]”.
Share
Purchase Agreement
among
Stereotaxis,
Inc.,
Access
Point Technologies EP, Inc.
and
APT
Holding Company, Inc.
Dated as of May 11, 2024
TABLE
OF CONTENTS
|
Page |
|
|
Article
I Definitions; Interpretation |
1 |
1.1
Definitions |
1 |
1.2
Interpretation |
1 |
|
|
Article
II Purchase and Sale of Acquired Shares |
2 |
2.1
Purchase and Sale of Acquired Shares |
2 |
2.2
Total Consideration |
2 |
2.3
Upfront Stock Consideration.. |
2 |
2.4
Purchase Price Adjustment |
2 |
2.5
Earnout Consideration |
6 |
2.6
Allocation and Distribution |
12 |
2.7
Withholding Tax |
12 |
|
|
Article
III Closing |
13 |
3.1
Closing |
13 |
3.2
Delivery of Acquired Shares |
13 |
3.3
Delivery by Purchaser of Consideration at Closing |
13 |
|
|
Article
IV Representations and Warranties Relating to Seller |
13 |
4.1
Standing |
13 |
4.2
Title to Acquired Shares |
13 |
4.3
Authority; Execution and Delivery; Enforceability |
13 |
4.4
Consents and Authorizations; No Conflicts |
14 |
4.5
Brokers |
14 |
4.6
Solvency |
14 |
4.7
Proceedings; Orders |
14 |
4.8
Investment Representations |
14 |
|
|
Article
V Representations and Warranties Relating to the Company |
15 |
5.1
Organization and Good Standing |
15 |
5.2
Equity Securities; Capitalization |
16 |
5.3
Authority; Execution and Delivery; Enforceability |
17 |
5.4
Consents and Authorizations; No Conflicts |
17 |
5.5
Financial Matters |
18 |
5.6
No Undisclosed Liabilities |
19 |
5.7
Absence of Changes or Events |
19 |
5.8
Indebtedness |
21 |
5.9
Deposits |
21 |
5.10
Title to Assets; Real Property |
21 |
5.11
Intellectual Property |
22 |
5.12
Material Contracts |
26 |
5.13
Insurance |
29 |
5.14
Legal Proceedings; Orders |
29 |
5.15
Compliance with Laws; Permits |
30 |
5.16
Taxes |
31 |
5.17
Employee Benefit Matters |
33 |
5.18
Employment Matters |
36 |
5.19
Environmental Matters |
38 |
5.20
Client Relations |
38 |
5.21
Vendors and Suppliers |
39 |
5.22
Brokers |
39 |
5.23
Product and Service Warranty; Service Levels; Liability |
39 |
5.24
Affiliate Transactions |
39 |
5.25
Certain Payments |
40 |
5.26
Bank Accounts |
40 |
5.27
Books and Records |
40 |
5.28
Full Disclosure |
40 |
Article
VI Representations and Warranties of Purchaser |
41 |
6.1
Organization; Good Standing; Authority |
41 |
6.2
No Conflicts; Consents |
41 |
6.3
Investment Purpose |
41 |
6.4
SEC Reports |
42 |
6.5
Purchaser Common Stock |
42 |
6.6
Financial Statements |
42 |
6.7
Capitalization of Purchaser |
42 |
6.8 |
|
6.8
Brokers |
42 |
|
|
Article
VII Covenants |
43 |
7.1
Conduct of Business Prior to the Closing |
43 |
7.2
Access to Information |
45 |
7.3
Reasonable Best Efforts; Third Party Consents |
45 |
7.4
Seller’s Disclosure Schedule Updates |
45 |
7.5
Stockholder Meeting. |
46 |
7.6
Tax Matters |
46 |
7.7
Expenses; Transfer Taxes |
49 |
7.8
Further Assurances; No Avoidance |
49 |
7.9
Publicity |
49 |
7.10
Seller Release |
50 |
7.11
Certain Restrictions |
50 |
7.12
Exclusivity. |
51 |
7.13
Resale Registration Statement. |
52 |
7.14
NYSE American Listing. |
53 |
7.15
Debt Restructuring |
53 |
7.16
D&O Tail Policy.. |
54 |
|
|
Article
VIII Closing Deliverables |
54 |
8.1
Seller’s Closing Deliveries |
54 |
8.2
Purchaser Closing Deliveries |
56 |
|
|
Article
IX |
56 |
|
|
Conditions
Precedent |
56 |
9.1
Conditions to Obligations of All Parties |
56 |
9.2
Conditions to Obligations of Purchaser |
56 |
9.3
Conditions to Obligations of Seller |
57 |
9.4
Frustration of Closing Conditions |
58 |
Article
X Termination |
58 |
10.1
Termination |
58 |
10.2
Effect of Termination |
58 |
|
|
Article
XI Survival; Indemnification |
60 |
11.1
Survival |
60 |
11.2
Indemnification by Seller |
60 |
11.3
Indemnification by Purchaser. |
62 |
11.4
Claim Notice |
62 |
11.5
Exclusive Remedy; No Double Recovery |
66 |
11.6
Specific Performance |
66 |
11.7
Indemnification in Case of Strict Liability or Indemnitee Negligence |
66 |
11.8
Determination of Losses |
66 |
11.9
Treatment of Indemnity Payments for Tax Purposes |
66 |
11.10
Payment or Reimbursement of Losses |
66 |
|
|
Article
XII [Reserved] |
67 |
|
|
Article
XIII General Provisions |
67 |
13.1
Seller’s Disclosure Schedule |
67 |
13.2
Assignment |
67 |
13.3
No Third-Party Beneficiaries |
67 |
13.4
Notices |
67 |
13.5
Counterparts |
68 |
13.6
Entire Agreement; Exclusivity of Agreement |
68 |
13.7
Amendments |
68 |
13.8
Severability |
68 |
13.9
Governing Law; Venue; Waiver of Jury Trial |
68 |
13.10
Waiver in Writing |
69 |
13.11
Attorneys’ Fees and Expenses |
69 |
13.12
Construction |
69 |
APPENDICES,
EXHIBITS, AND SCHEDULES |
|
Appendices |
|
|
|
|
|
Appendix
A |
|
Defined
Terms |
Appendix
B |
|
Notice
Addresses |
|
|
|
Exhibits |
|
|
|
|
|
Exhibit A |
|
Form
of Securities Assignment |
Exhibit
B |
|
Form
of Voting and Support Agreement |
|
|
|
Schedules |
|
|
|
|
|
Schedule 8.1(e) |
|
Third-Party
Consents |
Schedule
11.3(a)(iv) |
|
Tax
Indemnity Matters |
Seller’s
Disclosure Schedule |
|
|
|
|
|
Section
1.1 |
|
Permitted
Encumbrances |
Section
4.2 |
|
Title
to Acquired Shares |
Section
4.4 |
|
Seller’s
Consents and Authorizations |
Section
4.8(i) |
|
Seller’s
Residence Addresses |
Section
5.1 |
|
Foreign
Qualification |
Section
5.2(a) |
|
Company
Capitalization |
Section
5.2(g) |
|
Redemptions
and Voting Agreements |
Section
5.4(a) |
|
No
Conflicts |
Section
5.4(c)(1) |
|
Consents
and Authorizations |
Section
5.4(c)(2) |
|
Consents
and Authorizations (Governmental) |
Section
5.5(a)(1) |
|
Financial
Statements |
Section
5.5(a)(2) |
|
Fair
Presentation of Financial Statements |
Section
5.5(b) |
|
Working
Capital Exceptions to GAAP |
Section
5.5(c) |
|
Accounts
Receivable Aging |
Section
5.5(d) |
|
Accounts
Payable Aging |
Section
5.5(e) |
|
Accrued
Liabilities |
Section
5.6(c) |
|
Disclosed
Liabilities |
Section
5.7 |
|
Absence
of Changes or Events |
Section
5.8 |
|
Indebtedness |
Section
5.9 |
|
Deposits |
Section
5.10(b) |
|
Owned
Real Property |
Section
5.10(c) |
|
Leased
Real Property |
Section
5.10(d) |
|
Real
Property Permits |
Section
5.11(a) |
|
Company
Intellectual Property |
Section
5.11(b) |
|
Intellectual
Property Claims |
Section
5.11(d) |
|
Intellectual
Property Assignment Agreements |
Section
5.12(a) |
|
Material
Contracts |
Section
5.12(c) |
|
Related
Party Agreements |
Section
5.12(d) |
|
Government
Contract Exceptions |
Section
5.13(a) |
|
Insurance
Policies |
Section
5.13(b) |
|
Insurance
Exceptions |
Section
5.14(a)(i) |
|
Legal
Proceedings |
Section
5.14(a)(ii) |
|
Uninsured
Legal Proceedings |
Section
5.15(a) |
|
Compliance
with Laws |
Section
5.15(b) |
|
Permits |
Section
5.16 |
|
Taxes |
Section
5.16(g) |
|
Contested
Tax Matters |
Section
5.17(a) |
|
Benefit
Plans |
Section
5.17(g) |
|
Certain
Payments |
Section
5.17(k) |
|
Self-funded
or Self-insured Benefit Plans |
Section
5.18(a) |
|
Employee
List |
Section
5.20(a) |
|
Client
Relations |
Section
5.20(b) |
|
Client
Exceptions |
Section
5.21(a) |
|
Vendors
and Suppliers |
Section
5.21(b) |
|
Vendors
and Suppliers Exceptions |
Section
5.23(a) |
|
Warranties |
Section
5.23(b) |
|
Potential
Product Claims |
Section
5.23(c) |
|
Warranty
Claims |
Section
5.24(a) |
|
Affiliate
Transaction |
Section
5.24(b) |
|
Affiliate
Receivables and Payables |
Section
5.26 |
|
Bank
Accounts |
sHARE
purchase agreement
This
Share Purchase Agreement (this “Agreement”), dated as of May 11, 2024 (the “Effective Date”),
is among Stereotaxis, Inc., a Delaware corporation (“Purchaser”); Access Point Technologies, Inc., a Minnesota
corporation (the “Company”); and APT Holding Company, Inc., a Minnesota corporation (“Seller”).
Purchaser, Seller and the Company are referred to in this Agreement collectively as the “Parties,” and individually
as a “Party.”
Preliminary
Statements
A.
Seller will be, at the effectiveness of its subsidiary merger with and into the Company under Section 302A.626 of the Minnesota Business
Corporation Act (the “Seller Reorganization”), the holder of record and beneficial owner of 100% of the issued
and outstanding capital stock of the Company, which represents the only Equity Securities of the Company (the “Acquired Shares”).
B.
Seller desires to sell to Purchaser, and Purchaser desires to purchase, all of the Acquired Shares in exchange for the Purchase Price.
C.
As a condition and inducement to Purchaser entering into this Agreement, Steve Berhow, Tim Hanson and Corey Teigen, in their capacity
as stockholders of Seller following the holding company reorganization completed prior to the execution and delivery of this Agreement,
have concurrently herewith entered into one or more Voting and Support Agreements (the “Voting and Support Agreements”)
in the form attached hereto as Exhibit B in connection with the transactions contemplated hereby.
Agreement
In
consideration of the representations, warranties, covenants, and agreements contained in this Agreement, and intending to be legally
bound hereby, the Parties agree as follows:
Article
I
Definitions; Interpretation
1.1
Definitions. Capitalized terms and other terms used in this Agreement have the respective meanings set forth in Appendix
A.
1.2
Interpretation. As used in this Agreement, except as otherwise indicated in this Agreement or as the context may otherwise
require: (a) the words “include,” “includes,” and “including” are deemed to be followed by “without
limitation” whether or not they are in fact followed by such words or words of similar import; (b) the word “or” is
not exclusive; (c) references to an “Article,” “Section,” “preamble,” “Recital,” or any
other subdivision, or to an “Appendix,” “Exhibit,” “Schedule,” or “Disclosure Schedule”
are to an article, section, preamble, recital, or subdivision of this Agreement, or to an appendix, exhibit, schedule, or disclosure
schedule to this Agreement; (d) the words “this Agreement,” “hereby,” “hereof,” “herein,”
“hereunder,” and comparable words refer to all of this Agreement, including the Appendices, Exhibits, Schedules, and Disclosure
Schedules to this Agreement, and not to any particular article, section, preamble, recital, or other subdivision of this Agreement, or
appendix, exhibit, schedule, or disclosure schedule to this Agreement; (e) any pronoun in masculine, feminine, or neuter form includes
any other gender; (f) any word in the singular form includes the plural and vice versa; (g) except for references in Seller’s Disclosure
Schedule, references to any agreement or other document are to such agreement or document as amended, modified, superseded, supplemented,
and restated now or from time to time after the date of this Agreement; (h) references to any Law are to it as amended, modified, supplemented,
and restated as of the date of this Agreement, and, unless the context requires otherwise, any reference to any statute will be deemed
also to refer to all rules and regulations promulgated thereunder; (i) except for references in Seller’s Disclosure Schedule, references
to any Person include such Person’s respective successors and permitted assigns (and in the case of a natural person, such Person’s
heirs, estate, and personal representatives); (j) references to a “day” or number of “days” (without the explicit
qualification of “Business”) refer to a calendar day or number of calendar days; and (k) references to copies of documents
that have been delivered, provided or made available to Purchaser means copies of those documents made available in the Data Room to
Purchaser and its Representatives at least one day prior to the date of this Agreement. If interest is to be computed under this Agreement,
it will be simple interest computed on the basis of a 360-day year of twelve 30-day months. If any action or notice is to be taken or
given on or by a particular calendar day, and such calendar day is not a Business Day, then such action or notice may be taken or given
on the next succeeding Business Day. Any financial or accounting term that is not otherwise defined in this Agreement has the meaning
given such term under GAAP.
Article
II
Purchase and Sale of Acquired Shares
2.1
Purchase and Sale of Acquired Shares. Subject to the terms and conditions of this Agreement, at the Closing, Seller will transfer,
sell, and deliver to Purchaser, free and clear of all Encumbrances, and Purchaser will purchase and accept delivery of, the Acquired
Shares in exchange for the Upfront Stock Consideration delivered by or on behalf of Purchaser to Seller. To the extent requested by Purchaser,
Seller shall provide an allocation of the Upfront Stock Consideration and the Earnout Consideration as between outstanding shares of
common and preferred stock of the Company that comprise the Acquired Shares.
2.2 Total
Consideration. The aggregate consideration to be paid by Purchaser to Seller for the purchase of the Acquired Shares and the
other Contemplated Transactions (the “Purchase Price”) will be: (i) the Upfront Stock Consideration; plus
(ii) Global Revenue Earnout Consideration, if any; plus (iii) US Revenue Earnout Consideration, if any; plus (iv)
Regulatory Milestone Payments, if any. The Upfront Stock Consideration, as described in Section 2.2, shall amount to Purchaser
Common Stock with a value of $3,000,000, and the aggregate Earnout Consideration, as described in Section 2.5, may amount to a total
value of up to $24,000,000.
2.3
Upfront Stock Consideration. The Upfront Stock Consideration means Purchaser Common Stock with a value of $3,000,000 (Three
Million US Dollars), based upon the average of the closing per share price of Purchaser Common Stock for each of the five trading days
ending on the second Business Day prior to the Closing Date, rounded down to the nearest whole share.
2.4
Purchase Price Adjustment.
(a)
General. The Purchase Price will be subject to adjustment following the Closing in accordance with this Section 2.4. For
clarity, all references to calculations in accordance with GAAP in this Section 2.4 shall be without regard to any exceptions
noted on Section 5.5(b) of Seller’s Disclosure Schedule.
(b)
Preparation of Closing Balance Sheet and Closing Working Capital Amount. As promptly as practicable, but not later than 180 days
after the Closing Date, or such later date as Purchaser and Seller agree in writing, Purchaser shall prepare and deliver to Seller a
written notice (the “Closing Working Capital Notice”) containing (i) a consolidated balance sheet of the Company
as of the Closing Date (the “Closing Balance Sheet”), calculated in accordance with GAAP; (ii) Purchaser’s
calculation of the Working Capital of the Company as of the Closing Date determined in accordance with GAAP (such amount, the “Closing
Working Capital Amount”); and (iii) Purchaser’s calculation of Closing Date Indebtedness and unpaid Seller Transaction
Expenses. Seller will have a period of 45 days (the “Review Period”) following delivery of the Closing Working
Capital Notice to review the Closing Balance Sheet, the Closing Working Capital Amount, the Closing Date Indebtedness and the unpaid
Seller Transaction Expenses set forth in the Closing Working Capital Notice. Seller and its accountants may make inquiries of, and receive
supporting documentation from, Purchaser, the Company, and their respective accountants and employees regarding questions concerning,
or disagreements with, the Closing Balance Sheet, the Closing Working Capital Amount, the Closing Date Indebtedness and/or the unpaid
Seller Transaction Expenses set forth in the Closing Working Capital Notice, arising in the course of its review thereof, provided
that such inquiries do not unreasonably interfere with the operations of Purchaser or the Company, and Purchaser shall use, and shall
cause the Company to use, Commercially Reasonable Efforts to cause any such accountants and employees to cooperate with and respond to
such inquiries as promptly as practicable.
(c)
Acceptance by Seller. If (i) at any time during the Review Period, Seller notifies Purchaser in writing of its acceptance of Purchaser’s
estimate of the Closing Working Capital Amount, or amounts of the Closing Date Indebtedness, or the unpaid Seller Transaction Expenses
set forth in the Closing Working Capital Amount Notice, or (ii) Seller fails to deliver a timely Objection Notice in accordance with
Section 2.4(d), then such Closing Working Capital Amount and/or amounts of the Closing Date Indebtedness, and/or the unpaid Seller
Transaction Expenses, as the case may be, will be final, binding and conclusive and will be deemed to be the “Final Closing
Working Capital Amount” and/or final amounts of the Closing Date Indebtedness, and/or the unpaid Seller Transaction Expenses,
as the case may be, for purposes of this Agreement.
(d)
Disagreement by Seller. If Seller disagrees with Purchaser’s Closing Balance Sheet, Purchaser’s calculation of the
Closing Working Capital Amount or amounts of the Closing Date Indebtedness, or the unpaid Seller Transaction Expenses, as the case may
be, set forth in the Closing Working Capital Notice, then prior to the expiration of the Review Period, Seller may deliver a notice to
Purchaser disagreeing with such specific calculation and setting forth Seller’s objection(s) to Purchaser’s calculation of
the Closing Balance Sheet, the Closing Working Capital Amount and/or amounts of the Closing Date Indebtedness, or the unpaid Seller Transaction
Expenses, as the case may be (an “Objection Notice”). The Objection Notice must specify, (i) in reasonable
detail, those items or amounts as to which Seller disagrees and the reason(s) for such disagreement(s), together with any supporting
documentation available to Seller and (ii) Seller’s calculation of the Closing Working Capital Amount and/or amounts of the Closing
Date Indebtedness, and/or the unpaid Seller Transaction Expenses, as the case may be. Any particular amounts or items contained in the
Closing Working Capital Notice or the Closing Balance Sheet that are not specifically objected to by Seller in the Objection Notice will
be deemed accepted by Seller and Seller and will be final, binding, and conclusive on all Parties. If Seller does not timely deliver
an Objection Notice, Purchaser’s calculation of the Closing Working Capital Amount and/or amounts of the Closing Date Indebtedness,
and/or the unpaid Seller Transaction Expenses, as the case may be, in the Closing Working Capital Notice will be deemed final, binding,
and conclusive on all Parties.
(e)
Dispute Resolution.
(i)
If Seller delivers a timely Objection Notice in accordance with Section 2.4(d), Purchaser and Seller shall, during the 30 days
following such delivery, use Commercially Reasonable Efforts to reach agreement on the disputed items or amounts in order to determine
a mutually agreeable Closing Balance Sheet, Closing Working Capital Amount and/or amounts of the Closing Date Indebtedness, and/or the
unpaid Seller Transaction Expenses, as the case may be. If, during such period, Purchaser and Seller agree as to the Closing Working
Capital Amount and/or amounts of the Closing Date Indebtedness, and/or the unpaid Seller Transaction Expenses, as the case may be, then
Purchaser and Seller (on behalf of Seller) shall execute a written acknowledgement of such amount and the Closing Working Capital Amount
and/or amounts of the Closing Date Indebtedness, and/or the unpaid Seller Transaction Expenses, as the case may be, so agreed upon will
be final, binding and conclusive and will be deemed to be the “Final Closing Working Capital Amount” and/or final amounts
of the Closing Date Indebtedness, and/or the unpaid Seller Transaction Expenses, as the case may be, for purposes of this Agreement.
If, during such period, Purchaser and Seller are unable to reach agreement, then the disputed items will be resolved by the Accountant.
(ii)
Within 20 days of the retention of the Accountant, Purchaser and Seller shall jointly submit the matter to the Accountant and instruct
the Accountant that it: (A) will act as an expert in accounting, and not as an arbitrator, to resolve, in accordance with GAAP and in
a manner consistent with the provisions of this Agreement, only the matters specified in the Objection Notice that remain in dispute;
(B) shall adjust the calculation of Closing Working Capital Amount and/or amounts of the Closing Date Indebtedness, and/or the unpaid
Seller Transaction Expenses, as the case may be, based thereon to reflect such resolution; (C) may not determine an amount of the Closing
Working Capital Amount, Closing Date Indebtedness, or unpaid Seller Transaction Expenses, as the case may be, in excess of that claimed
by Seller or less than that claimed by Purchaser; (D) shall deliver to Purchaser and Seller, as promptly as practicable and in any event
within 75 days following the submission of the matters that remain in dispute to the Accountant for resolution, a written report setting
forth the Accountant’s determination of the Closing Working Capital Amount and/or amounts of the Closing Date Indebtedness, and/or
the unpaid Seller Transaction Expenses, as the case may be, and the calculations thereof; and (E) may not engage in ex parte communications
with either Purchaser or its Representatives, on the one hand, or Seller or its Representatives, on the other hand, without the other
party’s express written consent. Purchaser and Seller each will have the right to submit written information to the Accountant
in support of their respective positions, provided that, when doing so, it provides a copy of such written information to the
other Party as well as the Accountant. The Parties acknowledge and agree that if any dispute is submitted to the Accountant pursuant
to this Section 2.4(e), the Closing Working Capital Amount and/or amounts of the Closing Date Indebtedness, and/or the unpaid
Seller Transaction Expenses, as the case may be, determined by the Accountant will be final, binding and conclusive and will be deemed
to be the “Final Closing Working Capital Amount” and/or final amounts of the Closing Date Indebtedness, and/or the unpaid
Seller Transaction Expenses, as the case may be, for purposes of this Agreement.
(iii)
The cost of such review and report (including any retainer) will be borne (A) by Purchaser if Seller’s aggregate calculation of
Closing Working Capital Amount and amounts of the Closing Date Indebtedness, and the unpaid Seller Transaction Expenses, as the case
may be, is closer to the Final Closing Working Capital Amount and final amounts of the Closing Date Indebtedness, and the unpaid Seller
Transaction Expenses, as the case may be, calculated by the Accountant, or (B) Seller if Purchaser’s aggregate calculation of Closing
Working Capital Amount and amounts of the Closing Date Indebtedness, and the unpaid Seller Transaction Expenses, as the case may be,
is closer to the Final Closing Working Capital Amount and final amounts of the Closing Date Indebtedness, and the unpaid Seller Transaction
Expenses, as the case may be, calculated by the Accountant. Any retainer charged by the Accountant will be paid 50% by Purchaser and
50% by Seller, with such amount to be reimbursed by the Party responsible for paying the cost of the review in accordance with the immediately
preceding sentence.
(f)
Adjustment of Purchase Price.
(i)
Closing Working Capital. If the Final Closing Working Capital Amount, as determined pursuant to this Section 2.4, is:
(A)
less than $25,000 or more, then Purchaser shall have the right to offset such amounts from any Earnout Consideration; or
(B)
$25,000 or more, then there will be no adjustment.
(ii)
Closing Date Indebtedness. If the final amount of the Closing Date Indebtedness, as determined pursuant to this Section 2.4,
is greater than $0.00, then Seller shall pay to Purchaser by wire transfer of immediately available funds an amount equal to the amount
by which the amount of the final Closing Date Indebtedness exceeds $0.00.
(iii)
Unpaid Seller Transaction Expenses. If the final amount of the unpaid Seller Transaction Expenses, as determined pursuant to this
Section 2.4, is greater than $0.00, then Seller shall pay to Purchaser by wire transfer of immediately available funds an amount
equal to the amount by which the amount of the final unpaid Seller Transaction Expenses exceeds $0.00, and upon receipt thereof Purchaser
shall pay or cause to be paid such unpaid Seller Transaction Expenses.
(g)
Cooperation. Each of Purchaser, Company, and Seller will, and will use its respective Commercially Reasonable Efforts to cause
its respective accountants to, cooperate and assist as requested in the preparation of the Closing Balance Sheet and the calculation
(including the estimates) of the Closing Working Capital Amount, the Final Closing Working Capital Amount, Closing Date Indebtedness,
and the unpaid Seller Transaction Expenses by the other Party and the Accountant, including the making available to the extent necessary
of books, records, work papers, and personnel.
2.5
Earnout Consideration.
(a)
Revenue Earnout Consideration. If in any Revenue Earnout Period, the Earnout Measurement sets forth a final calculation of APT
Product Global Revenues equal or greater than to the Threshold Global Revenue set forth in the chart below for such period (the “Applicable
Threshold Global Revenue”), then Purchaser will deliver, or cause to be delivered, to Seller, by deposit with Purchaser’s
transfer agent, a number of shares of Purchaser Common Stock with an aggregate value equal to (i) $1,000,0000 plus (ii) an amount equal
to (x) $1,000,0000 multiplied by (y) a fraction (1) with a numerator equal to the amount by which the Earnout Measurement exceeds the
Applicable Threshold Global Revenue for such period and (2) a denominator equal to the amount by which the Maximum Global Revenue exceeds
the Applicable Threshold Global Revenue for such period (such amount, the “Global Revenue Earnout Consideration”);
provided, however, that the Global Revenue Earnout Consideration may not exceed an aggregate of $2,000,000.00 for any Revenue Earnout
Period.
If
in any Revenue Earnout Period, the Earnout Measurement sets forth a final calculation of APT Product US Revenues equal or greater than
to the Threshold US Revenue set forth in the chart below for such period (the “Applicable Threshold US Revenue”),
then Purchaser will deliver, or cause to be delivered, to Seller, by deposit with Purchaser’s transfer agent, a number of shares
of Purchaser Common Stock with an aggregate value equal to (i) $1,000,0000 plus (ii) an amount equal to (x) $1,000,0000 multiplied by
a fraction (1) with a numerator equal to the amount by which the Earnout Measurement exceeds the Applicable Threshold US Revenue for
such period and (2) a denominator equal to the amount by which the Maximum US Revenue exceeds the Applicable Threshold US Revenue for
such period (such amount, the “US Revenue Earnout Consideration”); provided, however, that the Global Revenue
Earnout Consideration may not exceed an aggregate of $2,000,000.00 for any Revenue Earnout Period.
All amounts in US$,
in millions | |
Revenue Earnout
Period 1 | | |
Revenue Earnout
Period 2 | | |
Revenue Earnout
Period 3 | | |
Revenue Earnout
Period 4 | | |
Revenue Earnout
Period 5 | |
APT Product Global Revenue | |
| | | |
| | | |
| | | |
| | | |
| | |
Threshold Global Revenue | |
$ | [***] | | |
$ | [***] | | |
$ | [***] | | |
$ | [***] | | |
$ | [***] | |
Maximum Global Revenue | |
$ | [***] | | |
$ | [***] | | |
$ | [***] | | |
$ | [***] | | |
$ | [***] | |
APT Product US Revenue | |
| | | |
| | | |
| | | |
| | | |
| | |
Threshold US Revenue | |
$ | [***] | | |
$ | [***] | | |
$ | [***] | | |
$ | [***] | | |
$ | [***] | |
Maximum US Revenue | |
$ | [***] | | |
$ | [***] | | |
$ | [***] | | |
$ | [***] | | |
$ | [***] | |
(b)
Regulatory Milestone Consideration. With respect to each of the following milestones (each a “Regulatory Milestone”)
that is achieved in accordance with the terms and limitations applicable to such Regulatory Milestone, the Purchaser will deliver, or
cause to be delivered to Seller, by deposit with Purchaser’s transfer agent, an aggregate amount of Purchaser Common Stock equal
to the applicable milestone payment (each a “Regulatory Milestone Earnout Payment”), to be made to the Seller
in the manner set forth below and otherwise in accordance with the terms of this Agreement:
Regulatory Milestones | |
Regulatory
Milestone Earnout Payments | |
FDA Regulatory Approval of a
Robotically-Navigated Map-iT Catheter on or before the end of the Regulatory Approval Milestone Period | |
$ | 1,000,000 | |
FDA Regulatory Approval of a Vascular Guidance
Catheter on or before the end of the Regulatory Approval Milestone Period | |
$ | 1,000,000 | |
European CE Mark Regulatory Approval of
a Robotically-Navigated Map-iT Catheter on or before the end of the Regulatory Approval Milestone Period | |
$ | 1,000,000 | |
European CE Mark Regulatory Approval of
a Vascular Guidance Catheter on or before the end of the Regulatory Approval Milestone Period | |
$ | 1,000,000 | |
Within
ten (10) Business Days of written receipt by Purchaser, the Company, or any of their respective Affiliates of FDA Regulatory Approval
or European CE Mark Regulatory Approval of a Robotically-Navigated Map-iT Catheter or a Vascular Guidance Catheter, as the case may be
(each an “Regulatory Earnout Notice Date”), Purchaser shall deliver to Seller a written statement advising
of such approval and Purchaser shall deliver, or cause to be delivered, within three Business Days thereafter, the Regulatory Milestone
Earnout Payment to Seller by issuance to Seller of Purchaser Common Stock, with the value thereof based on the average closing per share
price of Purchaser Common Stock for each of the five trading days ending on the second Business Day prior to the Regulatory Earnout Notice
Date, rounded down to the nearest whole share; provided that in the event that Purchaser determines that it will make open market
repurchases of Purchaser Common Stock in order to acquire all or a portion of the Purchaser Common Stock to satisfy the delivery thereof
pursuant to this subsection, Purchaser shall provide written notice to Seller of such election and shall instead deliver, on the date
that is 32 Business Days after such notice of election, an aggregate amount of shares of Purchaser Common Stock with the value in respect
of such Regulatory Milestone Earnout Payment that is based on the volume-weighted average trading price per share of Purchaser Common
Stock as reported by Bloomberg L.P. for the thirty (30) trading days ending on the second Business Day prior to the date of delivery
of such shares.
(c)
Revenue Earnout Determination.
(i)
Within 60 days following the end of any Revenue Earnout Period (or 90 days if a Revenue Earnout Period ends on December 31 of any year)
(each a “Revenue Earnout Notice Date”), Purchaser shall deliver to Seller a written statement setting forth
the proposed calculation of the Company’s APT Product Global Revenues and APT Product US Revenues for such Revenue Earnout Period,
together with supporting schedules as reasonably requested by Seller (each a “Proposed Revenue Earnout Measurement”
and the final calculation of Eligible Company Earnout Revenues for the applicable Revenue Earnout Period as determined pursuant to this
Section 2.5, an “Revenue Earnout Measurement”). After delivery of a Proposed Revenue Earnout Measurement,
Seller and its accountants shall be permitted reasonable access during normal business hours to review the Company’s books and
records (excluding any privileged work papers) related to the preparation of such Proposed Revenue Earnout Measurement. Seller and its
accountants may make inquiries of Purchaser, the Company, and their respective accountants and employees regarding questions concerning
or disagreements with such Proposed Revenue Earnout Measurement arising in the course of its review thereof, and Purchaser shall use,
and shall cause the Company to use, Commercially Reasonable Efforts to cause any such accountants and employees to cooperate with and
respond to such inquiries as promptly as practicable.
(ii)
If Seller disagrees in any respect with Purchaser’s calculation of a Proposed Revenue Earnout Measurement, Seller may deliver a
dispute notice (the “Dispute Notice”) to Purchaser within 15 days of receiving such Proposed Revenue Earnout
Measurement.
(iii)
If Seller does not deliver a Dispute Notice to Purchaser within 15 days of receiving a Proposed Revenue Earnout Measurement, then such
Proposed Revenue Earnout Measurement will be the Revenue Earnout Measurement for the applicable Revenue Earnout Period.
(iv)
If Seller does deliver a Dispute Notice to Purchaser (which Dispute Notice must set forth, in reasonable detail, (A) the items and amounts
in dispute and an alternative amount for each such disputed item and (B) a calculation by Seller of the Revenue Earnout Measurement for
the applicable Revenue Earnout Period) within such 15-day period commencing on the date that Seller receives the Proposed Revenue Earnout
Measurement for such Revenue Earnout Period from Purchaser, Purchaser and Seller shall exercise Commercially Reasonable Efforts to resolve
the dispute during the 15-day period commencing on the date Purchaser receives such Dispute Notice from Seller (the “Resolution
Period”), which Resolution Period may be extended by the mutual written agreement of Purchaser and Seller.
(v)
The only bases on which Seller may dispute any matter in any Proposed Revenue Earnout Measurement are: (A) the inaccuracy of such matter,
whether factually or numerically, or (B) that such Proposed Revenue Earnout Measurement, or any element thereof, or both, are not prepared
as provided in this Agreement.
(vi)
If Purchaser and Seller do not obtain a final resolution within the Resolution Period, then the items in dispute will be submitted immediately
to the Accountant for binding resolution. Seller and Purchaser shall act in good faith to execute such engagement letters and other documents
as will be necessary to engage the Accountant within 10 days but in no event later than 20 days after the expiration of the Resolution
Period. Purchaser and Seller shall jointly instruct the Accountant that it: (A) will act as an expert in accounting, and not as an arbitrator,
to resolve, in accordance with GAAP and this Agreement, only the matters specified in any timely delivered a Dispute Notice that remain
in dispute; (B) will adjust the calculation of the Proposed Revenue Earnout Measurement to reflect such resolution; (C) may not determine
an amount of Revenue Earnout Revenues for any Revenue Earnout Period in excess of that claimed by Seller or less than that claimed by
Purchaser for such Revenue Earnout Period; (D) will deliver to Purchaser and Seller a written decision of its calculation of the Revenue
Earnout Measurement as promptly as practicable and, in any event, within 75 days following the submission of the matters that remain
in dispute to the Accountant for resolution; and (E) may not engage in ex parte communications with either Purchaser or Seller
or any Representative of the foregoing without the other’s express written consent. Purchaser and Seller each shall have the right
to submit written information to the Accountant in support of their respective positions, provided that, when doing so, it provides
a copy of such written information to the other Party as well as the Accountant.
(vii)
The cost of such review and written decision will be borne (A) by Purchaser if Seller’s aggregate calculation of the Revenue Earnout
Measurement is closer to the Revenue Earnout Measurement calculated by the Accountant, or (B) by Seller if Purchaser’s aggregate
calculation of the Revenue Earnout Measurement is closer to the Revenue Earnout Measurement calculated by the Accountant. Any retainer
charged by the Accountant will be paid 50% by Purchaser and 50% by Seller, with such amount to be reimbursed by the Party responsible
for paying the cost of the review in accordance with the immediately preceding sentence.
(viii)
If applicable, and subject to Section 2.5(d), within seven (7) Business Days after final determination of the Revenue Earnout
Measurement for such Revenue Earnout Period pursuant to this Section 2.5(a), Purchaser or the Company shall deliver, or cause
to be delivered, any such Global Revenue or US Revenue Earnout Consideration (if any) to Seller (on behalf of and for distribution, as
applicable, to Seller) by issuance to Seller of a number of shares of Purchaser Common Stock, with the aggregate value thereof equal
to such Global Revenue or US Revenue Earnout Consideration, as the case may be, based on the average closing per share price of Purchaser
Common Stock for each of the five trading days ending on the second Business Day prior to the Revenue Earnout Notice Date, rounded down
to the nearest whole share; provided that in the event that Purchaser determines that it will make open market repurchases of
Purchaser Common Stock in order to acquire all or a portion of the Purchaser Common Stock to satisfy the delivery thereof pursuant to
this subsection, Purchaser shall provide written notice to Seller of such election and shall instead deliver, on the date that is 32
Business Days after such notice of election, an aggregate amount of shares of Purchaser Common Stock with the value in respect of such
Global Revenue and/or US Revenue Earnout Consideration, as the case may be, that is based on the volume-weighted average trading price
per share of Purchaser Common Stock as reported by Bloomberg L.P. for the thirty (30) trading days ending on the second Business Day
prior to the date of delivery of such shares.
(d)
Purchaser shall have the right to offset any Earnout Consideration for indemnity claim amounts on the terms and conditions set forth
in Article XI.
(e)
During the Revenue Earnout Periods, Purchaser shall operate the Company and the Business in a commercially reasonable manner and hereby
agrees not to take any action during the Revenue Earnout Periods which has as its intended purpose the diminution of the Earnout Consideration,
provided that Purchaser shall use Commercially Reasonable Efforts to conduct the operational aspects of Company’s Business as conducted
prior to the Closing Date, taken as a whole, including maintaining relationships with customers, suppliers, independent contractors,
Governmental Entities, and others having business dealings with it consistent with the Company’s practice prior to the Closing
Date. Subject only to the first sentence of this Section 2.5(e), the Parties acknowledge and agree that, from and after the Closing,
Purchaser shall have the complete right, power and authority to operate and control the Company and each of Purchaser’s, Purchaser’s
Affiliates’ and the Company’s business (including the Business) and its and their respective operations and all key business
decisions (including any and all decisions relating to the integration of the Business into the business and operations of Purchaser
and its Affiliates, any acquisitions, dispositions, purchases or sales of equity or assets and the timing thereof, capital expenditures
and the timing thereof, opening new or closing existing offices, developing new businesses or divisions, service offerings and pricing,
employee hiring and retention, subcontracting authority and facilities management) in any manner as it shall determine in its sole and
absolute discretion, regardless of the impact on any Earnout Consideration.
(f)
Notwithstanding anything in this Agreement to the contrary, in no event shall the number of shares of Purchaser Common Stock issuable
under this Agreement exceed the Share Cap without obtaining approval of Purchaser’s stockholders pursuant to the Rules of the NYSE
American.
(g)
Change of Control of Purchaser.
(i)
In the event a Change of Control of Purchaser occurs prior to September 30, 2029, then a portion of the Earnout Consideration equal to
the COC Value shall be deemed vested prior to the Change of Control. Prior to or simultaneously with the closing of such Change of Control
of Purchaser, Purchaser will deliver, or cause to be delivered, to Seller, by deposit with Purchaser’s transfer agent, a number
of shares of Purchaser Common Stock with an aggregate value equal to the COC Value, based on the per share value of the per share consideration
to which Purchaser’s stockholders in such Change of Control transaction are entitled.
(ii)
The “COC Value” means, as of immediately prior to any such Change of Control of Purchaser, the fair value of
(i) the previously unpaid amount of Global Revenue Earnout Consideration and US Revenue Earnout Consideration beginning in the Revenue
Earnout Period in which the Change of Control occurs and for any subsequent Revenue Earnout Period(s), and (ii) any previously unpaid
Regulatory Milestone Payments, in each case based on a probability-weighted average estimate based on multiple scenarios varying in timing
and amount of earnout payment, discounted to its net present value taking into account expected time when earnout would become payable
through September 30, 2029.
(iii)
Purchaser shall provide written notice (a “COC Notice”) to Seller as soon as reasonably practicable prior to
the consummation of a Change of Control, and the Parties agree as promptly as practicable thereafter, but not more than fifteen (15)
days, to mutually select and retain the services of a third party valuation expert to determine the COC Value, provided that the Parties
may elect to negotiate in good faith to determine a COC Value without referring to a valuation expert and provided further that Purchaser
may enter into and consummate a Change of Control subject to a reservation or escrow of Purchaser Common Stock to satisfy the requirement
to deliver the Earnout Consideration in Purchaser Common pursuant hereto.
(iv)
Notwithstanding the foregoing, to the extent that any acquiror of Purchaser, in the event of an Change of Control that results in Purchaser
Common Stock being converted into or exchanged solely for publicly traded securities of its acquiror, Purchaser may consummate such Change
of Control Transaction if such acquiror agrees to assume Purchaser’s earnout obligations in this Section 2.5 and to pay the Earnout
Consideration, if achieved, solely in shares of public traded stock, so long as such assumption by any Purchaser acquiror does not cause
the transactions contemplated hereby to fail to qualify as a tax-free reorganization under the Code as provided in Section 7.6(a)
(Intended Tax Treatment).
(h)
The number of shares of Purchaser Common Stock deliverable pursuant to this Section 2.5 shall equal the Earnout Stock Consideration Value.
(i)
Defined Terms Used in this Section.
(i)
“Annual Net Sales of APT Products” means the total amounts billed or invoiced on sales of APT Products during
any Revenue Earnout Period by a Selling Entity Ito Third Parties (including wholesalers or distributors), in bona fide arm’s length
transactions, less the following deductions, in each case related specifically to APT Products for the amounts accrued and subsequently
adjusted for actual amounts allowed and taken by such Third Parties and not otherwise recovered by or reimbursed to a Selling Entity:
(A)
trade, cash and quantity discounts;
(B)
discounts, price reductions, chargebacks or rebates, retroactive or otherwise, imposed by, negotiated with or otherwise paid to a Governmental
Entity or other payees;
(C)
Taxes on sales (such as sales, use value added, or other similar Taxes) to the extent added to the sale price and set forth separately
as such in the total amount invoiced;
(D)
amounts repaid or credited by reason of rejections, defects, return goods allowance, recalls or returns, or because of retroactive price
reductions;
(E)
the portion of administrative fees paid during the relevant time period to group purchasing organizations relating to APT Products;
(F)
tariffs, import/export duties, customs duties, and other imposts;
(G)
freight, insurance, import/export, and other transportation charges included in the total amount invoiced;
(H)
losses, costs and expenses (including reasonable attorneys’ fees and expenses) paid or incurred arising out of or resulting from
any claim or demand asserted by any Person claiming a contractual right to compensation arising out of, in connection with, or resulting
from the transactions contemplated by this Agreement (excluding, for the avoidance of doubt, any Person in such Person’s capacity
as a securityholder or employee of, or a financial advisor (as identified in the this Agreement) to, the Company), so long as Purchaser
is exercising or has exercised reasonable best efforts to defend against any such claim or demand; and
(I)
bad debts relating to sales of APT Products, which shall include accounts receivable that have not been collected within 150 days following
date of invoice.
Annual
Net Sales of APT Products shall not include (i) other contract work for Third Parties or other, non-product sale revenues, or (ii) transfers
or dispositions for charitable, promotional, pre-clinical, clinical, regulatory, or governmental purposes. Annual Net Sales of APT Products
shall include the amount of fair market value of all other consideration received by a Selling Entity in respect of APT Products, whether
such consideration is in cash, payment in kind, exchange, or other form. Annual Net Sales of APT Products shall be calculated in accordance
with the GAAP, including the accounting methods for translating activity denominated in foreign currencies into United States dollar
amounts, as historically and consistently applied by the Purchaser and its Affiliates. If APT Products is sold in combination with any
one or more other medical devices or products, and if any APT Products are also sold separately on a commercial basis, then the Annual
Net Sales of APT Products attributable to sales of APT Products in any bundle of product sales shall be determined according to the ratio
of (I) the price at which APT Products is sold separately to (II) the invoiced amount of any combination of other device or medical products
sold in which APT Products is included.
(ii)
“APT Product Global Revenues” means, with respect to any date of determination, the Annual Net Sales of APT
Products derived from customers located in the United States and located in other jurisdictions outside of the United States over any
applicable Revenue Earnout Period ending on such date of determination, as determined on a consolidated basis in accordance with GAAP
and calculated in a manner substantially consistent with the calculations for “revenue” in the Purchaser’s audited
financial statements, provided that any such revenue, if consisting of currency other than US Dollars, will be calculated using the foreign
exchange rates consistent with the preparation of Purchaser’s financial statements.
(iii)
“APT Product US Revenues” means, with respect to any date of determination, the Annual Net Sales of APT Products
derived from customers located only in the United States in any applicable Revenue Earnout Period ending on such date of determination,
as determined on a consolidated basis in accordance with GAAP and otherwise calculated in a manner substantially consistent with the
calculations for “revenue” in the Purchaser’s audited financial statements.
(iv)
“APT Products” means commercial products of the Company that are available as of the date of this Agreement,
that are currently in development by the Company or that are added by the mutual agreement of Purchase and the Seller Representative.
(v)
“Covered Catheter” means a Robotically-Navigated Map-iT Catheter or a Vascular Guidance Catheter.
(vi)
“EMA” means the European Medicines Agency and any successor agency thereto.
(vii)
“European CE Mark Regulatory Approval” means official written notice of approval by the EMA of a “marketing
authorization application” in the European Union, through the centralized procedure, for a Covered Catheter, with authorization
granting the Company or Seller the right to market and sell a Covered Catheter in the European Union in accordance with applicable Law.
For the avoidance of doubt, European CE Mark Regulatory Approval does not refer to approval in one or more individual countries of the
European Union or to a positive opinion by EMA’s Committee for Medicinal Products for Human Use.
(viii)
“FDA” means the United States Food and Drug Administration or any successor agency.
(ix)
“FDA Regulatory Approval” means official written notice of the approval by the FDA granting the Company or
Seller the right to market and sell a Covered Catheter in the United States in accordance with applicable Law.
(x)
“Regulatory Approval Milestone Period” means the period commencing as of the Closing Date of this Agreement
and ending on the last date of the Revenue Earnout Period.
(xi)
“Revenue Earnout Period” means each of the five 12-month periods beginning initially from the first day of
the Company’s next fiscal quarter following the Closing Date to the last day of the fourth fiscal quarter following such quarter.
By way of example, if the Closing Date is July 15, 2024, then “Revenue Earnout Period 1” means October 1, 2024
through September 30, 2025; “Revenue Earnout Period 2” means October 1, 2025 through September 30, 2026; “Revenue
Earnout Period 3” means October 1, 2026 through September 30, 2027; “Revenue Earnout Period 4”
means October 1, 2027 through September 30, 2028; and “Revenue Earnout Period 5” means October 1, 2028 through
September 30, 2029.
(xii)
“Robotically-Navigated Map-iT Catheter” means [***].
(xiii)
“Selling Entity” means the Purchaser and its Affiliates.
(xiv)
“Vascular Guidance Catheter” means [***].
2.6
Allocation and Distribution. In no event will Purchaser or the Company have any responsibility or liability for the allocation
or distribution of the Purchase Price among the equity holders of Seller or the former equity holders of the Company.
2.7
Withholding Tax. Purchaser will be entitled to deduct and withhold from any amounts otherwise payable pursuant to this Agreement
(or, as the case may be, be promptly reimbursed therefor) such amounts as may be required to be deducted or withheld with respect to
the making of such payment under the Code or any provision of state, local, provincial, or foreign Tax law. To the extent that amounts
are so withheld and paid over to the applicable Governmental Entity, such withheld amounts will be treated for all purposes of this Agreement
as having been paid to the Person in respect of which such deduction and withholding was made.
Article
III
Closing
3.1
Closing. The purchase and sale of the Acquired Shares will be consummated at a closing (the “Closing”)
to take place remotely via the electronic exchange of documents and signatures on a date no later than the fifth Business Day following
the satisfaction or (to the extent permitted by Law) waiver by the Party or Parties entitled to the benefits thereof of the conditions
set forth in Article IX (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the
satisfaction or (to the extent permitted by Law) waiver of those conditions), or at such other time and date as shall be agreed in writing
by the Parties. Notwithstanding the foregoing and regardless of the time at which funds are actually transmitted, the purchase and sale
of the Acquired Shares will be deemed to have been consummated at 11:59 p.m. Eastern Time on the Closing Date (the “Effective
Time”). The issuance of the Upfront Stock Consideration and the deductions to the Upfront Stock Consideration, and the
delivery of all Transaction Documents, certificates, and instruments delivered at the Closing, will be deemed to have been delivered
simultaneously, and neither the delivery of the Upfront Stock Consideration nor any such Transaction Documents, certificates, and instruments
will be deemed delivered or waived until all have been delivered.
3.2
Delivery of Acquired Shares. At the Closing, Seller shall deliver to Purchaser the certificate(s) representing all of the
Acquired Shares owned by Seller, free and clear of all Encumbrances, duly endorsed to Purchaser in blank or accompanied by duly executed
stock in substantially the form of Exhibit A (the “Securities Assignment”).
3.3
Delivery by Purchaser of Consideration at Closing. At the Closing, Purchaser shall issue to Seller the Upfront Stock Consideration,
by restricted book entry at Purchaser’s transfer agent into segregated accounts established by such transfer agent for the benefit
of, and registered in the name of, Seller (such establishment to occur no less than two Business Days prior to the Closing).
Article
IV
Representations and Warranties Relating to Seller
Seller
represents and warrants to Purchaser:
4.1
Standing. Seller has the legal capacity to enter into this Agreement. Seller is not a “foreign person” as such
term is described in Section 1445 of the Code.
4.2
Title to Acquired Shares. Seller: (i) has good and valid title to and record and beneficial ownership of the Acquired Shares,
in each case free and clear of all Encumbrances, other than Permitted Equity Encumbrances; (ii) has not granted any option or other right
in or to any of the Acquired Shares; and (iii) other than as contained in the Organizational Documents of the Company, copies of which
have been provided to Purchaser, and the Voting and Support Agreements entered into by certain shareholders of Seller in connection with
this Agreement, is not a party to any voting trust, voting agreement, shareholder, or other Contract relating to, binding on, or otherwise
affecting Seller’s right to freely transfer the Acquired Shares.
4.3
Authority; Execution and Delivery; Enforceability.
(a)
Power and Authority. Seller has full power and authority to execute and deliver the Transaction Documents to which Seller is a
party, to perform Seller’s obligations under such Transaction Documents, and to consummate the Contemplated Transactions applicable
to Seller, subject to the adoption of this Agreement by the holders of at least a majority in voting power of the outstanding capital
stock of Seller as a sale of substantially all of the assets of Seller under applicable Laws (the “Seller Stockholder Approval”).
The Seller Stockholder Approval is the only vote or consent of the holders of any class or series of capital stock of the Seller necessary
to approve this Agreement or the other transactions contemplated hereby.
(b)
Execution and Delivery; Enforceability. Each Transaction Document to which Seller is a party has been duly executed and delivered
by Seller and (assuming due authorization, execution, and delivery by Purchaser) constitutes the legal, valid, and binding obligation
of Seller, enforceable against Seller in accordance with its terms, subject to the Remedies Exception.
4.4
Consents and Authorizations; No Conflicts. The execution, delivery, and performance by Seller of each Transaction Document
to which Seller is a party, and the consummation of the Contemplated Transactions, do not and will not: (a) result in a violation or
breach of any provision of any Law or Order applicable to Seller; (b) except as contemplated by this Agreement, require the consent,
notice, or other action by any Person under, conflict with, result in a violation or breach of, constitute a default under (with notice
or lapse of time, or both), or give rise to any right of, or result in, the acceleration, termination, amendment, or cancellation of
any Contract to which Seller is a party; or (c) result in the creation or imposition of any Encumbrance, other than Permitted Equity
Encumbrances, on the Acquired Shares. Except as contemplated by this Agreement, no Consent of, declaration to, filing with, or notice
to, any Person or Governmental Entity is required by or with respect to Seller in connection with the execution and delivery of each
Transaction Document to which Seller is a party and the consummation of the Contemplated Transactions. Except as expressly set forth
in this Agreement and except for any compensation payable and expense reimbursements to Seller in the Ordinary Course of Business, the
Company neither owes, nor is obligated, to pay Seller (or any Affiliate(s) of Seller) any amount or owes any other obligation to any
of them, and neither Seller (nor any Affiliate(s) of Seller) has any claim of any kind against the Company or any shareholder, director,
officer, employee, agent, member, or manager of the Company.
4.5
Brokers. No broker, finder, or investment banker is entitled to any brokerage, finder’s, or other fee or commission
in connection with the Contemplated Transactions based upon arrangements made by or on behalf of Seller.
4.6
Solvency. There is no Proceeding pending or, to Seller’s Knowledge, threatened against Seller or any of its properties,
assets, or businesses, or any Order to which Seller is subject that (a) challenges or seeks to prevent, enjoin or otherwise delay the
Contemplated Transactions, or (b) would result in a Material Adverse Effect. Seller is not Insolvent as of immediately prior to the Closing.
4.7
Proceedings; Orders. There is no Proceeding pending or, to Seller’s Knowledge, threatened, or any outstanding Order
against, binding on, or otherwise affecting, Seller that may reasonably be expected to (a) cause, result in, or give rise to, any legal
restraint on, prohibition against, or delay of, the Contemplated Transactions, or (b) impair or have any adverse effect on, the ability
of Seller to perform its obligations under any Transaction Document to which Seller is a party or to consummate the Contemplated Transactions.
4.8
Investment Representations.
(a)
Seller is aware that the Purchaser Common Stock issued pursuant to this Agreement has not been registered under the Securities Act, and
that the such Purchaser Common is deemed to constitute “restricted securities” under Rule 144 promulgated under the Securities
Act (“Rule 144”). Seller also understands that such Purchaser Common Stock is being offered and sold pursuant
to an exemption from registration contained in the Securities Act based in part upon Seller’s warranties contained in this Article
IV.
(b)
Seller is obtaining the Purchaser Common Stock issued pursuant to this Agreement for its own account and has no present intention of
distributing or selling such Purchaser Common Stock except as permitted under the Securities Act, applicable state securities Laws and
the Voting and Support Agreements.
(c)
Seller has sufficient knowledge and experience in business and financial matters to evaluate Purchaser, its proposed activities and the
risks and merits of an investment in Purchaser Common Stock. Seller has the ability to accept the high risk and lack of liquidity inherent
in such an investment.
(d)
Seller has had an opportunity to discuss Purchaser’s business, management and financial affairs with directors, officers and management
of Purchaser. Seller has also had the opportunity to ask questions of and receive answers from Purchaser and its management regarding
the terms and conditions of an investment in Purchaser Common Stock. Seller understands the significant risks of such an investment.
(e)
Seller has the capacity to protect its own interests in connection with the issuance of the Purchaser Common Stock by virtue of its business
or financial expertise.
(f)
Seller understands that the Purchaser Common Stock issued pursuant to this Agreement must be held indefinitely unless such Purchaser
Common Stock is subsequently registered under the Securities Act or an exemption from such registration is available. Seller has been
advised or is aware of the provisions of Rule 144, as in effect from time to time, which permit limited resale of shares purchased in
a private placement subject to the satisfaction of certain conditions, including, among other things, the availability of certain current
public information about Purchaser, the resale occurring following the required holding period under Rule 144, and the number of shares
being sold during any three-month period not exceeding specified limitations. Seller further understands and agrees that an appropriate
restrictive legend will be placed on any certificates issued representing shares to be issued pursuant to this Agreement and appropriate
stop transfer instructions will be placed with Purchaser’s transfer agent with respect to the transfer of shares issued pursuant
to this Agreement.
(g)
Seller has satisfied itself as to the full observance of the Laws of its jurisdiction of residence in connection with the receipt of
the Purchaser Common Stock pursuant to this Agreement including (i) the legal requirements within its jurisdiction for the receipt of
such Purchaser Common Stock, (ii) any foreign exchange restrictions applicable to such acquisition, (iii) any government or other Consents
that may need to be obtained in connection with such acquisition, and (iv) the Income Tax and other Tax consequences, if any, that may
be relevant to the purchase, holding, redemption, sale or Transfer of such Purchaser Common Stock.
(h)
Seller is an “accredited investor” as defined in Regulation D promulgated under the Securities Act.
(i)
Seller is located at the address set forth next to Seller’s name on Section 4.8(i) of Seller’s Disclosure Schedule.
Article
V
Representations and Warranties Relating to the Company
Seller
represents and warrants to Purchaser:
5.1
Organization and Good Standing.
(a)
The Company was duly organized, is validly existing, and is in good standing (if the concept of good standing applies) under the laws
of the State of Minnesota. Copies of the Company’s Organizational Documents as of the Closing have been delivered or made available
to Purchaser prior to the date of this Agreement, and no changes have been made to such Organizational Documents since the date of delivery.
(b)
The Company has full corporate power and authority to own, lease, or otherwise hold its assets and properties and to carry on its business
as presently conducted. The Company is duly qualified, authorized, registered, or licensed and in good standing (if the concept of good
standing applies) to do business as a foreign Entity in each jurisdiction where the conduct or nature of its business or the ownership,
leasing, or holding of its assets and properties makes such qualification, authorization, registration, or licensure necessary. Each
jurisdiction where the Company is qualified, authorized, registered, or licensed as a foreign Entity is listed in Section 5.1 of Seller’s
Disclosure Schedule.
5.2
Equity Securities; Capitalization.
(a)
Capitalization. The Acquired Shares constitute 100% of the issued and outstanding Equity Securities of the Company. Section
5.2(a) of Seller’s Disclosure Schedule accurately and completely sets forth the capitalization of the Company immediately prior
to the Closing, including (i) each class of Equity Securities; and (ii) a list of the full legal names of each record and beneficial
owner of such Equity Securities, and opposite the name of each such owner, the percentage and class of Equity Securities owned by each
such owner.
(b)
Voting Debt. There are no authorized or outstanding bonds, debentures, notes, or other Indebtedness of the Company having the
right to vote on or approve (or containing any provision granting any holder thereof or other Person the right to vote on or approve),
or that are convertible into, or exchangeable for, securities having the right to vote on or approve, any matter on which any holder
of Equity Securities of the Company may vote on or approve (“Voting Debt”).
(c)
Subsidiaries. The Company has no Subsidiaries or other investments and does not own, directly or indirectly, (i) any Equity Security
in any other Person, or (ii) any interest in a partnership, unincorporated joint venture, or other arrangement with any other Person
involving the sharing of profits or losses, or in the nature of a partnership, joint venture, or other business enterprise.
(d)
Options. Except as set forth in Section 5.2(d) of Seller’s Disclosure Schedule, neither Seller nor the Company has
any options or other equity-based awards, issued, and outstanding or authorized for issuance, whether or not presently convertible, exercisable,
or exchangeable, or other commitments or undertakings (other than this Agreement) under which the Company is or may become obligated
to issue, deliver, transfer, or sell, or cause to be issued, delivered, transferred, or sold, any of its Equity Securities or any security
exercisable for, or convertible or exchangeable into, any Equity Securities of the Company or any Voting Debt. Prior to the Effective
Time, Seller and the Company shall have caused any options or other rights to acquired any Equity Securities of the Company to have been
assumed by the Seller or otherwise canceled by the Company, such that as of the Effective Time, there will be no other shares of the
Company’s capital stock subject to any option or other right to acquire any interest in the capital stock of the Company.
(e)
No Other Securities. Except for the Acquired Shares, there are no other Equity Securities or debt securities of the Company of
any class or series that are issued, reserved for issuance, or outstanding. No former equity owner of the Company, or any of its predecessors,
and no former holder of any right to acquire any interest in the Company, or any of its predecessors (whether by warrant, option, convertible
instrument, or otherwise), has any claim or rights against the Company.
(f)
Validity. The Acquired Shares were duly authorized and validly issued, are fully paid and non-assessable, and have been offered,
issued, sold, and delivered in compliance with all applicable Laws. None of the Acquired Shares were issued or are held in violation
of any purchase option, call option, right of first refusal, preemptive right, subscription right, or any similar right under the Organizational
Documents or any Contract of the Company or the owners of such Equity Securities.
(g)
Redemption; Voting Agreements. There are no agreements or outstanding obligations (contingent or otherwise) of the Company to
repurchase, redeem, or otherwise acquire any Acquired Shares. Except for the Voting and Support Agreements and as set forth in Section
5.2(g) of Seller’s Disclosure Schedule, there are no voting trusts, shareholder agreements, commitments, undertakings, understandings,
proxies, or other restrictions to which the Company is a party that, directly or indirectly, restrict or limit in any manner, or otherwise
relate to, the voting, sale, or other disposition of the Acquired Shares.
5.3
Authority; Execution and Delivery; Enforceability.
(a)
Power and Authority. The Company has full corporate power and authority to execute and deliver the Transaction Documents to which
it is a party, to perform its obligations under such Transaction Documents, and to consummate the Contemplated Transactions applicable
to the Company.
(b)
Due Authorization. The execution and delivery by the Company of the Transaction Documents to which it is a party, the Company’s
performance of its obligations under such Transaction Documents, and the Company’s consummation of the Contemplated Transactions
applicable to it, have been duly authorized by all necessary corporate action of the Company, including any required approvals under
applicable Law or the Company’s Organizational Documents.
(c)
Execution and Delivery; Enforceability. Each Transaction Document to which the Company is a party has been duly executed and delivered
by the Company, and (assuming due authorization, execution, and delivery by the other parties thereto) constitutes the legal, valid,
and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to the Remedies Exception.
5.4
Consents and Authorizations; No Conflicts. The execution, delivery, and performance by the Company of the Transaction Documents
to which it is a party, and the consummation of the Contemplated Transactions, do not and will not: (a) conflict with or result in a
violation or breach of any provision of the Company’s Organizational Documents; (b) result in a violation or breach of any provision
of any Law or Order applicable to the Company; (c) except as set forth in Section 5.4(c)(1) of Seller’s Disclosure Schedule,
require the consent, notice, or other action by any Person under, conflict with, result in a violation or breach of, constitute a default
under (with notice or lapse of time, or both), or give rise to any right of, or result in, the acceleration, termination, amendment,
or cancellation of any Benefit Plan or Contract to which the Company is a party or by which its assets are bound; or (d) result in the
creation or imposition of any Encumbrance, other than Permitted Encumbrances, with respect to any of the Company’s properties or
assets. Except as set forth in Section 5.4(c)(2) of Seller’s Disclosure Schedule, no Consent, Permit, Order, declaration,
or filing with, or notice to, any Governmental Entity is required by or with respect to the Company in connection with the execution
and delivery of any Transaction Document to which it is a party or the consummation of the Contemplated Transactions.
5.5
Financial Matters.
(a)
Section 5.5(a)(1) of Seller’s Disclosure Schedule sets forth correct and complete copies of (i) the Company’s unaudited
financial statements consisting of the consolidated balance sheets of the Company as of December 31, 2022 and December 31, 2023, and
the related statements of income, stockholders’ equity, and cash flows for the years then ended (collectively, the “Annual
Financial Statements”), and (ii) the unaudited financial statements consisting of the balance sheet of the Company as at
March 31, 2024, and the related statements of income, stockholders’ equity, and cash flows for the four-month period then ended,
(the “Interim Financial Statements” and, together with the Audited Financial Statements, the “Financial
Statements”). Except as set forth in Section 5.5(a)(2) of Seller’s Disclosure Schedule, the Financial Statements
(including the notes thereto, if any) fairly present in all material respects the financial position of the Company as of the respective
dates they were prepared and the results of the operations and cash flows of the Company for the periods indicated, all applied on a
consistent basis throughout the periods involved, subject to the absence of notes and, in the case of the Interim Financial Statements,
to normal and recurring year-end adjustments, none of which are material. The Financial Statements were derived from the books and records
of the Company. To the Knowledge of Seller, there has been no, and there does not currently exist any, fraud, nor the existence of or
allegation of financial improprieties that involves management of the Company. The balance sheet of the Company as of March 31, 2024,
is referred to in this Agreement as the “Interim Balance Sheet” and the date thereof as the “Interim
Balance Sheet Date.”
(b)
Neither the Company nor Seller has taken any action, or omitted to take any action, substantially for the purpose of artificially manipulating
the amount of the Company’s working capital since December 31, 2022. Since December 31, 2022, all operations of the Company, including
working capital, accounting policies, sales and marketing, human resources, and capital expenditures, have been managed in the Ordinary
Course of Business and in a manner required to support the on-going operations of the Company. Except as set forth in Section 5.5(b)
of Seller’s Disclosure Schedule, all working capital and accounting policies are presented on the Financial Statements in a
consistent fashion.
(c)
All notes and accounts receivable of the Company reflected on the Interim Balance Sheet or that have arisen since the Interim Balance
Sheet Date, except such notes and accounts receivable as have been collected after such date, are valid and enforceable claims and, to
the Knowledge of Seller, are not subject to any defense, offset, adjustment, or counterclaim, and none have been threatened in writing,
subject in each case to the reserve for bad debts reflected in the Interim Balance Sheet, which has been calculated in a consistent manner.
All such notes and accounts receivable of the Company arose in the Ordinary Course of Business from the sale and delivery of goods actually
made or the actual provision of services to customers of the Company, none of which, are equity owners or Affiliates of the Company.
All of the notes and accounts receivable of the Company are, in the aggregate, collectible within 90 days in full, net of the reserve
therefor, in the Ordinary Course of Business, except as provided for in the allowance for doubtful accounts. Section 5.5(c) of Seller’s
Disclosure Schedule sets forth a materially accurate aging of all accounts receivable of the Company as of the Interim Balance Sheet
Date. Neither the Company nor Seller has taken any action, or omitted to take any action, substantially for the purpose of artificially
manipulating the amount of the Company’s Accounts Receivable as of the Closing Date.
(d)
Section 5.5(d) of Seller’s Disclosure Schedule sets forth in reasonable detail, including aging by date of invoice, the
Company’s updated calculation of its Accounts Payable as of the Closing. Neither the Company nor Seller has taken any action, or
omitted to take any action, substantially for the purpose of artificially manipulating the amount of the Company’s Accounts Payable
as of the Closing Date.
(e)
Section 5.5(e) of Seller’s Disclosure Schedule sets forth in reasonable detail the Company’s updated calculation of
its Accrued Liabilities as of the Closing. Neither the Company nor Seller has taken any action, or omitted to take any action, substantially
for the purpose of artificially manipulating the amount of the Company’s Accrued Liabilities as of the Closing Date.
(f)
The Company maintains a system of internal controls over financial reporting (of a type customary for similarly situated companies) that
is reasonably sufficient to ensure that its books and records accurately reflect its assets and Liabilities in such a manner as to provide
reasonable assurance that the Company’s transactions are recorded as necessary to permit preparation of the Financial Statements
in a consistent manner, applicable Law and otherwise in a manner that fairly presents the financial condition and results of operations
of the Company as of the respective dates and periods thereof.
5.6
No Undisclosed Liabilities. The Company has no Liabilities of the nature required to be disclosed under GAAP, except
for the following, none of which results from, arises out of, relates to, is in the nature of, or was caused by any breach of Contract,
breach of warranty, tort, infringement, environmental liability, or violation of Law: (a) Liabilities included and reserved against on
its Interim Balance Sheet; (b) accounts payable and Liabilities (of the types required to be reflected as current liabilities on a balance
sheet prepared in accordance with GAAP) incurred by the Company since the Interim Balance Sheet Date in the Ordinary Course of Business;
or (c) the Liabilities set forth in Section 5.6(c) of Seller’s Disclosure Schedule.
5.7
Absence of Changes or Events. Since December 31, 2023, with the exception of any actions taken or Liabilities incurred as
expressly provided for in the Transaction Documents, the Company has conducted its business only in the Ordinary Course of Business.
Except as set forth by reference to the specific clause below in Section 5.7 of Seller’s Disclosure Schedule,
since December 31, 2023, other than actions taken or Liabilities incurred as expressly provided for in the Transaction Documents or as
otherwise approved by Purchaser, the Company has not:
(a)
sold, transferred, assigned, leased, subleased, licensed, or otherwise disposed of any of its assets, tangible or intangible, owned,
leased, or licensed, with a value in excess of $10,000.00 individually or $25,000.00 in any series of transactions, other than in the
Ordinary Course of Business;
(b)
entered into any Contract (or series of related Contracts) (i) in the Ordinary Course of Business and involving more than $25,000.00
and/or with a term greater than 12 months, which term may not be terminated by the Company upon 30 days’ notice, or (ii) outside
the Ordinary Course of Business and involving more than $10,000.00;
(c)
created, incurred, or permitted to arise any Encumbrance on any of its assets, tangible or intangible, other than Permitted Encumbrances;
(d)
made any capital expenditure (or series of related capital expenditures) or commitments therefor either (i) outside the Ordinary Course
of Business or (ii) involving more than $25,000.00 in the aggregate;
(e)
made any capital investment in, any loan to, or any acquisition of the securities or assets of, any other Person (or series of related
capital investments, loans, and acquisitions) outside the Ordinary Course of Business;
(f)
to the extent involving more than $25,000.00 in the aggregate, (i) issued, created, incurred, assumed, or guaranteed any Indebtedness
incurred other than in the Ordinary Course of Business, or (ii) made any voluntary purchase, cancellation, prepayment, or complete or
partial discharge in advance of a scheduled payment date with respect to any Indebtedness;
(g)
canceled, compromised, waived, or released any right or claim (or series of related rights and claims) outside the Ordinary Course of
Business;
(h)
made or authorized any change in its Organizational Documents;
(i)
issued, sold, or otherwise disposed of, or split, combined, or subdivided, any of its Equity Securities, or granted any options or other
rights to issue, sell, purchase, redeem, or acquire (including upon conversion, exchange, or exercise) any of its Equity Securities;
(j)
declared, set aside, or paid any dividends or other distributions, outside the Ordinary Course of Business distributions, with respect
to any of its Equity Securities or redeemed or purchased, directly or indirectly, any of its Equity Securities;
(k)
experienced any casualty, damage, destruction, theft, or loss (whether or not covered by insurance) to any of its assets and properties
resulting in losses in excess of $10,000.00 individually or $50,000.00 in the aggregate;
(l)
(i) increased or promised to increase the base compensation, wages, or other compensation of, or otherwise made any change in the employment
or retention terms for any of its respective employees, or (ii) paid any discretionary bonus or other cash or in kind award (other than
sales commissions in the Ordinary Course of Business) to, any of its respective employees;
(m)
adopted, entered into, become bound by, or amended, modified, or terminated, any collective-bargaining agreement, neutrality agreement
or other Contract of any kind with a labor union or labor organization;
(n)
other than in the Ordinary Course of Business or as required by applicable Laws, (i) adopted, entered into, become bound by, or amended,
modified, or terminated, any bonus, profit-sharing, incentive, severance, or other Benefit Plan, or any employment-related Contract or
compensation arrangement, or (ii) established or modified any (A) targets, goals, pools, or similar provisions under any Benefit Plan,
employment-related Contract, or other employee compensation arrangement, or (B) salary ranges, compensation increase guidelines, or similar
provision with respect to any Benefit Plan, employment-related Contract, or other employee compensation arrangement;
(o)
(i) made any change in the Tax reporting or accounting principles, practices, or policies, including with respect to (A) depreciation
or amortization policies or rates, (B) reserve amounts, or (C) the payment of accounts payable or the collection of accounts receivable;
(ii) settled, compromised, or agreed to any adjustment of any Tax liability or attribute; (iii) made, changed, or rescinded any Tax election;
(iv) amended any Tax Return; (v) surrendered any right in respect of a refund of Taxes; (vi) entered into any closing or similar agreement
with respect to Taxes; or (vii) consented to any extension or waiver of the limitation period applicable to any claim or assessment in
respect of Taxes;
(p)
instituted or settled any Proceeding;
(q)
made any write-off or write-down of or made any determination to write-off or write-down any of its properties and assets in excess of
$5,000.00 in the aggregate;
(r)
made any material change in the general pricing practices or policies or the credit or allowance practices or policies of the Company,
including any discounting or increased credit terms;
(s)
outside the Ordinary Course of Business, entered into any amendment, modification, termination (partial or complete), or granted any
waiver under or given any Consent with respect to any Contract that is required to be disclosed on Seller’s Disclosure Schedule;
(t)
excluding via commercially available shrink-wrap licenses, licensed in or purchased any Intellectual Property other than in the Ordinary
Course of Business or licensed out or otherwise permitted any Person to use any Company Intellectual Property outside the Ordinary Course
of Business;
(u)
accelerated the collection of any Accounts Receivable, deferred the payment of any Accounts Payable, or otherwise altered or amended
its practices with respect to items affecting working capital;
(v)
other than, in each case, as required by GAAP or applicable Law, (i) made any material changes to any of its methods of accounting or
methods of reporting revenue and expenses or accounting practices, or (ii) writing up, writing down, or writing off the book value of
any material assets, individually or in the aggregate, of the Company;
(w)
entered into (i) any Material Contract, or (ii) any new customer relationship reasonably expected to realize more than $100,000.00 in
the current calendar year;
(x)
commenced or terminated any line of business;
(y)
adopted any plan of merger, consolidation, reorganization, liquidation, or dissolution or filing of a petition in bankruptcy under any
provisions of federal or state bankruptcy Law or consented to the filing of any bankruptcy petition against it under any similar Law;
(z)
suffered or been threatened in writing with any material adverse change in the business operations or financial condition of the Company,
that has had, or would reasonably be expected to have, a Material Adverse Effect;
(aa)
entered into any transaction between the Company, on the one part, and any of its Related Parties or Representatives or any Affiliate
of any Representative or Related Party, on the other part; or
(bb)
agreed to enter into, offered to enter into, or amended or modified, verbally, orally, or by any other means, any Contract to do any
of the foregoing.
5.8
Indebtedness. Section 5.8 of Seller’s Disclosure Schedule sets forth, with respect to the Company, a correct
and complete itemized list of: (a) all Indebtedness of the Company (including the Non-Assumed Indebtedness), the Person to whom such
amounts are owed, and the amounts outstanding with respect to such Indebtedness as of the date of this Agreement; and (b) the Seller
Transaction Expenses and the Person to whom such amounts are owed. Except as set forth in Section 5.8 of Seller’s Disclosure
Schedule, the Company has the unrestricted right to pay or pre-pay all such Indebtedness at its par value without penalty or premium,
in part or in full, at any time or from time to time after the date of this Agreement. Neither the Company nor Seller has taken any action,
or omitted to take any action, substantially for the purpose of artificially manipulating the amount of the Company’s Indebtedness
or Seller Transaction Expenses.
5.9
Deposits. Section 5.9 of Seller’s Disclosure Schedule is an accurate and complete list of all assets
of the Company that constitute an unreturned security or other deposit, surety bond, rights under a letter of credit, collateral pledged
to secure an obligation or Liability, prepayment, prepaid expense, claim for refund or right to set off (each, a “Deposit”),
including any such Deposits in the possession or control of any lender or third-party financing source of the Company.
5.10
Title to Assets; Real Property.
(a)
Title to Assets. The Company has good and valid title to, or a valid leasehold interest in or license to, all of the tangible
personal property and other non-real estate assets reflected in its Interim Balance Sheet or acquired after the Interim Balance Sheet
Date, other than properties and assets sold or otherwise disposed of in the Ordinary Course of Business since the Interim Balance Sheet
Date. All such properties and assets are free and clear of Encumbrances except for Permitted Encumbrances. All such properties and assets
are in good condition and repair (subject to normal wear and tear) and are sufficient for the operation of the Company’s business.
The Company is the only operation through which the Business is conducted, and no similar business is conducted by any Affiliate of the
Company or Seller. Such properties and assets constitute all of the tangible personal property and assets necessary for the continued
conduct of the Business as currently conducted and are owned or leased (under a valid leasehold arrangement) by the Company and none
of such properties and assets are held by any Affiliate of the Company or Seller other than as set forth in Section 5.24 of Seller’s
Disclosure Schedule.
(b)
Owned Real Property. The Company neither currently owns, nor has it ever owned, any real property.
(c)
Leased Real Property. Section 5.10(c) of Seller’s Disclosure Schedule sets forth a correct and complete list of all
real property leased, licensed, or otherwise used or occupied (but not owned) at Closing by the Company (collectively, the “Leased
Real Property”) under any lease, sublease, license, concession, or other agreement allowing for occupancy of the Leased
Real Property (each, a “Real Property Lease”). The Company has a valid and subsisting leasehold interest in
its Leased Real Property, in each case free and clear of all Encumbrances, other than the Real Estate Encumbrances. All such Real Property
Leases are in full force and effect, and there are no existing breaches or defaults by, or any events that with or without the passage
of time or the giving of notice, or both, would constitute a breach, default, or an event of default by, the Company under any Real Property
Lease to which it is a party, or, to the Knowledge of Seller, by any other party to any such Real Property Lease. To the Knowledge of
Seller, there exists no condition, restriction or reservation that would prevent the Business, and the Company in its operation of the
Business after the Closing Date, from enforcing its rights with respect to Leased Real Property after the Closing to the same full extent
the Company could if the Contemplated Transactions did not occur. The operations of the Company on the Leased Real Property do not violate
any applicable Law. All material certificates of occupancy, permits, licenses, approvals and other authorizations required to be held
by the Company in connection with the past and present operations of the Company and the Business on the Leased Real Property have been
lawfully issued to the Company and are, as of the date of this Agreement, and will be following the consummation of the Contemplated
Transactions, in full force and effect. The Leased Real Property is in satisfactory operating condition and repair (ordinary wear and
tear excepted). Correct and complete copies of the Real Property Leases, including all amendments and modifications thereto, have been
delivered or made available to Purchaser prior to the date of this Agreement, and no changes have been made to any Real Property Leases
since the date of delivery. The Leased Real Property has not been subleased or licensed by the Company, and the Company is the only party
in occupancy of the Leased Real Property.
(d)
The Company has good and valid title to, or a valid leasehold or licensed interest in all Permits applicable to the Leased Real Property
that are set forth on Section 5.10(d) of Seller’s Disclosure Schedule.
5.11
Intellectual Property.
(a)
Section 5.11(a) of Seller’s Disclosure Schedule contains a true, correct and complete list of each of the following items
of Intellectual Property in which the Company has an ownership interest of any nature, or which is registered in the name of, on behalf
of or by the Company: all patents, patent applications, provisional patent applications, trademark registrations, trademark applications,
unregistered trademarks, trade names, copyright registrations, copyright applications, and Internet domain name registrations. Section
5.11(a) of Seller’s Disclosure Schedule accurately summarizes, where applicable, the following for each item of scheduled Intellectual
Property: patent number, application number, registration number, filing date, date of issuance, applicant, mark or name, country of
origin, and all steps required for the maintenance or protection of such Intellectual Property, including the filing of assignments or
declarations from inventors, each of the products or services of the Company that embodies, utilizes, or is based upon or derived from
(or, with respect to products and services under development, that are expected to embody, utilize, or be based upon or derived from)
such item. The Company exclusively owns all rights, title, and interests in and to the Intellectual Property currently used by the Company
or necessary to conduct the Business as currently conducted (the “Company Intellectual Property”), or otherwise
has the right or license to use the Intellectual Property currently used by the Company or necessary to conduct the Business as currently
conducted (the “Company Licensed Intellectual Property”), free from (i) any Encumbrances (except Permitted
Encumbrances), and (ii) any requirement of any past, present or future royalty payments, license fees, charges, or other payments. Except
pursuant to a Contract set forth in Section 5.12(a)(xxiii) of Seller’s Disclosure Schedule, the Company has not licensed
or granted, and is not otherwise obligated to license or grant any right to, any Person any Company Intellectual Property, nor has the
Company otherwise agreed not to assert any such Company Intellectual Property against any Person. All Company Intellectual Property is
(i) valid, subsisting, and enforceable, and (ii) in full force and effect (and all renewal and maintenance fees in respect of each item
of patented or registered Company Intellectual Property have been duly paid), and no Company Intellectual Property is the subject to
any challenge, opposition, cancellation or nullity proceeding, Inter Partes Review or reexamination, or interference or threats to commence
the same. To the Knowledge of Seller, all Company Licensed Intellectual Property is (i) valid, subsisting, and enforceable, and (ii)
in full force and effect (and all renewal and maintenance fees in respect of each item of patented or registered Company Licensed Intellectual
Property have been duly paid), and no Company Licensed Intellectual Property is the subject to any challenge, opposition, cancellation
or nullity proceeding, Inter Partes Review or reexamination, or interference or threats to commence the same.
(b)
Except as set forth in Section 5.11(b) of Seller’s Disclosure Schedule: (i) Company Intellectual Property as currently licensed
or used by the Company, the Company’s conduct of the Business as currently conducted, and the Company’s products and services,
do not infringe, violate, or misappropriate the Intellectual Property of any Person, and there is no pending or threatened action or
claim or allegation asserting such infringement, violation, or misappropriation of Intellectual Property by any Person; and (ii) to the
Knowledge of Seller, no Person is infringing, violating, or misappropriating any Company Intellectual Property, and there is no pending
or threatened action or claim or allegation asserting such infringement, violation, or misappropriation of Company Intellectual Property
against any third Person.
(c)
The Software and Information Systems owned by the Company or leased or licensed for use in the conduct of the Business: (i) are sufficient
for the immediate and future needs of the Business as currently conducted and as currently proposed to be conducted, and for their intended
function, operation and purposes; (ii) have operated and currently operate in a reasonable manner without material malfunction, unplanned
downtime, or disruption or interruption; (iii) are free from any disabling code, time bomb, virus or other malicious or harmful code,
and (iv) the Company has taken commercially reasonable actions consistent with other businesses in its industry, to safeguard the Software
and Information Systems owned by the Company or used in the conduct of the Business, including protecting its security, continuity and
integrity.
(d)
Except as set forth in Section 5.11(d) of Seller’s Disclosure Schedule, (i) all Persons who participated in or contributed
to the authorship, creation, development, or conception of any Intellectual Property or Company products for or on behalf of, or under
the direction or supervision of, the Company in connection with the Business, (ii)all current directors, officers, employees of the Company,
and (iii) all contractors, consultants, and agents of the Company with access to the Company’s Trade Secrets, have entered into
confidentiality, intellectual property assignment, waiver of moral rights, and proprietary information agreements with and in favor of
the Company, and with respect to clause (i), providing for the assignment (via a present grant of assignment) by such Person to the Company
of all right, title, and interest in and to all Intellectual Property arising out of such Person’s employment by, engagement by,
or contract with the Company, and, to the Knowledge of Seller, there has not been any breach of any of the foregoing agreements. The
Company has taken all actions reasonably necessary to maintain, protect and defend the Company Intellectual Property, including and where
applicable, (i) paying all application, examination, registration, issue, renewal and maintenance fees that have become due, (ii) filing
all necessary documents and certificates with the relevant patent, copyright, trademark or other authorities, including statements of
use for trademarks, (iii) recording documents of title and releases of liens required to perfect rights in the Company Intellectual Property,
(iv) marking its products to indicate ownership of Intellectual Property embodied in such products and to preserve the right to seek
and obtain damages for the violation of such Intellectual Property, (v) have policed Company Intellectual Property for infringement,
misappropriation or other violations, and (vi) using reasonable measures to maintain the secrecy of all of the Company’s Trade
Secrets that are material to the Company’s operations and are valuable thereto by virtue of their secrecy. The Company’s
Trade Secrets are not part of the public knowledge or literature and have not been used, divulged or appropriated for the benefit of
any Person and neither the Company nor Seller has received notice (in writing or otherwise) that any of the Company’s Trade Secrets
are or have become part of the public knowledge or literature or been used, divulged or appropriated by any Person.
(e)
Upon the Closing, the Company will own and have the valid right to exploit all Company Intellectual Property or be licensed to or otherwise
have the valid right to exploit the Company Licensed Intellectual Property as of the Closing Date upon the same terms and subject to
the same conditions as exploited by the Company prior to the Closing. There exists no condition, restriction or reservation affecting
the title to, rights in, or utility of Company Intellectual Property that would prevent the Company from enforcing or exploiting any
of its rights with respect to Company Intellectual Property after the Closing to the same full extent that the Company might do so if
the sale and transfer contemplated hereby did not take place.
(f)
To the Seller’s Knowledge, the Company is, and during the past three (3) years have been, in compliance, in all material respects,
with (i) all Privacy and Information Security Requirements, (ii) their Privacy Notices, and (iii) all contracts relating to the Processing
of Personal Information. The Company has reasonable safeguards in place designed to protect Personal Information and other confidential
data in its possession or under its control against, loss, theft, or unauthorized disclosure, and requires the same of all vendors that
Process Personal Information on its behalf. There have been no material breaches involving Personal Information in the possession or
control of the Company or any of its Subsidiaries, and to the Knowledge of Seller there has been no unauthorized or illegal use of or
access to any Personal Information, in the past four (4) years. The Company has not notified, nor to the Knowledge of Seller been required
to notify, any Person of any information security breach involving Personal Information. Neither the Company, nor any Subsidiary, has
received any notice, allegation, complaint or other communication, and there is no pending investigation by any Governmental Entity or
payment card association, regarding any actual or possible violation of any Privacy and Information Security Requirements by or with
respect to the Company or any of its Subsidiaries, in either case that would or would reasonably expected to result, individually or
in the aggregate, in a Material Adverse Effect. The Company and/or any of the Subsidiaries have provided all requisite notices and obtained
all required consents, and satisfied all other requirements in all material respects (including but not limited to notification to Governmental
Authorities), necessary for the Company and/or any of the Subsidiaries’ Processing (including international and onward transfer)
of all Personal Information in connection with the conduct of the business as currently conducted. For purposes hereof, “Personal
Information” means, in addition to any definition for any similar term (e.g., “personally identifiable information”
or “PII”) provided by applicable law, all information that identifies an individual or, in combination with any other information
or data, is capable of identifying or locating an individual; Personal Information includes (i) “Protected Health Information,”
as defined by the Health Insurance Portability and Accountability Act of 1986 (Pub. L. No. 104-191), as amended and the rules and regulations
issued thereunder (“HIPAA”), (ii) “Personal Data,” as defined by the EU’s General Data Protection
Regulation (“GDPR”), (iii) “Personal Information,” as defined by the California Consumer Privacy
Act of 2018 (the “CCPA”), and (iv) similar personal or private information under any other similar state law
to the CCPA (“Other State Privacy Law”); “Privacy and Information Security Requirements”
means (i) all Laws relating to the Processing of Personal Information, data privacy or information security, including HIPAA, GDPR, CCPA
or Other State Law, and the payment card information data security standards; “Privacy Notices” means any internal
and external notices, policies, disclosures, or public representations by the Company or any of the Subsidiaries with respect to the
Processing of Personal Information or privacy practices; “Process” or “Processing”
means the collection, use, storage, processing, distribution, transfer, import, export, protection (including security measures), disposal
or disclosure or other activity regarding data (whether electronically or in any other form or medium).
(g)
There are no problems or defects in the Software owned or used by the Company that prevent such Software from operating substantially
as described in its related documentation or specifications and otherwise in fulfillment of its intended purpose. The Company has given
Purchaser full access to any and all information, data, and databases in its possession documenting any defects, bugs or problems in
such Software.
(h)
The Company has not used, combined, incorporated, distributed, or embedded any Open Source Materials, copy left, or community Source
Code with or into any of its Software that is generally available or in development in a manner that would impose a requirement or condition
that any Intellectual Property necessary to conduct its business as currently conducted or otherwise in its possession (including any
portion of its products, platform, or Source Code) (i) be subject to an Open Source License, (ii) prohibits or limits the Company’s
freedom to seek full compensation in connection with marketing, licensing, and distributing any products offered by the Company, or (iii)
requires the Company to publish or distribute the Source Code to its products or allows any Person or requires that any Person have the
right to decompile, disassemble or otherwise reverse engineer any products offered by the Company.
(i)
All use and distribution of Open Source Materials utilized in the Software owned or used by the Company is in compliance with the Open
Source Licenses applicable to such use and distribution, including all copyright notice and attribution requirements.
(j)
Neither the Company nor any other party acting on behalf of the Company has disclosed or delivered, or permitted the disclosure or delivery
by any escrow agent, to any third party any Source Code owned by the Company. No event has occurred, and no breach or similar condition
exists, that (with or without notice or lapse of time, or both) will, or would reasonably be expected to, require the disclosure or delivery
of any Source Code owned by the Company or any other party acting on behalf of the Company, including any such delivery by an escrow
agent. The Company has not deposited, nor is or may be required to deposit, with an escrow agent, any Source Code owned by the Company.
(k)
The Company has taken commercially reasonable measures to prevent the inclusion of computer code in any of the Software owned by the
Company: (i) designed to intentionally harm in any manner the operation of such Software, or any other associated Software, firmware,
hardware, computer system, or network (sometimes referred to as “viruses” or “worms”); (ii) that would intentionally
disable such Software or impair in any way its operation based on the elapsing of a period of time or advancement of a particular date
(sometimes referred to as “time bombs,” “time locks,” or “drop dead” devices), except where the possibility
of such disabling is communicated to the user; (iii) that would permit the Company or any third party to access such Software (except
for Software for which the possibility of access is communicated to the user) to intentionally cause the Software to cease functioning;
or (iv) that would permit the Company or any third party to access such Software to intentionally cause any harmful and malicious procedures,
routines, or mechanisms that would cause the Software to damage or corrupt data, storage media, programs, equipment, or communications.
No Software owned by the Company currently contains such code or any bug, problem, flaw, or similar issue that may adversely affect the
value, functionality, or fitness for the intended purposes of its Software products.
(l)
The Company has implemented at least industry standard procedures and practices for the archival, back-up, recovery, and restoration
of its material business data.
(m)
No Person has claimed any compensation from the Company for the loss of or unauthorized disclosure or transfer of personal data, and
no facts or circumstances exist that might reasonably be expected to give rise to such a claim insofar as the same relate to the Company.
The Company has not had: (i) any data breaches; or (ii) any loss, unauthorized disclosure, or transfer of personal data.
(n)
None of the Company Intellectual Property was developed by or on behalf of, or using grants or any other subsidies of, any government
authority, public authority, university, corporate sponsor or other third party (“R&D Sponsor”), except
as set forth in Section 5.11(n) of Seller’s Disclosure Schedule. None of the employees, consultants or independent contractors
of the Company who are or were involved in, or who contributed to, the creation or development of any of the Company Intellectual Property
during the time period in which such Person was engaged by the Company for the purpose of such contribution, creation or development
of any of the Company Intellectual Property, was an employee of any R&D Sponsor without receiving the approval of the relevant R&D
Sponsor to such engagement with the Company, to the extent such approval was required.
5.12
Material Contracts.
(a)
Section 5.12(a) of Seller’s Disclosure Schedule sets forth a correct and complete list of each of the following Contracts
currently in force (other than any Permits set forth on Section 5.15(b) of Seller’s Disclosure Schedule and any Transaction
Documents to which Purchaser is a party), to which the Company is a party, under which the Company has any Liability, or by which the
Company or any of its assets and properties are bound (collectively and with all amendments, modifications, and supplements thereto,
the “Material Contracts”):
(i)
any Contract (or series of Contracts) with any (A) current customer of the Company, (B) Material Client, or (C) Governmental Entity (including
any Contract that relates to any Liability or obligation of the Company to any Governmental Entity);
(ii)
any Contract with a Material Vendor;
(iii)
any Contract (or series of Contracts) for the future or ongoing provision of products or services, or the future or ongoing purchase
or sale, maintenance, or acquisition of goods, materials, supplies, merchandise, or equipment (including computer hardware or software),
in each case, (A) the performance or term of which extends or will extend over a period of more than 12 months, (B) that results or is
reasonably anticipated to result in a material loss or reduction in profitability to Company, or (C) that constitutes a requirements,
output, or similar Contract;
(iv)
any Contract (or series of Contracts) under which the Company has any indemnification, defense, hold harmless, reimbursement, or contribution
obligation or Liability outside the Ordinary Course of Business;
(v)
any Contract involving a material distributor, sales representative, dealer broker, or marketing or advertising arrangement that by its
express terms is not terminable by the Company at will or by giving notice of 30 days or less, without liability;
(vi)
any Contract pursuant to which any third party agrees to act as an agent of the Company;
(vii)
any Contract that includes any of the following or similar terms: (A) profit, commission or cost sharing, (B) consignment or forward
warehousing, (C) production cost sharing, (D) marketing, advertising, or other allowances, (E) credit terms beyond 90 days, financing
other than on an accounts payable basis or the grant of a security interest to secure payment or credit extended, (F) joint ventures,
or (G) payment in any noncash form, including by way of example and not limitation equity, awards, incentives, or other property;
(viii)
any Contract under which the Company gives or has committed to give, or has made any or committed to make any change in any arrangement
for, any rebate or free or discounted services to any customer, or any other financial or in-kind incentive;
(ix)
any Contract under which the Company receives, has received, or is entitled to receive, any rebate or free or discounted merchandise
from any vendor, or other financial or in-kind incentive;
(x)
any Contract providing for any offset, countertrade, or barter arrangement;
(xi)
any Contract containing any (A) exclusivity provision, stand-still provision, non-solicitation or non-hire provision, or covenant prohibiting
or limiting competition in any line of business or with any Person or in any geographic area, (B) “most favored nation” provision,
special warranties, agreements to take back or exchange goods, consignment arrangements, or similar understandings with a customer or
supplier, (C) right of first refusal, right of first offer, or other preferential right to purchase any assets and properties of the
Company, (D) minimum purchase volumes or purchase volume discounts, (E) material “take-or-pay” provision (i.e., a
contract in which the buyer will pay some amount or a penalty in excess of $10,000.00 regardless of whether the product or service to
be provided thereunder is actually provided), or (F) confidentiality or non-disclosure terms other than Ordinary Course of Business purchase
orders;
(xii)
any Contract between or among the Company, on the one hand, and (A) Seller, (B) any Affiliate of the Company or Seller, (C) any directors,
managers, or officers of the Company, or (D) any Related Party of any Person described in clauses (A) through (C) of this
subsection (xii), on the other hand;
(xiii)
any Contract that (A) relates to Indebtedness, or (B) grants or creates any Encumbrance upon any material assets and properties of the
Company;
(xiv)
any Contract that constitutes (A) a guaranty of any Indebtedness of any other Person, or (B) a surety bond, performance bond, letter
of credit, hedge arrangement, or similar instrument;
(xv)
any Contract for capital expenditures or the acquisition or construction of fixed assets outside the Ordinary Course of Business requiring
the payment by the Company of an amount in excess of $10,000.00 per Contract;
(xvi)
any Contract providing for or relating to (including any review or non-disclosure Contract) (A) the assignment, sale, transfer, exchange,
pledge, or other disposition of any assets and properties owned, leased, licensed, used, or held for use by the Company (other than inventory
and vehicle fleet replacement sales in the Ordinary Course of Business), or (B) any merger, consolidation, or other business combination
involving the Company or Seller or any other Person in such Person’s capacity as a direct or indirect owner of the Company;
(xvii)
any Contract relating to the purchase, exchange, contribution, transfer, or other disposition, directly or indirectly (including by merger),
of the assets or business of any third party that involves (A) all or substantially all of the assets or business of such third party,
or (B) consideration payable by the Company;
(xviii)
any management, consulting, independent contractor, agency, brokerage, employment, commission, bonus, retention, severance, or similar
Contract, including any agreement obligating the Company to pay a bonus (or similar payment) as a result of the Contemplated Transactions;
(xix)
any Contract relating to any joint venture, partnership, or similar arrangement, and all other similar contracts (however named) that
involve a sharing of profits, losses, costs, or liabilities by the Company with any other Person;
(xx)
any voting trust or similar agreement relating to any Acquired Shares or any Equity Securities of Seller to which Seller or the Company
is a party;
(xxi)
any Contract relating to a matter disclosed or required to be disclosed in Section 5.7 of Seller’s Disclosure Schedule;
(xxii)
any collective-bargaining arrangement, neutrality agreement, or other Contract of any kind with a labor union or labor organization;
(xxiii)
any Contract concerning the use of or restricting the use of any Company Intellectual Property, or under which any third Person has granted
to the Company any license to Intellectual Property (other than generally commercially available software products);
(xxiv)
any Contract pertaining to the lease of real or personal property;
(xxv)
any Contract granting a power of attorney to any Person;
(xxvi)
any Contract (or series of Contracts) or Order, not otherwise identified in the foregoing subsections of this Section 5.12(a),
that (A) involves or is reasonably anticipated to involve consideration in the aggregate in excess of $25,000.00 in any 12-month period
or $50,000.00 over the term of the Contract, or (B) may not be terminated by the Company on 90 days’ notice or less, (C) is material
to the Business or the use of its assets and properties or (D) is not freely assignable without consent of the other party(ies) thereto;
and
(xxvii)
each material amendment, supplement, and modification in respect of any of the foregoing.
(b)
Purchaser has been provided correct and complete copies of each written Material Contract and description (including all material terms)
of each oral Material Contract, and no changes have been made to such Material Contracts since the date of delivery. All Material Contracts
are valid, binding, in full force and effect, and enforceable against the Company, and, to the Knowledge of Seller, the other parties
to such Material Contract. The Company has made all payments and performed all material obligations required to be paid or performed
by the Company under any Material Contract to which the Company is a party or bound. Neither the Company, nor, to the Knowledge of Seller,
any other Person that is a party to any Material Contract, is in breach of or default under such Material Contract in any material respect,
and no event has occurred that, with notice or lapse of time or both, would constitute such a breach or default. The Company has not
released any of its rights under any Material Contract and no party to a Material Contract has repudiated any of the terms thereof or,
to the Knowledge of Seller, threatened to terminate, cancel, or not renew any Material Contract. Except in the Ordinary Course of Business,
the Company is not participating in any discussions or negotiations regarding any material modification of, or any material amendment
to, any Material Contract or entry into any new Material Contract applicable to the Company or the real or personal property of the Company.
(c)
Except as set forth on Section 5.12(c) of Seller’s Disclosure Schedule, no Seller or any Related Party of Seller (other
than the Company), or, to the Knowledge of Seller, any employee of the Company has entered into any Contract or other material business
relationship (in each case other than on behalf of the Company as an authorized employee), including as a partner, joint venture party,
agent, representative or service provider, with any Person that is, or has at any time over the five-year period ending on the Closing
Date been a customer, vendor, supplier, service provider, business partner, or joint venture of the Company.
(d)
To the Seller’s Knowledge, except as described in Section 5.12(d) of Seller’s Disclosure Schedule, the Company
has complied and is currently in compliance in all material respects with all Laws and contractual requirements (including, for avoidance
of doubt, flow-down clauses and provisions incorporated by reference) pertaining to the Contracts and bids with any Governmental Entity.
With respect to any Contracts and bids with any Governmental Entity, (i) there is no outstanding claim or dispute involving the Company;
(ii) no Governmental Entity nor any higher-tier contractor or subcontractor has in the past five years notified the Company of Proceedings
or any actual or alleged violation or breach by the Company of any Law or contractual requirement of such Contract; (iii) all representations,
certifications, and disclosure statements made or submitted by or on behalf of the Company were current, accurate, and complete as of
the date submitted; and (iv) the Company has complied with all applicable representations, certifications, and disclosure requirements
with respect thereto.
(e)
None of the Company’s Material Contracts with a distributor or sales representative provides for the ability return any goods or
are otherwise subject to a restocking fee, and the Company is not under any obligation to accept the return of the any of the Company’s
products sold or delivered with respect to any such Agreement or obligation to otherwise refund purchase price of the products distributed
thereunder.
5.13
Insurance. Section 5.13(a) of Seller’s Disclosure Schedule sets forth a correct
and complete list of all insurance policies maintained by the Company or with respect to which the Company or any of its directors, managers,
or officers is a named insured or otherwise the beneficiary of coverage (excluding any policies relating to Benefits Plans) (collectively,
the “Insurance Policies”). The Insurance Policies are in full force
and effect and all premiums due on such Insurance Policies have been paid, except as set forth in Section 5.13(b) of Seller’s
Disclosure Schedule. Correct and complete copies of the Insurance Policies have been delivered or made available to Purchaser prior
to the date of this Agreement, and no changes have been made to any of the Insurance Policies since the date of delivery. No notice in
writing (or to the Knowledge of Seller, verbal or otherwise) of nonrenewal, cancellation, or termination or of material increases to
the premiums thereunder has been provided to the Company with respect to the Insurance Policies. The Insurance Policies are sufficient
to comply with the requirements of all applicable Laws and Contracts to which the Company or its assets or business are subject. During
the last three years, the Company has not been refused any insurance with respect to its assets or business, nor has coverage been limited
by any insurance carrier to which the Company applied for or has carried insurance. No event relating to the Company has occurred that
would reasonably be expected to result in a retroactive upward adjustment in premiums under any Insurance Policy. None of the policy
limits of such Insurance Policies have been exhausted, nor has the Company failed to give any notice or to present any claim thereunder
in due and timely fashion. No letters of credit have been posted or cash restricted for the benefit of any Insurance Policies.
5.14
Legal Proceedings; Orders.
(a)
Section 5.14(a)(i) of Seller’s Disclosure Schedule sets forth an accurate and complete list of all pending or, to the Knowledge
of Seller, threatened Proceedings involving the Company, Seller, or, to the Knowledge of Seller, the Company’s other Representatives
and includes for each such Proceeding the name of the claimant, the date of the alleged act or omission, a detailed narrative as to the
nature of the alleged act or omission, the date the matter was referred to an insurance carrier of the Company (if referred), the estimated
amount of exposure, the amount the Company has reserved, or the amount of the Company’s claim and estimated expenses of the Company
in connection with such matters. Except as set forth on Section 5.14(a)(ii) of Seller’s Disclosure Schedule, there is no
pending or threatened Proceeding that is not fully covered by the Insurance Policies referenced in Section 5.13. To the Knowledge
of Seller, there is no event or condition that would reasonably be expected to give rise to or serve as the basis for any Proceeding
that, individually or in the aggregate, would result in a material Liability to the Company (material defined as in excess of $25,000.00).
There is no pending or, to the Knowledge of Seller, threatened Proceeding that seeks to prevent consummation of the Contemplated Transactions
or that seeks damages in connection with the Contemplated Transactions.
(b)
There are no, and there have not been for the past five years any, outstanding Orders against or solely affecting the Company or any
of its properties or assets, or prohibiting any officer, director, manager, agent, consultant, or employee of the Company from engaging
in or continuing any conduct, activity, or practice, relating to the business of the Company or from consummating the Contemplated Transactions.
5.15
Compliance with Laws; Permits.
(a)
To the Seller’s Knowledge, except as set forth in Section 5.15(a) of Seller’s Disclosure Schedule, the Company is,
and for the past three years has been, in compliance in all material respects with all Laws and Orders applicable to it or its business,
properties, or assets. Within the three (3) years prior to Closing, the Company has not received any written notice (or to the Knowledge
of Seller, verbal or otherwise) from any Governmental Entity or any other Person regarding any actual or alleged violation of, or failure
to comply with, or liability under any applicable Law or Order.
(b)
Section 5.15(b) of Seller’s Disclosure Schedule sets forth a correct and complete list and description (including date of
issue and expiration) of all Permits held by the Company, during the past five years, and used by them in the conduct of their business.
The Company is in compliance in all material respects with all Permits set forth (or required to be set forth) on Section 5.15(b)
of Seller’s Disclosure Schedule. All Permits required for the Company to conduct its business have been obtained by them, including
all Permits required by the FDA or any other Governmental Entity engaged in the regulation of the development, testing, manufacturing,
labeling, storage, recordkeeping, promotion, marketing, distribution and service of medical devices (each, a “Regulatory
Agency”) and are valid and in full force and effect, and the Company is in material compliance with the terms of each Permit
listed, or required to be listed, on Section 5.15(b) of Seller’s Disclosure Schedule. The Company has not received any notice
of proceedings relating to the revocation or modification of any such Permit. To the Knowledge of Seller, there are no facts or circumstances
that could reasonably lead to the revocation or cancellation of any material Permit or would prevent the Company from obtaining and maintaining
in effect any material Permit.
(c)
Studies and Other Preclinical and Clinical Tests. The studies, tests and preclinical and clinical trials conducted by or on behalf
of the Company were, and if still pending are, being conducted in all material respects in accordance with experimental protocols, procedures
and controls pursuant to applicable statutory and regulatory requirements, as well as accepted professional and scientific standards;
and the Company has not received any notices or correspondence from the FDA or any foreign, state or local governmental body exercising
comparable authority or any institutional review board or comparable authority requiring the termination, suspension or material modification
of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company.
(d)
Debarment or Conviction. None of the Company or any of its Affiliates, subcontractors or employees (A) has been debarred, (B)
is subject to debarment or (C) is the subject of a conviction, in each case pursuant to Section 335a of the United States Federal Food,
Drug and Cosmetic Act, as amended.
(e)
Other Regulatory Matters. To the Seller’s knowledge, the Company is in compliance, in all material respects, with all Health
Care Laws (as defined below). As to each product of the Company subject to the jurisdiction of any Regulatory Agency that is manufactured,
packaged, labeled, tested, distributed, sold, and/or marketed by the Company, such product has been, and is being, manufactured, packaged,
labeled, tested, distributed, sold and/or marketed by the Company in compliance in all material respects with all applicable requirements
under the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder, and similar applicable U.S. federal, state
or local, EU or other foreign laws, rules and regulations relating to registration, investigational use, premarket clearance, licensure,
or application approval, good manufacturing practices, good laboratory practices, good clinical practices, product listing, quotas, labeling,
advertising, record keeping and filing of reports. There is no pending, completed or, to the Knowledge of Seller, threatened, action
(including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against
the Company, and the Company has not received any notice, warning letter or other communication from any Regulatory Agency, which (A)
contests the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging
of, the testing of, the sale of, or the labeling and promotion of any products of the Company, (B) withdraws its approval of, requests
the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to,
any such product, (C) imposes a clinical hold on any clinical investigation by the Company, (D) enjoins production at any facility of
the Company, (E) enters or proposes to enter into a consent decree of permanent injunction with the Company, or (F) otherwise alleges
any violation of any laws, rules or regulations by the Company . The properties, business and operations of the Company have been and
are being conducted in all material respects in accordance with all applicable laws, rules and regulations of applicable Regulatory Agencies,
including the FDA. The Company has not been informed by any Regulatory Agency that it will prohibit the marketing, sale, license or use
in the United States or any other jurisdiction of any product proposed to be developed, produced or marketed by the Company. The term
“Health Care Laws” means (i) all applicable federal, state, local, and foreign health care fraud and abuse laws, including,
but not limited to, the federal Anti-Kickback Statute (42 U.S.C. §1320a 7b(b)), the Stark Law (42 U.S.C. §1395nn and §1395(q)),
the federal False Claims Act (31 U.S.C. §3729 et seq.), the federal Civil Monetary Penalties Law (42 U.S.C §1320a 7a and 1320a
7b) and the regulations promulgated pursuant to such statutes; (ii) the Federal Food, Drug, and Cosmetic Act (21 U.S.C. §§
301 et seq., as amended) and all applicable requirements, regulations and guidance with the effect of law issued thereunder by the FDA
(including FDA Law and Regulation); (iii) all applicable licensure laws and regulations, certificates of operations and authority; (iv)
any requirement of law relating to the provision of, or payment for, health care services, items or supplies, or the participation in
governmental health care programs or other third party payor programs; (v) the Public Health Service Act (42 U.S.C. §§ 201
et seq.), (vi) any and all other applicable health care laws (whether foreign or domestic), regulations, governmental policies and administrative
guidance with the effect of law, including those related to state anti-kickback or self-referral prohibitions, and (vii) the Physician
Payment Sunshine Act (42 U.S.C. § 1320a-7h) and all other laws with mandatory transparency reporting requirements, each of (i) through
(vii) as may be amended from time to time.
5.16
Taxes. Except as set forth in Section 5.16 of Seller’s Disclosure Schedule:
(a)
The Company has timely filed with all appropriate Governmental Entities any and all Tax Returns required to be filed by Law. All such
Tax Returns are true, complete and correct in all respects. All Taxes of the Company (whether or not shown as due on any Tax Return)
have been timely and fully paid. The Company is not currently the beneficiary of any extension of time within which to file any Tax Return.
There are no Encumbrances on any of the assets or properties of the Company that arose in connection with any failure (or alleged failure)
to pay any Tax except for statutory liens for Taxes not yet due (and for which there are adequate accruals, in accordance with GAAP).
The Company has not received from any U.S. Tax Authority (including from jurisdictions where the Company has not filed a Tax Return)
any: (i) written notice indicating an intent to open an audit or other review; (ii) written request for information related to Tax matters;
or (iii) written notice of deficiency or proposed adjustment for any amount of Tax proposed, asserted, or assessed by any Tax Authority
against the Company. No claim has ever been made by any Governmental Entity in a jurisdiction where the Company does not file Tax Returns
that it is or may be subject to Taxation by that jurisdiction that would be covered by such Tax Returns.
(b)
The Company has collected and withheld all Taxes that it has been required to collect or withhold from its employees, agents, contractors,
nonresidents, creditors, shareholders, optionees, customers and third parties, and has timely paid over all such collected and withheld
Taxes to the appropriate Tax Authorities. The Company has complied and is in compliance in all respects with all Laws relating to the
payment, withholding and information reporting requirements relating to any Taxes required to be collected, withheld or paid over.
(c)
With respect to the Company, (i) there is no pending litigation concerning any Liability for Taxes of the Company, either (A) claimed
or raised by any Governmental Entity and delivered to the Company in writing or (B) to the Knowledge of Seller; (ii) no Tax audits or
other administrative proceedings or court proceedings are presently pending or, to the Knowledge of Seller, threatened with respect to
any Taxes for which the Company has been or will be liable; and (iii) no Governmental Entity has provided notice in writing of any intention
to propose or assert any deficiency or claim for additional Taxes against the Company.
(d)
The Company has made available to Purchaser true, correct, and complete copies of all Tax Returns and all written communications from
the IRS or any other Tax Authority in the Company’s custody, possession, or control and relating to any such Tax Returns, including
work papers, records, examination reports and statements of deficiencies filed, proposed or assessed against or agreed to by the Company
since 2019.
(e)
The Company has not requested from, executed, or entered into with, any Governmental Entity (i) any agreement, waiver, or other document
extending or having the effect of extending or waiving the period for assessments or collection of any Taxes for which the Company would
or could be liable, (ii) any closing agreement pursuant to Section 7121 of the Code, or any predecessor provision thereof or any similar
provision of state, local, or foreign Tax Law that relates to the assets or operations of the Company, or (iii) any power of attorney
with respect to any Tax matter that is currently in force.
(f)
The Company has not participated in any “reportable transaction” or any “listed transaction” within the meaning
of Treasury Regulation Section 1.6011-4. No Tax Return of the Company contains any position that is, or would be, subject to penalties
under Section 6662 of the Code (or any corresponding provisions of state, local or foreign Law). The Company is not a party to or bound
by any Tax allocation, Tax indemnification, or Tax sharing agreement or arrangement. The Company (i) is not now nor has it ever been
a member of an affiliated group filing a consolidated federal income Tax Return, other than the affiliated group, of which Seller is
the common parent, and (ii) has not ever had any liability for the Taxes of any Person as a transferee or successor, by Contract or otherwise.
(g)
All deficiencies proposed or asserted or assessments proposed or made as a result of any examinations of the Company have been fully
paid, or are fully reflected as a liability in the Financial Statements, or are being contested in good faith by appropriate proceedings,
and an adequate reserve therefor has been established and is fully reflected in the Financial Statements. Any such matter that is being
contested is set forth in Section 5.16(g) of Seller’s Disclosure Schedule.
(h)
The unpaid Taxes of the Company (i) did not, as of the Interim Balance Sheet Date, exceed the reserve for Tax liability (excluding any
reserve for deferred Taxes, established to reflect timing differences between book and Tax income) set forth on the face of its Financial
Statements (rather than in any notes thereto) and (ii) will not exceed that reserve as adjusted for the passage of time through the Closing
Date in accordance with the past custom and practice of the Company in filing its Tax Returns and as shown on the Closing Balance Sheet.
The accruals for deferred Taxes reflected in the Interim Balance Sheet are adequate to cover any deferred Tax liability of the Company
determined in accordance with GAAP through the date thereof.
(i)
There are no outstanding private letter rulings, private letter ruling requests, closing agreements, or similar agreements, whether oral
or written (including state, local, or foreign analogues), relating to Taxes (or Tax status) with respect to the Company.
(j)
Neither the Company, nor Purchaser or its Affiliates with respect to the Company, will be required to include any item of income in,
or exclude any item of deduction from, taxable income for any Tax period (or portion thereof) beginning after the Closing Date (each,
a “Post-Closing Tax Period”) as a result of any (i) change in accounting method for any Tax period (or portion
thereof) ending on or prior to the Closing Date (each, a “Pre-Closing Tax Period”) under Section 481 of the
Code (or any analogous or comparable provision of U.S. state or local or foreign Law); (ii) the use of an improper method of accounting
in a Pre-Closing Tax Period, (iii) written agreement with a Tax Authority with regard to the Tax liability of the Company for any Pre-Closing
Tax Period; (iv) installment sale or open transaction disposition made prior to the Closing Date or prior to the Closing on the Closing
Date; (v) deferred revenue or prepaid amount received on or prior to the Closing Date; (vi) the application of the completed contract
method of accounting or the cash method of accounting during any Pre-Closing Tax Period; or (vii) any intercompany transaction that occurred
on or prior to the Closing Date.
(k)
The Company is not now, nor has it ever been, a party to any joint venture, partnership or other arrangement or contract that could be
treated as a partnership for U.S. federal Income Tax purposes for any period for which the statute of limitations for any Tax on the
income therefrom has not expired.
(l)
In the last five (5) years, the Company has not constituted either a “distributing corporation” or a “controlled corporation”
in a distribution of stock intended to qualify for tax free treatment under Section 355 of the Code.
(m)
The Company is not, nor has it ever been, a United States real property holding corporation within the meaning of Section 897(c)(2) of
the Code during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code.
(n)
The Company has never had (i) a permanent establishment in any foreign country, as defined in any applicable Tax treaty or convention
between the United States and such foreign country or (ii) a presence in any foreign country that could subject the Company to Tax in
such foreign country.
(o)
The Company has never owned an interest in any entity that is a “controlled foreign corporation” within the meaning of Section
957(a) of the Code or a “passive foreign investment company” within the meaning of Section 1297 of the Code.
(p)
The Company has properly (i) collected and remitted sales, use, value added, and similar Taxes with respect to sales made to its customers
or services provided to its customers and (ii) for all sales or services that are exempt from sales, use, value added, and similar Taxes
and that were made without charging or remitting such Taxes, received and retained any appropriate Tax exemption certificates and other
documentation qualifying such sale or service as exempt.
(q)
The Company has either (i) filed or caused to be filed with the appropriate Tax Authority all unclaimed property reports required to
be filed and remitted to the appropriate Tax Authority all unclaimed property required to be remitted, or (ii) delivered or paid all
unclaimed property to its original or proper recipient.
(r)
The Company is not the recipient or beneficiary of any Tax holiday, abatement, incentive or similar grant made or awarded by any Governmental
Entity. The Company has not claimed any Tax credits under Section 2301 of the Coronavirus Aid, Relief, and Economic Security Act (Pub.
L. 116-136) (or any successor provision thereof) or any similar provision of state, local or non-U.S. law.
(s)
The Company has never used the cash basis method of accounting for income tax purposes.
(t)
Neither the Seller nor the Company has taken or agreed to take any action, nor do they have any knowledge of any fact or circumstance,
that would prevent the transactions contemplated by this Agreement from qualifying as a “reorganization” within the meaning
of Section 368(a) of the Code.
5.17
Employee Benefit Matters.
(a)
Section 5.17(a) of Seller’s Disclosure Schedule contains a correct and complete list of each Benefit Plan. The Company has
no liability with respect to any compensatory or benefit agreement, plan, policy, fund, arrangement, and program other than the Benefit
Plans. No Benefit Plan covers any current or former service provider of the Company located outside of the United States, and the Company
has never been obligated to contribute to any such plan. With respect to each Benefit Plan, copies of the documents, if any, described
below have been delivered or made available to Purchaser: (i) the most recent Internal Revenue Service determination letter or opinion
letter issued with respect to each Benefit Plan obtaining or relying upon such a letter and all other determination letters, rulings,
opinion letters, information letters, or advisory opinions issued by the IRS, the United States Department of Labor or the Pension Benefit
Guaranty Corporation during the current calendar year or any of the preceding three calendar years; (ii) Forms 5500 and summary annual
reports, audited or unaudited financial statements, actuarial reports, and valuations prepared for the current plan year and the three
(3) preceding plan years; (iii) all current plan documents and amendments or, in the case of an unwritten Benefit Plan, a written description
thereof; (iv) summary plan descriptions and summaries of material modifications; (v) all current trust agreements, insurance contracts,
and other documents relating to the funding or payment of benefits; and (vi) all material correspondence received by the Company from
any Governmental Entity relating to such Benefit Plan received during the current calendar year or any of the preceding three calendar
years.
(b)
To the Seller’s Knowledge, each Benefit Plan has been maintained and administered in compliance with all applicable Laws (including
ERISA and the Code) and in compliance with its terms and any related documents or agreements. Each Benefit Plan which is required to
satisfy Code Sections 401(k)(3) and 401(m)(2) has been, or will be, tested for compliance with, and has satisfied, or will satisfy, the
requirements of, such Sections of the Code for each plan year ending prior to the Closing Date in accordance with the requirements of
the Code. Each Benefit Plan intending to be a safe harbor 401(k) plan has met the requirements
for such a plan, including the applicable notice content and delivery requirements. Each Benefit Plan that is intended to be qualified
under Section 401(a) of the Code is so qualified and has received a favorable determination letter from the Internal Revenue Service,
or with respect to a prototype plan, can rely on an opinion letter from the Internal Revenue Service to the prototype plan sponsor, to
the effect that such Benefit Plan is so qualified and that the plan and the trust related thereto are exempt from federal Income Taxes
under Sections 401(a) and 501(a), respectively, of the Code. To the Knowledge of Seller, nothing has occurred that would reasonably be
expected to cause the revocation of such determination letter from the Internal Revenue Service or the unavailability of reliance on
such opinion letter from the Internal Revenue Service, as applicable. All benefits, contributions, transfers and premiums or other payments
required by and due under the terms of each Benefit Plan or applicable Law have been timely paid and accrued in accordance with the terms
of such Benefit Plan, the terms of all applicable Laws and GAAP. To the Knowledge of Seller, there have been no prohibited transactions
or breaches of any of the duties imposed on “fiduciaries” (within the meaning of Section 3(21) of ERISA) by ERISA with respect
to the Benefit Plans that could reasonably be expected to result in any liability or excise tax under ERISA or the Code being imposed
on the Company. The Company has reserved all rights necessary to amend or terminate each Benefit Plan that is sponsored or maintained
without the consent of any other Person, and have reserved all rights necessary to cease participation in each other Benefit Plan without
the consent of any other Person.
(c)
To the Seller’s Knowledge, the Company and each Benefit Plan are in compliance in all material respects with the ACA, including
compliance in all material respects with respect to all filing and reporting requirements, all waiting periods and the offering of affordable
health insurance coverage to all Persons who meet the definition of a full-time employee under the ACA. No excise Tax or penalty under
the ACA is outstanding or has accrued, or will become due with respect to any period prior to the Closing.
(d)
Neither the Company nor any member of the Controlled Group has ever had an obligation to contribute to a (i) “defined benefit plan”
as defined in Section 3(35) of ERISA, (ii) a pension plan subject to the funding standards of Section 302 of ERISA or Section 412 of
the Code, (iii) a “multiemployer plan” as defined in Section 3(37) of ERISA or Section 414(f) of the Code, (iv) a “multiple
employer plan” within the meaning of Section 210(a) of ERISA or Section 413(c) of the Code, (v) “welfare benefit fund”
as defined in Section 419(e) of the Code or (vi) a voluntary employees’ beneficiary association (within the meaning of Section
501(c)(9) of the Code).
(e)
Other than as required under Section 4980B of the Code or other applicable Law, no Benefit Plan provides benefits or coverage in the
nature of health, life, or disability insurance following retirement or other termination of employment (other than death benefits when
termination occurs upon death). No Benefit Plan provides benefits to any individual who is not a current or former employee of the Company,
or a dependent or other beneficiary of any such current or former employee. With respect to each group health plan benefiting any current
or former employee of the Company or any member of the Controlled Group that is subject to Section 4980B of the Code, the Company and
each member of the Controlled Group has complied in all material respects with the coverage continuation requirements of Section 4980B
of the Code and Part 6 of Subtitle B of Title I of ERISA. No Tax under Code Section 5000 has been incurred by the Company or any member
of the Controlled Group with respect to any Benefit Plan, or other plan or arrangement, and no circumstance exists which could give rise
to such Taxes.
(f)
To the Knowledge of Company, there has been no material oral or written representation or communication with respect to any aspect of
the Benefit Plans made to employees or former employees of the Company which is not in accordance with the written or otherwise preexisting
terms and provisions of such plans. To the Knowledge of Seller, neither the Company nor any member of its Controlled Group, any administrator
or fiduciary of any Benefit Plan (or any agent of any of the foregoing) has engaged in any transaction, or acted or failed to act in
any manner, which could subject Seller, the Company or Purchaser to any direct or indirect Liability (by indemnity or otherwise) for
breach of any fiduciary, co-fiduciary, or other duty under ERISA. There is no pending or threatened assessment or Proceeding relating
to a Benefit Plan (other than routine claims for benefits), nor, to the Knowledge of Seller, is there any basis for one. No Benefit Plan
is currently the subject of an audit or other inquiry from the Internal Revenue Service, U.S. Department of Labor, Pension Benefit Guaranty
Corporation, or other Governmental Entity.
(g)
To the Seller’s Knowledge, the governing plan documents and annual reports or returns, audited or unaudited financial statements,
actuarial valuations, summary annual reports, and summary plan descriptions issued with respect to the Benefit Plans are correct and
complete in all material respects, have been, to the extent applicable, timely adopted, timely filed with the United States Department
of Labor, and timely distributed to participants of the Benefit Plans, and there have been no material changes in the information set
forth therein.
(h)
Except as set forth in Section 5.17(g) of Seller’s Disclosure Schedule, the consummation of the Contemplated Transactions
will not (either alone or in combination with any other event) (i) accelerate the time of payment or vesting, result in any funding,
result in the forgiveness of indebtedness or increase the amount of any payment, compensation or benefit due any such director, manager,
employee, independent contractor, consultant or officer under any Benefit Plan, (ii) result in any new or increased contribution required
to be made to any Benefit Plan or (iii) give rise to the payment of any amounts or benefits that, individually or in combination with
any other amount or benefit owed under any Benefit Plan, would not be deductible in accordance with Section 280G of the Code.
(i)
Each Benefit Plan that provides for the deferral of compensation subject to Section 409A of the Code is, and has been properly operated
and documented in writing in accordance with Section 409A of the Code. No current or former service provider to the Company is or has
been subject to any Tax or penalty under Section 409A of the Code due to a documentary or operational failure thereunder, and no such
operational or documentary failures have occurred, whether or not such failures were corrected pursuant to applicable Internal Revenue
Service guidance. No current or former service provider to the Company is entitled to a gross-up, make whole or other payment as a result
of the imposition of any Tax or penalty under Section 409A or 4999 of the Code.
(j)
Neither the Company nor any member of its Controlled Group has made or is obligated to make any nondeductible contributions to any Benefit
Plan or to pay compensation to any employee that would be nondeductible under Code Section 162(m) if any of the entities were a publicly
held corporation within the meaning of Code Section 162(m). The actuarial present values of all accrued deferred compensation entitlements
(including entitlements under any executive compensation, supplemental retirement, or employment agreement) of employees and former employees
of the Company and any members of its Controlled Group, whether or not subject to the provisions of Code Sections 412 and 430 or ERISA
Section 302, have been fully reflected on the Financial Statements to the extent required by and in accordance with GAAP. The assets
of each Benefit Plan are reported at their fair market value on the books and records of such plan.
(k)
All assets attributable to any Benefit Plan that is subject to ERISA have been held in trust, unless a statutory or administrative exemption
to the trust requirements of Section 403(a) of ERISA applies. Except as disclosed in Section 5.17(k) of the Seller Disclosure Schedule,
no Benefit Plan is a self-funded or self-insured arrangement, and, with respect to each Benefit Plan that is funded in whole or in part
through an insurance policy, neither the Company nor any member of its Controlled Group has, or is reasonably expected to have, any Liability
in the nature of a retroactive rate adjustment, loss-sharing arrangement or other actual or contingent Liability arising wholly or partially
out of events occurring on or before the date of this Agreement or the Closing Date. Any Benefit Plan funded in whole or in part with
pre-tax contributions from participants has been made in accordance with a written plan instrument that for all relevant periods has
complied in form with the requirements under Code Section 125, other than changes required by statutes, regulations and rulings for which
amendments are not yet required.
(l)
The Company, and any successor entity, may terminate any Benefit Plan prospectively at any time without further Liability to the Company
or any member of its Controlled Group or the successor entity, including any additional contributions, penalties, premiums, fees, surrender
charges, market value adjustments or any other charges as a result of such termination, except to the extent of funds set aside for such
purpose or reflected as reserved for such purpose on the Financial Statements.
5.18
Employment Matters.
(a)
Section 5.18(a) of Seller’s Disclosure Schedule sets forth a true and complete list of each employee of the Company (including
any employee who is on a leave of absence or on layoff status) and each individual engaged by the Company as an independent contractor,
containing the following information: (i) to the extent permitted by Law, the name, title or classification of each employee or independent
contractor; (ii) to the extent permitted by Law, the aggregate dollar amounts of the compensation (including wages, salary, commissions,
director’s fees, fringe benefits, bonuses, profit sharing payments, and other payments or benefits of any type) received by each
employee or independent contractor from the Company with respect to services performed in calendar year 2023 and year to date 2024; (iii)
to the extent permitted by Law, each employee’s or independent contractor’s current annualized compensation, hourly wage
rate or remuneration, as applicable; (iv) the number of hours of sick-time that each employee has accrued as of the date of this Agreement
and the aggregate dollar amount thereof; (v) the number of hours of vacation time or paid time off that each employee has accrued and
the aggregate dollar amount thereof; (vi) the length of employment; (vii) status of each employee as full-time or part-time and exempt
or non-exempt, and (viii) whether the employee is receiving workers compensation or disability payments or is on leave or layoff status
and, if so, the anticipated date of return.
(b)
To the Seller’s Knowledge, the Company has at all times complied, in all material respects, with all applicable Laws regarding
labor and employment, including but not limited to the National Labor Relations Act, the Family and Medical Leave Act, employment discrimination
laws, wage and hour laws, employment standards legislation and wage payment laws and occupational health and safety (including but not
limited to any such obligations it may have under applicable Laws or any Contract to any employees providing services to the Company
through a third party). The Company has (i) timely paid in full to all Company employees all wages and other compensation (including
overtime compensation and compensation for meal periods and rest breaks) as required by all applicable Laws, in all material respects,
(ii) timely paid in full to all Company employees all reimbursement of expenses as required by all applicable Laws, in all material respects,
and (iii) properly reported to all Company employees (by pay stub, wage statement, or otherwise) their wages in accordance with all applicable
Laws, in all material respects.
(c)
All individuals who perform services for the Company have been classified correctly, including in accordance with the terms of each Benefit
Plan and ERISA, the Code, the Fair Labor Standards Act, and all other applicable Laws, as exempt employees, non-exempt employees, independent
contractors, or leased employees, and the Company has not received written (or to the Knowledge of Seller, verbal or otherwise) notice
to the contrary from any Person or Governmental Entity.
(d)
The employment of each Company employee is terminable by the Company at will and no employee is entitled to severance pay or other benefits
following termination or resignation, except as otherwise required by Law or any Benefit Plan set forth or required to be set forth on
Section 5.17(a) of Seller’s Disclosure Schedule. Seller has made available to Purchaser accurate and complete copies of
all employee manuals and handbooks, disclosure materials, policy statements and other materials relating to the employment of the current
and former employees of the Company and the Company is in material compliance with each of the foregoing.
(e)
There has not been pending or existing during the 3-year period preceding the date of this Agreement any strike, slowdown, work stoppage
or lockout involving the Company.
(f)
As of the date of this Agreement, to the Knowledge of Seller, there is no unfair labor practice charge or complaint against the Company
pending before (i) the National Labor Relations Board, or (ii) similar Governmental Entity outside of the United States, and to the Knowledge
of Seller, no such charge or complaint has been made against the Company during the 3-year period preceding the date of this Agreement.
(g)
To the Knowledge of Seller, no Seller, executive officer of the Company, or salaried Employee of the Company of a seniority level that
reports directly to Seller or any such executive officer: (i) intends to terminate his or her relationship with the Company, or (ii)
has received an offer to join a business that may be competitive with the business of the Company.
(h)
The Company is not now, nor has it ever been, a party to any collective-bargaining agreement, neutrality agreement, or other Contract
of any kind with a labor union or labor organization, or party to any representation proceeding before the National Labor Relations Board,
or subject to any duty to bargain with any labor union or labor organization, and there has not been within the last three years, and
is not now any labor union organizing activity pending or, to the Knowledge of Seller, threatened with respect to the Company.
(i)
To the Knowledge of Seller, (i) there has been no complaint or charge of discrimination or harassment (including sexual harassment) made,
filed or threatened against the Company or Employee (in such Employee’s capacity as an employee of the Company) with the Equal
Employment Opportunity Commission or similar Governmental Entity during the last three years prior to the date of this Agreement; and
(ii) no reasonable basis in fact or circumstances exists for the assertion of any such claim described in clause (i).
(j)
The Company has not experienced a “plant closing,” “business closing,” or “mass layoff” or similar
group employment loss as defined in the federal Worker Adjustment and Retraining Notification Act (“WARN Act”)
or any other applicable Law affecting any site of employment of the Company or one or more facilities or operating units within any site
of employment or facility of the Company. During the 90-day period preceding the date of this Agreement, no employee has suffered an
“employment loss” as defined in the WARN Act or any other applicable Laws with respect to the Company.
(k)
To the Seller’s Knowledge, the Company is in compliance in all material respects with the requirements of all applicable Laws regarding
immigration, including but not limited to the requirements under the federal Immigration Reform and Control Act of 1986 regarding verification
of employment eligibility, documentation fraud, document retention, non-discrimination, and the prohibition against knowing employment
of workers who are not authorized to work in the United States. The Company has on file a valid and current I-9 form for (i) all current
employees hired since November 6, 1986, and (ii) all former employees whose employment commenced less than three years prior to the date
of this Agreement or terminated less than one year prior to the date of this Agreement.
5.19
Environmental Matters.
(a)
Compliance with Environmental Laws. To the Seller’s Knowledge, the Company has at all times materially complied with, and
is in material compliance with, all Environmental Laws and all Permits that are or were required under any Environmental Laws for the
conduct of its businesses and the acquisition, ownership, lease, license, operation, use, sale, or other disposition of its assets and
properties.
(b)
Hazardous Material. To the Seller’s Knowledge, the Company has not caused, contributed to, or permitted any material release,
spill, emission, leaking, pumping, pouring, dumping, emptying, injection, deposit, disposal, discharge, dispersal, leaching, or migration
of any Hazardous Material on or into the Environment (collectively, a “Release”) so as to give rise to any
current or future Liabilities, including but not limited to any Liabilities for fines, penalties, personal injury, property damage, natural
resources damages, attorneys’ fees, or costs of Proceedings, under any Environmental Law or any applicable Contract. The Company
not has generated, manufactured, refined, transported, stored, handled, disposed, produced, or processed any Hazardous Materials anywhere
except in material compliance with Environmental Law. Within the five years prior to Closing, the Company has received no written (or
the Knowledge of Seller, verbal or otherwise) notice of any actual or potential Release or other environmental condition on the Real
Property that could reasonably give rise to any current or future Liabilities to the Company under any Environmental Law, including but
not limited to any Liabilities for fines, penalties, personal injury, property damage, natural resources damages, attorneys’ fees,
or costs of Proceedings.
(c)
To the Knowledge of Seller, there are no above or underground storage tanks or related pipes, whether active or abandoned, at the Real
Property.
(d)
To the Knowledge of Seller, there are no asbestos-containing materials, lead-based paint or polychlorinated biphenyls used in, applied
to or in any way incorporated in any building, structure, or equipment at the Real Property.
(e)
The Company has not assumed, undertaken, agreed to indemnify, or otherwise become subject to any liability of any other Person arising
from violation of any Environmental Law.
(f)
The Company has delivered, or caused to be delivered or made available in the Data Room for at least 15 Business Days prior to Closing,
to Purchaser copies of all documents, records, and information in its possession or control concerning compliance with or potential liability
under Environmental Laws, including previously conducted environmental site assessments, compliance audits, asbestos surveys, and documents
regarding any Releases at, upon, under, or from the Leased Real Property or any property formerly or currently owned, leased, or operated
by the Company.
5.20
Client Relations. Section 5.20(a) of Seller’s Disclosure Schedule is a correct
and complete list of: (a) the Company’s 20 largest customers, including distributors (in the aggregate, measured by fees generated)
for the current calendar year through April 2024, and each of the fiscal years ended December 31, 2022 and December 31, 2023 (collectively,
the “Material Clients”), and (b) the corresponding net sales generated
from the Material Clients. Except as set forth in Section 5.20(b) of Seller’s Disclosure Schedule, (i) to the Knowledge
of Seller, all Material Clients continue to be customers of the Company, and no Material Client has terminated its relationship with
the Company; (ii) no Material Client has advised the Company in writing (or to the Knowledge of Seller, verbally or otherwise) that it
(A) is terminating the handling of its business (including referral business) by the Company, as a whole or in respect of any material
project or service, (B) to the Knowledge of Seller, is planning to reduce its future spending or referral for spending, as applicable,
with the Company in any material manner from the levels maintained during the calendar year 2023, (C) has been offered or is seeking
a change in price or terms greater than 5.0%, or (D) is initiating or planning to initiate any request for proposal (RFP) process for
the procurement of products or services currently provided by the Company; (iii) the Company is not involved in any claim, dispute, or
controversy with any Material Client that, individually or in the aggregate, would reasonably be expected to have a Material Adverse
Effect; and (iv) to the Knowledge of Seller, no Material Clients are contemplating (A) a decline (or complete loss of) business with
the Company, or (B) a depressing of per diem rates, overtime rates, or hourly rates relative to existing levels. For purposes of this
Section 5.20, the word “client” refers to an entity consolidated for financial reporting purposes.
5.21
Vendors and Suppliers. Section 5.21(a) of Seller’s Disclosure Schedule is
a correct and complete list of: (a) the top 10 vendors and suppliers of the Company to which the Company, considered in the aggregate,
paid or incurred the highest amount of expenses or other expenditures during the current calendar year through April 2024, and each of
the fiscal years ended December 31, 2023 and December 31, 2022 (collectively, the “Material
Vendors”), and (b) the corresponding amount of expenses or other expenditures paid or
payable to the Material Vendors. Except as set forth in Section 5.21(b) of Seller’s Disclosure Schedule, (i) to the Knowledge
of Seller, all Material Vendors continue to be vendors and suppliers of the Company, and no Material Vendor has terminated its relationship
with the Company; (ii) no Material Vendor has advised the Company in writing (or to the Knowledge of Seller, verbally or otherwise) that
it (A) is terminating its relationship with the Company, as a whole or in respect of any material product or service, (B) to the Knowledge
of Seller, is planning to reduce its future supply or services to the Company in any material manner from the levels maintained during
the calendar year 2023, or (C) to the Knowledge of Seller, is planning to increase or decrease the prices charged to the Company for
the goods or services supplied by such Material Vendor except in the Ordinary Course of Business, and, to the Knowledge of Seller, no
Material Vendor has orally advised the Company or Seller of any of the foregoing events; (iii) the Company is not involved in any claim,
dispute, or controversy with any Material Vendor; and (iv) the Company is not involved in any claim, dispute, or controversy with any
of its other vendors or suppliers that, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect.
No vendor or supplier to the Company represents the Company’s sole source of supply for goods and services used in the conduct
of the Company’s business.
5.22
Brokers. No broker, finder, or investment banker is entitled to any brokerage, finder’s, or other fee or commission
in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its Affiliates.
5.23
Product and Service Warranty; Service Levels; Liability. Section 5.23(a) of Seller’s
Disclosure Schedule sets forth a list or description of the Company’s warranties and service
level agreements currently made with respect to its Business. Except as set forth in Section 5.23(b) of Seller’s Disclosure
Schedule, since January 1, 2019, the Company has not provided services that fail to materially comply with warranties, express or
implied, or service level agreements made by the Company, and the Company has no liability (and there is no basis for any present or
future Proceedings against the Company that would reasonably be expected to result in any liability) for corrective performance of any
services performed by the Company. Section 5.23(c) of Seller’s Disclosure Schedule lists all service warranty and service
level agreement actions or claims (including for failure to meet specifications) (i) paid by the Company since January 1, 2019, or (ii)
that are pending or, to the Knowledge of Seller, threatened, and such list is materially accurate and complete.
5.24
Affiliate Transactions.
(a)
Except as disclosed on Section 5.24(a) of Seller’s Disclosure Schedule, no Representative or Related Party of the Company
owns or has any beneficial interest in: (i) any Contract, arrangement or understanding with, or relating to, the Company or the properties
or assets of the Company; (ii) any loan, arrangement, understanding, agreement, or Contract for or relating to the Company or the properties
or assets of the Company; (iii) any property (real, personal, or mixed), tangible or intangible, used or currently intended to be used
by the Company; or (iv) any claim against the Company that could materially and adversely affect the Company’s assets, title to
or its right to use its assets, or Purchaser’s right to conduct its business following the Closing. No Related Party of the Company
is (x) an employee or contractor of the Company or (y) has received any preferential treatment in hiring or otherwise.
(b)
Section 5.24(b) of Seller’s Disclosure Schedule sets forth an accurate and complete list of all accounts receivable, notes
receivable, and other receivables and accounts payable owed to or due from any Related Party or Affiliate of the Company to the Company.
5.25
Certain Payments. None of Seller, the Company, or, to the Knowledge of Seller, any Entity Representative or any other strategic
partner, distributor, reseller, consultant, broker, agent, or other Person associated with or acting on behalf of the Company, has: (a)
used any funds, directly or indirectly, for any contribution, gift, entertainment expense, or other cost or expense relating to a political
or business activity in any manner contrary to applicable Law; (b) made a payment of money or transferred any other property of value,
directly or indirectly, to an official, employee, or other Person acting on behalf of any Governmental Entity or public international
organization, or to any political party or campaign in any manner contrary to applicable Law; (c) made a payment of money or transferred
any other property of value, directly or indirectly, to an official, employee or other Person acting on behalf of any Entity owned or
controlled by any Governmental Entity or public international organization; (d) violated any provision of the U.S. Foreign Corrupt Practices
Act of 1977 or similar Law; (e) established or maintained an unrecorded fund of corporate monies or other assets in any manner contrary
to applicable Law; (f) made a false or fictitious entry on the books of account of the Company; or (g) made or received a bribe, rebate,
payoff, influence payment, kickback, or other payment in any manner contrary to applicable Law. None of Seller, the Company, or any direct
or indirect owner of the Equity Securities of Seller or the Company, currently is identified on the list of specially designated nationals
and blocked persons subject to financial sanctions and Persons with whom a U.S. Person may not conduct business or transactions by prohibition
of United States federal Law or Executive Order of the President of the United States that is maintained by the United States Treasury
Department, Office of Foreign Assets Control (a “Prohibited Person”), and to the Knowledge of Seller, none
of Seller, the Company, or any direct or indirect owner of the Equity Securities of Seller or the Company, is in violation of any applicable
Law relating to anti-money laundering or anti-terrorism, including any applicable Law relating to making payments to (including payments
in response to ransomware demands) or otherwise transacting business with Prohibited Persons, or any comparable non-U.S. Laws for any
of the foregoing, including the UK Bribery Act 2010 or prior UK anti-corruption Laws, UK Terrorism Act 2000, Sections 44-45 of the UK
Serious Crime Act 2007, UK Proceeds of Crime Act 2002, UK Money Laundering Regulations 2007, or any applicable Law implementing the OECD
Convention on Combating Bribery of Foreign Public Officials in International Business.
5.26
Bank Accounts. Section 5.26 of Seller’s Disclosure Schedule sets forth a correct and complete list of (a) the
name and address of each bank with which the Company has an account or safe deposit box, (b) the name of each Person authorized to draw
thereon or have access thereto, and (c) the account number for each bank account of the Company.
5.27
Books and Records. All books, records, and accounts of the Company are accurate and are maintained in accordance with sound
business practices. The corporate minute books and equity record books of the Company previously delivered to Purchaser accurately reflect
all corporate or company actions taken by the Company.
5.28
Full Disclosure. None of this Agreement, the Financial Statements (including the footnotes thereto), Seller’s Disclosure
Schedule, exhibits or certificates delivered in accordance with the terms of this Agreement or any document or statement in writing which
has been supplied by or on behalf of Seller, the Company, or by the Company’s directors or officers, in connection with the transactions
contemplated under this Agreement contains any untrue statement of a material fact or omits any statement of a material fact necessary
in order to make the statements contained herein or therein not misleading. There is no fact, to the Knowledge of Seller, which materially
and adversely affects the business or financial condition of the Company or its properties or assets, which has not been set forth in
this Agreement or in Seller’s Disclosure Schedule, exhibits hereto or certificates or statements in writing furnished in connection
with the transactions under this Agreement.
Article
VI
Representations and Warranties of Purchaser
Purchaser
represents and warrants to Seller, except, with respect to Sections 6.4 and 6.6, as disclosed in any SEC Report (but excluding
any forward-looking disclosures set forth in any section of the SEC Reports entitled “Risk Factors” or “Forward-Looking
Statements”):
6.1
Organization; Good Standing; Authority.
(a)
Purchaser is a corporation that was duly organized, is validly existing, and in good standing (if the concept of good standing applies)
under the Laws of the State of Delaware.
(b)
Purchaser has full corporate power and authority to enter into each Transaction Document to which it is a party, to carry out its obligations
under such Transaction Documents, and to consummate the Contemplated Transactions. The execution and delivery by Purchaser of each Transaction
Document to which it is a party, the performance by Purchaser of its obligations under such Transaction Documents, and the consummation
by Purchaser of the Contemplated Transactions have been duly authorized by all requisite corporate action on the part of Purchaser. Each
Transaction Document to which it is a party has been duly executed and delivered by Purchaser, and (assuming due authorization, execution,
and delivery by the other Parties) such Transaction Documents constitute legal, valid, and binding obligation of Purchaser, enforceable
against Purchaser in accordance with their terms, except as such enforceability may be limited by the Remedies Exception.
6.2
No Conflicts; Consents. The execution, delivery, and performance by Purchaser of the Transaction Documents to which it is
a party, and the consummation of the Contemplated Transactions, do not and will not: (a) conflict with or result in a violation or breach
of any provision of the Organizational Documents of Purchaser; (b) result in a violation or breach of any provision of any Law or Order
applicable to Purchaser; (c) require the consent, notice, or other action by any Person under, conflict with, result in a violation or
breach of, constitute a default under (with notice or lapse of time, or both), or give rise to any right of, or result in, the acceleration,
termination, amendment, or cancellation of any Contract to which Purchaser is a party; or (d) result in the creation or imposition of
any Encumbrance, other than Permitted Encumbrances, with respect to, or otherwise have an adverse effect upon, any of the properties
or assets of Purchaser. No Consent, Permit, Order, declaration, or filing with, or notice to, any Person or Governmental Entity is required
by or with respect to Purchaser in connection with the execution and delivery of any Transaction Document to which it is a party and
the consummation of the Contemplated Transactions.
6.3
Investment Purpose. Purchaser is acquiring the Acquired Shares solely for its own account for investment purposes and not
with a view to, or for offer or sale in connection with, any distribution thereof. Purchaser acknowledges that the Acquired Shares are
not registered under the Securities Act, as amended, or any state securities laws, and that the Acquired Shares may not be transferred
or sold except pursuant to the registration provisions of the Securities Act or pursuant to an applicable exemption therefrom and subject
to state securities laws and regulations, as applicable. Purchaser is able to bear the economic risk of holding the Acquired Shares for
an indefinite period (including total loss of its investment), and has sufficient knowledge and experience in financial and business
matters so as to be capable of evaluating the merits and risk of its investment.
6.4
SEC Reports. Accurate and complete copies of each report, registration statement, prospectus, schedule, form, statement, and
definitive proxy statement that Purchaser has filed with the SEC in the 12-month period preceding the Effective Date (collectively, the
“SEC Reports”) have been filed through the SEC EDGAR system. As of the time it was filed with the SEC by Purchaser:
(a) each SEC Report was timely filed and complied in all material respects with the applicable requirements of the Securities Act and
the rules and regulations promulgated thereunder or the Exchange Act and the rules and regulations promulgated thereunder (as the case
may be), and (b) none of the SEC Reports contained any untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary in order to make the statements made therein, in light of the circumstances under which they were made,
not misleading. Neither Purchaser nor any of its consolidated or unconsolidated subsidiaries have, since the end of the last fiscal year
for which certified financial statements of Purchaser and its consolidated subsidiaries were included in a report filed pursuant to Section
13(a) or 15(d) of the Exchange Act: (x) failed to pay any dividend or sinking fund installment on preferred stock; or (y) defaulted (i)
on any installment or installments on indebtedness for borrowed money, or (ii) on any rental on one or more long term leases, which defaults
in the aggregate are material to the financial position of the registrant and its consolidated and unconsolidated subsidiaries, taken
as a whole.
6.5
Purchaser Common Stock. Upon issuance, the Purchaser Common Stock issued as Upfront Stock Consideration or in respect of Earnout
Consideration will be duly authorized, validly issued, fully paid and non-assessable and will not be subject to any option, call, preemptive,
subscription or similar rights or Encumbrances, other than Permitted Encumbrances, the Voting and Agreement ands restrictions on Transfer
imposed by state and federal securities Laws.
6.6
Financial Statements. Purchaser’s financial statements set forth in the SEC Reports filed since January 1, 2023 (the
“Purchaser Financial Statements”) have been prepared in accordance with GAAP (except as may be indicated in
any notes thereto). Each balance sheet in the Purchaser Financial Statements is accurate and complete in all material respects and fairly
presents in all material respects the financial condition of Purchaser as of its respective date. Each statement of income and cash flows
in the Purchaser Financial Statements is accurate and complete in all material respects and fairly presents in all material respects
the results of operations and cash flows, respectively, of the Purchaser for the periods covered thereby. Notwithstanding the foregoing,
the interim Purchaser Financial Statements (i.e., Purchaser Financial Statement as of a period other than a fiscal year-end) are subject
to customary year-end adjustments and lack footnotes. Purchaser maintains a system of internal account controls and procedures designed
to record transactions as reasonably necessary to permit the preparation of its financial statements in conformity with GAAP.
6.7
Capitalization of Purchaser. The authorized capital stock of the Purchaser consists of (i) 300,000,000 shares of Purchaser
Common Stock, of which, as of March 31, 2024, 82,132,777 shares are issued and outstanding, as well as (x) shares reserved for issuance
pursuant to the Company’s stock option, restricted stock and stock purchase plans, comprised of 3,470,733 shares issuable upon
the exercise of outstanding options and stock appreciation rights, and 1,741,741 shares of unvested restricted share units and 2,297,196
remaining shares available for future grants under Purchaser’s various equity plans and (y) 48,885,547 shares issuable upon conversion
of Purchaser’s Series A Convertible Preferred Stock, and (ii) 10,000,000 shares of preferred stock, $0.001 par value, of which
(x) 24,000 shares are designated as Series A Convertible Preferred Stock, of which, as of March 31, 2024, 21,908 shares are issued and
outstanding and (y) 5,610,121 shares are designated as Series B Convertible Preferred Stock, none of which, as of April 30, 2024, are
issued and outstanding. No other shares of Purchaser Common Stock, or securities exercisable or exchangeable for, or convertible into,
shares of Purchaser Common Stock, are issued or outstanding.
6.8
Brokers. No broker, finder, or investment banker is entitled to any brokerage, finder’s, or other fee or commission
in connection with the Contemplated Transactions based upon arrangements made by or on behalf of Purchaser.
Article
VII
Covenants
7.1
Conduct of Business Prior to the Closing. During the period from the date of this Agreement to the Closing, except (i) as
expressly contemplated or permitted by this Agreement or (ii) as Purchaser shall otherwise consent in writing, Seller shall, and shall
cause the Company to, (A) conduct the Business in the Ordinary Course of Business, (B) use Commercially Reasonable Efforts to maintain
and preserve intact the Company’s current business, organization, goodwill, relationships with customers, suppliers, independent
contractors, lenders, landlords, regulators and others having business dealings with it, retain the services of the Company’s officers
and employees, preserve its assets and properties in good repair and condition consistent with past practice, and maintain capital expenditure
levels consistent with past practice, and (C) promptly notify Purchaser of and provide to Purchaser a copy of, (1) any notice or other
communication Seller or the Company receives from (y) any Person alleging that the consent of such Person is or may be required in connection
with any of the Contemplated Transactions or (z) any Governmental Entity relating to the Business or (2) any change(s) that, individually
or in the aggregate, have had or would reasonably be expected to (y) have a Material Adverse Effect or (z) delay or impede the ability
of any of the Parties to perform their obligations under any of the Transaction Documents or consummate any of the Contemplated Transactions,
and (D) deliver to Purchaser copies of the Company’s monthly financial statements within ten (10) days after the end of each month.
In addition to and without limiting the generality of the foregoing, during the period from the date of this Agreement to the Closing,
except (i) as expressly contemplated or permitted by this Agreement, (ii) as set forth on Section 7.1 of the Seller’s Disclosure
Schedule or (iii) as Purchaser shall otherwise consent in writing, Seller shall not, and shall cause the Company not to:
(a)
propose or adopt any amendments to the Company’s Organizational Documents;
(b)
authorize, adopt or propose (i) a plan of complete or partial liquidation or dissolution of the Company or (ii) a merger or consolidation
of the Company with or into any other Person;
(c)
acquire in the name or on behalf of the Company, by merging or consolidating with, or by purchasing a substantial portion of the assets
of, or by any other manner, any business or any corporation, partnership, association or other Person or business organization or division
thereof;
(d)
(i) grant to any Employee any increase in, or agree to increase, base compensation or benefits paid or due to, or enter into or amend
any employment, change-in-control or severance agreement with any Employee, (ii) grant any bonuses to any Employee, (iii) enter into
or adopt any Benefit Plan or amend, terminate or modify in any material respect any existing Benefit Plan, or enter into or adopt any
collective bargaining agreement except to the extent required by Law, or (iv) take any action to accelerate the vesting or payment, or
in any other way secure the payment, of compensation or benefits under any Benefit Plan;
(e)
incur or assume, or modify in any respect the terms of, any Indebtedness or guarantee or otherwise become responsible for any such Indebtedness
of another Person, or issue or sell any debt securities or calls, options, warrants or other rights to acquire any debt securities of
the Company;
(f)
permit, allow or suffer any of the Acquired Shares or assets of the Company to become subjected to any Encumbrance;
(g)
cancel any material Indebtedness payable to Seller (individually or in the aggregate) or waive any claims or rights of material value
thereunder;
(h)
make in the name or on behalf of the Company any loans, advances or capital contributions to, or investments in, any other Person;
(i)
make with respect to the Company or the Business any change in any method of financial accounting or accounting practice, principle or
policy or practices affecting the reported consolidated assets, liabilities or results of operations of the Company, including (i) decreasing
the amount of any reserves for doubtful accounts receivable or writing down or writing up the value of any inventory or equipment or
other asset, except for decreases or write downs or write ups in the Ordinary Course of Business, and (ii) with respect to the payments
of accounts payable and collections of accounts receivable, other than those required by GAAP or Law;
(j)
make or incur any capital expenditure in the name or on behalf of the Company that is not currently approved in writing or budgeted which,
individually or in the aggregate, is in excess of $25,000;
(k)
acquire, lease or dispose of any assets of the Company outside of the Ordinary Course of Business;
(l)
form any subsidiary of the Company;
(m)
cause to expire or terminate, or fail to renew, any insurance policies of the Company currently in effect;
(n)
(i) enter into any Contract that would have been a Material Contract if entered into prior to the date of this Agreement, except to the
extent required by Law, or (ii) amend or waive any material right under, terminate, fail to renew or permit the lapse of any Material
Contract;
(o)
take any action, or omit to take any action, that could result in a material default under any Material Contract;
(p)
enter into, amend or terminate any collective bargaining agreement in respect of the Employees;
(q)
terminate the employment of any management-level Employee;
(r)
enter into any Contract or transaction in the name or on behalf of the Company with Seller or Affiliate of the Company or Seller;
(s)
fail to maintain all material Permits of the Company in full force and effect and to timely file all material reports, statements, renewal
applications and other filings, and pay all fees and charges in connection therewith, that are required to keep such Permits in full
force and effect;
(t)
with respect to Company Intellectual Property, (i) encumber, impair, abandon, fail to diligently maintain, transfer or otherwise dispose
of any right, title or interest of the Company in any Company Intellectual Property or (ii) divulge, furnish to or make accessible any
trade secrets within any Company Intellectual Property to any Person who is not subject to an enforceable written obligation to maintain
the confidentiality of such trade secrets;
(u)
disclose any material confidential or proprietary information of the Company or the Business to any Person other than to Purchaser, or
Purchaser’s representatives, agents, attorneys and accountants or the Employees or other than in the Ordinary Course of Business
subject to a customary nondisclosure agreement;
(v)
waive, release, assign, settle or compromise any Proceeding involving the Company or threatened Proceeding involving the Company other
than settlements or compromises of such Proceedings that involve solely cash payments where the amount paid by the Company in settlement
or compromise does not exceed $10,000 in the aggregate;
(w)
with respect to the Company or the Business, make or change any Tax election, change an annual accounting period, adopt or change any
accounting method, amend any Tax Return, fail to file on a timely basis any Tax Return, fail to pay on a timely basis any Tax, enter
into any closing or similar agreement with respect to Taxes, settle any Tax claim or assessment, surrender any right to claim a refund
of Taxes, or consent to any extension or waiver of the limitation period applicable to any Tax claim or assessment; or
(x)
agree, whether in writing or otherwise, to do any of the foregoing.
7.2
Access to Information. From the date of this Agreement until the Closing, Seller shall, and shall cause the Company and each
of their respective representatives to, (a) provide to Purchaser and its representatives reasonable access to the officers, employees,
agents, properties, offices and other facilities of the Company, the books and records thereof (including Tax Returns) and the assets
of the Company, and (b) furnish as promptly as practicable such information concerning the Company, the Business and the Acquired Shares
as Purchaser or their representatives may reasonably request; provided, however, that Seller or the Company may withhold
any document or information the disclosure of which would violate any applicable Law (provided that Seller or the Company, as the case
may be, shall use Commercially Reasonable Efforts to make appropriate substitute arrangements to permit reasonable disclosure of such
document or information in a manner that does not violate any applicable Law, and shall otherwise notify Purchaser of any such disclosure
withheld pursuant to this proviso); provided further, however, that any such access or disclosure shall not require Seller
or the Company to waive any applicable privilege (including attorney-client privilege) nor to violate any confidentiality obligation.
All information exchanged pursuant to this Section 7.2 shall be subject to the Confidentiality Agreement, to which the Purchaser
undertakes to abide, until the Closing, at which time the confidentiality obligations under the Confidentiality Agreement shall terminate.
7.3
Reasonable Best Efforts; Third Party Consents.
(a)
Each of the Parties shall use its reasonable best efforts to take, or cause to be taken, all actions, and do, or cause to be done, all
things necessary to consummate and make effective, as soon as reasonably practicable, the Contemplated Transactions in accordance with
the terms of the Transaction Documents.
(b)
In connection with and without limiting the foregoing, Seller shall cooperate with Purchaser, and use its reasonable best efforts to
take, or cause to be taken, all actions, to file, or cause to be filed, all documents and to do, or cause to be done, all things necessary,
proper or advisable to consummate the Contemplated Transactions, including preparing and filing as promptly as practicable all documentation
to effect, and obtaining, all necessary filings, consents, waivers, approvals, authorizations, Permits or orders from all third parties
and Governmental Entities, including those consents and approvals identified in Schedule 8.11(e), so as to enable the Closing
to occur as soon as reasonably practicable. To the extent Purchaser reasonably requests Seller or the Company to assist Purchaser in
obtaining the financing referred to in Section 9.2(g), Seller shall, and shall cause the Company to, use Commercially Reasonable
Efforts to provide such assistance, at Purchaser’s expense.
7.4
Seller’s Disclosure Schedule Updates.
(a)
Within seven (7) Business Days following the date of this Agreement, Seller will provide an updated Seller’s Disclosure Schedule
to Purchaser. In the event the updated Seller’s Disclosure Schedule or the original Disclosure Schedules delivered on the date
hereof identifies any matters that would constitute a Material Adverse Effect on or with respect to the Company or its Business, Purchaser
may terminate this Agreement pursuant to Article X by providing written notice of termination of this Agreement to Seller within
fourteen (14) Business Days after receipt of the updated Seller’s Disclosure Schedule, or otherwise Purchaser shall be deemed to
have waived its right to terminate this Agreement with respect to the matters set forth in the updated Seller’s Disclosure Schedule
and the updated Seller’s Disclosure Schedule will be deemed to have modified Seller’s representations and warranties for
all purposes under this Agreement. The right of termination set forth this Section 7.4(a) shall be Purchaser’s sole remedy
with respect to matters disclosed in the updated Seller’s Disclosure Schedule.
(b)
Thereafter, if necessary, in Seller’s sole discretion, on a periodic basis between the Effective Date and the Closing Date, Seller
may supplement or amend Seller’s Disclosure Schedule and deliver such supplemented or amended Seller’s Disclosure Schedule
to Purchaser with respect to any fact, occurrence, event, effect, change, circumstance or development occurring after the Effective Date.
If any such supplement or amendment gives Purchaser a right to terminate this Agreement pursuant to Article X, Purchaser shall
provide notice of termination of this Agreement to Seller within ten (10) Business Days of the receipt of such supplement or amendment,
or otherwise Purchaser shall be deemed to have waived its right to terminate this Agreement with respect to the matters set forth in
such supplement or amendment and such supplement or amendment will be deemed to have modified Seller’s representations and warranties
for all purposes under this Agreement.
7.5
Stockholder Meeting.
(a)
As promptly as reasonably practicable following the date of this Agreement, the Company and Seller shall, in accordance with applicable
Laws and their respective charter and bylaws, (i) establish a record date for a special meeting of its stockholders to be held solely
for the purpose of obtaining the Seller Stockholder Approval (the “Stockholders Meeting”), (ii) give notice of the
Stockholders Meeting and mail include such information in an information statement or other proxy materials as determined by the Company
and Seller, with Purchaser’s input, (iii) include in such information in an information statement or other proxy materials and
use reasonable best efforts to solicit votes or proxies in favor of the adoption of this Agreement, and (iv) hold the Stockholders Meeting;
provided, however, that the Company may postpone or adjourn the Stockholders Meeting from its originally noticed date for a reasonable
period (but not more than thirty (30) calendar days, individually or in the aggregate) only (A) in order to solicit additional proxies
so as to establish a quorum, (B) to allow time for the filing or dissemination of any supplemental or amended disclosure documents which
the Seller’s board has determined in good faith is necessary to be filed or disseminated under applicable Law, or (C) to allow
additional solicitation of votes in order to obtain the Seller Stockholder Approval; provided, further, that the Stockholders Meeting
shall occur at least three (3) Business Days prior to the End Date. Once the Seller has established a record date for the Stockholders
Meeting, neither Seller nor the Company shall change such record date or establish a different record date, or cause the same to be changed,
for the Stockholders Meeting without the prior written consent of Purchaser not to be unreasonably withheld.
(b)
Each of the Company, Seller and Purchaser shall, upon request, furnish to the other all information concerning itself, its subsidiaries,
directors, officers and (to the extent reasonably available to the applicable party) stockholders and such other matters as may be reasonably
necessary or advisable in connection with any such information in an information statement or other proxy materials. Such information
may include, at the reasonable request of Purchaser, such certifications and questionnaires as may be required from the underlying equity
holders of Seller for federal and state securities law purposes.
7.6
Tax Matters.
(a)
Intended Tax Treatment. The Parties intend for the purchase and sale of the Acquired Shares pursuant to this Agreement to be treated
for U.S. federal income Tax purposes as a tax-deferred reorganization pursuant to Section 368(a)(1)(B) of the Code (the “Intended
Tax Treatment”) and for this Agreement to constitute a “plan of reorganization” within the meaning of Treasury
Regulations Section 1.368-2(g). The Parties shall report, act and file their respective Tax Returns consistent with the Intended Tax
Treatment, and no Party shall take any position inconsistent with such treatment in any Tax Return or in any audit, examination, or administrative
or judicial proceeding, unless otherwise required by a “determination” within the meaning of Section 1313(a) of the Code.
From and after the Closing Date, Purchaser shall use reasonable best efforts not to take any action that is reasonably likely to cause
the purchase and sale of the Acquired Shares pursuant to this Agreement to fail to qualify as a tax-deferred reorganization pursuant
to Section 368(a)(1)(B) of the Code.
(b)
Tax Returns for Periods Ending on or Before the Closing Date. Seller will, at Seller’s expense, timely prepare, or cause
to be timely prepared, and timely file, or cause to be timely filed, all Tax Returns, prepared in a manner consistent with past custom
and practice of the Company (unless otherwise required by Law or the terms of this Agreement), for the Company for all Tax periods ending
on or prior to the Closing Date. Subject to the provisions of this Section 7.6, if such Tax Returns are filed after the Closing
Date, Seller will permit Purchaser to review and comment on each of such Tax Returns (i) if such Tax Return in an Income Tax Return,
for at least 30 days prior to the due date (with applicable extensions), and (ii) if such Tax Return is not an Income Tax Return, for
at least 10 days prior to the due date (with applicable extensions). Purchaser may provide any written comments to Seller not later than
15 days, with respect to an Income Tax Return, or 5 days, with respect to other Tax Returns, after receiving any such Tax Return, and
Seller will accept the reasonable comments of Purchaser. If Purchaser does not provide any written comments with the required period,
Purchaser will be deemed to have accepted such Tax Return. Seller will pay an amount equal to all Taxes shown due on any such Tax Returns
to Purchaser no later than five days before the date on which such Taxes are required to be paid to any Tax Authority, except to the
extent and in such amount as such Taxes were taken into account in the calculation of Closing Date Indebtedness, and Purchaser or the
Company will timely pay such Taxes to the relevant Tax Authority. The Parties acknowledge and agree that (i) the Company will join Purchaser’s
consolidated group for U.S. federal income tax purposes (and as applicable, state or local income tax purposes) effective as of the day
after the Closing Date, (ii) the taxable year of the Company will end as of the end of the Closing Date for U.S. federal income tax purposes
and, (iii) to the extent applicable Laws in other taxing jurisdictions so permit, the Parties will elect to cause the taxable year of
the Company to terminate on the Closing Date. The Company shall allocate all of its items of income, gain, deduction, loss and credit
accruing, or otherwise taken into account, on the Closing Date to the tax period ending on the Closing Date pursuant to Treasury Regulations
Section 1.1502-76(b)(1)(ii)(A)(1) (and not pursuant to the “next day” rule under Treasury Regulations Section 1.1502-76(b)(1)(ii)(B)
or pursuant to the ratable allocation method under Treasury Regulations Sections 1.1502-76(b)(2)(ii) or 1.1502-76(b)(2)(iii)).
(c)
Straddle Period Tax Returns. Purchaser will timely prepare and file, or cause to be timely prepared and filed, all Tax Returns
for the Company for all periods beginning on or before, and ending after the Closing Date (a “Straddle Period”).
Subject to the provisions of this Section 7.6, all such Tax Returns will be prepared in a manner consistent with past custom and
practice of the Company unless otherwise required by Law or the terms of this Agreement. To the extent any such Tax Returns are not prepared
in accordance with past custom and practice, Purchaser will permit Seller the opportunity to review and comment on each of such Tax Returns
for at least 10 days prior to the due date (with applicable extensions) and filing of such Tax Returns. Seller may provide any written
comments to Purchaser not later than 5 days after receiving any such Tax Return, and Purchaser will accept the reasonable comments of
Seller. If Seller does not provide any written comments with 5 days, Seller will be deemed to have accepted such Tax Return. Seller will
pay an amount equal to all Taxes shown due on any such Tax Returns that are attributable to a Pre-Closing Straddle Period (as determined
in accordance with Section 7.6(d)) to Purchaser no later than five days before the date on which such Taxes are required to be paid to
any Tax Authority, except to the extent and in such amount as such Taxes were taken into account in the calculation of Closing Date Indebtedness,
and Purchaser or the Company will timely pay such Taxes to the relevant Tax Authority.
(d)
For purposes of this Agreement, the Taxes of the Company for any Straddle Period will be apportioned between the portion of the Straddle
Period that ends on and includes the Closing Date (the “Pre-Closing Straddle Period”) and the portion of the
Straddle Period that begins on the day after the Closing Date (the “Post-Closing Straddle Period”) in accordance
with this Section 7.6(d). The portion of any such Tax that is attributable to the Pre-Closing Straddle Period will (i) in the
case of any Taxes other than sales or use taxes, value-added taxes, employment taxes, withholding taxes, and any Tax based on or measured
by income, receipts, or profits earned during a Straddle Period, be deemed to be the amount of such Tax for the entire taxable period
multiplied by a fraction, the numerator of which is the number of days in the Pre-Closing Straddle Period and denominator of which is
the number of days in the Straddle Period; and (ii) in the case of any sales or use taxes, value-added taxes, employment taxes, withholding
taxes, and any Tax based on or measured by income, receipts, or profits earned during a Straddle Period, be deemed equal to the amount
that would be payable if the Straddle Period ended on and included the Closing Date (and for such purpose, the taxable period of any
partnership or other pass-through entity or entity that is a “controlled foreign corporation” within the meaning of Section
957(a) of the Code in which the Company owns a beneficial interest shall be deemed to terminate at such time). The portion of Tax attributable
to a Post-Closing Straddle Period will be calculated in a corresponding manner.
(e)
Cooperation. Purchaser and Seller will cooperate fully, as and to the extent reasonably requested by another Party, in connection
with the preparation and filing of Tax Returns (including amendments thereto), audits, examinations, and administrative or judicial proceedings
with respect to Taxes of the Company. Such cooperation includes the retention and (upon such other Party’s request) the provision
of books and records and information reasonably relevant to any such Tax Returns and making employees available during normal business
hours on a mutually convenient basis to provide additional information and explanation of any material provided under this Agreement.
Following the Closing, Purchaser will cause the Company to (i) retain all books and records with respect to Tax matters pertinent to
the Company relating to any taxable period ending on or before the Closing Date until three months after the expiration of the statute
of limitations of the respective taxable periods, and to abide by all record retention agreements entered into with any Tax Authority;
and (ii) give the other Parties reasonable prior, and in no event less than five Business Days, written notice to transferring, destroying,
or discarding any such books and records and, if any such other Parties so request, Purchaser and Seller, as the case may be, will allow
such other Parties to take possession of such books and records.
(f)
Certain Controversies. This Section 7.6(f) and not Section 11.4 will control any inquiry, assessment, Proceeding,
or other similar event relating to any Taxes for a Pre-Closing Tax Period or Straddle Period of any of the Company (a “Tax
Matter”). Purchaser will notify Seller as soon as practicable after the commencement of any Tax Matter relating to any
Pre-Closing Tax Period (a “Pre-Closing Tax Matter”) or any Straddle Period, provided however, that the right
of any person to be indemnified under the terms of this Agreement shall not be adversely affected by a failure to give such notice unless,
and then only to the extent that, the indemnifying parties are actually and materially prejudiced thereby. Seller will have the right,
at the cost and expense of Seller, to represent the interests of the Company before the relevant Governmental Entity with respect to
any Tax Matter that is solely a Pre-Closing Tax Matter and has the right to control the defense, compromise or other resolution of any
such Pre-Closing Tax Matter, including responding to inquiries, preparing Tax Returns and contesting, defending against and resolving
any assessment for additional Taxes or notice of Tax deficiency or other adjustment of Taxes of, or relating to, such Pre-Closing Tax
Matter; provided, however, that (i) Purchaser has the right (but not the duty) to participate in the defense of such Pre-Closing
Tax Matter and to employ counsel, at its own expense, separate from counsel employed by Seller, and (ii) Seller shall not enter into
any settlement of or otherwise compromise any such Pre-Closing Tax Matter without the prior written consent of Purchaser, which consent
shall not be unreasonably conditioned, withheld, or delayed. With respect to any Tax Matter that is (A) not solely a Pre-Closing Tax
Matter, or (B) is solely a Pre-Closing Tax Matter but Seller has not provided Purchaser with written notice of its intent to control
such Pre-Closing Tax Matter, then Purchaser will have the right to represent the interests of the Company before the relevant Governmental
Entity with respect to such Tax Matter and has the right to control the defense, compromise, or other resolution of any such Tax Matter,
including responding to inquiries, filing Tax Returns, and contesting, defending against, and resolving any assessment for additional
Taxes or notice of Tax deficiency or other adjustment of Taxes of, or relating to, such Tax Matter. If Seller would be required to indemnify
Purchaser, the Company, or any of their Affiliates pursuant to this Agreement with respect to any Tax Matter controlled by Purchaser
then: (1) Seller will have the right (but not the duty) to participate in the defense of such Tax Matter and to employ counsel, at its
own expense, separate from counsel employed by Purchaser, and (2) Purchaser shall not enter into any settlement of or otherwise compromise
any such Tax Matter to the extent that it adversely affects the Tax liability of Seller without the prior written consent of Seller,
which consent shall not be unreasonably conditioned, withheld, or delayed.
7.7
Expenses; Transfer Taxes.
(a)
Whether or not the Closing takes place, except as otherwise specifically provided in this Agreement, all Transaction Expenses will be
paid by the Party incurring such expense (and all such expenses incurred pre-Closing by the Company will be expenses of Seller); provided,
however, that the fees and expenses of the Accountant, if applicable, will be paid or reimbursed in accordance with Section
2.4(e)(iii) and/or Section 2.5(c).
(b)
Provided that the Closing takes place, all transfer, documentary, sales, use, stamp, and registration Taxes and fees (including any penalties
and interest) incurred in connection with this Agreement will be paid by Seller when due. At the expense of Seller, Purchaser or the
Company will file all necessary Tax Returns and other documentation with respect to all such transfer, documentary, sales, use, stamp,
and registration Taxes and fees. If required by applicable Law, Seller will join in the execution of any such Tax Returns and other documentation.
7.8
Further Assurances; No Avoidance.
(a)
From time to time, as and when requested by any Party, each other Party will execute and deliver, or cause to be executed and delivered,
all such documents and instruments and will take, or cause to be taken, all such further or other actions as such requesting Party may
reasonably request to consummate the Contemplated Transactions.
(b)
Each Party agrees that such Party will not, through reorganization, consolidation, merger, dissolution, or sale or other transfer of
assets, or by any other voluntary act, avoid or seek to avoid the observance or performance of any of the covenants, stipulations, or
conditions to be observed or performed in any Transaction Document by such Party.
(c)
During the 24-month period after the Closing, Seller agrees (i) to cooperate with Purchaser and its Affiliates and counsel, to the extent
reasonably requested, in the registration, issuance, protection, perfection, contest, or defense of any Company Intellectual Property
owned at Closing, and (ii) to make reasonably available their personnel, to provide any testimony and access to their books and records
in connection with, and to provide the Company with such other assistance as the Company may reasonably request, in each case at the
sole expense of the Company (except as results from a breach of this Agreement), for the purpose of protecting the Company Intellectual
Property owned at Closing. For the avoidance of doubt, nothing in this subsection (c) is intended to require Seller to take any
action against his, her, or its self interest in connection with any direct dispute with Purchaser and its Affiliates, including any
such dispute under the Transaction Documents or any claim for indemnity under this Agreement.
7.9
Publicity. Each of Purchaser, on the one hand, and the Company and Seller, on the other hand, shall, to the extent reasonably
practicable, consult with each other before issuing, and give each other a reasonable opportunity to review and comment upon, any press
release or other analogous public statement with respect to this Agreement and the other transactions contemplated hereby and shall not
issue any such press release or make any other analogous public statement prior to such consultation and without considering carefully
and in good faith all comments timely received from the other party, except as may be required by applicable Law, court process or rule
or regulation of NYSE American in the case of Purchaser.
7.10
Seller Release.
(a)
Seller (i) represents, warrants, and acknowledges that Seller has been fully advised by Seller’s attorney that, under certain statutory
or common-law principles applied in certain states, a general release does not extend to claims that a creditor does not know or suspect
to exist in such creditor’s favor at the time of executing the release, which if known by such creditor must have materially affected
such creditor’s settlement with the debtor, and (ii) hereby expressly waives the benefits thereof and any rights Seller may have
under any statute or common law principle of similar effect in any jurisdiction.
(b)
Seller hereby (i) generally, irrevocably, unconditionally, and completely releases and forever discharges each of the Releasees from,
and hereby irrevocably, unconditionally, and completely waives and relinquishes, each of the Released Claims, and (ii) irrevocably covenants
to refrain from, directly or indirectly, asserting any Released Claim, or commencing, instituting, or causing to be commenced, any litigation,
action, audit, suit, investigation or proceeding of any kind against any Releasee with respect to the Released Claims.
(c)
Seller hereby acknowledges and intends that this release will be effective as a bar to each and every one of the Released Claims and
expressly consents that this release will be given full force and effect in accordance with every express term or provision, including
those (i) relating to any Released Claims, or (ii) relating to unknown and unsuspected Released Claims (notwithstanding any state statute
that expressly limits the effectiveness of a general release of unknown, unsuspected and/or unanticipated claims).
7.11
Certain Restrictions.
(a)
Seller acknowledges and agrees that, in light of (x) Purchaser’s substantial investment in the Company, including its good will,
customer relationships, employee relationships, Intellectual Property and other proprietary and/or confidential information, (y) Purchaser’s
present intent to expand upon the scope, geographic, industry, types of services and otherwise, of the Business’ relationships
with its current and former customers, and (z) the continued employment of certain employees of the Company by the Company or its post-Closing
Affiliates following the Closing Date, as a condition precedent to Purchaser’s obligations to enter into and perform its obligations
under the Transaction Documents, for a period of two (2) years commencing on the Closing Date, Seller will not, directly or indirectly,
either for itself or for any other Person, without the prior written consent of the Purchaser:
(i)
own, consult for, provide services to, engage in sales, brokerage, or marketing for, manage, participate in, be employed by, permit its,
his, or her name to be used by, or be connected or do any business, or otherwise have any direct or indirect interest in, whether as
a manager, officer, director, employee (including of any competitor of the Business), partner, sole proprietor, agent, broker, representative,
independent contractor, consultant, franchisor, franchisee, creditor, shareholder, owner, joint venture partner, or otherwise, any Person
or business engaged in a business that competes with Purchaser or the Company, including any business that designs, develops, manufactures,
markets and/or sells endovascular catheters (any such business, a “Competing Business”), or a type of business
planned as of the Closing Date to be entered into by the Company within the 12-month period immediately following the Closing Date, throughout
North America, the UK, and the EU; provided, however, that the foregoing does not prohibit: (A) a Seller’s ownership of
2.0% or less of the stock of a publicly held corporation whose stock is traded on a nationally or internationally recognized securities
exchange, automated dealer quotation system or in a U.S. or foreign over-the-counter-market; or (B) a Seller’s passive ownership
of less than 2.0% of the equity interest in a private equity fund that is not formed specifically to invest in a particular Competing
Business;
(ii)
(A) induce or solicit, or attempt to induce or solicit, any then-current employee or contractor of any member of Company Group, to terminate
or reduce such employee or contractor’s employment or engagement with any member of Company Group, or to accept employment with,
provide services to, or partner with another Person, (B) in any way materially interfere with the relationship between any member of
Company Group, on the one hand, and any employee or contractor thereof, on the other hand, or (C) hire or attempt to hire any then-current
or past (within the preceding 12 months, as applicable to such time) employee or contractor of any member of Company Group; or
(iii)
call on or solicit any customer, client, strategic partner, joint venture partner, breach-coach or other similar referral source, vendor,
supplier, consultant, contractor, licensee, licensor, bona fide potential acquisition or investment target or other material business
relation (collectively, “Excluded Persons”) of any member of Company Group (including any Excluded Persons
of the Company at any time during the 12-month period immediately prior to the Closing Date), in order to induce or attempt to induce
such Excluded Person to utilize the services of a Competing Business or cease doing business with any member of Company Group or its
Affiliates, or in any way materially interfere with the relationship between any Excluded Person and any member of Company Group or its
Affiliates.
Notwithstanding
the foregoing, the placement of general advertisement that may be targeted to a particular geographic or technical area, but is not targeted
specifically towards employees or contractors of any member of Company Group will not be deemed to breach the non-solicit provisions
of Section 7.11(a)(ii); provided that the preceding clause will not limit or otherwise modify the prohibitions against
hiring set forth in Section 7.11(a)(ii)(C).
(b)
Seller acknowledges and agrees that the covenants set forth in this Section 7.11 (collectively, the “Restrictions”)
are reasonably designed to protect Purchaser’s substantial investment in the acquisition of the Company and are reasonable with
respect to their duration, geographical area and scope. It is the desire and intent of the Parties that the provisions of this Section
7.11 be enforced to the fullest extent permissible under the Laws and public policies applied in each jurisdiction in which enforcement
is sought, and each Party hereby consents to the jurisdiction of the state, provincial and federal courts in any such jurisdiction. If
any particular provision(s) or portion of this Section 7.11 is adjudicated to be invalid or unenforceable, this Section 7.11
will be deemed amended to delete therefrom such provision(s) or portion adjudicated to be invalid or unenforceable, such amendment
to apply only with respect to the operation of this Section 7.11 in the particular jurisdiction in which such adjudication is
made.
(c)
Seller recognizes and affirms that in the event of breach of any of the provisions of this Section 7.8, money damages would be
inadequate and that Purchaser would have no adequate remedy at Law. Accordingly, Seller agrees that each member of Company Group and
its Affiliates, will be entitled, in addition to any other rights and remedies existing in their favor, to enforce its and Purchaser’s
rights and Seller’s obligations under this Section 7.8 not only by an action or actions for damages, but also by an action
or actions for specific performance, injunctive and/or other equitable relief (without any requirement of notice or to post any bond
or deposit) in order to enforce or prevent any violations (whether anticipatory, continuing or future) of the provisions of this Section
7.8 including injunctive relief to restrain the violation of such covenants by Seller or by any person or persons acting for or with
Seller in any capacity whatsoever.
7.12
Exclusivity.
(a)
Prior to the Closing, or until this Agreement is terminated in accordance with its terms, neither Seller nor the Company shall, and each
such Person shall cause its and their respective shareholders, members, officers, employees, directors, managers, agents and representatives
not to, directly or indirectly (i) solicit, initiate, knowingly induce, knowingly assist or take any action with the intent to facilitate
or encourage (including by way of furnishing information) any inquiries with respect to, or the making of, any inquiry, proposal or offer
(whether or not in writing, and including any proposal or offer to Seller) from any Person or group of Persons, other than Purchaser
and its Affiliates, that may constitute, or that would reasonably be expected to lead to, an Alternative Transaction; (ii) engage or
enter into, continue or otherwise participate in any discussions, negotiations or agreements with any Person or group of Persons, other
than Purchaser and its Affiliates, regarding, or intended to result in, or would reasonably be expected to lead to, an Alternative Transaction;
(iii) furnish any information relating to the Company or any of its Affiliates, assets or businesses, or afford access to the assets,
business, properties, books or records of the Company or any of its Affiliates to any Person or group of Persons, other than Purchaser
and its Affiliates, or cooperate in any way with any Person or groups of Persons, in each such case for the purpose of contemplating,
knowingly assisting, or knowingly facilitating any proposal that may constitute, or that would reasonably be expected to lead to, an
Alternative Transaction; or (iv) enter into an Alternative Transaction or any agreement, arrangement or understanding with respect thereto,
including, without limitation, any letter of intent, memorandum of understanding, agreement in principle, joint venture agreement, partnership
agreement, term sheet or other similar document (whether oral or written) regarding, or that is intended to result in, or would reasonably
be expected to lead to, an Alternative Transaction.
(b)
Until the Closing or the earlier termination of his Agreement in accordance with its terms, the Company, Seller shall promptly (and in
any event within three Business Days after receipt thereof by Seller, the Company or any of their respective Affiliates or representatives)
advise Purchaser orally and in writing of any proposal of the kind described in this Section 7.12 (including the identity
of the proposing party and the proposed terms thereof), any request for information with respect to any such proposal or any inquiry
with respect to or which could result in a proposal of the kind described in this Section 7.12.
(c)
In addition to any other remedy that may be available to Purchaser at law, in equity or otherwise, Seller acknowledges and agrees that
it shall be liable to Purchaser for any breach of the obligations set forth in this Section 7.12 by any of its Affiliates,
directors, officers, employees, securityholders, agents, subsidiaries, representatives or members (including those not party hereto).
Seller (for itself and on behalf of its Affiliates) acknowledges and agrees that Purchaser’s remedies at law for any breach of
Seller’s, the Company’s or their Affiliates’ obligations hereunder would be inadequate, and agree and consent that,
in addition to any other relief available to Purchaser at law or in equity, temporary and permanent injunctive relief, including specific
performance, may be granted in a proceeding brought to enforce any provision hereof without the necessity of proof of actual damage or
the posting of a bond or other security.
7.13
Resale Registration Statement.
(a)
Purchaser shall prepare and, within 45 Business Days of the Closing Date, file with the SEC a registration statement on Form S-3, or,
if such registration statement is not available, such other form as may provide for a registered resale, under the Securities Act (together
with all amendments or supplements thereto, and all information incorporated by reference therein, the “Registration Statement”),
covering the resale of the Closing Shares issued and Earnout Shares issuable pursuant to Section 2.5 of this Agreement (“Registrable
Securities”). Purchaser will use its reasonable best efforts to cause the Registration Statement to be declared effective
as soon as reasonably practicable following the filing of the Registration Statement and shall use its reasonable best efforts to cause
the Registration Statement to be maintained effective until the earliest to occur of (i) the sixth anniversary of the date the Registration
Statement has first become effective, or (ii) the date that all of the Registrable Securities issued or issuable pursuant to Section
2.5 have actually been sold, or may be sold pursuant to Rule 144 under the Securities Act without any restrictions (including as
to volume or manner of sale), including preparing and filing any amendments, post-effective amendments, and prospectus supplements as
may be reasonably requested by Seller or required by the rules, regulations or instructions applicable to the registration form used
by Purchaser or by the Securities Act or rules and regulations thereunder to keep the Registration Statement effective until all Registrable
Securities covered by such Registration Statement are sold. Purchaser shall, at least three (3) days prior to the filing of the Registration
Statement or any amendment or supplement thereto, Purchase shall furnish a copy thereof to Seller.
(b)
For not more than sixty (60) consecutive days or for a total of not more than ninety (90) days in any twelve (12) month period, Purchaser
may, by written notice to the Seller, suspend the use of any prospectus included in the Registration Statement if Purchaser’s board
of directors or an authorized committee thereof determines in good faith that such suspension is necessary to (x) delay the disclosure
of material nonpublic information concerning Purchaser, the disclosure of which Purchaser’s board of directors or such committee
reasonably determines to be significantly disadvantageous to the Purchaser and its stockholders, or (y) amend or supplement the Registration
Statement or the related prospectus so that the Registration Statement or prospectus will not include an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the case of the prospectus
in light of the circumstances under which they were made, not misleading (and, in the event of a suspension pursuant to clause (y), Purchaser
agrees to use reasonable best efforts to complete such amendment or supplement as soon as reasonably practicable). The Company and the
Seller shall (a) promptly furnish such information, questionnaires, certificates or other documents as Purchaser may reasonably request
in connection with any such Registration Statement and (b) use their reasonable best efforts to cause to be furnished by the appropriate
representatives of the Company or by a Seller such information, questionnaires, certificates or other documents as may be reasonably
requested by Purchaser in connection with the filing of any such Registration Statement. It shall be a condition precedent to the obligations
of Purchaser to take any action pursuant to this Section (c) with respect to Seller that Seller furnish to Purchaser a fully completed
questionnaire and such other information in writing regarding itself, the Purchaser Common Stock held by it, and the intended method
of disposition of such securities by Seller as Purchaser shall reasonably request. In addition, Seller shall promptly notify Purchaser
of the occurrence, from the date on which such information or documents are furnished to the date of the closing for the sale of such
Purchaser Common Stock held by it, of any event relating to Seller that is required under the Securities Act to be set forth in any such
Registration Statement. All expenses relating to the preparation, filing and otherwise relating to the preparation and filing of the
Registration Statement (but not as to sales costs, fees and commissions relating to any sales of Registrable Securities thereunder) shall
be the sole responsibility of Purchaser.
(c)
So long as Seller holds Registrable Securities, Purchaser, at all times while it shall be a reporting company under the Exchange Act,
covenants to file timely (or obtain extensions in respect thereof and file within the applicable grace period) all SEC Reports required
to be filed by Purchaser after the date hereof and to promptly notify Seller of its filing of all such SEC Reports. Purchaser further
covenants that it shall take such further action as Seller may reasonably request, all to the extent required from time to time to enable
Seller to sell the shares of Purchaser Common Stock held by Seller without registration under the Securities Act within the limitation
of the exemptions provided by Rule 144, including providing any customary legal opinions. Upon the request of Seller, Purchaser shall
deliver to Seller a written certification of a duly authorized officer as to whether it has complied with such requirements.
7.14
NYSE American Listing. Purchaser shall use its reasonable best efforts to cause the Registrable Securities to be issued in
connection with the transactions contemplated hereby to be approved for listing on the NYSE American promptly following the Closing Date.
7.15
Debt Restructuring; Lease Extension.
(a)
On or prior to the Closing Date, the Company shall, working with the Seller, use its reasonable best efforts to cause the Company to
restructure its Non-Assumed Indebtedness such that Seller shall have the sole obligation to pay or cause the repayment of such Non-Assumed
Indebtedness from (i) the Upfront Stock Consideration paid at Closing or the cash proceeds of the sale of such Upfront Stock Consideration
and (ii) any Earnout Consideration payable hereunder, and to cause the Company to be fully and unconditionally released from such obligations
at Closing, including release of all security interests on the assets or property of the Company thereon (the “Debt Restructuring”).
It shall be a condition to the Parties’ respective obligations to consummate the Transactions contemplated hereby, that such Debt
Restructuring and Purchaser release be obtained on terms satisfactory to Purchaser in its sole discretion.
(b)
On or prior to the Closing Date, the Company shall use its Commercially Reasonable Efforts to cause the Company to extend the real property
lease on the Leased Real Property, (the “Lease Extension”), having the following minimum key terms (unless
waived by Purchaser) (i) options to extend the current lease on the Leased Real Property for not less than three successive extension
periods of four years at each renewal, (ii) at a rental rate increase for each extension period that does not exceed standard inflation
rates, and (iii) an option to expand the leased space when/if additional adjacent space becomes available on commercially similar terms
and otherwise on such other commercially reasonable terms as Purchaser may approve. It shall be a condition to Purchaser’s obligation
to consummate the Transactions contemplated hereby, that such Lease Extension be obtained on terms satisfactory to Purchase in its sole
discretion.
7.16
Insurance Tail Policies. Prior to the Closing Date, the Company and Seller, with Purchaser’s cooperation, will use the
Commercially Reasonable Efforts to obtain and maintain in effect, for a reasonable period after the Closing Date, a pre-paid tail policy
of errors and omissions liability insurance, general liability insurance and any other insurance that would cover pre-Closing Liabilities
of the Company (the “Tail Policies”) providing coverage and amounts and containing terms and conditions comparable
to such existing policies for all Persons and Entities that are currently covered by any such policies of the Company, with respect to
claims arising from facts or events that occurred at or prior to the Closing Date. The cost of any such Tail Policies shall be the responsibility
of Seller.
7.17
Director and Officer Indemnification. Until the sixth anniversary of the Closing Date, Purchaser will cause the Company to maintain
in effect provisions in the Organizational Documents of the Company (or in such documents of any successor to the Business) regarding
exculpation and elimination of Liability of and indemnification in favor of each present and former director, manager, officer, or employee
of the Company, in each case that are no less advantageous to the intended beneficiaries than the corresponding provisions in existence
as of the Closing. The obligations of Purchaser under this Section 7.17 may not be terminated or modified in such a manner as
to materially, disproportionately and adversely affect any Person to whom this Section 7.17 applies.
7.18
Alterra Matter. Prior to the Closing, the Company will assign to Seller all of the Company’s rights to collect on the
jury verdict and judgment it obtained against Alterra with respect to the Alterra litigation described in in Section 5.14(a) of Seller’s
Disclosure Schedule (the “Alterra Matter”). Additionally, the Company will assign the right to defend the
Company in the Alterra Matter to Seller. To the extent that the Company cannot assign the Alterra Matter to Seller, Purchaser and Steve
Berhow will enter into an agreement pursuant to which Steve Berhow, individually, will agree to indemnify and hold harmless Purchaser
for any Liability the Company may suffer with respect to the Alterra Matter that Seller is unable to fully satisfy.
Article
VIII
Closing Deliverables
8.1
Seller’s Closing Deliveries. Seller will deliver or cause to be delivered the following to Purchaser at the Closing,
each of which will, unless otherwise indicated, be dated as of the Closing Date:
(a)
the applicable brokerage account and related information requirement by the Purchaser’s Transfer Agent to transfer the Upfront
Stock Consideration;
(b)
evidence reasonably satisfactory to Purchaser that all Seller Transaction Expenses have been paid in full;
(c)
documentation in form and substance reasonably acceptable to Purchaser relating to the Debt Restructuring and related release of the
Company by the Lenders with respect to the Indebtedness as of the Closing Date, including authorization to file UCC termination statements
in connection therewith (if applicable), and such other documents as Purchaser may reasonably require to evidence the termination and
release in full of all associated Encumbrances relating to such Indebtedness on or promptly after the Closing Date;
(d)
evidence satisfactory to Purchaser that all approvals and actions of or by, and all notices to, all Governmental Entities have been obtained
or taken place;
(e)
the Third-Party Consents set forth in Schedule 8.1(e);
(f)
documents necessary to terminate all shareholders and similar agreements affecting the Company, in form and substance reasonably acceptable
to Purchaser;
(g)
a termination agreement between the Company and each Person that has an employment agreement, offer letter or equity agreement with the
Company, in form and substance reasonably acceptable to Purchaser, terminating any such existing employment agreements, offer letters
or equity agreements between the Company and such Person, executed by such Person (or assigning such to the Seller, in the case of equity
agreements);
(h)
any real estate related documents, to the extent necessary, e.g., an estoppel certificate from landlord, SNDA, waivers, etc.
(i)
a duly executed IRS Form W-9 from Seller;
(j)
a certificate of the president of the Company dated as of the Closing Date, certifying as to (i) the incumbency and signatures of the
officers of the Company executing each of the Transaction Documents, (ii) copies of the Company’s Organizational Documents, each
as in effect on the Closing Date, (iii) copies of all resolutions adopted by the Company’s board of directors or similar governing
body relating to the Contemplated Transactions and attached to such certificate, and (iv) copies of all resolutions adopted by the Company’s
shareholders relating to the Contemplated Transactions and attached to such certificate;
(k)
a certificate of good standing or equivalent for the Company, issued as of a date not more than 10 days before the Closing Date by the
Secretary of State or similar official of the jurisdiction of its organization or formation and each other jurisdiction where it is qualified
to do business as a foreign corporation or other Entity;
(l)
to the extent specified by Purchaser prior to Closing, resignations, effective as of the Closing Date, of each director and officer of
the Company from all positions held by such Person;
(m)
evidence satisfactory to Purchaser that all amounts outstanding with respect to loans and advances, if any, made by the Company to any
Representative of the Company have been repaid in full;
(n)
evidence satisfactory to Purchaser that the Tail Policies have been obtained;
(o)
the original minute books, stock ledger, and option or similar ledger (if any) of the Company;
(p)
an electronic copy of the full contents of the virtual Data Room or file hosting service used in connection with the Contemplated Transactions;
and
(q)
all other documents, instruments, or certificates as may be reasonably requested by Purchaser or the Lenders.
8.2
Purchaser Closing Deliveries. Purchaser will deliver or cause to be delivered, the following to Seller at the Closing, each
of which (if a document) will, unless otherwise indicated, be dated as of the Closing Date:
(a)
the Upfront Stock Consideration, issued in accordance with and to the recipients referenced in Section 3.3;
(b)
a certificate of the secretary of Purchaser dated as of the Closing Date, certifying as to (i) the incumbency and signatures of the officers
of Purchaser executing each of the Transaction Documents, (ii) copies of Purchaser’s Organizational Documents, each as in effect
on the Closing Date and attached to such certificate, and (iii) copies of all resolutions adopted by Purchaser’s board of directors
or similar governing body relating to the Contemplated Transactions and attached to such certificate; and
(c)
for Purchaser, a certificate of good standing or equivalent issued as of a date not more than 30 days before the Closing Date by the
Secretary of State or similar official of the state of its organization or formation.
Article IX
Conditions
Precedent
9.1
Conditions to Obligations of All Parties. The obligation of each party to consummate the Contemplated Transactions is subject
to the satisfaction at or prior to the Closing, of the following conditions:
(a)
No Injunctions or Restraints. No Law or Proceeding shall be in effect against or involving any Purchaser, the Company or Seller
that would prevent the consummation of the Contemplated Transactions.
9.2
Conditions to Obligations of Purchaser. The obligation of Purchaser to consummate the Contemplated Transactions is subject
to the satisfaction, or waiver by Purchaser in writing, at or prior to the Closing, of the following conditions:
(a)
Representations and Warranties. (i) Each of the Fundamental Seller Representations, the Fundamental Company Representations and
the representation and warranty of Seller set forth in Section 5.7(z) shall be true and correct in all respects on the date of
this Agreement and as of the Closing Date, as if made at and as of such date (except to the extent that any such representation or warranty
speaks as of an earlier date, in which case such representation or warranty shall be true and correct as of such earlier date), and (ii)
each of the other representations and warranties of Seller set forth in this Agreement shall be true and correct in all respects (without
giving effect to any limitation as to “materiality” or “Material Adverse Effect” set forth therein) on the date
of this Agreement and as of the Closing Date, as if made at and as of such date (except to the extent that any such representation or
warranty speaks as of an earlier date, in which case such representation or warranty shall be true and correct as of such earlier date),
except, in the case of clause (ii), where such failure would not have a Material Adverse Effect.
(b)
Performance of Obligations of Seller. Seller shall have performed in all material respects all obligations required to be performed
by Seller under this Agreement at or prior to the Closing Date.
(c)
Material Adverse Effect. During the period from the date of this Agreement through the Closing Date, there shall not have occurred
any Material Adverse Effect.
(d)
Officer’s Certificate. Purchaser shall have received a certificate, dated as of the Closing Date and executed by Seller,
certifying to the fulfillment of the conditions specified in Sections 9.2(a)-(c).
(e)
Closing Deliveries. Purchaser shall have received all deliverables in accordance with Section 8.1.
(f)
Debt Restructuring. Seller and Company shall have completed the Debt Restructuring (and obtained Purchaser release therefrom)
in a manner acceptable to Purchaser.
(g)
Lease Extension. The Company shall have completed the Lease Extension on terms acceptable to Purchaser in its reasonable discretion.
(h)
Voting and Support Agreements. The Voting and Support Agreements shall not have been withdrawn and the shareholders of the Seller
shall have performed in all material respects all obligations required to be performed by Seller under Voting and Support Agreements
at or prior to the Closing Date.
(i)
Seller Stockholder Approval. The Seller Reorganization shall have occurred and the Stockholder Approval shall have been obtained.
(j)
Tail Policies. The Company shall have obtained the Tail Policies.
9.3
Conditions to Obligations of Seller
.
The obligation of Seller to consummate the Contemplated Transactions is subject to the satisfaction, or waiver by Seller in writing,
at or prior to the Closing, of the following conditions:
(a)
Representations and Warranties. (i) Each of the Fundamental Purchaser Representations shall be true and correct in all respects
on the date of this Agreement and as of the Closing Date, as if made at and as of such date (except to the extent that any such representation
or warranty speaks as of an earlier date, in which case such representation or warranty shall be true and correct as of such earlier
date), and (ii) the other representations and warranties of Purchaser set forth in this Agreement shall be true and correct in all respects
(without giving effect to any limitation as to “materiality” set forth therein) on the date of this Agreement and as of the
Closing Date, as if made at and as of such date (except to the extent that any such representation or warranty speaks as of an earlier
date, in which case such representation or warranty shall be true and correct as of such earlier date), except, in the case of clause
(ii), where such failure would not have a material adverse effect on Purchaser.
(b)
Performance of Obligations of Purchaser. Purchaser shall have performed in all material respects all obligations required to be
performed by it under this Agreement at or prior to the Closing Date.
(c)
Officer’s Certificate. Seller shall have received a certificate, dated as of the Closing Date and executed by a duly authorized
executive officer of Purchaser, certifying to the fulfillment of the conditions specified in Sections 9.3(a)-(b).
(d)
Closing Deliveries. Purchaser shall have completed all deliverables in accordance with Section 8.2.
(e)
Debt Restructuring. Seller and Company shall have completed the Debt Restructuring (and obtained Purchaser release therefrom)
in a manner acceptable to Seller.
(f)
Seller Stockholder Approval. The Seller Stockholder Approval shall have been obtained.
9.4
Frustration of Closing Conditions. With respect to its obligation to effectuate the Closing and any right to terminate this
Agreement pursuant to Section 10.1, no Party may rely on the failure of any condition set forth in Sections 9.19.2 or 9.3,
as the case may be, to be satisfied if such failure was caused by the failure of such Party or any of its Affiliates to use its reasonable
best efforts to consummate the Contemplated Transactions.
Article
X
Termination
10.1
Termination. This Agreement may be terminated at any time prior to the Closing:
(a)
by mutual written consent of Purchaser and Seller;
(b)
by either Purchaser or Seller if any Governmental Entity of competent jurisdiction shall have issued a final and nonappealable Order
permanently enjoining or otherwise prohibiting the consummation of the transactions contemplated by this Agreement; provided, that the
Party seeking to terminate this Agreement shall have used its reasonable best efforts to have such Order lifted;
(c)
by either Purchaser or Seller if the Closing shall not have been consummated on or before December 31, 2024 (the “End Date”);
provided, however, that no Party may terminate this Agreement pursuant to this Section 10.1(c) if such Party’s breach of
its obligation under this Agreement resulted in or was a primary cause of the failure of the Closing to occur on or before the End Date;
(d)
by Purchaser if there has been a breach by Seller of any representation, warranty, covenant or agreement contained in this Agreement
which would result in a failure of a condition set forth in Section 9.2; provided, however, that if such breach
is curable by Seller and Seller cures such breach within thirty (30) days following the Purchaser’s delivery of written notice
thereof to Seller, Purchaser may not terminate this Agreement under this Section 10.1(d) due to such breach; provided further,
however, that Purchaser shall not have the right to terminate this Agreement pursuant to this Section 10.1(d) if Purchaser
is then in breach of any representation, warranty, covenant or agreement contained in this Agreement if such breach would give rise to
Seller’s right to terminate this Agreement pursuant to Section 10.1(e); or
(e)
by Seller if there has been a breach by Purchaser of any representation, warranty, covenant or agreement contained in this Agreement
which would result in a failure of a condition set forth in Section 9.3; provided, however, that if such breach
is curable by Purchaser and Purchaser cures such breach within thirty (30) days following Seller’s delivery of written notice thereof
to Purchaser, Seller may not terminate this Agreement under this Section 10.1(e) due to such breach, failure to perform or inaccuracy;
provided further, however, that Seller shall not have the right to terminate this Agreement pursuant to this Section
10.1(e) if Seller is then in breach of any representation, warranty, covenant or agreement contained in this Agreement if such breach
would give rise to Purchaser’s right to terminate this Agreement pursuant to Section 10.1(d).
10.2
Effect of Termination.
(a)
In the event of termination of this Agreement by either Purchaser or Seller, or both, in accordance with Section 10.1, (a) written notice
thereof shall forthwith be given to the other Parties and (b) this Agreement shall forthwith become void and have no effect, and none
of the Parties nor any of their respective subsidiaries or Affiliates or any of the officers, directors or managers of any of the foregoing
shall have any Liability of any nature whatsoever under this Agreement or any other Transaction Document or in connection with the Contemplated
Transactions, except that Section 7.7(a), Article VIII and this Article X shall survive any termination of this Agreement.
(b)
Breakup Fee. In the event that this Agreement is terminated by Purchaser pursuant to Section 10.1(d) as a result of a breach
of Section 7.12 hereof, and Seller closes on an Alternative Transaction within 12 months thereafter) then the Seller and the Company
shall, on a joint and several liability basis, pay Purchaser a break-up fee of $1,000,000.00 (the “Break-Up Fee”)
in cash by wire transfer of same-day U.S. dollars to the applicable account or accounts designated in writing to the Company by Purchaser
within three (3) Business Days after such termination. In the event that Purchaser shall receive full payment pursuant to this Section
10.2(b), the receipt of the Breakup Fee shall be deemed to be liquidated damages for any and all losses or damages suffered or incurred
by Purchaser, any of its Affiliates or any other Person in connection with this Agreement (and the termination hereof), the transactions
contemplated by this Agreement (and the abandonment thereof) or any matter forming the basis for such termination, the Company shall
have no further liability, whether pursuant to a claim at law or in equity, to Purchaser or any of its Affiliates in connection with
this Agreement (and the termination hereof), the transactions contemplated by this Agreement (and the abandonment thereof) or any matter
forming the basis for such termination, and none of Purchaser, its Affiliates or any other Person shall be entitled to bring or maintain
any proceeding against the Company or any of its Affiliates for damages or any equitable relief arising out of or in connection with
this Agreement (other than equitable relief to require payment of the Breakup Fee), any of the transactions contemplated by this Agreement
or any matters forming the basis for such termination; provided, that (A) nothing in this Section 10.2(b) shall relieve the Company
from any liabilities or damages resulting from any fraud or willful breach committed by the Company prior to such termination and (B)
if the Company fails to pay the Breakup Fee in accordance with this Section 10.2(b) and Purchaser commences a suit which results
in a final, non-appealable judgment against the Company for the Breakup Fee or any portion thereof, then the Company shall pay Purchaser
it costs and expenses (including reasonable attorney’s fees and disbursements) in connection with such suit, together with interest
on the Breakup Fee from and including the date payment of such amount was due through the date of payment, at the “prime rate”
as published in The Wall Street Journal, Eastern Edition, in effect on the date such payment was required to be made plus two percent
(2%) (calculated daily on the basis of a year of 365 days and the actual number of days elapsed, without compounding). The Breakup Fee
is non-refundable and shall not be offset by or credited against any other payment. Each of the parties acknowledges and agrees that
the agreements contained in this Section 10.2(b) are an integral part of the transactions contemplated by this Agreement,
and that, without these agreements, Purchaser would not enter into this Agreement. Notwithstanding the foregoing, nothing in this Section
10.2(b) shall require Seller to close the Contemplated Transactions, to waive the conditions to Seller’s obligations in Sections
9.1 or 9.3 or to pay the Break-Up Fee in the conditions to Purchaser’s obligations in Section 9.2 are not satisfied
in full.
(c)
Reverse Break-Up Fee. In the event that this Agreement is terminated by Seller pursuant to Section 10.1(e) then Purchaser shall
pay Seller a reverse break-up fee equal to $1,000,000.00 (the “Reverse Break-Up Fee”) in cash by wire transfer
of same-day U.S. dollars to the applicable account or accounts designated in writing to Purchaser by Seller within three (3) Business
Days after such termination, provided that Purchaser shall have the option to deliver such Reverse Break-Up Fee in Purchaser
Common Stock having a value of the Reverse Break-Up Fee using the closing price of Purchaser Common Stock on the date that is two Business
Days prior to such payment being made, and Seller shall cooperate with Seller to accept such delivery of Purchaser Common Stock. In the
event that Seller shall receive full payment pursuant to this Section 10.2(c), the receipt of the Reverse Breakup Fee shall
be deemed to be liquidated damages for any and all losses or damages suffered or incurred by Seller, any of its Affiliates or any other
Person in connection with this Agreement (and the termination hereof), the transactions contemplated by this Agreement (and the abandonment
thereof) or any matter forming the basis for such termination, Purchaser shall have no further liability, whether pursuant to a claim
at law or in equity, to Seller, Company oir any of their respective Affiliates in connection with this Agreement (and the termination
hereof), the transactions contemplated by this Agreement (and the abandonment thereof) or any matter forming the basis for such termination,
and none of Seller, Seller, their respective Affiliates or any other Person shall be entitled to bring or maintain any proceeding against
Purchaser or any of its subsidiaries or Affiliates for damages or any equitable relief arising out of or in connection with this Agreement
(other than equitable relief to require payment of the Reverse Breakup Fee), any of the transactions contemplated by this Agreement or
any matters forming the basis for such termination. Each of the parties acknowledges and agrees that the agreements contained in this
Section 10.2(c) are an integral part of the transactions contemplated by this Agreement, and that, without these agreements,
Seller would not enter into this Agreement. Notwithstanding the foregoing, nothing in this Section 10.2(c) shall require Purchaser
to close the Contemplated Transactions, to waive the conditions to Purchaser’s obligations in Section 9.2 or to pay the
Reverse Break-Up Fee in the conditions to Purchaser’s obligations in Section 9.2 are not satisfied in full.
Article
XI
Survival; Indemnification
11.1
Survival.
(a)
Survival of Representations and Warranties. The representations and warranties contained in this Agreement shall survive the Closing
until the expiration of its Applicable Limitation Date as set forth, and each Party shall be entitled to recover for any Loss related
thereto pursuant to Section 11.2(a)(i) or Section 11.3(a)(i), as applicable, if written notice of a claim thereof complying
with the terms of this Agreement is delivered to the other Party prior to the Applicable Limitation Date. For purposes of this Agreement,
the term “Applicable Limitation Date” means (i) with respect to Fundamental Representations, indefinitely,
(ii) with respect to SOL Representations, 60 days after the date upon which the applicable statute of limitations expires, and (iii)
with respect to representations or warranties other than Fundamental Representations and the SOL Representations, the date that is eighteen
(18) months following the Closing Date.
(b)
Survival of Covenants. All of the covenants or other agreements contained in this Agreement will survive the Closing Date until
the first to occur of (i) the expiration by their terms of the obligations of the applicable Party under such covenant and (ii) such
covenant being fully performed or fulfilled, unless non-compliance with such covenants or agreements is expressly waived in writing by
the Party entitled to such performance.
(c)
Claims for indemnification related to Fraud may be brought at any time following the Closing.
(d)
Any Claims pending on the expiration of the survival period for which notice has been given in accordance with this Article XI
on or before such expiration may continue to be asserted and indemnified against until finally resolved (each, a “Pending
Claim”). Any Claim that is not pending as of the expiration of the survival period will be forfeited by the holder of such
Claim vis-à-vis the Indemnifying Person.
11.2
Indemnification by Seller and Other Seller Indemnifying Party.
(a)
Seller’s Indemnification. From and after the Closing and subject to any applicable limitation set forth in this Article
XI, Seller and Steven Berhow (the “Other Indemnifying Party” and together with Seller, the “Seller
Indemnifying Parties”) will indemnify, defend, and hold harmless Purchaser and each of its Representatives and Affiliates
(including the Company) (each, a “Purchaser Indemnitee”), without duplication, from and against any and all
Losses that are suffered or incurred by any of Purchaser Indemnitees and arising out of the following (each, a “Seller Indemnifiable
Matter”):
(i)
any inaccuracy in or breach of any of the representations or warranties made by Seller contained in this Agreement or any other Transaction
Document to which it is a party;
(ii)
any breach of any covenant of Seller in this Agreement or any other Transaction Document to which Seller is a party;
(iii)
any liability or obligation related to any Closing Date Indebtedness or unpaid Seller Transaction Expenses;
(iv)
any Indemnified Taxes;
(v)
any claims, actions, or disputes between or between Seller and the other Seller Indemnifying Party or among Seller and the equity holders
of Seller, including without limitation any claims, actions, or disputes relating to the organization of Seller prior to the date hereof;
(vi)
any claims by Seller, or other Person asserting any legal interest in the Company, Seller or Seller’s assets, against Purchaser
or the Company in connection with the allocation or disbursement by Seller of the Purchase Price, provided that Purchaser has
complied with all of its obligations under this Agreement in connection with the payment of the Purchase Price;
(vii)
any matter referred to, or required to be referred to, in Section 5.14(a) of Seller’s Disclosure Schedule;
(viii)
any amounts payable by Seller to Purchaser pursuant to Section 2.4(f);
(ix)
any matter arising prior to the Indemnity Expiration Date but related to the ownership or operation of the Company prior to the Closing
Date and that would have been required to be listed on in Section 5.14(a) of Seller’s Disclosure Schedule if such matter
had arisen or been know prior to the Closing Date; or
(x)
any Fraud on the part of the Company, Seller, or any Representative of any of the foregoing in connection with this Agreement, any Transaction
Document, or any Contemplated Transaction.
(b)
Limitations. All obligations of Seller Indemnifying Parties under this Section 11.2 are subject to each applicable limitation
below:
(i)
In no event will: (A) the aggregate amount of indemnification paid by Seller for all Seller Indemnifiable Matters owed to Purchaser Indemnitees
exceed the Purchase Price; (B) the aggregate amount of indemnification paid by the Other Seller Indemnifying Party for all Seller Indemnifiable
Matters owed to Purchaser Indemnitees exceed $500,000 in the aggregate and the survival period therefor set forth in Section 11.1(a)(iii)
above shall be twelve (12) months instead of eighteen (18) months; and (C) any payment for Seller Indemnifiable Matters under Section
9.2(a)(i) (other than with respect to Fundamental Seller Representations and SOL Representations) be made to any Purchaser Indemnitee
unless and until the aggregate amount of all such payments owed by Seller with respect to all such Claims equals at least $50,000, after
which all such Claims shall be paid from the first dollar; provided, however, that (x) as to Seller only, in no event will any
of the Limitations apply to any Losses arising out of or relating to any Fraud the part of the Company, Seller, or any Representative
of any of the foregoing in connection with this Agreement, any Transaction Document, or any Contemplated Transaction and (y) as to the
Other Indemnifying Party only, in no event will any of the Limitations apply to any Losses arising out of or relating to the Other Indemnifying
Party’s Fraud in connection with this Agreement, any Transaction Document, or any Contemplated Transactions, or such Other Indemnifying
Party’s Fraud or gross negligence prior to the Effective Time.
(ii)
Subject to the Limitations and to the obligation to use Commercially Reasonable Efforts to seek recovery under available insurance pursuant
to Section 11.8 below, all indemnification payments required to be made to any Purchaser Indemnitee in respect of Seller Indemnifiable
Matters by Seller Indemnifying Parties will be: first, to the full extent available, offset against the Earnout Consideration,
if any, which shall serve as the first source of recovery for any Seller Indemnifiable Matters, payable and deliverable to Seller in
the chronological order of such payments, provided that, second, if no such Earnout Consideration has been earned, Purchaser shall
have direct recourse against Seller; provided that, third, if no amount is recoverable as to the first, second and third above,
in cash by Seller, provided that, fourth if no amount is recoverable as to the first, second and third above (or in the case of
any intentional misconduct, intentional misrepresentation or gross negligence claimed within 12 months after the Effective Time, as provided
in Section 11.2(b)(i)(y) above), in cash by the other Seller Indemnifying Party.
(iii)
For purposes of calculating the amount of Losses to which an Indemnified Person is entitled under this Article XI for Seller Indemnifiable
Matters and for purposes of determining whether a Seller representation or warranty is inaccurate or has been breached, the terms “material,”
“materiality,” “Material Adverse Effect” and words of similar import will be disregarded; provided, however,
that the foregoing materiality scrape will not (A) affect any “knowledge” qualifiers, or (B) apply to limit any list within
representations and warranties calling for scheduling of “material” items.
11.3
Indemnification by Purchaser.
(a)
Purchaser Indemnification. From and after the Closing and subject to any applicable limitation set forth in this Article XI,
Purchaser will indemnify, defend, and hold harmless Seller and each of its Representatives, Affiliates (excluding the Company), and equityholders
(each, a “Seller Indemnitee”), without duplication, from and against any and all Losses that are suffered or
incurred by any of Seller Indemnitees, directly or indirectly, and arising out of any of the following (each, a “Purchaser
Indemnifiable Matter”):
(i)
any inaccuracy in or breach of any of the representations or warranties made by Purchaser contained in this Agreement or any other Transaction
Document to which it is a party;
(ii)
any breach of any covenant of Purchaser in this Agreement or any other Transaction Document to which Purchaser is a party; or
(iii)
any Fraud on the part of Purchaser, or any Representative of Purchaser in connection with this Agreement, any Transaction Document, or
any Contemplated Transactions.
(b)
Limitations. Other than in respect of any Fraud, Purchaser’s obligations to indemnify Seller Indemnitees pursuant to a Purchaser
Indemnifiable Matter are subject to the following limitation: in no event will Purchaser’s aggregate Liability under any claims
of any inaccuracy in or breach of any Purchaser representation or warranty exceed an amount in the aggregate equal to the Purchase Price
(other than, for the avoidance of doubt, Purchaser’s obligation to pay the Purchase Price).
11.4
Claim Notice.
(a)
Notice of Direct Claims. As soon as is reasonably practicable after any Purchaser Indemnitee or any Seller Indemnitee (each, as
applicable, an “Indemnified Person”) or any Party becomes aware of any event or condition that would reasonably
be expected to result in a Loss with respect to which Purchaser or any Seller Indemnifying Party (in each case as the case may be, an
“Indemnifying Person”) may become obligated to indemnify, defend, hold harmless, compensate, or reimburse any
Indemnified Person pursuant to this Article XI (a “Claim”), such Person will give notice of such Claim
(a “Direct Claim Notice”) (i) if such Person is Purchaser or a Purchaser Indemnitee, to Seller and Seller Indemnifying
Party, or (ii) if such Person is any Seller Indemnitee, to Purchaser. A Direct Claim Notice (A) must describe the Claim in reasonable
detail; (B) on an informal and non-binding basis, reserving all future rights, identify whether such Claim pertains to a representation
or warranty, or Fraud; and (C) must in good faith indicate the amount (estimated, if necessary and to the extent feasible) of the Loss
that has been or may reasonably be expected to be suffered by the Indemnified Person (the “Claimed Amount”).
(b)
Notice of Third-Party Claims. In the event of the assertion of any Claim by any third-party Person with respect to which an Indemnifying
Person may become obligated to indemnify, defend, compensate, or reimburse any Indemnified Person pursuant to this Article XI,
or the commencement by any third-party Person of any Proceeding (whether against a Party or any other Indemnified Person) with respect
to which any Indemnifying Person may become obligated to indemnify, defend, compensate, or reimburse any Indemnified Person pursuant
to this Article XI (each, a “Third-Party Claim”), the Indemnified Person or Indemnifying Person, as
the case may be, if having notice of such Third-Party Claim, will provide the other party with prompt written notice (providing the same
information as a Direct Claim Notice) of such Third-Party Claim (together with a Direct Claim Notice, a “Claim Notice”)
together with copies of all documents (including court pleadings) received by the notifying Person relating to the Third-Party Claim
together with such supporting documents reasonably available to such Person.
(c)
Failure to Deliver Notice. The delay or failure to provide such Claim Notice to the Indemnifying Person will not affect the rights
or remedies of any Indemnified Person to receive indemnification for Losses or alter or relieve the Indemnifying Person of its obligations
to indemnify for Losses, unless (i) such Claim Notice is delivered after the expiration of the applicable survival period (in which case
the Indemnifying Person has no obligation to indemnify), or (ii) as a result of a material delay, the Indemnifying Person is materially
prejudiced.
(d)
Response to Claim Notice. During the 30-day period commencing upon the delivery to the Indemnifying Person of a Direct Claim Notice
(the “Dispute Period”), the Indemnifying Person will deliver to the Indemnified Person a written response (the
“Response Notice”) in which the Indemnifying Person: (i) agrees that the full Claimed Amount is owed to the
Indemnified Person; (ii) agrees, with specificity as to the reasons and amount, that part (but not all) of the Claimed Amount (the “Agreed
Amount”) is owed to the Indemnified Person; or (iii) asserts that no part of the Claimed Amount is owed to the Indemnified
Person. Any part (or all) of the Claimed Amount that is not agreed by the Indemnifying Person to be owing to the Indemnified Person pursuant
to the Response Notice will be referred to as the “Contested Amount.” If a Response Notice is not timely received
by the Indemnified Person prior to 5:00 p.m. Central Time on the 30th day of the Dispute Period, then the Indemnifying Person will be
conclusively deemed to have agreed that the full Claimed Amount is owed to the Indemnified Person.
(e)
Payment of Full Claimed Amount. If (i) the Indemnifying Person delivers a timely Response Notice agreeing that the full Claimed
Amount is owed to the Indemnified Person, or (ii) the Indemnifying Person does not deliver a timely Response Notice during the Dispute
Period, then, subject to the limitations of this Article XI, (A) if a Purchaser Indemnitee is the Indemnified Person, the Seller
Indemnifying Parties will pay such Indemnified Person any amount of the Claimed Amount that remains unpaid; or (B) if a Seller Indemnitee
is the Indemnified Person, Purchaser will pay to such Indemnified Person cash in an amount equal to the Claimed Amount.
(f)
Payment of Less Than Full Claimed Amount. If the Indemnifying Person delivers a timely Response Notice agreeing that less than
the full Claimed Amount is owed to the Indemnified Person, then, subject to the limitations of this Article XI, (i) if a Purchaser
Indemnitee is the Indemnified Person, Seller Indemnifying Parties will pay such Indemnified Person any amount of the Agreed Amount that
remains unpaid; or (ii) if a Seller Indemnitee is the Indemnified Person, Purchaser will pay to such Indemnified Person cash in an amount
equal to the Agreed Amount.
(g)
Settlement of Contested Amount. If the Indemnifying Person delivers a timely Response Notice indicating that there is a Contested
Amount, the Indemnifying Person and the Indemnified Person will attempt in good faith to resolve the dispute related to the Contested
Amount. If the Indemnifying Person and the Indemnified Person resolve such dispute as to all or a portion of the Contested Amount (which
mutually resolved amount will then become an “Agreed Amount”), then the Indemnifying Person and the Indemnified Person will
execute a written settlement agreement, and then, subject to the limitations of this Article XI, (i) if a Purchaser Indemnitee
is the Indemnified Person, Seller Indemnifying Parties will pay such Indemnified Person any amount of the Agreed Amount that remains
unpaid, or (ii) if a Seller Indemnitee is the Indemnified Person, Purchaser will pay to such Indemnified Person cash in an amount equal
to the Agreed Amount.
(h)
Failure to Settle Contested Amount. If the Indemnifying Person and the Indemnified Person are unable to resolve any part of the
dispute relating to any Contested Amount during the 30-day period commencing upon the delivery of the Response Notice, then with respect
to the remaining Contested Amount, either the Indemnified Person or the Indemnifying Person (with Purchaser or Seller as the sole authorized
agents of the Parties, as the case may be) may submit the dispute to a court of competent jurisdiction within one year following the
delivery of the Response Notice, and the remaining Contested Amount will only be payable upon the earlier of the agreement of the parties
or entry of a final, non-appealable Order concerning the matter issued by a court of competent jurisdiction (a “Final Award”),
and, subject to the limitations of this Article XI, (i) if a Purchaser Indemnitee is the Indemnified Person, Seller Indemnifying
Parties will pay to such Indemnified Person any amount of the Final Award that remains unpaid after such reduction; or (ii) if a Seller
Indemnitee is the Indemnified Person, Purchaser will pay cash to such Indemnified Person in an amount equal to the amount of the Final
Award. If neither the Indemnified Person nor the Indemnifying Person submit the dispute to a court of competent jurisdiction within such
one-year period following delivery of the Response Notice, such dispute will be deemed resolved in favor of the Person delivering the
Response Notice.
(i)
Defense of Third-Party Claims. The Indemnifying Person will be entitled to conduct the defense of any Third-Party Claim on the
terms set forth in this Section 11.4(i), provided that (A) the Indemnifying Person promptly notifies the Indemnified Person
in writing (but, in any event, within 10 Business Days following the delivery of the Third-Party Claim Notice) of the Indemnifying Person’s
intent to conduct such defense, and (B) if any of Purchaser or its Affiliates are the Indemnified Person under this Agreement with respect
to such Third-Party Claim, such Third-Party Claim (I) has not been brought by then-current customers or vendors of Purchaser or its Affiliates,
and (II) is not otherwise disruptive to the Company if not defended directly by Purchaser, the Company or any of their respective Affiliates.
Subject to the foregoing, the Indemnified Person will be entitled to conduct the defense of any Third-Party Claim on the terms set forth
in Section 11.4(i)(iii), provided that the Indemnifying Person has not elected to conduct the defense pursuant to the preceding
sentence.
(i)
If the Indemnifying Person does deliver such written notice of its intent to conduct the defense of such Third-Party Claim in accordance
with this Section 9.4(i), the Indemnifying Person will assume the defense of such Third-Party Claim; except that: (A) the
Indemnifying Person must provide the Indemnified Person with an affidavit attesting that the Indemnifying Person has sufficient financial
resources to satisfy the amount of any adverse monetary judgment that is reasonably likely to result; (B) the Third-Party Claim must
seek (and continue to seek) solely monetary damages and may not involve any criminal proceeding, action, investigation or allegations;
(C) the Indemnifying Person must expressly agree in writing that as between the Indemnifying Person and the Indemnified Person, the Indemnifying
Person may only satisfy and discharge the Third-Party Claim in accordance with the limits set forth in this Agreement; (D) counsel selected
by the Indemnifying Person must be reasonably acceptable to the Indemnified Person; (E) the Indemnifying Person expressly agrees in writing
that it will be liable for any Loss incurred by the Indemnified Person, subject only to the limitations set forth in this Article
XI; and (F) the Indemnified Person has not been advised in writing by counsel that (I) a reasonable likelihood exists of a material
conflict of interest between the Indemnifying Person and the Indemnified Person with respect to the defense of such Third-Party Claim,
or (II) the Indemnified Person has one or more defenses not available to, and not otherwise being covered by counsel to, the Indemnifying
Person (the conditions set forth in clauses (A) through (F) of this paragraph are, collectively, the “Litigation
Conditions”).
(ii)
Subject to continued fulfillment of the Litigation Conditions:
(A)
the Indemnifying Person will proceed to defend such Third-Party Claim in a diligent manner with counsel reasonably satisfactory to the
Indemnified Person at the sole expense of the Indemnifying Person, subject to any applicable limitations in this Article XI;
(B)
the Indemnifying Person will keep the Indemnified Person reasonably informed of all material developments and events relating to such
Third-Party Claim;
(C)
the Indemnified Person will cooperate in connection with the defense, compromise or settlement of any Third-Party Claim and will furnish
such non-privileged records, information and testimony and attend such conferences, discovery, hearings, trials and appeals as may be
reasonably requested by, and at the cost of, the Indemnifying Person in connection therewith;
(D)
the Indemnified Person will have the right to participate (but not control), at its sole cost and expense, in the defense of such Third-Party
Claim; except that, if (A) any of the Litigation Conditions cease to be met, or (B) the Indemnifying Person fails to take reasonable
steps necessary to defend diligently such Third-Party Claim, and, in either case, the Indemnified Person provides notice and the Indemnifying
Person fails to cure within 10 days, then the Indemnified Person may assume and control the defense of the Third-Party Claim; and
(E)
the Indemnifying Person may not settle, adjust, or compromise such Third-Party Claim without the prior written consent of the Indemnified
Person, unless such settlement or compromise includes only the payment of funds satisfied entirely by the Indemnifying Person.
(iii)
If the Indemnified Person proceeds with the defense of any Third-Party Claim pursuant to this Section 9.4:
(A)
all reasonable expenses relating to the defense of such Third-Party Claim (whether or not incurred by the Indemnified Person) to the
extent they are indemnifiable Losses pursuant to this Article XI will be borne and paid exclusively by the Indemnifying Person,
subject to any applicable limitations in this Article XI;
(B)
the Indemnified Person will proceed to defend such Third-Party Claim in a commercially reasonable, diligent manner;
(C)
the Indemnifying Person will make available to the Indemnified Person any documents and materials (other than privileged documents or
materials) in the possession or control of the Indemnifying Person that may be necessary to the defense, compromise or settlement of
such Third-Party Claim and will furnish such information and testimony and attend such conferences, discovery, hearings, trials and appeals
as may be reasonably requested by the Indemnified Person in connection therewith;
(D)
the Indemnified Person will keep the Indemnifying Person reasonably informed of all material developments and events relating to such
Third-Party Claim; and
(E)
the Indemnified Person may not settle, adjust or compromise such Third-Party Claim without the prior written consent of the Indemnifying
Person, which consent may not be unreasonably withheld, delayed or denied.
(iv)
Additionally, the Indemnifying Person will lose its right to contest, defend, litigate and settle the Third-Party Claim if it fails to
accept a tender of the defense of the Third-Party Claim. In such event, the Indemnified Person will have the right to conduct and control,
through counsel of its choosing, the defense, compromise or settlement of any such Third-Party Claim; provided, however, that
at least 10 days prior to any such settlement, written notice of its intention to settle is given to the Indemnifying Person.
11.5
Exclusive Remedy; No Double Recovery. Other than Fraud and the equitable remedies described in this Agreement,
the exclusive remedy of any Party or other Person entitled to indemnification under this Article XI for Losses arising out of
or relating to any Purchaser Indemnifiable Matter or Seller Indemnifiable Matter will be indemnification under this Article XI.
No Indemnified Person will be entitled to recover any Losses relating to any matter arising under one provision of this Agreement to
the extent that any Indemnified Person had already recovered the same Losses with respect to such matter pursuant to other provisions
of this Agreement.
11.6
Specific Performance. Each Party hereby acknowledges that the rights of each Party with respect to such matter are special,
unique and of extraordinary character and that, in the event that any Party violates or fails or refuses to perform any covenant or agreement
made by it in this Agreement, the non-breaching Party may be without an adequate remedy at law. In the event that any Party violates
or fails or refuses to perform any covenant or agreement made by such Party in this Agreement, the non-breaching Party or Parties will
be entitled to: (a) subject to the terms of this Agreement and in addition to any remedy at law for damages or other relief, (i) a decree
or order of specific performance or mandamus to enforce the observance and performance of such covenant, obligation or other provision,
and (ii) an injunction restraining such breach or threatened breach; and (b) seek any other equitable relief.
11.7
Indemnification in Case of Strict Liability or Indemnitee Negligence. The indemnification provisions in this Article
XI will be enforceable regardless of whether (a) the Liability is based upon past, present, or future acts, claims, or Laws (including
any past, present, or future bulk sales Law, Environmental Law, fraudulent transfer act, products liability, securities, or other Law)
and (b) any Person (including any Person from whom indemnification is sought) alleges or proves the sole, concurrent, contributory, or
comparative negligence of the Person seeking indemnification or the sole or concurrent strict liability imposed upon the Person seeking
indemnification.
11.8
Determination of Losses. Losses payable to or received by an Indemnified Person under this Article IX will be reduced
by the amount of any (a) insurance proceeds with respect to such Losses, net of any increase in premiums or other out-of-pocket costs
of the Indemnified Person as a result of such insurance claims; and (b) indemnification payments, contribution payments, collections,
or reimbursements with respect to such Losses (collectively, “Third-Party Recovery Proceeds”), in each case,
actually received by any Indemnified Person, it being understood that in no event will any indemnification payment under this Article
IX be delayed in anticipation of the receipt of any Third-Party Recovery Proceeds nor will any Indemnified Person be obligated to
make any insurance or other claim, or to initiate any Proceeding, against any third party, provided that any Indemnified Party shall
use Commercially Reasonable Efforts (but shall not be required to institute legal proceedings) to pursuant insurance claims that may
reduce any indemnified Losses hereunder. The representations, warranties, covenants, and obligations of Seller, and the rights and remedies
that may be exercised by the Purchaser Indemnitees, will survive Purchaser’s investigation and not be limited or otherwise affected
by or as a result of any information furnished to, or any investigation made by or any knowledge of, any of the Purchaser Indemnitees
or any of their respective agents or representatives.
11.9
Treatment of Indemnity Payments for Tax Purposes. All amounts payable by Seller to or for the benefit of a Purchaser Indemnitee
under this Article XI will, for Tax purposes, be treated as an adjustment to the Purchase Price payable by Purchaser to Seller,
unless otherwise required by applicable Law.
11.10
Payment or Reimbursement of Losses. Subject to the limitations of this Article XI, payment or reimbursement for Losses
incurred by an Indemnified Person will be made by or on behalf of the Indemnifying Person within 15 Business Days of the final resolution
of any related claim for indemnification under the terms of this Agreement. Any offset against the Earnout Consideration by the Purchaser
with respect to a claim for indemnification by any Purchaser Indemnitee under this Article XI will be deemed a payment by Seller
to such Purchaser Indemnitee.
Article
XII
[Reserved]
Article
XIII
General Provisions
13.1
Seller’s Disclosure Schedule. The information in Seller’s Disclosure Schedule constitute (a) exceptions to particular
representations and warranties of Seller in this Agreement, or (b) descriptions or lists of Equity Securities, assets, Liabilities, and
other items referred to in particular representations and warranties of Seller in this Agreement. The statements in Seller’s Disclosure
Schedule relate to the specific sections of this Agreement to which they refer and shall be deemed disclosed in all other sections of
the Agreement to which such fact or item may reasonably apply so long as such disclosure is in sufficient detail to enable a reasonable
person to identify the other Section of this Agreement to which such information is responsive.
13.2
Assignment. This Agreement is binding upon, and inures to the benefit of, each Party to this Agreement and such Party’s
successors and assigns (if any). No Party may assign any of its rights or delegate any of its obligations under this Agreement without
the other Parties’ prior written consent; provided, however, that Purchaser may, with notice to but without the consent
of the other Parties, assign all (but not less than all) of its rights and obligations under this Agreement to any lenders of Purchaser
or the Company or any Affiliate of either as collateral security.
13.3
No Third-Party Beneficiaries. This Agreement is for the sole benefit of the Parties and their permitted assigns and nothing
in this Agreement expressed or implied will give or be construed to give to any Person, other than the Parties and such permitted assigns,
any legal or equitable rights under this Agreement. Without limiting the generality of the foregoing, (a) no employee or former employee
(including any beneficiary or dependent thereof) of the Company or other representatives of such employees or former employees, or trustees,
administrators, participants, or beneficiaries of any Benefit Plan, will have any rights under this Agreement or under any of the Transaction
Documents to which he, she, or it is not personally a party, and (b) other than as an express party to this Agreement or the Transaction
Documents, if applicable, no creditor of any of the Parties will have any rights under this Agreement or any of the Transaction Documents.
Nothing in this Agreement may be deemed or construed to affect any change or amendment to any Benefit Plans, and nothing in this Agreement
modifies or will be deemed to modify the ability of any Benefit Plan to be amended or terminated in accordance with its terms.
13.4
Notices. All notices and other communications pursuant to this Agreement must be in writing and will be deemed given if delivered
personally, sent by electronic mail, sent by nationally recognized overnight courier, or mailed by registered or certified mail (return-receipt
requested), postage prepaid, to the Parties at the addresses set forth in Appendix B or to such other address as the Party to
whom notice is to be given may have furnished to the other Parties in writing in accordance with this Section 13.4, which will
not constitute an amendment for the purpose of Section 13.7. Any such notice or communication will be deemed to have been delivered
and received (a) in the case of personal delivery, on the date of such delivery; (b) in the case of electronic mail, on the date sent
if confirmation of receipt is received; (c) in the case of a nationally recognized overnight courier in circumstances under which such
courier guarantees next Business Day delivery, on the next Business Day after the date sent; and (d) in the case of mailing, on the third
Business Day after that on which the piece of mail containing such communication is posted.
13.5
Counterparts. This Agreement may be executed and delivered in one or more counterparts, each of which when executed and delivered
will be an original, and all of which when executed will constitute one and the same instrument. The exchange of copies of this Agreement
and of signature pages by electronic image scan transmission in .pdf will constitute effective execution and delivery of this Agreement
as to the Parties and may be used in lieu of the original Agreement for all purposes. Signatures of the Parties transmitted by electronic
image scan transmission in .pdf will be deemed to be their original signatures for all purposes. Any Party that delivers an executed
counterpart signature page by electronic image scan transmission in .pdf will, upon the request of a Party, promptly thereafter deliver
a manually executed counterpart signature page to such Party; provided, however, that the failure to do so will not affect
the validity, enforceability, or binding effect of this Agreement.
13.6
Entire Agreement; Exclusivity of Agreement. This Agreement and the other Transaction Documents, along with the Exhibits, Schedules,
and Seller’s Disclosure Schedule to this Agreement and thereto, contain the entire agreement and understanding among the Parties
with respect to the subject matter of this Agreement and thereof and supersede all prior agreements and understandings relating to such
subject matter. The representations, warranties, and covenants in this Agreement are intended to be part of the bargain among the Parties.
Except in the case of Fraud arising from any breach of any representations, warranties, or covenants made in this Agreement or the Transaction
Documents, respectively, none of the Parties will be liable or bound to any other Party in any manner by any representations, warranties,
or covenants relating to such subject matter except as specifically set forth in this Agreement and the Transaction Documents. The Parties
have voluntarily agreed to define their rights, liabilities, and obligations respecting the subject matter of this Agreement exclusively
in contract pursuant to the express terms and provisions of this Agreement, and the Parties expressly disclaim that they are owed any
duties or are entitled to any remedies not expressly set forth in this Agreement. Furthermore, the Parties each hereby acknowledge that
this Agreement embodies the justifiable expectations of sophisticated parties derived from arm’s length negotiations; all Parties
specifically acknowledge that no Party has any special relationship with another party that would justify any expectation beyond that
of any ordinary buyer and an ordinary seller in an arm’s length transaction.
13.7
Amendments. This Agreement may not be amended except pursuant to the written agreement of Purchaser and Seller and any attempted
amendment to the contrary will be void ab initio.
13.8
Severability. If any provision of this Agreement is invalid or unenforceable in any jurisdiction, such provision will be fully
severable from this Agreement and the other provisions of this Agreement will remain in full force and effect in such jurisdiction and
the remaining provisions of this Agreement will be liberally construed to carry out the provisions and intent of this Agreement; provided,
if any one or more of the provisions contained in this Agreement will be determined or held to be invalid or unenforceable because such
provision is overly broad as to duration, geographic scope, activity, subject or otherwise, such provision will be deemed amended by
limiting and reducing it to the minimum extent necessary to make such provision valid and enforceable. The invalidity or unenforceability
of any provision of this Agreement in any jurisdiction will not affect the validity or enforceability of such provision in any other
jurisdiction, nor will the invalidity or unenforceability of any provision of this Agreement with respect to any Person affect the validity
or enforceability of such provision with respect to any other Person. To the extent not prohibited by Law, each Party hereby waives any
provision of Law that renders any such provision prohibited or unenforceable in any respect.
13.9
Governing Law; Venue; Waiver of Jury Trial.
(a)
Governing Law. This Agreement, and all claims or causes of action (whether in contract or tort) that may be based upon, arise
out of, or relate to this Agreement or the negotiation, execution, or performance of this Agreement (including any claim or cause of
action based upon, arising out of, or related to any representation or warranty made in or in connection with this Agreement or as an
inducement to enter into this Agreement) will be governed solely by the internal laws of the State of Delaware , without regard to the
conflict-of-law principles thereof.
(b)
Venue and Jurisdiction. Except as provided in Section 7.11(c) or Section 11.6, any Proceeding or other legal action
relating to this Agreement or the enforcement of any provision of this Agreement must be brought or otherwise commenced in any state
or federal court located in St. Louis, Missouri. Each Party:
(i)
expressly and irrevocably consents and submits to the exclusive jurisdiction of each state and federal court located in St. Louis, Missouri
(and each appellate court located in the State of Missouri) in connection with any such Proceeding;
(ii)
agrees that each state and federal court located in the Eastern District of Missouri, will be deemed to be a convenient forum; and
(iii)
agrees not to assert (by way of motion, as a defense or otherwise), in any such Proceeding commenced in any state or federal court located
in the Eastern District of Missouri, any claim that such Party is not subject personally to the jurisdiction of such court, that such
Proceeding has been brought in an inconvenient forum, that the venue of such Proceeding is improper or that this Agreement or the subject
matter of this Agreement may not be enforced in or by such court.
(c)
WAIVER OF JURY TRIAL. EACH OF THE PARTIES HEREBY IRREVOCABLY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ALL RIGHT
TO TRIAL BY JURY AND ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT, OR OTHERWISE) ARISING OUT OF OR RELATING
TO THIS AGREEMENT OR THE ACTIONS OF ANY PARTY IN NEGOTIATION, ADMINISTRATION, PERFORMANCE OR ENFORCEMENT TO THIS AGREEMENT. EACH PARTY
(i) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY
WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER; (ii) UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF
THIS WAIVER; (iii) MAKES THIS WAIVER VOLUNTARILY; AND (iv) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HAVE BEEN INDUCED TO ENTER INTO
THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS Section
13.9(c).
13.10
Waiver in Writing. No failure on the part of any Person to exercise any power, right, privilege, or remedy under this Agreement,
and no delay on the part of any Person in exercising any power, right, privilege, or remedy under this Agreement, will operate as a waiver
of such power, right, privilege, or remedy; and no single or partial exercise of any such power, right, privilege, or remedy will preclude
any other or further exercise thereof or of any other power, right, privilege, or remedy. No Person will be deemed to have waived any
claim arising out of this Agreement, or any power, right, privilege, or remedy under this Agreement, unless the waiver of such claim,
power, right, privilege, or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such Person;
and any such waiver will not be applicable or have any effect except in the specific instance in which it is given.
13.11
Attorneys’ Fees and Expenses. In the event of any legal action or other legal proceeding among the Parties relating
to this Agreement or the enforcement of any provision of this Agreement, the prevailing Party will be entitled to payment by the non-prevailing
Party of all costs and expenses (including reasonable attorneys’ fees) incurred by the prevailing Party.
13.12
Construction.
(a)
Each Party acknowledges that it has participated in the drafting of this Agreement, and, as a result, the Parties agree that any rule
of construction to the effect that ambiguities are to be resolved against the drafting Party may not be applied in the construction or
interpretation of this Agreement.
(b)
The Parties intend that each representation, warranty, and covenant contained in this Agreement have independent significance.
[The
remainder of page intentionally left blank.]
The
Parties have duly executed this Agreement as of the date first written above.
|
PURCHASER: |
|
|
|
|
STEREOTAXIS, INC. |
|
|
|
|
By: |
/s/ David
Fischel |
|
Name: |
David Fischel |
|
Title: |
Chief Executive Officer |
[Signature
Page to Share Purchase Agreement]
|
COMPANY: |
|
|
|
|
Access Point
Technologies EP, Inc. |
|
|
|
|
By: |
/s/
Steven Berhow |
|
Name: |
Steven Berhow |
|
Title: |
Chief Executive Officer |
|
|
|
|
SELLER: |
|
|
|
|
APT HOLDING COMPANY, INC. |
|
|
|
|
By: |
/s/ Steven
Berhow |
|
Name: |
Steven Berhow |
|
Title: |
Chief Executive Officer |
[Signature Page to Share Purchase Agreement]
Appendix
A
Definitions
Capitalized
terms and other terms used in this Agreement have the following respective meanings:
“ACA”
means the Patient Protection and Affordable Care Act of 2010, as amended.
“Accountant”
means a firm of independent accountants having no material relationship with any party to this Agreement and reasonably acceptable to
both Purchaser and Seller.
“Accounts
Payable” means the bona fide trade accounts payable of the Company as determined in accordance with GAAP.
“Accounts
Receivable” means all bona fide trade accounts receivable of the Company representing amounts receivable in respect of goods
shipped/provided or services rendered in connection with the Business as determined in accordance with GAAP.
“Accrued
Liabilities” means all expenses or losses incurred by the Company that have not yet been paid or recorded elsewhere in the
Company’s financial statements, including all expenses and losses in respect of returned or rejected goods.
“Acquired
Shares” is defined in the Preliminary Statements to this Agreement.
“Affiliate”
means (a) with respect to a Person, any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled
by, or is under common control with such Person, and (b) with respect to a natural person, also any Related Party of such natural person.
As used in this definition, the word “control” means the possession, directly or indirectly, of the power to direct or cause
the direction of the management and policies of a Person, whether through ownership of voting securities, by contract, or otherwise;
provided, that any beneficial owner (as defined in Rule 13d-3 of the Exchange Act) of 10% or more of the Equity Securities or
voting securities will be deemed to control such other Person.
“Agreed
Amount” is defined in Section 11.4(d).
“Agreement”
is defined in the opening paragraph of this Agreement.
“Aggregate
Consideration” is defined in Section 7.3(e)(ii).
“Alternative
Transaction” shall mean any transaction or series of transactions (including any sale, merger, consolidation, recapitalization,
reorganization, dividend, distribution, joint venture, share exchange or other business combination or similar transaction) involving
the potential sale of capital stock or Equity Securities of, or merger, consolidation, combination, sale or license of assets (other
than in the ordinary course or sale or replacement of any immaterial operating assets of the Company in the ordinary course), reorganization,
or other similar transaction involving, the Company, other than the transactions contemplated by this Agreement.
“Annual
Financial Statements” is defined in Section 5.5(a).
“Applicable
Limitation Date” is defined in Section 11.1(a).
“Benefit
Plan” means each “employee benefit plan” within the meaning of Section 3(3) of ERISA and each other benefit, retirement,
pension, compensation, incentive, stock option, restricted stock, stock appreciation right, phantom equity, deferred compensation, golden
parachute, profit sharing, bonus, change in control, severance, salary continuation, vacation, disability, medical, hospitalization,
cafeteria, dental, life, sick leave, health-care reimbursement, dependent-care assistance, paid time off, and fringe-benefit agreement,
plan, policy, fund, arrangement, and program, whether or not reduced to writing, and any trust, escrow or similar agreement related thereto,
whether or not funded, in respect of one or more current or former employees, directors, shareholders, consultants, or independent contractors
of the Company or the beneficiaries or dependents of any such Persons, and is maintained, sponsored, contributed to, or required to be
contributed to by the Company or any member of the Controlled Group, or under which the Company, or any member of the Controlled Group
has or reasonably could have any liability.
“Break-Up
Fee” is defined in Section 10.2(b).
“Business”
means the business of designing, developing, manufacturing, marketing and/or selling endovascular catheters.
“Business
Day” means any day other than a Saturday, Sunday, or a day on which banks in New York are authorized or obligated to close.
“Cash”
means unrestricted cash and cash equivalents (including marketable securities) of the Company, as of the Effective Time, determined in
accordance with GAAP, but less all Liabilities of the Company under outstanding checks, money orders, or similar instruments of, or issued
or sent by, the Company (except to the extent such amount is included in the calculation of Indebtedness of the Company).
“Change
of Control” means (a) the acquisition of ownership, directly or indirectly, beneficially or of record, by any Person or group
(within the meaning of the Securities Exchange Act of 1934 and the rules of the Securities and Exchange Commission thereunder as in effect
on the date hereof), of capital stock representing more than 50% of the aggregate voting power represented by the issued and outstanding
capital of Purchaser or the Company; (b) any sale, lease, or transfer or series of sales, leases, or transfers of all or substantially
all of the assets of Purchaser or the Company; (c) any sale, transfer, or issuance (or series of sales, transfers, or issuances) of capital
stock by Purchaser or the Company or the holders of common stock (or other voting stock of Purchaser or the Company) that results in
the inability of the holders of common stock (or other voting stock of Purchaser or the Company) immediately prior to such sale, transfer,
or issuance to designate or elect a majority of the board of directors (or its equivalent) of Purchaser or the Company, as the case may
be; or (d) any merger, consolidation, recapitalization, or reorganization of Purchaser or the Company with or into another Person (whether
or not Purchaser or the Company is the surviving corporation) that results in the inability of the holders of common stock (or other
voting stock of Purchaser or the Company, as the case may be) immediately prior to such merger, consolidation, recapitalization, or reorganization
to designate or elect a majority of the board of directors (or its equivalent) of the resulting entity or its parent company.
“Claim”
is defined in Section 11.4(a).
“Claim
Notice” is defined in Section 11.4(b).
“Claimed
Amount” is defined in Section 11.4(a).
“Closing”
is defined in Section 3.1.
“Closing
Balance Sheet” is defined in Section 2.4(b).
“Closing
Date” is defined in Section 3.1.
“Closing
Date Indebtedness” means the aggregate amount of Indebtedness of the Company at Closing, but shall not include the Non-Assumed
Indebtedness that will be assumed by Seller in connection with the Debt Restructuring.
“Closing
Working Capital Amount” is defined in Section 2.4(b).
“Closing
Working Capital Notice” is defined in Section 2.4(b).
“COC
Notice” is defined in Section 2.5(g).
“COC
Value” is defined in Section 2.5(g).
“Code”
means the U.S. Internal Revenue Code of 1986, as amended, and the Treasury Regulations promulgated thereunder.
“Commercially
Reasonable Efforts” means the commercially reasonable efforts that a prudent Person that desires to achieve a result would
use in similar circumstances to ensure that the result is achieved as expeditiously as possible; provided, however, that a Person
required to use its Commercially Reasonable Efforts may not be required to take actions that would result in a material adverse change
in the benefits to such Person under the Transaction Documents and the Contemplated Transactions, commence any litigation, or offer or
grant any material accommodation (financial or otherwise) to any third-party.
“Company”
is defined in the opening paragraph of this Agreement.
“Company
Group” means Purchaser together with each of its direct and indirect Subsidiaries (including Company).
“Company
Intellectual Property” is defined in Section 5.11(a).
“Company
Licensed Intellectual Property” is defined in Section 5.11(a).
“Competing
Business” is defined in Section 7.11(a)(i).
“Confidentiality
Agreement” means that certain confidentiality agreement, dated March 1, 2023, between Purchaser and the Company.
“Consent”
means, with respect to a Person, any (a) consent, novation, approval, qualification, license, Permit, order, or authorization of any
other Person; (b) obligation of such Person under any Law, Order, or Contract to provide notice; (c) waiver that such Person is required
to obtain under any Law, Order, Contract, or Permit, including the waiver of a breach, default, or event of default of such Person or
the right of any other Person to terminate any rights or accelerate any obligations of such Person, and, for the avoidance of doubt,
waiver of any event of default or right of termination triggered by the Contemplated Transactions; or (d) release that such Person is
required to obtain of any Encumbrance, in each case of the foregoing, without regard to any cure periods, the requirement of any other
Person to provide notice, the requirement that time elapse, or any combination of the foregoing.
“Contemplated
Transactions” means the purchase and sale of the Acquired Shares and the other transactions and obligations contemplated by
or provided for by this Agreement and the other Transaction Documents.
“Contested
Amount” is defined in Section 11.4(d).
“Contract”
means, with respect to any Person, any written, oral, implied, or other agreement, contract, instrument, note, mortgage, bond, loan,
indenture, guaranty, option, indemnity, representation, warranty, deed, assignment, power of attorney, sale or purchase order, work order,
insurance policy, lease, license, commitment, covenant, or legally binding arrangement to which such Person is a party, by which it or
its assets are bound or subject or under which it has or may have any current or future Liability (notwithstanding the Statute of Frauds
requirement that any such oral agreement be in writing if in excess of a certain amount in order to be binding).
“Controlled
Group” means any trade or business (whether or not incorporated) (a) under common control within the meaning Section 4001(b)(1)
of ERISA with the Company, or (b) that together with the Company is treated as a single employer under Section 414(t) of the Code.
“Data
Room” means the virtual data room Drop Box established by the Company in connection with the Contemplated Transactions and
accessible to Purchaser and its Representatives.
“Deposit”
is defined in Section 5.9.
“Direct
Claim Notice” is defined in Section 11.4(a).
“Dispute
Notice” is defined in Section 2.5(c)(ii).
“Dispute
Period” is defined in Section 11.4(d).
“Earnout
Consideration” means any Global Revenue Earnout Consideration, any US Revenue Earnout Consideration and any Regulatory Milestone
Payments, as the case may be.
“Revenue
Earnout Measurement” is defined in Section 2.5(c)(i).
“Earnout
Stock Consideration Value” means, for Purchaser Common Stock issued in the case of payment of any Global Revenue Earnout, US
Revenue Earnout or Regulatory Milestone Payment, the applicable amount of such payments calculated in accordance with this Agreement,
rounded down to the nearest whole share.
“Effective
Time” is defined in Section 3.1.
“Employee”
means any individual who, as of the Closing Date, (a) is actively employed by the Company, or (b) but for the fact that such individual
is on Leave, would otherwise be actively employed by the Company.
“Encumbrances”
means any mortgage, assessment, deed of trust, security interest, charge, easement, servitude, right of way, pledge, negative pledge,
proxy, voting trust or agreement, claim, lien (for Taxes or any other Indebtedness or matter), adverse interest, levy, preference, option,
warrant to purchase, right of possession or use, lease, sublease, tenancy, license, community or other marital property interest, condition,
equitable interest, encroachment, right of first option, right of first refusal or offer, preemptive right or similar restriction, defect,
exception, reservation, limitation, impairment, imperfection of title, or encumbrance of any kind, including any conditional sales Contract,
title retention Contract, or other Contract to give any of the foregoing, restriction on voting (in the case of any security or equity
interest), transfer, receipt of income, or exercise of any other attribute of ownership or financing statement under the Law of any jurisdiction.
“Entity”
means any firm, corporation, partnership, limited liability company, trust, joint venture, Governmental Entity, organization, or other
entity.
“Entity
Representative” means, with respect to a Person, such Person’s directors, managers, partners, members, trustees, officers,
employees, equity holders, and agents.
“Environment”
means soil, land surface, or subsurface strata, surface waters (including navigable waters and ocean waters), groundwater, drinking-water
supply, stream sediments, ambient air (including indoor air), and any other environmental medium or natural resource.
“Environmental
Law” means any requirement under any Law that relates to (a) the protection of the Environment or human health and safety,
(b) pollution, protection of the environment, or (c) generation, storage, handling, labeling, transport, disposal or Release of any Hazardous
Material, including the Globally Harmonized System of Classification and Labeling of Chemicals (as implemented under applicable Law),
the Comprehensive Environmental Response, Compensation and Liability Act; the Superfund Amendments and Reauthorization Act; the Solid
Waste Disposal Act; the Federal Water Pollution Control Act; the Clean Air Act; the Clean Water Act; the Asbestos Hazard Emergency Response
Act; the Safe Drinking Water and Enforcement Act of 1986; the Toxic Substances Control Act; the Hazardous Materials Transportation Act;
the Occupational Safety and Health Act of 1970; the Oil Pollution Act; the Emergency Planning and Community Right-to-Know Act of 1986;
the Resource Conservation and Recovery Act of 1976; each as amended and including regulations promulgated thereunder and their state
counterparts.
“Equity
Security” means (a) any common, preferred, or other capital stock, limited liability company interest, or membership interest,
partnership interest, or similar security; (b) any warrants, options, or other rights to, directly or indirectly, acquire any security
described in clause (a) above; (c) any other security containing equity features or profit participation features; (d) any security
or instrument convertible or exchangeable, directly or indirectly, with or without consideration, into or for any security described
in clauses (a) through (c) above or another similar security (including convertible notes); and (e) any security carrying
any warrant or right to subscribe for or purchase any security described in clauses (a) through (d) above or any similar
security.
“ERISA”
means the Employee Retirement Income Security Act of 1974, as amended, and the regulations thereunder.
“EU”
means the European Union, together with, as of the date in question, all of its then-current constituent member-countries.
“Exchange
Act” means the Securities Exchange Act of 1934.
“Excluded
Person” is defined in Section 7.11(a)(iii).
“Final
Award” is defined in Section 11.4(h).
“Final
Closing Working Capital Amount” is defined in Section 2.4(c).
“Financial
Statements” is defined in Section 5.5(a).
“Fraud”
means an act committed by a Person, an actual and intentional misrepresentation of a material existing fact with respect to the making
of any representation or warranty in Article 3 or Article 4 hereof, as applicable (in each case, as modified or supplemented by the Disclosure
Schedules), which constitutes actual common law fraud in the state of Delaware.
“Fundamental
Company Representations” means the representations and warranties contained in Section 5.1 (Organization and Good Standing),
Section 5.2 (Equity Securities; Capitalization), Section 5.3 (Authority; Execution and Delivery; Enforceability), Section
5.10 (Title to Assets; Real Property), Section 5.22 (Brokers) and Section 5.25 (Certain Payments).
“Fundamental
Purchaser Representations” means the representations contained in Section 6.1 (Organization; Good Standing; Authority),
Section 6.5 (Purchaser Common Stock), Section 6.7 (Capitalization of Purchaser) and Section 6.8 (Brokers).
“Fundamental
Representations” means the Fundamental Company Representations, the Fundamental Purchaser Representations, and the Fundamental
Seller Representations.
“Fundamental
Seller Representations” means the representations and warranties contained in Section 4.1 (Standing), Section 4.2
(Title to Acquired Shares), Section 4.3 (Authority; Execution and Delivery; Enforceability) and Section 4.5 (Brokers).
“GAAP”
means United States generally accepted accounting principles in effect as of the Closing Date, applied in a manner consistent with the
Financial Statements and past practice of the Company.
“Governmental
Entity” means any court, tribunal, arbitrator or any government or political subdivision thereof, whether federal, state, county,
municipal, local or foreign, or any agency, authority (including transit authority), contractor, official or instrumentality of such
governmental or political subdivision, or any entity exercising executive, legislative, judicial, regulatory or administrative functions
of government (including any department, agency, bureau, branch, office, commission, council, board, instrumentality, officer, official,
representative, organization, unit, body, or entity).
“Hazardous
Material” means: (a) any petroleum, waste oil, crude oil, asbestos, urea formaldehyde, or polychlorinated biphenyl; or (b)
any “hazardous substance,” “pollutant,” “contaminant,” “hazardous waste,” “regulated
substance,” “hazardous chemical,” “toxic substance,” “toxic chemical” or any other substance
or material of similar import or regulatory effect under any Environmental Law.
“Holdback
Amount” is defined in Section 2.3(a).
“Income
Tax” means any Tax based on or measured by reference to net income or gross income (excluding any Tax based solely on gross
receipts), including any interest, penalty, or addition thereto, whether or not disputed.
“Income
Tax Return” means any Tax Return filed or required to be filed with respect to Income Taxes.
“Indebtedness”
of any Person means, without duplication, (a) all Liabilities of such Person created, issued, or incurred for borrowed money (including
the current portion thereof); (b) all obligations of such Person to pay the deferred purchase price or acquisition price of property
or services, or similar payment, to the extent constituting a Liability (other than accrued expenses and trade accounts payable incurred
in the Ordinary Course of Business of such Person that are not more than 60 days past due), including any “earnout” or similar
payments or any non-compete payments; (c) all Liabilities of such Person evidenced by a note, bond, debenture, or similar Contract (including
a purchase money obligation); (d) the then-drawable stated amount of and, without duplication, all reimbursement obligations of such
Person under letters of credit, bankers’ acceptance, note purchase facility, or similar instruments issued or accepted by banks
and other financial institutions; (e) all accumulated dividends or distributions of such Person, whether or not declared; (f) all Liabilities
of such Person for severance, bonus, commissions (including origination commissions related to the pre-Closing period), incentive, or
similar arrangements (including bonuses and commissions for Sellers or employees and any bonuses or commissions that are overdue), including
the employer portion of any related employment, payroll, unemployment, withholding, or similar Taxes; (g) any accrued severance and paid-time-off,
sick day, or vacation obligations owed by such Person that are included on the Interim Balance Sheet, in each case, including the employer
portion of any related employment, payroll, unemployment, withholding, or similar Taxes; (h) Liabilities for any accrued Taxes (i) the
principal amount of all Liabilities under or in respect of leases required to be capitalized under GAAP; (j) all Liabilities of such
Person under any interest rate swap, hedging, or similar agreements; (k) all Liabilities of such Person for any credit card payables
with respect to charges having a transaction date of 45 days past due or related to non-business related activities; (l) all Liabilities
in respect of any off-balance sheet transactions; (m) obligations to any Affiliate of Seller; (n) all Liabilities for the Company funded
401(k) distributions and profit sharing or deferred compensation obligations of such Person; (o) all Liabilities for prepaid deferred
revenue, third-party deposits or escrows for crypto currency purchases, and customer incentive or rebate programs or payments; and (p)
all obligations of another Person of the types listed in clauses (a) through (o) above, payment of which is guaranteed
by, or secured by Encumbrances on the property of (with respect to liens, to the extent of the value of property pledged pursuant to
such Encumbrances if less than the amount of such obligations), such Person. “Indebtedness” includes (i) any and all accrued
interest, success fees, prepayment premiums, make-whole premiums or penalties, commitment and other fees, sale or liquidity participation
amounts, reimbursements, indemnities, and fees or expenses; (ii) all “cut” but uncashed checks; (iii) cash, book, or bank
account overdrafts; and (iv) any and all amounts owed to any Affiliates of such Person, including any equity holders of such Person.
For purposes of clarity, the Parties agree that Indebtedness does not include any Liabilities included in the calculation of Net Working
Capital.
“Indemnified
Person” is defined in Section 11.4(a).
“Indemnified
Taxes” means (without duplication) any of the following Taxes:
(a)
all Taxes of Seller;
(b)
(i) all Taxes of the Company (or Taxes imposed on the Purchaser or its Affiliates with respect to the Company) for any Tax period ending
on or before the Closing Date, or attributable to the portion of any Straddle Period ending on the Closing Date; or (ii) any Taxes of
any Person (other than the Company) imposed on the Company as a transferee or successor, by contract or pursuant to any Law, which Taxes
relate to an event or transaction occurring on or before the Closing Date;
(c)
all Taxes resulting from a breach of a representation or warranty contained in Section 5.16 (Taxes);
(d)
all Taxes resulting from a breach of any covenant set forth in Section 7.6;
(e)
any Taxes set forth in Section 7.7(b).; and
(f)
all Taxes related to or arising out of the Debt Restructuring.
“Indemnifying
Person” is defined in Section 11.4(a).
“Information
Systems” means all computer hardware, databases and data storage systems, computers, data, databases, and communications networks
(other than the Internet), architecture, interfaces and firewalls (whether for data, voice, video or other media access, transmission,
or reception), and other apparatus used to create, store, transmit, exchange, or receive information in any form.
“Insolvency”
or “Insolvent” means, with respect to a Person, any transaction, event, or occurrence or series of transactions, events,
or occurrences resulting in (a) the inability of such Person to meet its debt obligations as they fall due and avoid default; (b) such
Person having negative net assets such that liabilities exceed assets; (c) such Person voluntarily commencing any case, proceeding, or
other action seeking to adjudicate such Person as a bankrupt or insolvent, or seek liquidation or dissolution under any law relating
to bankruptcy, insolvency, reorganization, or relief of debtors or seek appointment of a receiver, trustee, custodian, or other similar
fiduciary, with respect to material parts of such Person’s businesses; or (d) commencement against such Person any case, proceeding
or other action of a nature referred to in clause (c) above that (i) results in the entry of an order for relief or any such adjudication
or appointment, or (ii) remains undismissed, undischarged or unbonded for a period of 90 days.
“Insurance
Policies” is defined in Section 5.13.
“Intellectual
Property” means all intellectual property and other proprietary rights worldwide including: (a) all patents and patent and
industrial design applications, together with all re-issuances, continuations, continuations-in-part, divisionals, revisions, re-examinations,
and extensions thereof, and all industrial designs (including utility model rights, design rights and industrial property rights); (b)
all registered and unregistered trademarks, trademark applications, services marks, trade dress, trade names, brand names, logos and
corporate names, slogans and all other indicia of origin, together with all goodwill associated therewith, and all applications, registrations,
and renewals in connection therewith; (c) all copyrights and works of authorship, whether registered or unregistered, mask works, moral
rights and database rights, and all applications and registrations in connection therewith including the right to make derivative works
and all other associated statutory rights; (d) all Trade Secrets; and (e) all Internet domain names.
“Interim
Balance Sheet Date” is defined in Section 5.5(a).
“Interim
Balance Sheets” is defined in Section 5.5(a).
“Interim
Financial Statements” is defined in Section 5.5(a).
“IRS”
means the U.S. Internal Revenue Service.
“Knowledge
of Seller” or “Seller’s Knowledge” and other phrases of like substance means, with respect to a fact
or other matter, the actual knowledge of Steve Berhow, Desmond Lewis, Lukas Peine, and Lisa Rathbun, or the knowledge they should have
after reasonable inquiry into the fact or matter represented or warranted.
“Law”
means any federal, state, provincial, local, municipal, foreign, tribal, or other law, statute, legislation, constitution, common law
or principle thereof, resolution, ordinance, code, proclamation, treaty, convention, rule, regulation, proposed regulation, listing standard,
directive, requirement, specification, executive decree, or Order or interpretation that is issued, enacted, promulgated, or otherwise
put into effect, by or under the authority of any Governmental Entity.
“Lease
Extension” is defined in Section 7.15(b).
“Leased
Real Property” is defined in Section 5.10(c).
“Leave”
means the absence from active employment as of the Closing Date on account of vacation, ordinary sick leave reasonably expected to result
in an absence of short duration, short-term disability leave, medical leave, long-term disability leave, administrative leave, military
leave, or any other type of leave that entitles the individual to reinstatement upon the completion of the applicable leave based on
the policies of the employing Company.
“Lenders”
means each of (i) First Western Bank & Trust, (ii) State of North Dakota, d/b/a The Bank of North Dakota for the benefit of the Innovation
Loan Fund to Support Technology Advancement (the “Bank of North Dakota”), (iii) the City of Rogers, Minnesota and (iv) the
Rogers Economic Development Authority, and each individually, a “Lender”.
“Liability”
means, with respect to any Person, any liability, debt, or obligation of such Person of any kind, character, description, or nature,
whether known or unknown, direct or indirect, fixed, absolute or contingent, matured or unmatured, accrued or unaccrued, asserted or
unasserted, ascertained or ascertainable, disputed or undisputed, liquidated or unliquidated, secured or unsecured, joint or several,
vested or unvested, executory, determined, determinable or indeterminable in contract, tort, strict liability, or otherwise, or otherwise
due or to become due and whether or not the same is required to be reflected on the financial statements of such Person, including all
costs and expenses relating thereto and any liability for Taxes.
“Limitations”
means the limitations set forth in clauses (A), (B) and (C) of Section 11.3(b)(i)(i).
“Litigation
Conditions” is defined in Section 11.4(i)(i).
“Litigation
Indemnity Expiration Date” means the date that all matters described on Section 5.14(a) of Seller’s Disclosure Schedule
are settled pursuant to a full, final and conclusive settlement agreement, or a Final Award has been entered with respect thereto.
“Lock-up
and Voting Agreement” is defined in Section 8.1(l).
“Loss”
means, with respect to any Person at the time of determination, any damage, injury, decline in value, lost opportunity, lost profit,
lost Tax deduction or benefit, Liability, claim, action, deficiency, demand, settlement, Order, award, payment, recovery, fine, penalty,
insurance premium increase, Tax, loss of the value of amortization or depreciation deductions resulting from a breach of Sections
5.16 (Taxes), Encumbrance, assessment, fee (including any legal fee, expert fee, accounting fee, or advisory fee), charge, disbursement,
remediation, cost, interest, expense (including any cost of investigation, penalty, fee, disbursement of counsel or expense of any nature)
or other loss suffered or incurred by such Person, including consequential damages (i.e., any loss or damage resulting from a
breach of contract that does not directly and naturally result in the ordinary course of events but instead arises from special circumstances
not ordinarily predictable or in the contemplation of the Parties as of the date of this Agreement) but excluding punitive damages (except
to the extent that any such damages are part of any Order against the Indemnified Person in connection with a Third-Party Claim).
“Material
Adverse Effect” means any change or effect that, when taken individually or together with all other adverse changes or effects
(whether or not constituting a breach of a representation, warranty, or covenant set forth in the definitive agreement), is or would
reasonably be expected to have a material adverse effect on the business, results of operations, financial condition, or assets of the
Company, including without limitation, the inability to extend existing European CE Mark Regulatory Approvals with respect to current
APT Products prior to the after the date of this Agreement; provided, however, that “Material Adverse Effect”
will not include any event, change or occurrence, directly or indirectly, arising from (a) general economic or industry-wide conditions,
(b) national or international political conditions, including the engagement by the United States in hostilities, whether or not pursuant
to the declaration of a national emergency or war, or the occurrence of any military or terrorist attack upon the United States, or any
of its territories, possessions, or diplomatic or consular offices or upon any military installation, equipment of personnel of the United
States, or (c) actions or omissions taken with the prior written consent of Purchaser or expressly required by this Agreement, except
with respect to clauses (a) through (b) above, to the extent that the effects of such change are disproportionately adverse
to the business, results of operations, or financial condition of the Company, taken as a whole, as compared to other companies in the
industries in which the Company operates.
“Material
Clients” is defined in Section 5.20.
“Material
Contracts” is defined in Section 5.12(a).
“Material
Vendors” is defined in Section 5.21.
“Non-Assumed
Indebtedness” means that certain third-party Indebtedness to each of the Lenders, as follows: (i) all loans from First Western
Bank & Trust to the Company, and all guarantees by the Company in favor of First Western Bank, the Company; (ii) all loans from the
Bank of North Dakota to the Company; (iii) that certain loan from the City of the Rogers Economic Development Authority to the Company;
and (iv) that certain loan from Rogers, Minnesota to the Company.
“Object
Code” means computer software that is substantially or entirely in binary form and that is intended to be directly executable
by a computer after suitable processing and linking but without any intervening steps of compilation or assembly.
“Objection
Notice” is defined in Section 2.4(d).
“Open
Source License” means, without limitation, any version of the GNU General Public License (GPL), Lesser/Library General Public
License (LGPL), Mozilla Public License (MPL), Common Public License (CPL), or any other license for Software where the license includes
terms that require as a condition of use, modification, and/or distribution of such Software that such Software or other Software incorporated
into it, derived from, or distributed with such Software (a) be disclosed or distributed in Source Code form, (b) be licensed to authorize
modifications to, or derivative works of, the Source Code for the Software, (c) be redistributable at no or minimal charge, or (d) be
licensed to authorize the distribution of modifications or derivative works of the Software only if subsequent licensees are authorized
to further modify or make derivative works of licensee’s works.
“Open
Source Materials” means all Software that is licensed or distributed under an Open Source License.
“Order”
means any: (a) order, judgment, injunction, edict, decree, ruling, assessment, stipulation, pronouncement, determination, decision, opinion,
verdict, sentence, subpoena, writ, or award issued, made, entered, rendered, or otherwise put into effect by or under the authority of
any court, administrative agency, or other Governmental Entity or any arbitrator or arbitration panel (in each case, whether preliminary
or final); or (b) Contract with any Governmental Entity entered into in connection with any Proceeding.
“Ordinary
Course of Business” means, with respect to any Person, any action taken by such Person: (a) consistent in nature, scope, and
magnitude with the past practices of such Person and taken in the ordinary course of the normal, day-to-day operations of such Person;
(b) not requiring authorization by the shareholders, members, or other equity owners of such Person, the board of directors or managers
of such Person, or any committee of the board of directors or managers of such Person (or by any Person or group of Persons exercising
similar authority) nor requiring any other separate or special authorization of any nature; (c) taken in accordance with sound and prudent
business practices; (d) not resulting from, arising out of, relating to, in the nature of, or caused by any breach of Contract, tort,
infringement, or violation of Law; and (e) not related to any acquisition of, or investment in, the debt or equity of any Person.
“Organizational
Documents” means, with respect at a Person, the following documents that are presently in effect, including any amendments,
modifications, or supplements thereto: (a) the articles or certificate of incorporation, formation, organization, or association; (b)
general or limited partnership agreement; (c) limited liability company or operating agreement; (d) trust agreement; (e) bylaws; and
(f) other agreements, documents, or instruments relating to the organization, management, or operation of such Person that is an Entity
or relating to the rights, duties, and obligations of the equityholders of any such Person, including any equityholders’ agreements,
voting agreements, voting trusts, joint venture agreements, registration rights agreements, or similar agreements.
“Other
Seller Indemnifying Person” is defined in Section 11.2(a).
“Party”
and “Parties” are defined in the opening paragraph of this Agreement.
“Permit”
means any: (a) permit, license, certificate, franchise, concession, approval, consent, ratification, permission, clearance, confirmation,
endorsement, waiver, certification, designation, registration, qualification, or authorization issued, granted, given, or otherwise made
available by or under the authority of any Governmental Entity or pursuant to any Law, or (b) right under any Contract with any Governmental
Entity.
“Permitted
Encumbrances” means (a) with respect to any asset, property, or right, (i) Encumbrances for Taxes not yet due and payable or
for Taxes being contested in good faith through appropriate proceedings and for which adequate reserves according to GAAP have been established,
and (ii) liens arising in the Ordinary Course of Business by operation of Law, including mechanic’s, materialmen’s, repairmen’s,
employee’s, contractor’s, operator’s and other similar liens to the extent not incurred in connection with the borrowing
of money, that are not material to the business, operations, and financial condition of the applicable Person’s property so encumbered
and that are not delinquent or resulting from a breach, default, or violation by such Person of any Contract or Law; (b) purchase money
security interests and Encumbrances securing rental payments; (c) Real Estate Encumbrances; (d) Permitted Equity Encumbrances; and (e)
Encumbrances set forth in Section 1.1 of Seller’s Disclosure Schedule.
“Permitted
Equity Encumbrances” means, with respect to any Equity Securities of the Company, (a) the provisions of the Company’s
Organizational Documents, and (b) the restrictions on the sale, transfer, pledge, or other disposition of securities provided in the
Securities Act and any state or “blue sky” securities laws.
“Person”
means any individual and any Entity.
“Post-Closing
Straddle Period” is defined in Section 7.6(d).
“Post-Closing
Tax Period” is defined in Section 5.16(j).
“Pre-Closing
Straddle Period” is defined in Section 7.6(d).
“Pre-Closing
Tax Matter” is defined in Section 7.6(f).
“Pre-Closing
Tax Period” is defined in Section 5.16(j).
“Proceeding”
means any action, claim, demand, charge, complaint, arbitration, proceeding, prosecution, investigation, hearing, litigation, or suit
(whether civil, criminal, administrative, judicial, or investigative, whether formal or informal, whether public or private) commenced,
brought, conducted, or heard by or before, or otherwise involving, any Governmental Entity or arbitrator.
“Prohibited
Person” is defined in Section 5.25.
“Proposed
Revenue Earnout Measurement” is defined in Section 2.5(c)(i).
“Purchaser
Common Stock” means the common stock, $0.001 par value, of Stereotaxis, Inc.
“Purchase
Price” means an amount up to $27,000,000.00 (inclusive of the Upfront Stock Consideration and the maximum Earnout Consideration,
if any), as adjusted pursuant to Article II.
“Purchaser”
is defined in the opening paragraph of this Agreement.
“Purchaser
Financial Statements” is defined in Section 6.6.
“Purchaser
Indemnifiable Matter” is defined in Section 11.3(a).
“Purchaser
Indemnitee” is defined in Section 11.3(a).
“R&D
Sponsor” is defined in Section 5.11(n).
“Real
Estate Encumbrances” means any (a) easement, covenant, right-of-way, and other similar matters of record, which does not materially
interfere with the operation of the Company’s business, as currently conducted, or materially adversely affect the value of the
real property interest burdened thereby; (b) zoning and building restrictions; and (c) the provisions of any Law (including but not limited
to statutory liens of landlords, zoning, entitlement, building and other land use regulations), which does not materially interfere with
the operation of the Company’s business, as currently conducted, or materially adversely affect the value of the real property
interest burdened thereby.
“Real
Property” means, collectively, any owned real property (if any) and the Leased Real Property.
“Real
Property Lease” is defined in Section 5.10(c).
“Related
Party” means, with respect to a Person, (a) any Affiliate of such Person, and any direct or indirect beneficial owner (as defined
in Rule 13d-3 of the Exchange Act) of 10% or more of the Equity Securities or voting securities or other voting interests in such Person;
(b) any member, manager, general partner, director, officer, trustee, executor, receiver, guardian, or personal representative of such
Person or Person described in clause (a) above or the estate of such Person or any Person described in clause (a) above;
(c) that is an individual, (i) any individual living with such Person, (ii) any other individual who is related (by blood, marriage,
or adoption) to the individual, (iii) the individual’s spouse, or (iv) any Person related to (A) such Persons within the second
degree or (B) any Person described in clauses (a) and (b) above; and (d) any trust, family partnership, family limited partnership, family
limited liability company, or other Entity established for the benefit of such Person or any Person described in any of clauses (a)
through (c) above.
“Release”
is defined in Section 5.19(b).
“Released
Claims” means each and all past and present disputes, claims, controversies, demands, rights, obligations, liabilities, actions,
and causes of action of every kind and nature against the Releasees, including: (a) any unknown, unsuspected, or undisclosed claim; (b)
any claim or right that may be asserted or exercised by Seller in its capacity as an equity holder of the Company or in any other capacity;
and (c) any claim, right, or cause of action based upon any breach of any express, implied, oral, or written contract or agreement that
(i) Seller may have had in the past, or may now have, and (ii) has arisen or arises, directly or indirectly, out of, or relates, directly
or indirectly, to, any circumstance, agreement, activity, action, omission, event, or matter occurring or existing on or prior to the
Effective Date; provided, however, that “Released Claims” shall exclude any claim of the nature described in this
definition that Seller may have against any of the Releasees that arises under this Agreement or any Transaction Document or in connection
with the transactions contemplated hereby or thereby.
“Releasees”
means: (a) Purchaser and each of its Affiliates; (b) the Company; and (c) each of the predecessors, successors, Purchasers, Subsidiaries,
divisions, and past, present, and future assigns, successors, beneficiaries, heirs, assigns, attorneys, and Representatives of each Person
identified or otherwise referred to in clauses (a) and (b) above.
“Remedies
Exception” means, with respect to enforceability of a Contract against a Person, such Contract is enforceable against such
Person in accordance with such Contract’s terms, except to the extent that its enforceability may be subject to applicable bankruptcy,
Insolvency, reorganization, moratorium, or other similar laws affecting the enforcement of creditors’ rights generally and to general
equitable principles.
“Representative”
means, with respect to a Person, such Person’s Entity Representatives and independent contractors.
“Resolution
Period” is defined in Section 2.5(c)(iv).
“Response
Notice” is defined in Section 11.4(d).
“Restrictions”
is defined in Section 7.11(b).
“Revenue
Earnout Measurement” is defined in Section 2.5(c)(i).
“Revenue
Earnout Notice Date” is defined in Section 2.5(c)(i).
“Revenue
Earnout Period” means the five 12-month periods beginning initially from the first day of the Company’s next fiscal quarter
following Closing to the last day of the fourth fiscal quarter following closing. By way of example, if the Closing Date is July 15,
2024, then “Revenue Earnout Period 1” means October 1, 2024 through September 30, 2025; “Revenue Earnout
Period 2” means October 1, 2025 through September 30, 2026; “Revenue Earnout Period 3” means October 1,
2026 through September 30, 2027; “Revenue Earnout Period 4” means October 1, 2027 through September 30, 2028; and
“Revenue Earnout Period 5” means October 1, 2028 through September 30, 2029.
“Review
Period” is defined in Section 2.4(b).
“Rule
144” is defined in Section 4.8(a).
“SEC”
means the United States Securities and Exchange Commission.
“SEC
Reports” is defined in Section 6.4.
“Securities
Act” means the Securities Act of 1933.
“Securities
Assignment” is defined in Section 3.2.
“Seller”
and “Sellers” are defined in the opening paragraph of this Agreement.
“Seller
Indemnitee” is defined in Section 11.3(a).
“Seller
Transaction Expenses” means all Transaction Expenses incurred or otherwise payable by the Company or Seller, whether incurred
in connection with the Transaction Documents, the Contemplated Transactions or otherwise.
“Seller’s
Disclosure Schedule” means the schedule attached to this Agreement and referred to in this Agreement as “Seller’s
Disclosure Schedule” that are referenced in Seller’s representations and warranties set forth in this Agreement.
“Seller
Indemnifiable Matter” is defined in Section 11.3(a).
“Share
Cap” means 19.9% of the total number of shares of Purchaser Common Stock issued and outstanding immediately prior to the Closing.
“Software”
means all computer software and code and firmware, including assemblers, applets, compilers, data files, schematics, application programming
interfaces, computerized databases, Source Code, Object Code, development tools, design tools, user interfaces and data, and other related
know-how, processes, formula, design, specifications, and documentation related to the foregoing, in any form or format, however fixed.
“SOL
Representations” means the representations and warranties contained in Section 5.16 (Taxes), Section 5.17 (Employee
Benefit Matters) and Section 5.19 (Environmental Matters).
“Source
Code” means computer software that may be displayed or printed in human-readable form, including all related programmer comments,
annotations, flowcharts, diagrams, help text, data and data structures, instructions, procedural, object-oriented, or other human-readable
code, and that is not intended to be executed directly by a computer without an intervening step of compilation or assembly.
“Straddle
Period” is defined in Section 7.6(c).
“Subsidiary”
means, with respect to any Person, any corporation, limited liability company, partnership, association, or other business entity of
which (a) if a corporation, a majority of the total voting power of shares of stock entitled (without regard to the occurrence of any
contingency) to vote in the election of directors, managers, or trustees thereof is at the time owned or controlled, directly or indirectly,
by that Person or one or more of the other Subsidiaries of that Person or a combination thereof; or (b) if a limited liability company,
partnership, association, or other business entity (other than a corporation), a majority of the partnership or other similar ownership
interests thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more Subsidiaries of that Person
or a combination thereof and, for this purpose, a Person or Persons own a majority ownership interest in such a business entity (other
than a corporation) if such Person or Persons will be allocated a majority of such business entity’s gains or losses or will be
or control any managing director or general partner of such business entity (other than a corporation). The term “Subsidiary”
includes all Subsidiaries of such Subsidiary.
“Tax”
or “Taxes” (and with correlative meaning, “Taxable,” “Taxing,” and “Taxation”)
means: (a) all forms of taxation or duties imposed, or required to be collected or withheld, including any United States federal, state,
or local, or non-United States, income, gross receipts, franchise, estimated, alternative minimum, add-on minimum, sales, goods and services,
use, transfer, registration, value added, excise, natural resources, severance, stamp, withholding, occupation, premium, windfall profit,
profits, license, environmental, ad valorem, escheat, unclaimed or abandoned property, customs, duties, real property, personal property,
capital stock, net worth, intangibles, social security, unemployment, employment disability, payroll, employee, workers’ compensation,
deductions at source, or other tax, similar levy, similar governmental fee, similar assessment, or similar charge of any kind whatsoever,
together with any interest, penalty, addition to tax, or additional amount imposed by any Law or Tax Authority, whether disputed or not;
(b) any liability for the payment of any amounts of any of the foregoing types as a result of being a member of an affiliated, consolidated,
combined, or unitary group; (c) any liability for the payment of any amounts as a result of being a party to any tax indemnity, sharing
or allocation agreements with respect to the payment of any amounts of any of the foregoing types as a result of any express or implied
obligation to indemnify any other Person; and (d) any liability for the payment of any of the foregoing types as a successor, transferee,
or otherwise.
“Tax
Authority” means any Governmental Entity having jurisdiction over the assessment, determination, collection, or imposition
of any Tax.
“Tax
Matter” is defined in Section 7.6(f).
“Tax
Return” means any return, form, statement, election, declaration, report, claim for refund, information return or other document
filed or required to be filed with a Governmental Authority in connection with the determination, assessment, collection, or imposition
of any Tax or the administration of any Law relating to any Tax, including any schedule, supplement or attachment thereto and any amendment
thereof.
“Third-Party
Claim” is defined in Section 11.4(b).
“Third-Party
Consent” means any Consent of any Person other than a Governmental Entity.
“Third-Party
Recovery Proceeds” is defined in Section 11.8.
“Trade
Secret” means all trade secrets, and, without limitation, all other inventions (whether patentable or not), Software, industrial
designs, discoveries, improvements, ideas, designs, models, formulae, specifications, technologies, processes, algorithms, architectures,
layouts, look-and-feel, methodologies, patterns, compilations, data collections, drawings, blueprints, mask works, devices, methods,
techniques, processes, know how, confidential information, proprietary information, research and development, compositions, manufacturing
and production processes and techniques, customer lists, supplier lists, pricing and cost information, business and marketing plans,
and proposals, and the moral and economic rights of authors and inventors in any of the foregoing.
“Transaction
Documents” means this Agreement, the Securities Assignment, the and the Voting & Support Agreements, together with such
other agreements, certificates, and documents, and any exhibits, annexes, schedules, or other attachments thereto, delivered or caused
to be delivered incident to or in connection with the Contemplated Transactions.
“Transaction
Expenses” means, with respect to any Person, all fees, costs, and expenses (including all legal fees and expenses, all fees
and expenses payable to any broker or finder, and all fees and expenses of any audit firm, accountants, consultants, and tax advisors)
that have been incurred in connection with the Contemplated Transactions on behalf of or for the benefit of such Person and its Affiliates.
“Transfer”
means a sale, assignment, transfer, conveyance, gift, exchange, or other disposition of such asset, whether such disposition be voluntary,
involuntary or by merger, exchange, consolidation, or operation of Law.
“Treasury
Regulations” means the regulations issued by the U.S. Department of Treasury under the Code.
“UK”
means the United Kingdom, together with, as of the date in question, all of its then-current constituent member-countries.
“Voting
Debt” is defined in Section 5.2(b).
“WARN
Act” is defined in Section 5.18(j).
“Working
Capital” means, with respect to the Company, at the time of determination, the amount, as of the Closing Date, as finally determined
in accordance with Section 2.4, equal to its current assets (including Cash) minus its current liabilities, all as determined
in accordance with GAAP. For avoidance of doubt, Working Capital shall be calculated as follows: (a) current assets will exclude
all Related Party payables and receivables, third-party escrow or other deposits in respect of cryptocurrency purchases, Cash, and all
current Tax assets, but will include (without double counting) (i) Cash and Cash Equivalent Securities, (ii) Accounts Receivable,
(iii) unbilled work in progress, (iv) undeposited funds, (v) prepaid insurance, (vi) prepaid dues and subscriptions, (vii) prepaid other,
(viii) prepaid equipment, (ix) employee advances, (x) prepaid rent, (xi) prepaid services – retainers, and (xii) prepaid general
liabilities; and (b) current liabilities will include (i) all Indebtedness of the Company (but not any Non-Assumed Indebtedness),
(ii) all current Tax Liabilities, (iii) all payroll liabilities, (iv) all Related Party payables, (v) profit sharing, (vi) accrued interest,
(vii) accrued bonus, (viii) accrued commission, and (ix) Seller Transaction Expenses, (x) Accounts Payable, (xi) 401(k) plan and 401(k)
loan, (xii) accrued expenses, (xiii) business insurance liability, (xiv) PTO Liability, (xv) credit cards payable, (xvi) accrued travel
costs, (xvii) accrued sick leave, (xviii) accrued 401(k) Liability, (xix) health insurance payable, (xx) life insurance, (xxii) dental
and vision, (xxiii) state and local sales taxes payable, (xxiv) franchise taxes payable, and (xxv) personal or business property taxes
payable.
Appendix
B
Notice
Addresses
|
|
Stereotaxis, Inc. |
|
|
710 North Tucker Boulevard,
Suite 110 |
|
|
St. Louis, Missouri 63101 |
|
|
Attention: David Fischel
(david.fischel@stereotaxis.com) |
|
|
Kimberly
Peery (kim.peery@stereotaxis.com) |
|
|
Laura
Spencer Garth (laura.garth@stereotaxis.com) |
|
With a copy to (which will
not constitute notice): |
|
|
Bryan Cave Leighton Paisner
LLP |
|
|
One Metropolitan Square |
|
|
211 North Broadway, Suite
3600 |
|
|
St. Louis, MO 63102 |
|
|
Attention:
Robert J. Endicott |
|
|
Email:
rob.endicott@bclplaw.com |
|
|
Access Point Technologies
EP, Inc. |
|
|
12560 Fletcher Lane, Ste.
300 |
|
|
Rogers, MN 55374 |
|
|
Attention: Steve Berhow,
President |
|
|
Email:
Steve.Berhow@apt-inc.us |
|
With a copy to (which will
not constitute notice): |
|
|
Donohue McKenney Ltd. |
|
|
11222 86th Ave. N. |
|
|
Maple Grove, MN 55369 |
|
|
Attention: Chad McKenney,
Esq. |
|
|
Email:
chad@dmlawltd.com |
Exhibit
A
Form
of Securities Assignment
FOR
VALUE RECEIVED, the undersigned, APT Holding Company, Inc., a Minnesota corporation (the “Assignor”), hereby
sells, assigns and transfers unto Stereotaxis, Inc., a Delaware corporation, [(i) 1,000 shares of Common Shares, par value $0.01
per share, and (ii) 1,000 shares of Series A Convertible Preferred Stock, par value $0.01 per share,] of Access Point Technologies
EP, Inc., a Minnesota corporation (the “Company”), standing in the name of the undersigned on the books of
the Corporation and represented by Certificate Nos. ___ and ___, respectively, dated as of May 10, 2024, which comprise 100% of the capital
stock of the Company standing in the Assignor’s name on the books of the Company; and does hereby irrevocably constitute and appoint
an officer of the Company as attorney-in-fact to transfer said shares on the books of the Company, with full power of substitution in
the premises
Dated:
_____________, 2024
|
ASSIGNOR:
|
|
|
|
APT
HOLDING COMPANY, INC. |
|
|
|
By:
|
|
|
Name: |
|
|
Title |
|
Exhibit
B
Form
of Voting and Support Agreement
This
VOTING AND SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of May 11, 2024, by and among Stereotaxis,
Inc., a Delaware corporation (“Stereotaxis”), and the stockholders of Access Point Technologies EP, Inc., a Minnesota
corporation (the “Company”), set forth on Schedule A hereto (each a “Stockholder”
and collectively, the “Stockholders”). Stereotaxis and the Stockholders are sometimes referred to collectively herein
as the “Parties” and individually as a “Party”.
BACKGROUND
A.
Concurrently with the execution and delivery of this Agreement, Stereotaxis and the Company and APT Holding Company, a Minnesota corporation
(“NewCo”), are entering into that certain Share Purchase Agreement, dated as of the date of this Agreement (as the
same may be amended or supplemented, the “Purchase Agreement”), which provides (subject to the terms and conditions
set forth therein) for the sale of all of the outstanding equity capital stock of the Company to Stereotaxis (the “Transaction”)
(capitalized terms used but not defined herein shall have the meaning given to them in the Purchase Agreement).
B.
As of the date hereof, each Stockholder is the record and/or beneficial owner (as defined in Rule 13d-3 under the Securities Exchange
Act of 1934, as amended, and the rules and regulations promulgated thereunder (the “Exchange Act”)) of the number
of shares of common stock, par value $0.01 per share, of the Company (“Company Common Stock”) and Series A Convertible
Preferred Stock, par value $0.01 per share (the “Company Series A Preferred Stock”) set forth opposite such Stockholder’s
name on Schedule A hereto (such shares of Common Company Common Stock and Company Series A Preferred Stock collectively,
the “Shares”).
C.
The Parties acknowledge that, substantially concurrently with entering into this Agreement, NewCo will be the sole Seller of Company
Common Stock under the Purchase Agreement, following the reorganization of the Company into a holding company structure under Minnesota
law, wherein NewCo does or will own all of the outstanding shares of capital stock of the Company and the former stockholders, including
the Stockholders, will own all of the equity voting interests in NewCo in the same number and proportion as the current ownership of
the Company (the “NewCo Shares”), and accordingly, all New Interests held by the Stockholders will be deemed to be
“Shares” for all purposes of this Agreement even if not expressly set forth herein.
D.
As a condition and material inducement to Stereotaxis entering into the Purchase Agreement, Stereotaxis have requested that the Stockholders
agree, and, in order to induce Stereotaxis to enter into the Purchase Agreement, the Stockholders are willing to agree, to the matters
set forth herein.
In
consideration of the foregoing and the representations, warranties, covenants, agreements, obligations, and undertakings set forth herein,
and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as
follows:
Article
I AGREEMENT TO VOTE; GRANT AND APPOINTMENT OF PROXY
1.1
Agreement to Vote. From and after the date hereof until the earlier to occur of (a) the Effective Time and (b) the termination
of the Purchase Agreement pursuant to and in compliance with the terms therein (such earlier date, the “Expiration Date”),
each Stockholder hereby irrevocably and unconditionally agrees that, during the time this Agreement is in effect, at any annual or special
meeting of the Company’s stockholders or of voting equity holders of NewCo, as the case may be, however called, including any adjournment
or postponement thereof, and in connection with any action proposed to be taken by written consent of the Company’s stockholders,
each Stockholder shall, in each case to the fullest extent that Stockholder’s Shares or NewCo Shares are entitled to vote thereon:
(i) appear at each such meeting or otherwise cause all of its Shares or NewCo Shares, as the case may be, to be counted as present thereat
for purposes of determining a quorum and (ii) be present (in person or by proxy) and vote or cause to be voted (including by proxy or
written consent, if applicable) all such Shares or NewCo Shares, as the case may be, (A) in favor of (1) the Purchase Agreement and the
Transaction and the other transactions contemplated by the Purchase Agreement, (2) the formation of NewCo and NewCo’s participation
in the Transaction and (3) any proposal to adjourn or postpone such meeting of stockholders of the Company or the voting equity holders
of NewCo to a later date if there are not sufficient votes to approve the Transaction, (B) against any material change in the capitalization
of the Company or of NewCo (except for its initial formation), or the corporate structure of the Company or of NewCo, as the case may
be, and (C) against any action, proposal, transaction or agreement that is intended, or would reasonably be likely to prevent, materially
impede, materially delay or otherwise materially and adversely affect the Company’s, NewCo’s or Stereotaxis’s ability
to timely consummate the transactions contemplated by the Purchase Agreement, including the Transaction (clauses (A) through (C), the
“Required Votes”).
1.2
Grant of Irrevocable Proxy; Appointment of Proxy.
From
and after the date hereof until the Expiration Date, each Stockholder hereby irrevocably and unconditionally grants to, and appoints,
Stereotaxis and any designee thereof as such Stockholder’s proxy and attorney-in-fact (with full power of substitution) in accordance
with the Minnesota Business Corporation Act (“MBCA”) (or other applicable state law for the NewCo Shares), for and
in the name, place and stead of such Stockholder, to vote or cause to be voted (including by proxy or written consent, if applicable),
the Shares and/or NewCo Shares, as the case may be, owned by such Stockholder as of the applicable record date in accordance with the
Required Votes; provided, that each Stockholder’s grant of the proxy contemplated by this Section 1.2 shall be effective
if, and only if, such Stockholder has not delivered to the Company prior to the meeting at which any of the matters described in Section
1.1 are to be considered, a duly executed irrevocable proxy card directing that the Shares or NewCo Shares of such Stockholder be
voted in accordance with the Required Votes; provided, further, that any grant of such proxy shall only entitle Stereotaxis
or its designee to vote on the matters specified by Section 1.1(ii), and each Stockholder shall retain the authority to vote on
all other matters.
Each
Stockholder hereby represents that any proxies heretofore given in respect of the Shares, if any, are revocable, and hereby revokes all
such proxies,, and shall file any such revocation and appointment hereunder in accordance with any applicable provisions of the MBCA.
Each
Stockholder hereby affirms that the irrevocable proxy set forth in this Section 1.2, if it becomes effective, is given in connection
with the execution of the Purchase Agreement, and that such irrevocable proxy is given to secure the performance of the duties of such
Stockholder under this Agreement. The Parties hereby further affirm that the irrevocable proxy, if it becomes effective, is coupled with
an interest and is intended to be irrevocable until the Expiration Date, at which time it will terminate automatically. The proxy granted
by the Stockholder herein shall survive the dissolution, bankruptcy, death or incapacity of the Stockholder. If for any reason any proxy
granted herein is not irrevocable after it becomes effective, then the Stockholder granting such proxy agrees, until the Expiration Date,
to vote, or to cause the holder of record on any applicable record date to vote, the Shares and/or NewCo Shares, as the case may be,
in accordance with the Required Votes. The Parties agree that the foregoing is a voting agreement.
1.3
Restrictions on Transfers.
Except
as otherwise provided in Section 1.3(b), absent the prior written consent of Stereotaxis (which consent may be granted or withheld
in Stereotaxis’s sole discretion), each Stockholder hereby agrees that, from the date hereof until the Expiration Date, it shall
not, directly or indirectly, (i) sell, transfer, assign, tender in any tender or exchange offer, pledge, encumber, hypothecate or similarly
dispose of (by merger, by testamentary disposition, by operation of applicable Law or otherwise) (a “Transfer”), either
voluntarily or involuntarily, or enter into any contract, option or other arrangement or understanding providing for the Transfer of
any Shares or NewCo Shares (or any rights attached thereto, or any economic interests therein), (ii) deposit any Shares or NewCo Shares
into a voting trust or enter into a voting agreement or arrangement or grant any proxy or power of attorney with respect thereto, or
(iii) agree (whether or not in writing) to take any of the actions prohibited by the foregoing clause (i) or (ii). Any purported Transfer
of Shares or NewCo Shares inconsistent with this Section 1.3 shall be null and void. For the avoidance of doubt, nothing herein
shall be deemed to restrict the ability of Stockholder to exercise, prior to the end of the Expiration Date, any Company Stock Options
and Other Rights held by Stockholder.
The
restrictions set forth in Section 1.3(a) shall not apply to any Transfer of Shares or NewCo Shares by Stockholder (i) for the
net settlement of such Stockholder’s Company Stock Options and Other Rights (defined below) (to pay the exercise price thereof
and any Tax withholding obligations), (ii) for the exercise of such Stockholder’s Company Stock Options and Other Rights and the
sale of a sufficient number of such Shares acquired upon exercise of such Company Stock Options and Other Rights as would generate sale
proceeds sufficient to pay to the Company the aggregate applicable exercise price of shares then exercised under such Company Stock Options
and Other Rights and any Tax withholding obligations of the Company arising as a result of such exercise, (iii) in the case of any Stockholder
that is a partnership or limited liability company, to one or more partners or members of Stockholder or to an affiliated corporation,
trust or other business entity under common control with Stockholder or (iv) in the case of any Stockholder that is a trust, a transfer
to a beneficiary; provided, that in each case, the transferee shall concurrently with such Transfer execute a customary joinder
in form and substance reasonably satisfactory to Stereotaxis agreeing to be a “Stockholder” hereunder if such transferee
is not already a party to this Agreement, and to perform all obligations as a Stockholder pursuant to this Agreement with respect to
the Shares; provided, further, that such Stockholder shall remain liable for the breaches by any of such transferee of
the terms hereof.
1.4
Inconsistent Agreements. Each Stockholder hereby covenants and agrees that, except for this Agreement, it (a) shall not enter
into, at any time while this Agreement remains in effect, any voting agreement or voting trust with respect to the Shares and (b) shall
not grant, at any time while this Agreement remains in effect, a proxy, consent or power of attorney with respect to the Shares.
Article
II
No
SOLICITATION
2.1
No Solicitation.
Prior
to the Expiration Date, each Stockholder (in its capacity as a stockholder of the Company) shall not, and shall cause (if applicable)
each of its Affiliates and its and their respective directors, officers or employees not to, and shall use its reasonable best efforts
to cause its and their other Representatives not to, directly or indirectly (other than with respect to Stereotaxis), (i) solicit, initiate,
knowingly facilitate or knowingly encourage any inquiries, proposals or offers that constitute, or that could reasonably be expected
to lead to, a proposal for an Alternative Transaction, as defined in the Purchase Agreement (an “Acquisition Proposal”),
(ii) engage in, continue or otherwise participate in any discussions or negotiations with any third party regarding an Acquisition Proposal
or an Alternative Transaction or any inquiry, proposal or offer that could reasonably be expected to lead to an Acquisition Proposal
or an Alternative Transaction, or furnish to any third party information or provide to any third party access to the businesses, properties,
assets or personnel of the Company, in each case in connection with an Acquisition Proposal or any inquiry, proposal or offer that could
reasonably be expected to lead to an Acquisition Proposal or an Alternative Transaction, or for the purpose of encouraging or facilitating
an Acquisition Proposal or an Alternative Transaction, (iii) enter into any letter of intent, agreement, contract, commitment or agreement
in principle with respect to an Acquisition Proposal or an Alternative Transaction (as such terms are defined in the Purchase Agreement)
or enter into any agreement, contract or commitment requiring the Company to abandon, terminate or fail to consummate the transactions
contemplated by the Purchase Agreement, (iv) approve, support, adopt or recommend any Acquisition Proposal or an Alternative Transaction,
or (v) resolve or agree to do any of the foregoing. From and after the execution of this Agreement, each Stockholder shall, and shall
cause (if applicable) each of its Affiliates and direct its and their respective Representatives to immediately cease and cause to be
terminated all existing discussions or negotiations with any third party conducted heretofore with respect to any Acquisition Proposal
or any inquiry, proposal, offer that could reasonably be expected to lead to an Acquisition Proposal.
For
purposes of this Agreement, the term “Affiliate” shall have the meaning assigned to it in the Purchase Agreement;
provided, that, for the avoidance of doubt, the Company shall not be deemed to be an Affiliate of any of the Stockholders.
Article
III
REPRESENTATIONS,
WARRANTIES AND COVENANTS
3.1
Representations and Warranties of each Stockholder. Each Stockholder represents and warrants to Stereotaxis as follows:
(a)
(i) such Stockholder has full legal right, power and capacity to execute and deliver this Agreement, to perform Stockholder’s obligations
hereunder and to consummate the transactions contemplated hereby, (ii) this Agreement has been duly executed and delivered by such Stockholder
and the execution, delivery and performance of this Agreement by such Stockholder and the consummation of the transactions contemplated
hereby have been duly authorized by all necessary action on the part of such Stockholder and no other company actions or proceedings
on the part of such Stockholder are necessary to authorize this Agreement or to consummate the transactions contemplated hereby, and
(iii) assuming due execution by Stereotaxis, this Agreement constitutes the legal, valid and binding agreement of such Stockholder, enforceable
against such Stockholder in accordance with its terms (except to the extent that enforceability may be limited by applicable bankruptcy,
insolvency, moratorium, reorganization or similar Laws affecting the enforcement of creditors’ rights generally or by general principles
of equity); provided that if such Stockholder is married, and any of the Shares constitute community property or spousal approval
is otherwise necessary for this Agreement to be legal, binding and enforceable, this Agreement has been duly authorized, executed and
delivered by, and constitutes the legal, valid and binding obligation of, such Stockholder’s spouse, enforceable against such Stockholder’s
spouse in accordance with its terms;
(b)
the execution and delivery of this Agreement by such Stockholder does not, and the consummation of the transactions contemplated hereby
and the compliance with the provisions hereof will not, to the Stockholder’s knowledge, conflict with or violate any applicable
Law or agreement binding upon such Stockholder or the Shares, nor require any authorization, consent or approval of, or filing with,
any Governmental Entity, except in each case for filings with the SEC by such Stockholder or as would not impact such Stockholder’s
ability to perform or comply with its obligations under this Agreement in any material respect;
(c)
(i) such Stockholder beneficially owns (as such term is used in Rule 13d-3 of the Exchange Act) the Shares and/or the NewCo Shares set
forth on Schedule A hereto, and (ii) such Stockholder (A) owns, beneficially and of record, or controls all of such Shares and/or
NewCo Shares free and clear of any proxy, voting restriction, adverse claim or other Lien (other than any restrictions created by this
Agreement or under applicable federal or state securities laws), (B) has sole voting power, sole power of disposition, sole power to
demand dissenters’ rights and sole power to agree to all of the matters set forth in this Agreement, each with respect to all of
such Stockholder’s Shares and/or the NewCo Shares, (C) does not own, of record or beneficially, any shares of capital stock of
the Company other than the Shares set forth on Schedule A hereto, and (D) no Person other than such Stockholder has any
right to direct or approve the voting or disposition of any of such Shares and/or NewCo Shares; provided, however, that
each Stockholder may be deemed to share voting power and the power of disposition over its Shares with each other Stockholder;
(d)
as of the date hereof, Stockholder does not own any options or other equity-based awards of the Company or NewCo, warrants and other
rights to acquire, directly or indirectly, shares of the Company Common Stock or Company Series A Preferred Stock (collectively, the
“Company Stock Options and Other Rights”); and
(e)
as of the date hereof, to the knowledge of such Stockholder, there is no action (including any lawsuit, arbitration, or legal or administrative
or regulatory proceeding, charge, complaint, or investigation) (each, an “Action”) pending or threatened against such
Stockholder before or by any Governmental Entity, except, as would not reasonably be expected, either individually or in the aggregate,
to impair the ability of such Stockholder to perform its, his or her obligations hereunder or to consummate the transactions contemplated
hereby on a timely basis.
3.2
Representations and Warranties of Stereotaxis. Stereotaxis represents and warrants to each Stockholder as follows:
(a)
(i) Stereotaxis has full legal right, power and capacity to execute and deliver this Agreement, to perform its obligations hereunder
and to consummate the transactions contemplated hereby, (ii) this Agreement has been duly executed and delivered by Stereotaxis and the
execution, delivery and performance of this Agreement by Stereotaxis and the consummation of the transactions contemplated hereby have
been duly authorized by all necessary action on the part of Stereotaxis and no other company actions or proceedings on the part of Stereotaxis
are necessary to authorize this Agreement or to consummate the transactions contemplated hereby, and (iii) assuming due execution by
the Stockholders, this Agreement constitute the legal, valid and binding agreement of Stereotaxis, enforceable against Stereotaxis in
accordance with its terms (except to the extent that enforceability may be limited by applicable bankruptcy, insolvency, moratorium,
reorganization or similar Laws affecting the enforcement of creditors’ rights generally or by general principles of equity); and
(b)
the execution and delivery of this Agreement by Stereotaxis does not, and the consummation of the transactions contemplated hereby and
the compliance with the provisions hereof will not, conflict with or violate any applicable Law or agreement binding upon Stereotaxis,
nor require any authorization, consent or approval of, or filing with, any Governmental Entity, except in each case for filings with
the SEC by Stereotaxis or as would not impact such Stereotaxis’s ability to perform or comply with its obligations under this Agreement
in any material respect.
3.3
Covenants. Each Stockholder hereby:
(a)
irrevocably waives, and agrees not to exercise, any dissenters’ rights that such Stockholder may have with respect to the Shares
pursuant to the MBCA or other applicable state law relative to the Company or NewCo;
(b)
if and to the extent Stereotaxis reasonably deems necessary or advisable, agrees to permit Stereotaxis to publish and disclose, including
in filings with the SEC and in the press release announcing the transactions contemplated by the Purchase Agreement, this Agreement and
the Stockholders’ identity and ownership of the Shares and the nature of the Stockholders’ commitments, arrangements and
understandings under this Agreement, provided that to the extent practicable, the Stockholders
shall have a reasonable opportunity to review and approve such disclosure prior to any such announcement or disclosure;
(c)
acknowledges that such Stockholder has received and reviewed a copy of the Purchase Agreement and that Stereotaxis is entering into the
Purchase Agreement in reliance upon such Stockholder’s execution, delivery and performance of this Agreement;
(d)
agrees (i) not to take, agree or commit to take any action that would reasonably be expected to make any representation or warranty of
such Stockholder contained in this Agreement inaccurate in any respect as of any time during the term of the Agreement and (ii) to take
all reasonable action necessary to prevent any such representation or warranty from being inaccurate in any respect at any time;
(e)
agrees and acknowledges that, upon the reasonable request of Stereotaxis, such Stockholder shall execute and deliver any additional documents
and take, or cause to be taken, all actions, and to do, or cause to be done, all things as may reasonably be deemed by Stereotaxis to
be necessary or desirable to fulfill such Stockholder’s obligations under this Agreement;
(f)
shall and does authorize Stereotaxis or its counsel to notify the Company’s or NewCo’s transfer agent that there is a stop
transfer order with respect to all of the Shares and/or NewCo Shares (and that this Agreement places limits on the voting and transfer
of the Shares and NewCo Shares); provided that if Stereotaxis or its counsel gives such notification, Stereotaxis or its counsel
shall on the Expiration Date further notify the Company’s or NewCo (or their respective transfer agents, as the case may be) that
the stop transfer order (and all other restrictions) have terminated as of such date;
(g)
agrees that all Shares that Stockholder purchases, acquires the right to vote or otherwise acquires beneficial ownership of, after the
execution of this Agreement and prior to the Expiration Date shall be subject to the terms and conditions of this Agreement and shall
constitute Shares for all purposes of this Agreement. In the event of any stock split, stock dividend, merger, reorganization, recapitalization,
reclassification, combination, exchange of shares or the like of the capital stock of the Company or NewCo affecting the Shares or the
NewCo Shares, the terms of this Agreement shall apply to the resulting securities and such securities shall be deemed to be “Shares”
for all purposes of this Agreement; and
(h)
agrees that such Stockholder shall not bring, commence, institute, maintain, prosecute, join or voluntarily aid any Action in law or
in equity, in any court or before any Governmental Entity, which (i) challenges the validity of or seeks to enjoin the operation of any
provision of this Agreement or the Purchase Agreement or (ii) alleges that the execution and delivery of this Agreement by such Stockholder,
either alone or together with any other voting agreements and proxies to be delivered in connection with the execution of the Purchase
Agreement, or the approval of the Purchase Agreement by the Board of Directors of the Company, breaches any fiduciary duty of the Board
of Directors of the Company or any member thereof.
Article
IV
TERMINATION
4.1
Termination. This Agreement shall terminate without any further action by any Party and be of no further force or effect on
the Expiration Date, and no Party shall have any rights or obligations hereunder following the Expiration Date. Notwithstanding the preceding
sentence, this Section Article IV and Section Article V shall survive any termination of this Agreement. Nothing in this
Section 4 shall relieve or otherwise limit any Party of liability of any Willful Breach of this Agreement prior to the termination hereof.
Article
V
MISCELLANEOUS
PROVISIONS
5.1
Fiduciary Duties. Notwithstanding anything in this Agreement to the contrary, (i) no Stockholder makes any agreement or understanding
herein in any capacity other than in such Stockholder’s capacity as a beneficial owner of such Stockholder’s Shares and/or
NewCo Shares, (ii) nothing in this Agreement shall be construed to limit or affect any Stockholder’s rights and obligations as
a director or officer of the Company, and (iii) no Stockholder shall have any liability to Stereotaxis or any of their Affiliates under
this Agreement as a result of any action or inaction by such Stockholder acting in his or her capacity as a director or officer of the
Company.
5.2
Expenses. Whether or not the Transaction is consummated, all costs, expenses and fees (including attorneys’ fees, if
any) incurred in connection with the preparation, execution and delivery of this Agreement and compliance herewith, shall be paid by
the Party incurring or required to incur such expenses.
5.3
No Ownership Interest. Except as specifically provided herein, (a) all rights, ownership and economic benefits of and relating
to a Stockholder’s Shares and/or NewCo Shares shall remain vested in and belong to such Stockholder and (b) Stereotaxis shall not
have authority to exercise any power or authority to direct or control the voting or disposition of any Shares and/or NewCo Shares or
direct such Stockholder in the performance of its duties or responsibilities as a stockholder of the Company.
5.4
Notices. All notices and other communications hereunder shall be in writing and shall be deemed duly given (a) on the date
of receipt, if delivered personally, (b) on the date of receipt, if delivered by facsimile or e-mail during normal business hours on
a Business Day or, if delivered outside of normal business hours on a Business Day or on a day that is not a Business Day, on the first
Business Day thereafter, or (c) on the first Business Day following the date of dispatch if delivered utilizing a next-day service by
a recognized next-day courier. All notices hereunder shall be delivered to the addresses set forth below, or pursuant to such other instructions
as may be designated in writing by the Party to receive such notice:
If
to Stereotaxis, to:
710
North Tucker Boulevard, Suite 110
St.
Louis, Missouri 63101
|
Attention: |
David Fischel (david.fischel@stereotaxis.com) |
|
|
Kimberly Peery (kim.peery@stereotaxis.com) |
|
|
Laura Spencer Garth (laura.garth@stereotaxis.com) |
with
a copy (which shall not constitute notice) to:
Bryan
Cave Leighton Paisner
211 North Broadway, Suite 3600
St. Louis, MO 63102
Attention: Robert J. Endicott
Phone: (314) 259-2447
Email: rob.endicott@bclplaw.com
If
to Stockholder to:
The
address set forth on Schedule A
5.5
Amendments; Waivers. Any provision of this Agreement may be amended or waived if, and only if, such amendment or waiver is
in writing and signed (a) in the case of an amendment, by Stereotaxis and each Stockholder, and (b) in the case of a waiver, by the Party
(or Parties) against whom the waiver is to be effective. No failure or delay by any Party hereto in exercising any right, power or privilege
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or further exercise
thereof or the exercise of any other right, power or privilege.
5.6
Assignment. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned or delegated
(including by sale of stock, operation of applicable Law in connection with a merger or sale of substantially all the assets) by any
of the parties hereto without the prior written consent of the other parties, except that Stereotaxis may assign, in its sole discretion,
all or any of the rights, interests or obligations hereunder to any of its Affiliates. Any purported assignment inconsistent with this
Section 5.6 shall be null and void.
5.7
No Partnership, Agency or Joint Venture. This Agreement is intended to create, and creates, a contractual relationship and
is not intended to create, and does not create, any agency, partnership, joint venture or any like relationship between the parties hereto.
5.8
Entire Agreement. This Agreement (including Schedule A hereto), the proxy granted in Section 1.2, and,
to the extent referenced herein, the Purchase Agreement, constitute the entire agreement, and supersede all other prior and contemporaneous
agreements, understandings, undertakings, arrangements, representations and warranties, both written and oral, among the Parties with
respect to the subject matter hereof.
5.9
No Third-Party Beneficiaries. Each Stockholder and Stereotaxis agree that (a) its representations, warranties, covenants and
agreements set forth herein are solely for the benefit of Stereotaxis (in the case of a Stockholder) or each Stockholder (in the case
of Stereotaxis), in accordance with and subject to the terms of this Agreement, and (b) this Agreement is not intended to, and does not,
confer upon any Person other than the parties hereto any rights or remedies hereunder, including the right to rely upon the representations
and warranties set forth herein.
5.10
Governing Law; Waiver of Jury Trial. This Agreement and all disputes or controversies arising out of or relating to this Agreement
or the transactions contemplated hereby shall be governed by, and construed in accordance with, the internal laws of the State of Minnesota,
without regard to the laws of any other jurisdiction that might be applied because of the conflicts of laws principles of the State of
Minnesota.
Each
of the Parties hereto hereby irrevocably waives any and all right to trial by jury in any action or proceeding arising out of or related
to this Agreement or the transactions contemplated hereby.
5.11
Specific Performance; Remedies. Each of the Stockholders agrees and acknowledges that irreparable harm would occur in the
event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached.
Each of the Stockholders accordingly agrees that, without posting bond or other undertaking, Stereotaxis shall be entitled to seek injunctive
or other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement
in any court of competent jurisdiction, this being in addition to any other remedy to which they are entitled at law or in equity. In
the event that any such action is brought in equity to enforce the provisions of this Agreement, no Stockholder will allege, and each
Stockholder hereby waives the defense or counterclaim, that there is an adequate remedy at law.
5.12
Headings. Headings of the Sections of this Agreement are for convenience of the Parties only and shall be given no substantive
or interpretive effect whatsoever.
5.13
Interpretation. When a reference is made in this Agreement to a Section or Schedule, such reference shall be to a Section
or Schedule of this Agreement unless otherwise indicated. Whenever the words “include,” “includes” or “including”
are used in this Agreement, they shall be deemed to be followed by the words “without limitation.” The words “hereof,”
“herein” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement
as a whole and not to any particular provision of this Agreement, unless the context otherwise requires. The word “extent”
and the phrase “to the extent” when used in this Agreement shall mean the degree to which a subject or other thing extends,
and such word or phrase shall not mean simply “if”. The definitions contained in this Agreement are applicable to the singular
as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such term. References
in this Agreement to specific laws or to specific provisions of laws shall include all rules and regulations promulgated thereunder,
and any statute defined or referred to herein or in any agreement or instrument referred to herein shall mean such statute as from time
to time amended, modified or supplemented, including by succession of comparable successor statutes. Each of the Parties has participated
in the drafting and negotiation of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement must
be construed as if it is drafted by all the parties, and no presumption or burden of proof shall arise favoring or disfavoring any Party
by virtue of authorship of any of the provisions of this Agreement.
5.14
Counterparts. This Agreement may be signed in any number of counterparts, each of which shall be an original, with the same
effect as if the signatures thereto and hereto were upon the same instrument. This Agreement shall become effective when each Party hereto
shall have received a counterpart hereof signed by all of the other Parties hereto. Until and unless each Party hereto has received a
counterpart hereof signed by each other Party hereto, this Agreement shall have no effect and no Party shall have any right or obligation
hereunder (whether by virtue of any other oral or written agreement or other communication). Signatures to this Agreement transmitted
by facsimile transmission, by electronic mail in PDF form, or by any other electronic means designed to preserve the original graphic
and pictorial appearance of a document, will be deemed to have the same effect as physical delivery of the paper document bearing the
original signatures.
5.15
Severability. Any term or provision of this Agreement which is invalid or unenforceable in any jurisdiction shall, as to that
jurisdiction, be ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining
terms and provisions of this Agreement in any other jurisdiction. If any provision of this Agreement is so broad as to be unenforceable,
such provision shall be interpreted to be only so broad as is unenforceable and a suitable and equitable provision shall be substituted
therefor in order to carry out, so far as may be valid and enforceable, the intent and purpose of such invalid or unenforceable provision.
5.16
No Agreement Until Executed. Irrespective of negotiations among the Parties or the exchanging of drafts of this Agreement,
this Agreement shall not constitute or be deemed to evidence a contract, agreement, arrangement or understanding between the Parties
hereto unless and until the Purchase Agreement is executed by all Parties thereto.
(The
remainder of this page is intentionally left blank; signature pages follow)
IN
WITNESS WHEREOF, the Parties to this Agreement have caused this Agreement to be duly executed as of the date first written above.
|
STEREOTAXIS: |
|
|
|
|
STEREOTAXIS,
INC. |
|
|
|
|
By: |
|
|
Name: |
David
Fischel |
|
Title:
|
Chief
Executive Officer |
[Stereotaxis
Signature Page to Voting and Support Agreement]
IN
WITNESS WHEREOF, the Parties to this Agreement have caused this Agreement to be duly executed as of the date first written above.
|
STOCKHOLDERS: |
|
|
|
|
|
Name:
Steven Berhow |
|
|
|
|
|
Name:
Corey L. Teigen |
|
|
|
|
|
Name:
Timothy S. Hanson |
Exhibit
2.2
AMENDMENT
NO. 1 TO
SHARE
PURCHASE AGREEMENT
THIS
AMENDMENT NO. 1 TO SHARE PURCHASE AGREEMENT (this “Amendment”), dated as of July 31, 2024, is entered into by and
among Stereotaxis, Inc., a Delaware corporation (“Purchaser”); Access Point Technologies EP, Inc., a Minnesota corporation
(the “Company”); and APT Holding Company, Inc., a Minnesota corporation (“Seller”). Purchaser,
Seller and the Company are referred to in this Agreement collectively as the “Parties,” and individually as a “Party.”
Capitalized terms that are used but not otherwise defined herein shall have the meanings ascribed to such terms in the Agreement (as
defined below).
RECITALS:
WHEREAS,
the Parties entered into that certain Share Purchase Agreement, dated as of May 11, 2024 (the “Agreement”).
WHEREAS,
pursuant to the Agreement, in exchange for all the issued and outstanding Equity Securities of the Company, Seller is entitled to receive
(i) shares of Purchaser Common Stock with a value of $3,000,000, calculated as set forth in the Agreement (the “Upfront Stock
Consideration”), and (ii) if and when earned in accordance with the Agreement, a series of earnout payments based on the achievement
of revenue performance and regulatory milestones described in the Agreement, deliverable in the form of a number of shares of
Purchaser Common Stock to be determined and calculated in accordance with the Agreement, rounded down to the nearest whole share (“Earnout
Consideration”);
WHEREAS,
in connection with the Debt Restructuring contemplated by the Agreement, Seller has agreed, pursuant to a Commercial Security Agreement
dated on or about the date hereof (the “Commercial Security Agreement”), to grant a security interest in the Purchaser
Common Stock deliverable thereunder to secure all loans from First Western Bank & Trust (“FWBT”) being assumed
by Seller;
WHEREAS,
in order to facilitate the Debt Restructuring and the perfecting of such security interest under the Commercial Security Agreement, Seller
and FWBT have requested that Purchaser direct its transfer agent to issue the Upfront Stock Consideration and any Earnout Consideration
in the form of and represented by a physical stock certificate registered in the name of Seller issued by Purchaser’s transfer
agent on Purchaser’s behalf and delivered to FWBT, as directed by FWBT and set forth below; and
WHEREAS,
the Parties desire to amend the terms of the Agreement as set forth herein.
IN
CONSIDERATION OF THE FOREGOING RECITALS AND THE MUTUAL PROMISES, covenants and conditions herein contained, the receipt and sufficiency
of which are hereby acknowledged, the parties hereto do hereby covenant and agree as follows:
AMENDMENT:
1.
The preamble of the Agreement is hereby amended by correcting the name of the Company to “Access Point Technologies EP, Inc.”
(replacing “Access Point Technologies, Inc.).
2.
Section 3.3 of the Agreement is hereby deleted in its entirety and replaced with the following:
“Delivery
by Purchaser of Consideration at Closing. At the Closing, Purchaser shall issue to Seller the Upfront Stock Consideration by
delivering to Seller a copy of the duly executed issuance instruction letter (the “Transfer Instructions”) to Broadridge
Financial Solutions, Inc. (the “Transfer Agent”) instructing the Transfer Agent to issue, via physical certificate,
a number of shares of Purchaser Common Stock equal to the Upfront Stock Consideration due at Closing, duly registered in the name of
Seller. Purchaser shall also (i) deliver to FWBT a copy of the Transfer Instructions, which shall direct the Transfer Agent to deliver
the physical certificate to First Western Bank & Trust, Attn: Thomas Stromme, 855 26th Ave E, West Fargo, ND 58078 via oversight
mail, (ii) use Commercially Reasonable Efforts to obtain a tracking number therefor and (iii) request that the Transfer Agent provide
an individual shareholder summary, showing the issuance of the shares, holder’s name, address of record, and Broadridge account
number, and reflecting such physical delivery request, or such other reasonable record of issuing such shares as the Transfer Agent is
willing to provide.”
3.
All references to delivery of Earnout Consideration as described and set forth in the Agreement (including Section 2.5(c)(viii) and 2.5(g)
thereof) are hereby modified to require that Purchaser to provide for delivery such Earnout Consideration via one or more physical certificates
through its Transfer Agent in the same manner as described in Section 2 above, unless and until (i) FWBT confirms in writing to Purchaser
that the security interest in the Purchaser Common Stock delivered or deliverable under this Agreement has been terminated or (ii) FWBT
provides other direction in writing to Purchaser to deliver such shares in a customary and reasonable fashion (including without limitation
to a secured collateral brokerage account in favor of FWBT). Such modification shall be deemed to modify solely the delivery mechanism
for any such Earnout Consideration and shall not be deemed to modify any of the other terms, conditions or entitlement to such Earnout
Consideration, which shall remain as set forth in the Agreement.
4.
The Parties acknowledge and agree that FWBT is an intended third-party beneficiary of this Amendment.
5.
This Amendment shall be deemed a part of the Agreement and together with the Agreement (as amended hereby), contains the entire agreement
of the Parties with respect to the amendment contemplated hereby and thereby and supersedes all prior written and oral agreements, and
all contemporaneous oral agreements, relating to such amendment. All provisions set forth in Article XIII of the Agreement shall apply
to this Amendment as if fully set forth herein. The Agreement (as amended hereby) remains in full force and effect and is hereby ratified
and confirmed by the parties in all respects and any references to the Agreement shall hereafter be deemed to mean the Agreement as amended
hereby.
[signature
page follows]
IN
WITNESS WHEREOF, the parties have caused this Amendment Not 1. to Share Agreement to be duly executed as of the date first above
written.
|
PURCHASER: |
|
|
|
|
STEREOTAXIS, INC. |
|
|
|
|
By: |
/s/
David Fischel |
|
Name: |
David Fischel |
|
Title: |
Chief Executive Officer |
|
|
|
|
COMPANY: |
|
|
|
|
Access Point Technologies EP,
Inc. |
|
|
|
|
By: |
/s/ Steven
Berhow |
|
Name: |
Steven Berhow |
|
Title: |
Chief Executive Officer |
|
|
|
|
SELLER: |
|
|
|
|
APT HOLDING COMPANY, INC. |
|
|
|
|
By: |
/s/ Steven
Berhow |
|
Name: |
Steven Berhow |
|
Title: |
Chief Executive Officer |
[Signature
Page to Amendment No. 1 to Share Purchase Agreement]
Exhibit
31.1
Certification
of Principal Executive Officer
I,
David L. Fischel, certify that:
1. |
I
have reviewed this quarterly report on Form 10-Q of Stereotaxis, Inc.; |
|
|
2. |
Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
the period covered by this report; |
|
|
3. |
Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in
this report; |
|
|
4. |
The
registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
Act Rules 13a – 15(f) and 15d – 15(f)) for the registrant and have: |
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s
most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal
control over financial reporting; and
5. |
The
registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing
the equivalent functions): |
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information;
and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s
internal control over financial reporting.
Date:
August 14, 2024 |
/s/
David L. Fischel |
|
David
L. Fischel |
|
Chief
Executive Officer |
|
Stereotaxis,
Inc. |
|
(Principal
Executive Officer) |
Exhibit
31.2
Certification
of Principal Financial Officer
I,
Kimberly R. Peery, certify that:
1. |
I
have reviewed this quarterly report on Form 10-Q of Stereotaxis, Inc.; |
|
|
2. |
Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
the period covered by this report; |
|
|
3. |
Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in
this report; |
|
|
4. |
The
registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
Act Rules 13a – 15(f) and 15d – 15(f)) for the registrant and have: |
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s
most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal
control over financial reporting; and
5. |
The
registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing
the equivalent functions): |
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information;
and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s
internal control over financial reporting.
Date:
August 14, 2024 |
/s/
Kimberly R. Peery |
|
Kimberly
R. Peery |
|
Chief
Financial Officer |
|
Stereotaxis,
Inc. |
|
(Principal
Financial Officer) |
Exhibit
32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the quarterly report of Stereotaxis, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2024
as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David L. Fischel, Chief Executive
Officer of the Company, certify, pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.
Date:
August 14, 2024 |
/s/
David L. Fischel |
|
David
L. Fischel |
|
Chief
Executive Officer |
|
Stereotaxis,
Inc. |
Exhibit
32.2
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the quarterly report of Stereotaxis, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2024
as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kimberly R. Peery, Chief Financial
Officer of the Company, certify, pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.
Date:
August 14, 2024 |
/s/
Kimberly R. Peery |
|
Kimberly
R. Peery |
|
Chief
Financial Officer |
|
Stereotaxis,
Inc. |
v3.24.2.u1
Cover - shares
|
6 Months Ended |
|
Jun. 30, 2024 |
Jul. 31, 2024 |
Cover [Abstract] |
|
|
Document Type |
10-Q
|
|
Amendment Flag |
false
|
|
Document Quarterly Report |
true
|
|
Document Transition Report |
false
|
|
Document Period End Date |
Jun. 30, 2024
|
|
Document Fiscal Period Focus |
Q2
|
|
Document Fiscal Year Focus |
2024
|
|
Current Fiscal Year End Date |
--12-31
|
|
Entity File Number |
001-36159
|
|
Entity Registrant Name |
STEREOTAXIS,
INC.
|
|
Entity Central Index Key |
0001289340
|
|
Entity Tax Identification Number |
94-3120386
|
|
Entity Incorporation, State or Country Code |
DE
|
|
Entity Address, Address Line One |
710
North Tucker Boulevard
|
|
Entity Address, Address Line Two |
Suite 110
|
|
Entity Address, City or Town |
St.
Louis
|
|
Entity Address, State or Province |
MO
|
|
Entity Address, Postal Zip Code |
63101
|
|
City Area Code |
(314)
|
|
Local Phone Number |
678-6100
|
|
Title of 12(b) Security |
Common
Stock, par value $0.001 per share
|
|
Trading Symbol |
STXS
|
|
Security Exchange Name |
NYSEAMER
|
|
Entity Current Reporting Status |
Yes
|
|
Entity Interactive Data Current |
Yes
|
|
Entity Filer Category |
Non-accelerated Filer
|
|
Entity Small Business |
true
|
|
Entity Emerging Growth Company |
false
|
|
Entity Shell Company |
false
|
|
Entity Common Stock, Shares Outstanding |
|
84,656,254
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionEnd date of current fiscal year in the format --MM-DD.
+ References
+ Details
Name: |
dei_CurrentFiscalYearEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:gMonthDayItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.
+ References
+ Details
Name: |
dei_DocumentFiscalPeriodFocus |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fiscalPeriodItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThis is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
+ Details
Name: |
dei_DocumentFiscalYearFocus |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:gYearItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true only for a form used as an quarterly report.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Form 10-Q -Number 240 -Section 308 -Subsection a
+ Details
Name: |
dei_DocumentQuarterlyReport |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true only for a form used as a transition report.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Forms 10-K, 10-Q, 20-F -Number 240 -Section 13 -Subsection a-1
+ Details
Name: |
dei_DocumentTransitionReport |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
+ Details
Name: |
dei_EntityCommonStockSharesOutstanding |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionIndicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
+ Details
Name: |
dei_EntityCurrentReportingStatus |
Namespace Prefix: |
dei_ |
Data Type: |
dei:yesNoItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityFilerCategory |
Namespace Prefix: |
dei_ |
Data Type: |
dei:filerCategoryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-T -Number 232 -Section 405
+ Details
Name: |
dei_EntityInteractiveDataCurrent |
Namespace Prefix: |
dei_ |
Data Type: |
dei:yesNoItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityShellCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicates that the company is a Smaller Reporting Company (SRC).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntitySmallBusiness |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Balance Sheets - USD ($) $ in Thousands |
Jun. 30, 2024 |
Dec. 31, 2023 |
Current assets: |
|
|
Cash and cash equivalents |
$ 14,683
|
$ 19,818
|
Restricted cash - current |
481
|
525
|
Accounts receivable, net of allowance of $640 and $672 at 2024 and 2023, respectively |
2,782
|
3,822
|
Inventories, net |
9,284
|
8,426
|
Prepaid expenses and other current assets |
842
|
676
|
Total current assets |
28,072
|
33,267
|
Property and equipment, net |
3,059
|
3,304
|
Restricted cash |
|
219
|
Operating lease right-of-use assets |
4,767
|
4,982
|
Prepaid and other non-current assets |
116
|
137
|
Total assets |
36,014
|
41,909
|
Current liabilities: |
|
|
Accounts payable |
4,146
|
3,190
|
Accrued liabilities |
2,698
|
2,972
|
Deferred revenue |
4,950
|
6,657
|
Current portion of operating lease liabilities |
458
|
428
|
Total current liabilities |
12,252
|
13,247
|
Long-term deferred revenue |
2,121
|
1,637
|
Operating lease liabilities |
4,823
|
5,062
|
Other liabilities |
54
|
43
|
Total liabilities |
19,250
|
19,989
|
Series A - Convertible preferred stock: |
|
|
Convertible preferred stock, Series A, par value $0.001; 10,000,000 shares authorized, 21,683 and 22,358 shares outstanding at 2024 and 2023, respectively |
5,408
|
5,577
|
Stockholders’ equity: |
|
|
Common stock, par value $0.001; 300,000,000 shares authorized, 82,990,159 and 80,949,697 shares issued at 2024 and 2023, respectively |
83
|
81
|
Additional paid in capital |
559,499
|
554,148
|
Treasury stock, 4,015 shares at 2024 and 2023 |
(206)
|
(206)
|
Accumulated deficit |
(548,020)
|
(537,680)
|
Total stockholders’ equity |
11,356
|
16,343
|
Total liabilities and stockholders’ equity |
$ 36,014
|
$ 41,909
|
X |
- DefinitionCarrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(19)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10
+ Details
Name: |
us-gaap_AccountsPayableCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2
+ Details
Name: |
us-gaap_AccountsReceivableNetCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionCarrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_AccruedLiabilitiesCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(18)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)(a)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_AdditionalPaidInCapital |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of asset recognized for present right to economic benefit.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 49 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32
Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (bb) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28
Reference 12: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10
Reference 13: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(12)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(8)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(18)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7
Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30
Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(11)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1
+ Details
Name: |
us-gaap_Assets |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of asset recognized for present right to economic benefit, classified as current.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (bb) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28
Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7
+ Details
Name: |
us-gaap_AssetsCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_AssetsCurrentAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4
+ Details
Name: |
us-gaap_CashAndCashEquivalentsAtCarryingValue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(22)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1
+ Details
Name: |
us-gaap_CommonStockValue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2
+ Details
Name: |
us-gaap_ContractWithCustomerLiabilityCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2
+ Details
Name: |
us-gaap_ContractWithCustomerLiabilityNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_InventoryNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)) -SubTopic 10 -Topic 210 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(24)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(19)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(25)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(26)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(23)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(21)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (bb) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28
Reference 15: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(14)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7
Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7
Reference 29: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30
+ Details
Name: |
us-gaap_Liabilities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(25)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1
Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3
Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(23)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1
Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(32)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_LiabilitiesAndStockholdersEquity |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionTotal obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(21)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (bb) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28
Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7
Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7
+ Details
Name: |
us-gaap_LiabilitiesCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_LiabilitiesCurrentAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionPresent value of lessee's discounted obligation for lease payments from operating lease, classified as current.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1
+ Details
Name: |
us-gaap_OperatingLeaseLiabilityCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionPresent value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1
+ Details
Name: |
us-gaap_OperatingLeaseLiabilityNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's right to use underlying asset under operating lease.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1
+ Details
Name: |
us-gaap_OperatingLeaseRightOfUseAsset |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(24)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_OtherLiabilitiesNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_PrepaidExpenseAndOtherAssetsCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(10)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(18)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 360 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A
Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(8)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 360 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8
+ Details
Name: |
us-gaap_RestrictedCashCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(17)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 45 -Paragraph 5 -SubTopic 210 -Topic 954 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8
+ Details
Name: |
us-gaap_RestrictedCashNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of accumulated undistributed earnings (deficit).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)(a)(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(23)(a)(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(17)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1
Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1
+ Details
Name: |
us-gaap_RetainedEarningsAccumulatedDeficit |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(31)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10
Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(19)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.6-05(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2
Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3
Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1
Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3
Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28
Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 4.E) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2
+ Details
Name: |
us-gaap_StockholdersEquity |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_StockholdersEquityAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_TemporaryEquityAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCarrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(23)(a)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.E.Q2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
+ Details
Name: |
us-gaap_TemporaryEquityCarryingAmountAttributableToParent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1
+ Details
Name: |
us-gaap_TreasuryStockCommonValue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
v3.24.2.u1
Balance Sheets (Parenthetical) - USD ($) $ in Thousands |
Jun. 30, 2024 |
Dec. 31, 2023 |
Statement of Financial Position [Abstract] |
|
|
Accounts receivable, allowance |
$ 640
|
$ 672
|
Series A convertible preferred stock, par value |
$ 0.001
|
$ 0.001
|
Series A convertible preferred stock, shares authorized |
10,000,000
|
10,000,000
|
Series A convertible preferred stock, shares outstanding |
21,683
|
22,358
|
Common stock, par value |
$ 0.001
|
$ 0.001
|
Common stock, shares authorized |
300,000,000
|
300,000,000
|
Common stock, shares issued |
82,990,159
|
80,949,697
|
Treasury stock, shares |
4,015
|
4,015
|
X |
- DefinitionAmount of allowance for credit loss on accounts receivable, classified as current.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4
+ Details
Name: |
us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionFace amount or stated value per share of common stock.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_CommonStockParOrStatedValuePerShare |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionThe maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(16)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1
+ Details
Name: |
us-gaap_CommonStockSharesAuthorized |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionTotal number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_CommonStockSharesIssued |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_StatementOfFinancialPositionAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionPer share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(27)) -SubTopic 10 -Topic 210 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 480 -SubTopic 10 -Section S99 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1
+ Details
Name: |
us-gaap_TemporaryEquityParOrStatedValuePerShare |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionThe maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(27)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_TemporaryEquitySharesAuthorized |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionThe number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(27)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_TemporaryEquitySharesOutstanding |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionNumber of previously issued common shares repurchased by the issuing entity and held in treasury.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1
+ Details
Name: |
us-gaap_TreasuryStockCommonShares |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
v3.24.2.u1
Statements of Operations (Unaudited) - USD ($) $ in Thousands |
3 Months Ended |
6 Months Ended |
Jun. 30, 2024 |
Jun. 30, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
Revenue: |
|
|
|
|
Total revenue |
$ 4,502
|
$ 7,859
|
$ 11,382
|
$ 14,407
|
Cost of revenue: |
|
|
|
|
Total cost of revenue |
1,189
|
3,672
|
4,103
|
6,344
|
Gross margin |
3,313
|
4,187
|
7,279
|
8,063
|
Operating expenses: |
|
|
|
|
Research and development |
2,273
|
2,647
|
4,516
|
5,393
|
Sales and marketing |
3,301
|
3,340
|
6,304
|
6,488
|
General and administrative |
3,760
|
3,477
|
7,226
|
7,078
|
Total operating expenses |
9,334
|
9,464
|
18,046
|
18,959
|
Operating loss |
(6,021)
|
(5,277)
|
(10,767)
|
(10,896)
|
Other income (expense) |
(3)
|
27
|
(3)
|
27
|
Interest income, net |
191
|
293
|
430
|
565
|
Net loss |
(5,833)
|
(4,957)
|
(10,340)
|
(10,304)
|
Cumulative dividend on convertible preferred stock |
(325)
|
(335)
|
(656)
|
(666)
|
Net loss attributable to common stockholders |
$ (6,158)
|
$ (5,292)
|
$ (10,996)
|
$ (10,970)
|
Net loss per share attributable to common stockholders: |
|
|
|
|
Basic |
$ (0.07)
|
$ (0.07)
|
$ (0.13)
|
$ (0.14)
|
Diluted |
$ (0.07)
|
$ (0.07)
|
$ (0.13)
|
$ (0.14)
|
Weighted average number of common shares and equivalents: |
|
|
|
|
Basic |
84,570,738
|
81,049,211
|
84,025,335
|
78,787,652
|
Diluted |
84,570,738
|
81,049,211
|
84,025,335
|
78,787,652
|
Systems [Member] |
|
|
|
|
Revenue: |
|
|
|
|
Total revenue |
$ 240
|
$ 3,313
|
$ 2,852
|
$ 5,134
|
Cost of revenue: |
|
|
|
|
Total cost of revenue |
187
|
2,703
|
2,087
|
4,400
|
Disposables Service and Accessories [Member] |
|
|
|
|
Revenue: |
|
|
|
|
Total revenue |
4,262
|
4,546
|
8,530
|
9,273
|
Cost of revenue: |
|
|
|
|
Total cost of revenue |
$ 1,002
|
$ 969
|
$ 2,016
|
$ 1,944
|
X |
- DefinitionThe aggregate cost of goods produced and sold and services rendered during the reporting period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
+ Details
Name: |
us-gaap_CostOfRevenue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_CostOfRevenueAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_EarningsPerShareAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 52 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (e)(4) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(25)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(27)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(23)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7
+ Details
Name: |
us-gaap_EarningsPerShareBasic |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 52 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (e)(4) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(25)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(27)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(23)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7
+ Details
Name: |
us-gaap_EarningsPerShareDiluted |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(2)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1
+ Details
Name: |
us-gaap_GeneralAndAdministrativeExpense |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32
Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30
Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1
Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32
Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32
Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2
Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 23: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31
+ Details
Name: |
us-gaap_GrossProfit |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of interest income (expense) classified as operating.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(10)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1
+ Details
Name: |
us-gaap_InterestIncomeExpenseNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4
Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 32: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B
Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7
Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28
Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A
Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B
Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1
+ Details
Name: |
us-gaap_NetIncomeLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 5 -Subparagraph (SAB Topic 6.B) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B
+ Details
Name: |
us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionGenerally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
+ Details
Name: |
us-gaap_OperatingExpenses |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_OperatingExpensesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe net result for the period of deducting operating expenses from operating revenues.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30
Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1
Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32
Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32
Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31
+ Details
Name: |
us-gaap_OperatingIncomeLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of income (expense) related to nonoperating activities, classified as other.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2
+ Details
Name: |
us-gaap_OtherNonoperatingIncomeExpense |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.
+ References
+ Details
Name: |
us-gaap_PreferredStockDividendsIncomeStatementImpact |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 985 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 730 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1
Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 912 -SubTopic 730 -Name Accounting Standards Codification -Section 25 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1
+ Details
Name: |
us-gaap_ResearchAndDevelopmentExpense |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32
Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32
Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 924 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4
+ Details
Name: |
us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_RevenuesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe aggregate total amount of expenses directly related to the marketing or selling of products or services.
+ References
+ Details
Name: |
us-gaap_SellingAndMarketingExpense |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 16 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16
+ Details
Name: |
us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionNumber of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10
+ Details
Name: |
us-gaap_WeightedAverageNumberOfSharesOutstandingBasic |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
srt_ProductOrServiceAxis=STXS_SystemsMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_ProductOrServiceAxis=STXS_DisposablesServiceAndAccessoriesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.24.2.u1
Statements of Convertible Preferred Stock and Stockholders' Equity (Unaudited) - USD ($) $ in Thousands |
Convertible Preferred Stock Series A [Member] |
Convertible Preferred Stock Series B [Member] |
Common Stock [Member] |
Additional Paid-in Capital [Member] |
Treasury Stock, Common [Member] |
Retained Earnings [Member] |
Total |
Balance at Dec. 31, 2022 |
$ 5,583
|
$ 6
|
$ 75
|
$ 543,438
|
$ (206)
|
$ (516,967)
|
$ 26,346
|
Balance, shares at Dec. 31, 2022 |
22,383
|
5,610,121
|
74,874,459
|
|
|
|
|
Stock issued for the exercise of stock options |
|
|
|
(18)
|
|
|
(18)
|
Stock issued for the exercise of stock options, shares |
|
|
29,384
|
|
|
|
|
Stock-based compensation |
|
|
|
5,314
|
|
|
5,314
|
Stock-based compensation, shares |
|
|
144,054
|
|
|
|
|
Components of net loss |
|
|
|
|
|
(10,304)
|
(10,304)
|
Employee stock purchase plan |
|
|
|
48
|
|
|
48
|
Employee stock purchase plan, shares |
|
|
24,568
|
|
|
|
|
Preferred stock conversion |
|
$ (6)
|
$ 6
|
|
|
|
|
Preferred stock conversion, shares |
|
(5,610,121)
|
5,610,121
|
|
|
|
|
Balance at Jun. 30, 2023 |
$ 5,583
|
|
$ 81
|
548,782
|
(206)
|
(527,271)
|
21,386
|
Balance, shares at Jun. 30, 2023 |
22,383
|
|
80,682,586
|
|
|
|
|
Balance at Mar. 31, 2023 |
$ 5,583
|
$ 6
|
$ 75
|
546,149
|
(206)
|
(522,314)
|
23,710
|
Balance, shares at Mar. 31, 2023 |
22,383
|
5,610,121
|
75,059,499
|
|
|
|
|
Stock issued for the exercise of stock options |
|
|
|
(52)
|
|
|
(52)
|
Stock issued for the exercise of stock options, shares |
|
|
196
|
|
|
|
|
Stock-based compensation |
|
|
|
2,660
|
|
|
2,660
|
Stock-based compensation, shares |
|
|
|
|
|
|
|
Components of net loss |
|
|
|
|
|
(4,957)
|
(4,957)
|
Employee stock purchase plan |
|
|
|
25
|
|
|
25
|
Employee stock purchase plan, shares |
|
|
12,770
|
|
|
|
|
Preferred stock conversion |
|
$ (6)
|
$ 6
|
|
|
|
|
Preferred stock conversion, shares |
|
(5,610,121)
|
5,610,121
|
|
|
|
|
Balance at Jun. 30, 2023 |
$ 5,583
|
|
$ 81
|
548,782
|
(206)
|
(527,271)
|
21,386
|
Balance, shares at Jun. 30, 2023 |
22,383
|
|
80,682,586
|
|
|
|
|
Balance at Dec. 31, 2023 |
$ 5,577
|
|
$ 81
|
554,148
|
(206)
|
(537,680)
|
16,343
|
Balance, shares at Dec. 31, 2023 |
22,358
|
|
80,949,697
|
|
|
|
|
Stock issued for the exercise of stock options |
|
|
|
12
|
|
|
12
|
Stock issued for the exercise of stock options, shares |
|
|
11,763
|
|
|
|
|
Stock-based compensation |
|
|
|
5,127
|
|
|
5,127
|
Stock-based compensation, shares |
|
|
504,375
|
|
|
|
|
Components of net loss |
|
|
|
|
|
(10,340)
|
(10,340)
|
Employee stock purchase plan |
|
|
|
46
|
|
|
46
|
Employee stock purchase plan, shares |
|
|
23,022
|
|
|
|
|
Preferred stock conversion |
$ (169)
|
|
$ 2
|
166
|
|
|
168
|
Preferred stock conversion, shares |
(675)
|
|
1,501,302
|
|
|
|
|
Balance at Jun. 30, 2024 |
$ 5,408
|
|
$ 83
|
559,499
|
(206)
|
(548,020)
|
11,356
|
Balance, shares at Jun. 30, 2024 |
21,683
|
|
82,990,159
|
|
|
|
|
Balance at Mar. 31, 2024 |
$ 5,464
|
|
$ 82
|
556,878
|
(206)
|
(542,187)
|
14,567
|
Balance, shares at Mar. 31, 2024 |
21,908
|
|
82,132,777
|
|
|
|
|
Stock issued for the exercise of stock options |
|
|
|
4
|
|
|
4
|
Stock issued for the exercise of stock options, shares |
|
|
2,213
|
|
|
|
|
Stock-based compensation |
|
|
|
2,538
|
|
|
2,538
|
Stock-based compensation, shares |
|
|
342,901
|
|
|
|
|
Components of net loss |
|
|
|
|
|
(5,833)
|
(5,833)
|
Employee stock purchase plan |
|
|
|
24
|
|
|
24
|
Employee stock purchase plan, shares |
|
|
9,634
|
|
|
|
|
Preferred stock conversion |
$ (56)
|
|
$ 1
|
55
|
|
|
56
|
Preferred stock conversion, shares |
(225)
|
|
502,634
|
|
|
|
|
Balance at Jun. 30, 2024 |
$ 5,408
|
|
$ 83
|
$ 559,499
|
$ (206)
|
$ (548,020)
|
$ 11,356
|
Balance, shares at Jun. 30, 2024 |
21,683
|
|
82,990,159
|
|
|
|
|
X |
- DefinitionThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4
Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 32: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B
Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7
Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28
Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A
Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B
Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1
+ Details
Name: |
us-gaap_NetIncomeLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionNumber of shares issued which are neither cancelled nor held in the treasury.
+ References
+ Details
Name: |
us-gaap_SharesOutstanding |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionNumber of shares issued during the period as a result of the conversion of convertible securities.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1E -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionNumber of shares issued during the period as a result of an employee stock purchase plan.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionNumber of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
+ References
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodSharesIssuedForServices |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionNumber of share options (or share units) exercised during the current period.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(02) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe gross value of stock issued during the period upon the conversion of convertible securities.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(31)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAggregate change in value for stock issued during the period as a result of employee stock purchase plan.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionValue of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.
+ References
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodValueIssuedForServices |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionValue of stock issued as a result of the exercise of stock options.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(31)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(31)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10
Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(19)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.6-05(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2
Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3
Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1
Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3
Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28
Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 4.E) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2
+ Details
Name: |
us-gaap_StockholdersEquity |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
v3.24.2.u1
Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands |
3 Months Ended |
6 Months Ended |
Jun. 30, 2024 |
Jun. 30, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
Cash flows from operating activities |
|
|
|
|
Net loss |
$ (5,833)
|
$ (4,957)
|
$ (10,340)
|
$ (10,304)
|
Adjustments to reconcile net loss to cash used in operating activities: |
|
|
|
|
Depreciation |
|
|
276
|
310
|
Non-cash lease expense |
|
|
6
|
16
|
Stock-based compensation |
|
|
5,127
|
5,314
|
Accretion and short-term investment discount |
|
|
|
(287)
|
Changes in operating assets and liabilities: |
|
|
|
|
Accounts receivable |
|
|
1,040
|
(1,555)
|
Inventories |
|
|
(858)
|
173
|
Prepaid expenses and other current assets |
|
|
(166)
|
217
|
Other assets |
|
|
21
|
54
|
Accounts payable |
|
|
946
|
(143)
|
Accrued liabilities |
|
|
(274)
|
(386)
|
Deferred revenue |
|
|
(1,223)
|
866
|
Other liabilities |
|
|
11
|
(8)
|
Net cash used in operating activities |
|
|
(5,434)
|
(5,733)
|
Cash flows from investing activities |
|
|
|
|
Purchase of property and equipment |
|
|
(22)
|
(356)
|
Proceeds from maturity of short-term investments |
|
|
|
20,131
|
Net cash (used in) provided by investing activities |
|
|
(22)
|
19,775
|
Cash flows from financing activities |
|
|
|
|
Proceeds from issuance of stock, net of issuance costs |
|
|
58
|
30
|
Net cash provided by financing activities |
|
|
58
|
30
|
Net (decrease) increase in cash, cash equivalents, and restricted cash |
|
|
(5,398)
|
14,072
|
Cash, cash equivalents, and restricted cash at beginning of period |
|
|
20,562
|
9,855
|
Cash, cash equivalents, and restricted cash at end of period |
15,164
|
23,927
|
15,164
|
23,927
|
Supplemental disclosure of cash flow information: |
|
|
|
|
Purchase of property and equipment included in accounts payable |
|
|
10
|
17
|
Reconciliation of cash, cash equivalents, and restricted cash to balance sheet as of June 30th: |
|
|
|
|
Cash and cash equivalents |
14,683
|
22,877
|
14,683
|
22,877
|
Restricted cash - current |
481
|
569
|
481
|
569
|
Restricted cash |
|
481
|
|
481
|
Total cash, cash equivalents, and restricted cash |
$ 15,164
|
$ 23,927
|
$ 15,164
|
$ 23,927
|
X |
- DefinitionOperating lease expense income.
+ References
+ Details
Name: |
STXS_OperatingLeaseExpenseIncome |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionPurchases of property and equipment included in accounts payable and accrued liabilities.
+ References
+ Details
Name: |
STXS_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4
+ Details
Name: |
us-gaap_CashAndCashEquivalentsAtCarryingValue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4
+ Details
Name: |
us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 1 -SubTopic 230 -Topic 830 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1
+ Details
Name: |
us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1
+ Details
Name: |
us-gaap_Depreciation |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_IncreaseDecreaseInAccountsPayable |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_IncreaseDecreaseInAccountsReceivable |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_IncreaseDecreaseInAccruedLiabilities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 912 -SubTopic 310 -Name Accounting Standards Codification -Section 45 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_IncreaseDecreaseInContractWithCustomerLiability |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_IncreaseDecreaseInInventories |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_IncreaseDecreaseInOperatingCapitalAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of increase (decrease) in operating assets classified as other.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_IncreaseDecreaseInOtherOperatingAssets |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of increase (decrease) in operating liabilities classified as other.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_IncreaseDecreaseInOtherOperatingLiabilities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of increase (decrease) in prepaid expenses, and assets classified as other.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24
+ Details
Name: |
us-gaap_NetCashProvidedByUsedInFinancingActivities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24
+ Details
Name: |
us-gaap_NetCashProvidedByUsedInInvestingActivities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25
+ Details
Name: |
us-gaap_NetCashProvidedByUsedInOperatingActivities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4
Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 32: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B
Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7
Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28
Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A
Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B
Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1
+ Details
Name: |
us-gaap_NetIncomeLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 25 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 30 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 30 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 45 -Paragraph 13 -Subparagraph (c) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13
+ Details
Name: |
us-gaap_PaymentsToAcquireProductiveAssets |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe cash inflow from the additional capital contribution to the entity.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14
+ Details
Name: |
us-gaap_ProceedsFromIssuanceOfCommonStock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12
+ Details
Name: |
us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4
+ Details
Name: |
us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8
+ Details
Name: |
us-gaap_RestrictedCashCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(17)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 45 -Paragraph 5 -SubTopic 210 -Topic 954 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8
+ Details
Name: |
us-gaap_RestrictedCashNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of noncash expense for share-based payment arrangement.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_ShareBasedCompensation |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
v3.24.2.u1
Description of Business
|
6 Months Ended |
Jun. 30, 2024 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
|
Description of Business |
1.
Description of Business
Stereotaxis
designs, manufactures and markets robotic systems, instruments and information systems for the interventional laboratory. Our proprietary
robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled
magnetic fields to directly control the tip of flexible interventional catheters or devices. Direct control of the tip of an interventional
device, in contrast to all manual hand-held devices that are controlled from their handle, can improve the precision, stability, reach
and safety of these devices during procedures.
Our
primary clinical focus has been electrophysiology, specifically cardiac ablation procedures for the treatment of arrhythmias. Cardiac
ablation has become a well-accepted therapy for arrhythmias and a multi-billion-dollar medical device market with expectations for substantial
long-term growth. Our product strategy is to expand the clinical focus of our technology to several additional endovascular indications
including coronary, neuro, and peripheral interventions.
There
is substantial real-world evidence and clinical literature for Robotic Magnetic Navigation in electrophysiology. Hundreds of electrophysiologists
at over one hundred hospitals globally have treated over 100,000 arrhythmia patients with our robotic technology. Clinical use of our
technology has been documented in over 500 clinical publications. Robotic Magnetic Navigation is designed to enable physicians to complete
more complex interventional procedures with greater success and safety by providing image-guided delivery of catheters through the blood
vessels and chambers of the heart to treatment sites. This is achieved using externally applied computer-controlled magnetic fields that
govern the motion of the working tip of the catheter, resulting in improved navigation. The more flexible atraumatic design of catheters
driven using magnetic fields may reduce the risk of patient harm and other adverse events. Performing the procedure from a control cockpit
enables physicians to complete procedures in a safe location protected from x-ray exposure, with greater ergonomics, and improved efficiency.
We believe these benefits can be applicable in other endovascular indications where navigation through complex vasculature is often challenging
or unsuccessful and generates significant x-ray exposure, and we are investing in research and development in these areas.
Our
primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through our strategic
relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties,
we offer our customers x-ray systems and other accessory devices.
The
Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided
delivery of catheters through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied
magnetic fields that govern the motion of the working tip of the catheter, resulting in improved navigation, efficient procedures, and
reduced x-ray exposure.
The
Odyssey Solution consolidates lab information onto one large integrated display, enabling physicians to view and control all the
key information in the operating room. This is designed to improve lab layout and procedure efficiency. The system also features a remote
viewing and recording capability called Odyssey Cinema, which is an innovative solution that delivers synchronized content for
optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store
and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local
area network and over the global Odyssey Network providing physicians with a tool for clinical collaboration, remote consultation, and
training.
We
have arrangements with fluoroscopy system manufacturers to provide such systems in a bundled purchase offer for hospitals establishing
robotic interventional operating rooms. These are single-plane, full-power x-ray systems and include the c-arm and powered table. The
combination of RMN Systems with our partnered x-ray systems reduces the cost of acquisition, the ongoing cost of ownership, and the complexity
of installation of a robotic electrophysiology practice.
We
promote our full suite of products in a typical hospital implementation, subject to regulatory approvals or clearances. This implementation
requires a hospital to agree to an upfront capital payment and recurring payments. The upfront capital payment typically includes equipment
and installation charges. The recurring payments typically include disposable costs for each procedure, equipment service costs beyond
the warranty period, and ongoing software updates. In hospitals where our full suite of products has not been implemented, equipment
upgrade or expansion can be implemented upon purchasing of the necessary upgrade or expansion.
We
have received regulatory clearances and approvals necessary for us to market the Genesis RMN System in the U.S. and Europe, and
we are in the process of obtaining necessary registrations for extending our markets in other countries. The Niobe System, our
prior generation robotic magnetic navigation system, the Odyssey Solution, Cardiodrive, e-Contact, and various disposable
interventional devices have received regulatory clearances and approvals in the U.S., Europe, Canada, China, Japan and various other
countries. We have regulatory clearances and approvals that allow us to market the Vdrive and Vdrive Duo Systems with the V-CAS device
in the U.S., Canada and Europe. We are pursuing regulatory approvals for the Stereotaxis MAGiC catheter, a robotically-navigated magnetic
ablation catheter designed to perform minimally invasive cardiac ablation procedures, in various global geographies. Approval processes
can be lengthy and uncertain, submissions may require revised or additional non-clinical and clinical data, and regulatory applications
could be denied.
We
have strategic relationships with technology leaders and innovators in the global interventional market. Through these strategic relationships
we provide compatibility between our robotic magnetic navigation system, x-ray systems, and digital imaging and 3D catheter location
sensing technology, as well as disposable interventional devices. The maintenance of these strategic relationships, or the establishment
of equivalent alternatives, is critical to our commercialization efforts. There are no guarantees that any existing strategic relationships
will continue, and efforts are ongoing to ensure the availability of compatible systems and devices and/or equivalent alternatives. We
cannot provide assurance as to the timeline of the ongoing availability of such compatible systems or our ability to obtain equivalent
alternatives on competitive terms or at all.
|
X |
- DefinitionThe entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Topic 275 -Publisher FASB -URI https://asc.fasb.org/275/tableOfContent
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -SubTopic 10 -Topic 275 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1
+ Details
Name: |
us-gaap_NatureOfOperations |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Summary of Significant Accounting Policies
|
6 Months Ended |
Jun. 30, 2024 |
Accounting Policies [Abstract] |
|
Summary of Significant Accounting Policies |
2.
Summary of Significant Accounting Policies
Basis
of Presentation
The
accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with U.S. generally accepted accounting
principles (“GAAP”) for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include
all the disclosures required by GAAP for complete financial statements. In the opinion of management, they include all adjustments, consisting
only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results
for the six-month period ended June 30, 2024, are not necessarily indicative of the results that may be expected for the year ending
December 31, 2024, or for future operating periods.
These
interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included
in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission
(SEC) on March 8, 2024.
Risks
and Uncertainties
Future
results of operations could be materially adversely impacted by macroeconomic and geopolitical factors. The Company continues to experience
difficulties with periodic worldwide supply chain disruptions, including shortages and inflationary pressures, and logistics delays which
make it difficult for us to source parts and ship our products. We have generally been able to conduct normal business activities albeit
in a more deliberate manner than prior to the pandemic, including taking action to increase inventory levels and engaging in discussions
with our vendors on contractual obligations, but we cannot guarantee that they will not be impacted more severely in the future. Our
suppliers and contract manufacturers have experienced, and may continue to experience, similar difficulties. If our manufacturing operations
or supply chains are materially interrupted, it may not be possible for us to timely manufacture or service our products at required
levels, or at all. Changes in economic conditions and supply chain constraints could lead to higher inflation than previously experienced
or expected, which could, in turn, lead to an increase in costs. We may be unable to raise the prices of our products sufficiently to
keep up with the rate of inflation. A material reduction or interruption in any of our manufacturing processes or a substantial increase
in costs would have a material adverse effect on our business, operating results, and financial condition.
Many
of our hospital customers, for whom the purchase of our system involves a significant capital purchase which may be part of a larger
construction project at the customer site (typically the construction of a new building), may themselves be under economic pressures.
Hospitals continue to experience challenges with staffing and cost pressures as supply chain constraints and inflation drive up operating
costs. This may cause delays or cancellations of current purchase orders and other commitments and may exacerbate the long and variable
sales and installation cycles for our robotic magnetic navigation systems. Our hospital customers have also experienced challenges in
sourcing supplies, such as catheters, needed to perform procedures. Such shortages have, and may continue to, put pressure on procedures
and our disposable revenue.
Any
disruption to the capital markets could negatively impact our ability to raise capital. If the capital markets are disrupted for an extended
period of time and we need to raise additional capital, such capital may not be available on acceptable terms, or at all. Disruptions
to the capital markets and other financing sources could also negatively impact our hospital customers’ ability to raise capital
or otherwise obtain financing to fund their operations and capital projects. Such could result in delayed spending on current projects,
a longer sales cycle for new projects where a large capital commitment is required, and decreased demand for our disposable products
as well as an increased risk of customer defaults or delays in payments for our system installations, service contracts and disposable
products.
In
addition to the aforementioned macroeconomic factors, the COVID-19 pandemic negatively affected, and any resurgence of a variant of COVID-19
or any similar occurrences may in the future negatively affect demand for both our systems and our disposable products. In the past,
we have experienced business disruptions, including travel restrictions on us and our third-party distributors, which negatively affected
our complex sales, marketing, installation, distribution and service network relating to our products and services. We also experienced
reductions in demand for our disposable products as our healthcare customers (physicians and hospitals) re-prioritized the treatment
of patients and diverted resources away from non-coronavirus areas, leading to the performance of fewer procedures in which our disposable
products are used. Significant decreases to our capital or recurring revenues could have a material adverse effect on our business, operating
results, and financial condition. While we cannot reliably estimate the ultimate duration of the impact or the severity of ongoing periodic
resurgences of pandemic-related issues, we continue to anticipate periodic disruptions to our manufacturing operations, supply chains,
procedures volumes, service activities, and capital system orders and placements, any of which could have a material adverse effect on
our business, financial condition, results of operations, or cash flows. The impact has varied widely over time by individual geography.
Concentration
of Credit Risk
Financial
instruments that potentially subject the Company to concentration of credit risk consist of cash, cash equivalents and marketable securities.
Our investments may include, at any time, a diversified portfolio of cash equivalents and short- and long-term investments in a variety
of high-quality securities, including money market funds, U.S. treasury and U.S. government agency securities, corporate notes and bonds,
commercial paper, non-U.S. government agency securities, and municipal notes. The Company’s exposure to any individual corporate
entity is limited by policy. Deposits may exceed federally insured limits, and the Company is exposed to credit risk on deposits in the
event of default by the financial institutions to the extent account balances exceed the amount insured by the Federal Deposit Insurance
Corporation (FDIC). The Company closely monitors events involving limited liquidity, defaults, non-performance or other adverse developments
that affect financial institutions or other companies in the financial services industry or the financial services industry generally,
including Silicon Valley Bank. On March 10, 2023, Silicon Valley Bank (“SVB”), where the Company maintained accounts with
a cash balance of less than 6% of the Company’s total cash, cash equivalents and marketable securities, was closed by the California
Department of Financial Protection and Innovation and the FDIC was appointed as receiver. On March 12, 2023, the U.S. Department of the
Treasury, Federal Reserve Board, and FDIC released a joint statement announcing that the FDIC would complete its resolution of SVB in
a manner that fully protected all depositors at SVB and that depositors would have access to all of their money starting March 13, 2023.
On March 26, 2023, it was announced that First-Citizens Bank & Trust Company would assume all of SVB’s deposits and loans as
of March 27, 2023. During the periods presented, the Company has not experienced any losses on its deposits of cash, cash equivalents
or marketable securities.
Cash
and Cash Equivalents
Cash
and cash equivalents include cash on hand, money market instruments, and other highly liquid investments with original maturities of
three months or less from the date of purchase. Accrued interest receivable on money market instruments, included in other current assets,
was less than $0.1 million as of June 30, 2024, and December 31, 2023.
Restricted
Cash
Restricted
cash primarily consists of cash that the Company is obligated to maintain in accordance with contractual obligations. The Company’s
restricted cash was $0.5 million and $0.7 million as of June 30, 2024, and December 31, 2023, respectively.
Investments
Our
investments may include, at any time, a diversified portfolio of cash equivalents and short-and long-term investments in a variety of
high-quality securities, including money market funds, U.S. treasury and U.S. government agency securities, corporate notes and bonds,
commercial paper, non-U.S. government agency securities, and municipal notes. As of June 30, 2024, and December 31, 2023, the Company
had no short-term investments.
Amortized
cost of U.S. treasury securities and marketable debt securities are based on the Company’s purchase price adjusted for accrual
of discount, or amortization of premium, and recognition of impairment charges, if any. The amortized cost of securities the Company
purchases at a discount or premium will equal the face or par value at maturity or the call date, if applicable. Stated interest on investments
is reported as income when earned and is adjusted for amortization or accretion of any premium or discount.
The
Company segments its portfolio based on the underlying risk profiles of the securities and has a zero-loss expectation for U.S. treasury
and U.S. government agency securities. The Company regularly reviews the securities using the probability of default method and analyzes
the unrealized loss positions and evaluates the current expected credit loss by considering factors such as credit ratings, issuer-specific
factors, current economic conditions, and reasonable and supportable forecasts. The Company did not have any material expected credit
losses on investments or material expected credit losses on accrued interest related to investments during the six months ended June
30, 2024, or year ended December 31, 2023.
Fair
Value Measurements
Financial
instruments consist of cash and cash equivalents, restricted cash, investments, accounts receivable, and accounts payable.
The
Company measures certain financial assets and liabilities at fair value on a recurring basis. General accounting principles for fair
value measurement establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value.
The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level
1”) and the lowest priority to unobservable inputs (“Level 3”). The three levels of the fair value hierarchy are described
below:
Level
1: |
|
Values
are based on unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets
or liabilities. |
|
|
|
Level
2: |
|
Values
are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets
that are not active, or other model-based valuation techniques for which all significant assumptions are observable in the market. |
|
|
|
Level
3: |
|
Values
are generated from model-based techniques that use significant assumptions not observable in the market. |
As
of June 30, 2024, and December 31, 2023, financial assets classified as Level 2 consisted of money market funds. The Company reviews
trading activity and pricing for these investments as of the measurement date. When sufficient quoted pricing for identical securities
is not available, the Company uses market pricing and other observable market inputs for similar securities. These inputs either represent
quoted prices for similar assets in active markets or have been derived from observable market data. This approach results in the Level
2 classification of these securities within the fair value hierarchy.
Accounts
Receivable, Contract Assets, and Allowance for Credit Losses
Accounts
receivable primarily include amounts due from hospitals and distributors for acquisition of magnetic systems, associated disposable device
sales and service contracts, net of allowances for expected credit losses. Credit is granted on a limited basis, with balances due generally
within 30 days of billing. Contract assets primarily represent the difference between the revenue that was earned but not billed on service
contracts and revenue from system contracts that was recognized based on the relative selling price of the related performance obligations
and the contractual billing terms in the arrangements. The Company reports accounts receivable and contract assets net of an allowance
for expected credit losses in accordance with Accounting Standards Codification Topic 326, Financial Instruments – Credit Losses
(“ASC 326”). The provision for credit loss is based upon management’s assessment of historical and expected net collections
considering business and economic conditions and other collection indicators. We assess collectability by reviewing the accounts receivable
aging schedule on an aggregated basis where similar characteristics exist and on an individual basis when we identify specific customers
with known disputes or collectability issues. Amounts deemed uncollectible are recorded as an allowance for expected credit losses.
Revenue
and Costs of Revenue
The
Company accounts for revenue in accordance with Accounting Standards Codification Topic 606 (“ASC 606”), Revenue from
Contracts with Customers.
We
generate revenue from the initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices,
from royalties paid to the Company on the sale of various devices as provided by co-development and co-placement arrangements, and from
other recurring revenue including ongoing software updates and service contracts.
We
account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights
of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We
record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that
are remitted to government authorities.
For
contracts containing multiple products and services, the Company accounts for individual products and services as separate performance
obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package,
and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes
revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.
For
arrangements with multiple performance obligations, revenue is allocated to each performance obligation based on its relative standalone
selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services.
If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market
conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market
conditions. The Company regularly reviews standalone selling prices and updates these estimates if necessary.
Our
revenue recognition policy affects the following revenue streams in our business as follows:
Systems:
Contracts
related to the sale of systems typically contain separate obligations for the delivery of system(s), installation, service-type
warranty, and an implied obligation to provide software enhancements if and when available for one year following installation.
Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs
that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from
service-type warranties and the implied obligation to deliver software enhancements if and when available is included in Other
Recurring Revenue and is recognized ratably typically over the first year following installation of the system as the customer
receives the service-type warranty and right to software updates throughout the period. The Company’s system contracts
generally do not provide a right of return. Systems may be covered by a one-year assurance-type warranty in lieu of a service-type
warranty. Assurance-type warranty costs were less than $0.1
million for the six months ended June 30, 2024, and 2023. Revenue from system delivery and installation represented 25%
and 36%
of revenue for the six months ended June 30, 2024, and 2023, respectively.
Disposables:
Revenue
from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment,
but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type
warranty that provides for the return of defective products. Warranty costs were not material for the six months ended June 30, 2024,
and 2023. Disposable revenue represented 28% and 22% of revenue for the six months ended June 30, 2024, and 2023, respectively.
Royalty:
The
Company receives royalties on the sale of various devices as provided by co-development and co-placement arrangements with various manufacturers.
Royalty revenue represented less than 1% of revenue for the six months ended June 30, 2024, and 2023.
Other
Recurring Revenue:
Other
recurring revenue includes revenue from product maintenance plans, service-type warranties, other post warranty maintenance, and the
implied obligation to provide software enhancements if and when available for a specified period, typically one year following installation
of our systems. Revenue from services and software enhancements, service-type warranties, and the implied obligation to provide software
enhancements are deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed
on a time-and-materials basis is recognized when performed. Other recurring revenue represented 47% and 41% of revenue for the six months
ended June 30, 2024, and 2023, respectively.
The
following table summarizes the Company’s revenue for systems, disposables, and service and accessories for the six months ended
June 30, 2024, and 2023 (in thousands):
Schedule of Revenue Disaggregated by Type
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
Systems | |
$ | 240 | | |
$ | 3,313 | | |
$ | 2,852 | | |
$ | 5,134 | |
Disposables, service and accessories | |
| 4,262 | | |
| 4,546 | | |
| 8,530 | | |
| 9,273 | |
Total revenue | |
$ | 4,502 | | |
$ | 7,859 | | |
$ | 11,382 | | |
$ | 14,407 | |
Transaction
price allocated to remaining performance obligations relates to amounts allocated to products and services for which the revenue has
not yet been recognized. A significant portion of this amount relates to the Company’s systems contracts and obligations that will
be recognized as revenue in future periods. These obligations are generally satisfied within two years after contract inception but may
occasionally extend longer. Transaction price representing revenue to be earned on remaining performance obligations on system contracts
was approximately $15.3 million as of June 30, 2024. Performance obligations arising from contracts for disposables and service are generally
expected to be satisfied within one year after entering into the contract.
The
following table summarizes the Company’s contract assets and liabilities (in thousands):
Summary of Contract Assets and Liabilities
| |
June 30, 2024 | | |
December 31, 2023 | |
Contract Assets - unbilled receivables | |
$ | 116 | | |
$ | 72 | |
| |
| | | |
| | |
Customer deposits | |
$ | 1,845 | | |
$ | 2,105 | |
Product shipped, revenue deferred | |
| 1,371 | | |
| 1,413 | |
Deferred service and license fees | |
| 3,855 | | |
| 4,776 | |
Total deferred revenue | |
$ | 7,071 | | |
$ | 8,294 | |
Less: Long-term deferred revenue | |
| (2,121 | ) | |
| (1,637 | ) |
Total current deferred revenue | |
$ | 4,950 | | |
$ | 6,657 | |
The
Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference
between the revenue that was earned but not billed on service contracts and revenue from system contracts that was recognized based on
the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Customer deposits
primarily relate to future system sales but can also include deposits on disposable sales. Deferred revenue is primarily related to service
contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system
contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally
recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance
obligations are satisfied. The Company did not have any impairment losses on its contract assets for the periods presented.
Revenue
recognized for the six months ended June 30, 2024, and 2023, that was included in the deferred revenue balance at the beginning of each
reporting period was $4.3 million.
Assets
Recognized from the Costs to Obtain a Contract with a Customer
The
Company has determined that sales incentive programs for the Company’s sales team meet the requirements to be capitalized as the
Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction.
The costs capitalized as contract acquisition costs included in prepaid expenses and other assets, in the Company’s balance sheet
were $0.1 million as of June 30, 2024, and December 31, 2023. The Company did not incur any impairment losses during any of the periods
presented.
Costs
of systems revenue include direct product costs, installation labor and other costs including estimated assurance-type warranty costs,
and initial training costs, when applicable. These costs are recognized at the time of sale. Costs of disposable revenue include direct
product costs and estimated warranty costs and are recognized at the time of sale. Cost of revenue from services and license fees are
recognized when incurred.
Leasing
Arrangements
A
lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or equipment
for a period of time in exchange for consideration. The Company accounts for leases in accordance with Accounting Standards Update No.
2016-02 “Leases” (Topic 842) and all subsequent ASUs that modified Topic 842 (“ASC 842”). The Company determines
if an arrangement contains a lease at inception.
The
Company leases its facilities under operating leases. In accordance with ASC 842, operating lease agreements are recognized on the balance
sheet as a right-of-use (“ROU”) asset and a corresponding lease liability. These leases generally do not have significant
rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. Further, the leases do not contain
contingent rent provisions. Many of our leases include both lease (i.e., fixed payments including rent, taxes, and insurance costs) and
non-lease components (i.e., common-area or other maintenance costs) which are accounted for as a single lease component as we have elected
the practical expedient to group lease and non-lease components for all leases.
The
Company’s lease agreements often include one or more options to renew at the Company’s discretion. If at lease inception,
the Company considers the exercising of a renewal option to be reasonably certain, the Company will include the extended term in the
calculation of the ROU asset and lease liability. The Company elected not to include short-term leases (i.e., leases with initial terms
of twelve months or less) on the balance sheet.
The
calculated amounts of the ROU assets and lease liabilities are impacted by the length of the lease term and the discount rate used to
calculate the present value of the minimum lease payments. ASC 842 requires the use of the discount rate implicit in the lease whenever
this rate is readily determinable. As this rate is rarely determinable, the Company utilizes its incremental borrowing rate at lease
inception.
Stock-Based
Compensation
The
Company accounts for its grants of stock options, non-qualified stock options, stock appreciation rights, restricted shares, restricted
stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based
payments. These accounting principles require the determination of the fair value of the stock-based compensation at the grant date and
the recognition of the related expense over the period in which the stock-based compensation vests.
For
time-based awards, the Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation
rights at the date of grant. The weighted average assumptions and fair value for options granted during the six months ended June 30,
2024, were 1) expected dividend rate of 0%; 2) expected volatility of 76% based on the Company’s historical volatility; 3) risk-free
interest rate based on the Treasury yield on the date of grant; and 4) expected term of 6.25 years. The resulting compensation expense
is recognized over the requisite service period, which is generally four years. Restricted shares and units granted to employees and
non-employee directors are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense
over the service period, which is generally four years except for grants to directors which are generally earned over a period of six
months. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting
period and is subject to adjustment based on the actual achievement of objectives.
For
market-based awards, stock-based compensation expense is recognized over the minimum service period regardless of whether or not the
market target is probable of being achieved. The fair value of such awards is estimated on the grant date using Monte Carlo simulations.
Shares
purchased by employees under the 2022 Employee Stock Purchase Plans are considered to be non-compensatory.
Net
Loss per Common Share
Basic
earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common
shares outstanding during the period. In periods where there is net income, we apply the two-class method to calculate basic and diluted
net income (loss) per share of common stock, as our convertible preferred stock is a participating security. The two-class method is
an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available
to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as
our convertible preferred stock does not contractually participate in our losses. We compute diluted net income (loss) per common share
using net income (loss) as the “control number” in determining whether potential common shares are dilutive, after giving
consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding
during the period and potential issuance of stock upon the conversion of our convertible preferred stock issued and outstanding during
the period, except where the effect of such securities would be antidilutive.
The
following table sets forth the computation of basic and diluted EPS (in thousands except for share and per share amounts):
Schedule of Computation of Basic and Diluted Earnings Per Share
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
Net loss | |
$ | (5,833 | ) | |
$ | (4,957 | ) | |
$ | (10,340 | ) | |
$ | (10,304 | ) |
Cumulative dividend on convertible preferred stock | |
| (325 | ) | |
| (335 | ) | |
| (656 | ) | |
| (666 | ) |
Net loss attributable to common stockholders | |
$ | (6,158 | ) | |
$ | (5,292 | ) | |
$ | (10,996 | ) | |
$ | (10,970 | ) |
| |
| | | |
| | | |
| | | |
| | |
Weighted average number of common shares and equivalents: | |
| 84,570,738 | | |
| 81,049,211 | | |
| 84,025,335 | | |
| 78,787,652 | |
Basic EPS | |
$ | (0.07 | ) | |
$ | (0.07 | ) | |
$ | (0.13 | ) | |
$ | (0.14 | ) |
Diluted EPS | |
$ | (0.07 | ) | |
$ | (0.07 | ) | |
$ | (0.13 | ) | |
$ | (0.14 | ) |
The
Company did not include any portion of unearned restricted shares, outstanding options, stock appreciation rights, warrants or convertible
preferred stock in the calculation of diluted loss per common share because all such securities are anti-dilutive for all periods presented.
The application of the two-class method of computing earnings per share under general accounting principles for participating securities
is not applicable during these periods because those securities do not contractually participate in its losses.
As
of June 30, 2024, the Company had 4,103,847 shares of common stock issuable upon the exercise of outstanding options and stock appreciation
rights at a weighted average exercise price of $3.77 per share, 48,882,491 shares of our common stock issuable upon conversion of our
Series A Convertible Preferred Stock and 1,399,157 shares of unvested restricted share units. The Company had no unearned restricted
shares outstanding as of June 30, 2024.
Recently
Issued Accounting Pronouncements
In
June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial
Instruments” and also issued subsequent amendments to the initial guidance under ASU 2018-19, ASU 2019-04 and ASU 2019-05. The
standard modifies the measurement approach for credit losses on financial instruments, including trade receivables, from an incurred
loss method to a current expected credit loss method, otherwise known as “CECL.” The standard requires the measurement of
expected credit losses to be based on relevant information, including historical experience, current conditions and a forecast that is
supportable. The Company adopted the standard in the first quarter of 2023. The impact to the Company’s financial results was immaterial.
In
December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”),
which requires enhanced income tax disclosures, primarily related to the effective tax rate reconciliation and income taxes paid. The
Company does not expect a significant impact on its income tax disclosures upon adoption of the ASU which will be effective in the Company’s
year ending December 31, 2025.
|
X |
- References
+ Details
Name: |
us-gaap_AccountingPoliciesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for all significant accounting policies of the reporting entity.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 235 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/235/tableOfContent
+ Details
Name: |
us-gaap_SignificantAccountingPoliciesTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Financial Instruments
|
6 Months Ended |
Jun. 30, 2024 |
Investments, All Other Investments [Abstract] |
|
Financial Instruments |
3.
Financial Instruments
The
following tables summarize the Company’s cash and fair value by significant category reported as cash and cash equivalents and
restricted cash as of June 30, 2024, and December 31, 2023:
Schedule of Cash and Cash Equivalents, Restricted Cash and Investments
| |
June 30, 2024 | |
| |
Valuation | | |
Reported as: | |
(in thousands) | |
Amortized Cost | | |
Gross Unrealized Gains | | |
Gross Unrealized Losses | | |
Fair Value | | |
Cash and Cash Equivalents | | |
Restricted Cash- current | | |
Short-term Investments | | |
Restricted Cash | |
Cash | |
$ | 1,726 | | |
$ | - | | |
$ | - | | |
$ | 1,726 | | |
$ | 1,726 | | |
$ | - | | |
$ | - | | |
$ | - | |
Level 2 | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Money market funds | |
| 13,438 | | |
| - | | |
| - | | |
| 13,438 | | |
| 12,957 | | |
| 481 | | |
| - | | |
| - | |
Subtotal | |
| 13,438 | | |
| - | | |
| - | | |
| 13,438 | | |
| 12,957 | | |
| 481 | | |
| - | | |
| - | |
Total assets measured at fair value | |
$ | 15,164 | | |
$ | - | | |
$ | - | | |
$ | 15,164 | | |
$ | 14,683 | | |
$ | 481 | | |
$ | - | | |
$ | - | |
| |
December 31, 2023 | |
| |
Valuation | | |
Reported as: | |
(in thousands) | |
Amortized Cost | | |
Gross Unrealized Gains | | |
Gross Unrealized Losses | | |
Fair Value | | |
Cash and Cash Equivalents | | |
Restricted Cash- current | | |
Short-term Investments | | |
Restricted Cash | |
Cash | |
$ | 2,122 | | |
$ | - | | |
$ | - | | |
$ | 2,122 | | |
$ | 2,122 | | |
$ | - | | |
$ | - | | |
$ | - | |
Level 2 | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Money market funds | |
| 18,440 | | |
| - | | |
| - | | |
| 18,440 | | |
| 17,696 | | |
| 525 | | |
| - | | |
| 219 | |
Subtotal | |
| 18,440 | | |
| - | | |
| - | | |
| 18,440 | | |
| 17,696 | | |
| 525 | | |
| - | | |
| 219 | |
Total assets measured at fair value | |
$ | 20,562 | | |
$ | - | | |
$ | - | | |
$ | 20,562 | | |
$ | 19,818 | | |
$ | 525 | | |
$ | - | | |
$ | 219 | |
Interest
income was approximately $0.4 million and $1.1 million during the six months ended June 30, 2024, and the year ended December 31, 2023,
respectively.
As
of June 30, 2024, and December 31, 2023, the Company did not have any financial assets classified as Level 1 or Level 3 nor did the Company
have financial liabilities valued at fair value on a recurring basis.
|
X |
- DefinitionThe entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.
+ References
+ Details
Name: |
us-gaap_FinancialInstrumentsDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_InvestmentsAllOtherInvestmentsAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Inventories
|
6 Months Ended |
Jun. 30, 2024 |
Inventory Disclosure [Abstract] |
|
Inventories |
4.
Inventories
Inventories
consist of the following (in thousands):
Schedule
of Inventories
| |
June 30, 2024 | | |
December 31, 2023 | |
Raw materials | |
$ | 6,064 | | |
$ | 5,918 | |
Work in process | |
| 1,112 | | |
| 1,034 | |
Finished goods | |
| 4,111 | | |
| 3,413 | |
Reserve for excess and obsolescence | |
| (2,003 | ) | |
| (1,939 | ) |
Total inventory | |
$ | 9,284 | | |
$ | 8,426 | |
The
reserve for excess and obsolescence primarily includes Niobe Systems and related raw materials and spare parts.
|
X |
- References
+ Details
Name: |
us-gaap_InventoryDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 330 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/330/tableOfContent
+ Details
Name: |
us-gaap_InventoryDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Prepaid Expenses and Other Assets
|
6 Months Ended |
Jun. 30, 2024 |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] |
|
Prepaid Expenses and Other Assets |
5.
Prepaid Expenses and Other Assets
Prepaid
expenses and other assets consist of the following (in thousands):
Schedule
of Prepaid Expenses and Other Assets
| |
June 30, 2024 | | |
December 31, 2023 | |
Prepaid expenses | |
$ | 297 | | |
$ | 181 | |
Prepaid commissions | |
| 97 | | |
| 110 | |
Deposits | |
| 467 | | |
| 424 | |
Other assets | |
| 97 | | |
| 98 | |
Total prepaid expenses and other assets | |
| 958 | | |
| 813 | |
Less: Noncurrent prepaid expenses and other assets | |
| (116 | ) | |
| (137 | ) |
Total current prepaid expenses and other assets | |
$ | 842 | | |
$ | 676 | |
|
X |
- References
+ Details
Name: |
us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.
+ References
+ Details
Name: |
us-gaap_OtherAssetsDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Property and Equipment
|
6 Months Ended |
Jun. 30, 2024 |
Property, Plant and Equipment [Abstract] |
|
Property and Equipment |
6.
Property and Equipment
Property
and Equipment consist of the following (in thousands):
Schedule
of Property and Equipment
| |
June 30, 2024 | | |
December 31, 2023 | |
Equipment | |
$ | 4,288 | | |
$ | 4,269 | |
Leasehold improvements | |
| 2,911 | | |
| 2,911 | |
Gross property and equipment | |
| 7,199 | | |
| 7,180 | |
Less: Accumulated depreciation | |
| (4,140 | ) | |
| (3,876 | ) |
Net property and equipment | |
$ | 3,059 | | |
$ | 3,304 | |
The
Company had less than $0.1 million of property and equipment additions during the six months ended June 30, 2024, and the year ended
December 31, 2023. The additions in the current year period were for purchases
of equipment and the additions in the prior year period were associated with the buildout of the new leased space in St. Louis, Missouri.
|
X |
- References
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 360 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/360/tableOfContent
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 6 -SubTopic 360 -Topic 958 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -SubTopic 360 -Topic 958 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 7 -SubTopic 360 -Topic 958 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Leases
|
6 Months Ended |
Jun. 30, 2024 |
Leases |
|
Leases |
7.
Leases
On
March 1, 2021, the Company entered into an office lease agreement (the “Lease”) with Globe Building Company (the “Landlord”),
under which the Company leases executive office space and manufacturing facilities of approximately 43,100 square feet of rentable space
located at 710 N. Tucker Boulevard, St. Louis, Missouri (the “Premises”) that serves as the Company’s principal executive
and administrative offices and manufacturing facility. Lease payments commenced on January 1, 2022, and the lease has a term of ten years,
with two renewal options of five years each. The minimum annual rent under the terms of the Lease ranges from approximately $0.8 million
in 2022 to $1.0 million in 2031.
As
of June 30, 2024, the weighted average discount rate for operating leases was 9% and the weighted average remaining lease term for operating
lease term is 7.49 years.
The
following table represents lease costs and other lease information (in thousands):
Schedule
of Lease Costs and Other Lease Information
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
Operating lease cost | |
$ | 227 | | |
$ | 227 | | |
$ | 454 | | |
$ | 454 | |
Short-term lease cost | |
| 5 | | |
| 4 | | |
| 8 | | |
| 8 | |
Total net lease cost | |
$ | 232 | | |
$ | 231 | | |
$ | 462 | | |
$ | 462 | |
| |
| | | |
| | | |
| | | |
| | |
Cash paid within operating cash flows | |
$ | 253 | | |
$ | 245 | | |
$ | 510 | | |
$ | 486 | |
Variable
lease costs consist primarily of taxes, insurance, and common area or other maintenance costs for our leased facilities and equipment
which are paid based on actual costs incurred.
Future
minimum payments for operating leases with initial or remaining terms of one year or more as of June 30, 2024, were as follows (in thousands):
Schedule
of Future Minimum Operating Lease Payments
| | |
June 30, 2024 | |
2024 | | |
$ | 449 | |
2025 | | |
| 919 | |
2026 | | |
| 935 | |
2027 | | |
| 956 | |
2028 | | |
| 976 | |
2029 and thereafter | | |
| 3,054 | |
Total lease payments | | |
| 7,289 | |
Less: Interest | | |
| (2,008 | ) |
Present value of lease liabilities | | |
$ | 5,281 | |
|
X |
- References
+ Details
Name: |
STXS_DisclosureLeasesAbstract |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/842-20/tableOfContent
+ Details
Name: |
us-gaap_LesseeOperatingLeasesTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Accrued Liabilities
|
6 Months Ended |
Jun. 30, 2024 |
Payables and Accruals [Abstract] |
|
Accrued Liabilities |
8.
Accrued Liabilities
Accrued
liabilities consist of the following (in thousands):
Schedule
of Accrued Liabilities
| |
June 30, 2024 | | |
December 31, 2023 | |
Accrued salaries, bonus, and benefits | |
$ | 1,230 | | |
$ | 1,222 | |
Accrued licenses and maintenance fees | |
| - | | |
| 484 | |
Accrued warranties | |
| 83 | | |
| 107 | |
Accrued professional services | |
| 176 | | |
| 138 | |
Accrued investigational sites | |
| 101 | | |
| - | |
Deferred contract obligation | |
| 1,045 | | |
| 1,045 | |
Other | |
| 117 | | |
| 19 | |
Total accrued liabilities | |
| 2,752 | | |
| 3,015 | |
Less: Long term accrued liabilities | |
| (54 | ) | |
| (43 | ) |
Total current accrued liabilities | |
$ | 2,698 | | |
$ | 2,972 | |
The
Company reversed an aged accrued regulatory fee of approximately $0.5 million during the three-month period ended June 30, 2024. The
release was recognized as a reduction of research and development expenses within the Statement of Operations.
|
X |
- DefinitionThe entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(24)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 720 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(19)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_PayablesAndAccrualsAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Convertible Preferred Stock and Stockholders’ Equity
|
6 Months Ended |
Jun. 30, 2024 |
Equity [Abstract] |
|
Convertible Preferred Stock and Stockholders’ Equity |
9.
Convertible Preferred Stock and Stockholders’ Equity
The
holders of common stock are entitled to one vote for each share held and to receive dividends when and as declared by the Board of Directors
out of funds legally available for dividends, subject to the prior rights or preferences applicable to any preferred stock as may then
be outstanding. No dividends have been declared or paid as of June 30, 2024, and the Company does not presently intend to pay any cash
dividends in the foreseeable future.
Series
A Convertible Preferred Stock and Warrants
In
September 2016, the Company issued (i) 24,000 shares of Series A Convertible Preferred Stock (the “Series A Preferred Stock”),
par value $0.001 per share, with a stated value of $1,000 per share, which are convertible into shares of the Company’s common
stock at an initial conversion rate of $0.65 per share, subject to adjustment for events such as stock splits, combinations and the like
as provided in the certificate of designations covering such Series A Preferred Stock, and (ii) (the SPA Warrants) to purchase an aggregate
of 36,923,078 shares of common stock. The shares of Series A Preferred Stock are entitled to vote on an as-converted basis with the common
stock, subject to specified beneficial ownership issuance limitations. The Series A Preferred Stock bear dividends at a rate of six percent
(6%) per annum, which are cumulative and accrue daily from the date of issuance on the $1,000 stated value. Such dividends will not be
paid in cash except in connection with any liquidation, dissolution or winding up of the Company or any redemption of the Series A Preferred
Stock. Each holder of convertible preferred shares has the right to require us to redeem such holder’s shares of Series A Preferred
Stock upon the occurrence of specified events, which include certain business combinations, the sale of all or substantially all of the
Company’s assets, or the sale of more than 50% of the outstanding shares of the Company’s common stock. In addition, the
Company has the right to redeem the Series A Preferred Stock in the event of a defined change of control. The Series A Preferred Stock
ranks senior to our common stock as to distributions and payments upon the liquidation, dissolution, and winding up of the Company. Since
the Series A Preferred Stock are subject to conditions for redemption that are outside the Company’s control, the Series A Preferred
Stock are presently reported in the mezzanine section of the balance sheet.
2021
CEO Performance Award Unit Grant
On
February 23, 2021, the Company`s Board of Directors, upon recommendation of the Compensation Committee, approved the grant of the CEO
Performance Award to the Company’s Chief Executive Officer. The CEO Performance award is a 10-year performance award of up to 13,000,000
shares, tied to the achievement of market capitalization milestones and subject to minimum service requirements.
As
detailed in the table below, the CEO Performance Award consists of ten vesting tranches. The first market capitalization milestone is
$1.0 billion, and each of the remaining nine market capitalization milestones are in additional $500 million increments, up to $5.5 billion.
Summary
of Performance Award And Market Capitalization Milestones
Tranche # | | |
No. of Shares Subject to PSU | | |
Market Capitalization Milestones(1) | |
1 | | |
| 1,000,000 | | |
$ | 1,000,000,000 | |
2 | | |
| 1,500,000 | | |
$ | 1,500,000,000 | |
3 | | |
| 1,500,000 | | |
$ | 2,000,000,000 | |
4 | | |
| 2,000,000 | | |
$ | 2,500,000,000 | |
5 | | |
| 1,000,000 | | |
$ | 3,000,000,000 | |
6 | | |
| 1,000,000 | | |
$ | 3,500,000,000 | |
7 | | |
| 1,000,000 | | |
$ | 4,000,000,000 | |
8 | | |
| 2,000,000 | | |
$ | 4,500,000,000 | |
9 | | |
| 1,000,000 | | |
$ | 5,000,000,000 | |
10 | | |
| 1,000,000 | | |
$ | 5,500,000,000 | |
Total: | | |
| 13,000,000 | | |
| | |
Each
tranche represents a portion of the PSUs covering the number of shares outlined in the table above. Each tranche vests upon (i) satisfaction
of the market capitalization milestones and (ii) continued employment as CEO of the Company from the grant date through December 31,
2030. Absent an earlier termination, the PSUs will expire on December 31, 2030. If our CEO ceases employment as CEO of the Company for
any reason including death, disability, termination for cause or without cause (as defined in the award agreement), or if he voluntary
terminates after service as CEO for at least five years, the remaining service period will be waived and he will retain any PSUs that
have vested through the date of termination.
The
Company received Shareholder approval at its annual meeting on May 20, 2021, for shares to be issued under the award.
The
market capitalization requirement is considered a market condition under FASB Accounting Standards Codification Topic 718 “Compensation
– Stock Compensation” and is estimated on the grant date using Monte Carlo simulations. Recognition of stock-based compensation
expense of all the tranches commenced on February 23, 2021, the date of grant, as the probability of meeting the ten market capitalization
milestones is not considered in determining the timing of expense recognition. The expense will be recognized on an accelerated basis
through 2030. Key assumptions for estimating the performance-based awards fair value at the date of grant included share price on grant
date, volatility of the Company’s common stock price, risk free interest rate, and grant term.
Total
stock-based compensation recorded as operating expense for the CEO Performance Award was $3.6 million and $3.5 million for the six months
ended June 30, 2024, and 2023. As of June 30, 2024, and 2023, the Company had approximately $33.4 million and $40.6 million, respectively,
of total unrecognized stock-based compensation expense remaining under the CEO Performance Award assuming the grantee’s continued
employment as CEO of the Company, or in a similar capacity, through 2030. As of June 30, 2024, none of the performance milestones established
by the 2021 CEO Incentive Program have been achieved, and no awards have been earned.
Stock
Award Plans
In
February 2022, the Compensation Committee of the Board of Directors adopted the 2022 Stock Incentive Plan (the “Plan”) which
was subsequently approved by the Company’s shareholders. This plan replaced the 2012 Stock Incentive Plan which expired on May
19, 2022. The 2022 Stock Incentive Plan allows for the grant of incentive stock options, non-qualified stock options, stock appreciation
rights, restricted shares and restricted share units to employees, non-employee directors, and third-party consultants.
At
June 30, 2024, the Company had 5,633,730 remaining shares of the Company’s common stock to provide for current and future grants
under its various equity plans.
At
June 30, 2024, the total compensation cost related to options and non-vested stock granted to employees and non-employees under the Company’s
stock award plans but not yet recognized was approximately $3.6 million, excluding compensation not yet recognized related to the CEO
Performance Award discussed above. This cost will be amortized over a period of up to four years over the underlying estimated service
periods and will be adjusted for subsequent changes in actual forfeitures and anticipated vesting periods.
A
summary of the option and stock appreciation rights activity for the six-month period ended June 30, 2024, is as follows:
Summary
of Option and Stock Appreciation Rights Activity
| |
Number of Options/SARs | | |
Range of Exercise Price | | |
Weighted Average Exercise Price per Share | |
Outstanding, December 31, 2023 | |
| 3,650,115 | | |
| $0.74 - $9.87 | | |
$ | 3.93 | |
Granted | |
| 716,500 | | |
| $2.45 - $3.01 | | |
$ | 3.00 | |
Exercised | |
| (11,763 | ) | |
| $0.74 - $2.57 | | |
$ | 1.02 | |
Forfeited | |
| (251,005 | ) | |
| $0.74 - $9.20 | | |
$ | 3.99 | |
Outstanding, June 30, 2024 | |
| 4,103,847 | | |
| $0.74 - $9.87 | | |
$ | 3.77 | |
A
summary of the restricted stock unit activity for the six-month period ended June 30, 2024, is as follows:
Schedule
of Restricted Stock Unit Activity
| |
Number of Restricted Stock Units | | |
Weighted Average Grant Date Fair Value per Unit | |
Outstanding, December 31, 2023 | |
| 1,502,131 | | |
$ | 3.94 | |
Granted | |
| 389,610 | | |
$ | 1.54 | |
Vested | |
| (492,584 | ) | |
$ | 3.03 | |
Outstanding, June 30, 2024 | |
| 1,399,157 | | |
$ | 3.60 | |
|
X |
- References
+ Details
Name: |
us-gaap_EquityAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent
+ Details
Name: |
us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Product Warranty Provisions
|
6 Months Ended |
Jun. 30, 2024 |
Guarantees and Product Warranties [Abstract] |
|
Product Warranty Provisions |
10.
Product Warranty Provisions
The
Company’s standard policy is to warrant all capital systems against defects in material or workmanship for one year following
installation with an assurance or a service-type warranty. The Company’s estimate of costs to service the warranty obligations is based on historical experience and
current product performance trends. A regular review of warranty obligations is performed to determine the adequacy of the reserve
and adjustments are made to the estimated warranty liability as appropriate.
Accrued
assurance-type warranty, which is included in other accrued liabilities, consists of the following (in thousands):
Schedule
of Accrued Warranty
| |
June 30, 2024 | | |
December 31, 2023 | |
Warranty accrual, beginning of the fiscal period | |
$ | 107 | | |
$ | 163 | |
Accrual adjustment for product warranty | |
| (8 | ) | |
| 547 | |
Payments made | |
| (16 | ) | |
| (603 | ) |
Warranty accrual, end of the fiscal period | |
$ | 83 | | |
$ | 107 | |
|
X |
- References
+ Details
Name: |
us-gaap_GuaranteesAndProductWarrantiesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a)(4) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482425/460-10-50-4
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a)(5) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482425/460-10-50-4
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482425/460-10-50-4
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482425/460-10-50-4
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482425/460-10-50-4
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482425/460-10-50-4
+ Details
Name: |
us-gaap_ProductWarrantyDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Commitments and Contingencies
|
6 Months Ended |
Jun. 30, 2024 |
Commitments and Contingencies Disclosure [Abstract] |
|
Commitments and Contingencies |
11.
Commitments and Contingencies
The
Company at times becomes a party to claims in the ordinary course of business. Management believes that the ultimate resolution of pending
or threatened proceedings will not have a material effect on the financial position, results of operations or liquidity of the Company.
In February 2024, a vendor filed financing statements under the Uniform Commercial Code (“UCC”) on underlying inventory for
approximately $0.6 million. We believe the financing statements were filed without merit, and we are fully contesting the propriety
of such actions.
In
April 2021, the Company entered into a letter of credit pursuant to the Lease agreement totaling approximately $1.8 million to be delivered
in four equal installments of which the first was delivered in April 2021, the second was delivered in July 2021, the third was delivered
in October 2021, and the fourth was delivered in January 2022. The amount available under this letter of credit automatically reduces
by one fortieth at the end of each month during the lease term.
|
X |
- References
+ Details
Name: |
us-gaap_CommitmentsAndContingenciesDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for commitments and contingencies.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 405 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/405-30/tableOfContent
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 440 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/450/tableOfContent
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 954 -SubTopic 440 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 440 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 440 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/440/tableOfContent
+ Details
Name: |
us-gaap_CommitmentsAndContingenciesDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Subsequent Events
|
6 Months Ended |
Jun. 30, 2024 |
Subsequent Events [Abstract] |
|
Subsequent Events |
12.
Subsequent Events
On
July 31, 2024, the Company completed its previously announced acquisition of all the shares of capital stock of Access Point Technologies
EP, Inc., a Minnesota corporation (“APT”), from APT Holding Company, Inc., a Minnesota corporation, pursuant to that certain
Share Purchase Agreement, dated May 11, 2024.
APT,
based in Rogers, Minnesota, designs, manufactures, and commercializes a portfolio of differentiated high-quality diagnostic catheters
used during cardiac ablation procedures that are commercially available across key global geographies.
At
closing, the Company issued 1,486,620 shares of its common stock.
|
X |
- References
+ Details
Name: |
us-gaap_SubsequentEventsAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 855 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/855/tableOfContent
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 855 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2
+ Details
Name: |
us-gaap_SubsequentEventsTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Summary of Significant Accounting Policies (Policies)
|
6 Months Ended |
Jun. 30, 2024 |
Accounting Policies [Abstract] |
|
Basis of Presentation |
Basis
of Presentation
The
accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with U.S. generally accepted accounting
principles (“GAAP”) for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include
all the disclosures required by GAAP for complete financial statements. In the opinion of management, they include all adjustments, consisting
only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results
for the six-month period ended June 30, 2024, are not necessarily indicative of the results that may be expected for the year ending
December 31, 2024, or for future operating periods.
These
interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included
in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission
(SEC) on March 8, 2024.
|
Risks and Uncertainties |
Risks
and Uncertainties
Future
results of operations could be materially adversely impacted by macroeconomic and geopolitical factors. The Company continues to experience
difficulties with periodic worldwide supply chain disruptions, including shortages and inflationary pressures, and logistics delays which
make it difficult for us to source parts and ship our products. We have generally been able to conduct normal business activities albeit
in a more deliberate manner than prior to the pandemic, including taking action to increase inventory levels and engaging in discussions
with our vendors on contractual obligations, but we cannot guarantee that they will not be impacted more severely in the future. Our
suppliers and contract manufacturers have experienced, and may continue to experience, similar difficulties. If our manufacturing operations
or supply chains are materially interrupted, it may not be possible for us to timely manufacture or service our products at required
levels, or at all. Changes in economic conditions and supply chain constraints could lead to higher inflation than previously experienced
or expected, which could, in turn, lead to an increase in costs. We may be unable to raise the prices of our products sufficiently to
keep up with the rate of inflation. A material reduction or interruption in any of our manufacturing processes or a substantial increase
in costs would have a material adverse effect on our business, operating results, and financial condition.
Many
of our hospital customers, for whom the purchase of our system involves a significant capital purchase which may be part of a larger
construction project at the customer site (typically the construction of a new building), may themselves be under economic pressures.
Hospitals continue to experience challenges with staffing and cost pressures as supply chain constraints and inflation drive up operating
costs. This may cause delays or cancellations of current purchase orders and other commitments and may exacerbate the long and variable
sales and installation cycles for our robotic magnetic navigation systems. Our hospital customers have also experienced challenges in
sourcing supplies, such as catheters, needed to perform procedures. Such shortages have, and may continue to, put pressure on procedures
and our disposable revenue.
Any
disruption to the capital markets could negatively impact our ability to raise capital. If the capital markets are disrupted for an extended
period of time and we need to raise additional capital, such capital may not be available on acceptable terms, or at all. Disruptions
to the capital markets and other financing sources could also negatively impact our hospital customers’ ability to raise capital
or otherwise obtain financing to fund their operations and capital projects. Such could result in delayed spending on current projects,
a longer sales cycle for new projects where a large capital commitment is required, and decreased demand for our disposable products
as well as an increased risk of customer defaults or delays in payments for our system installations, service contracts and disposable
products.
In
addition to the aforementioned macroeconomic factors, the COVID-19 pandemic negatively affected, and any resurgence of a variant of COVID-19
or any similar occurrences may in the future negatively affect demand for both our systems and our disposable products. In the past,
we have experienced business disruptions, including travel restrictions on us and our third-party distributors, which negatively affected
our complex sales, marketing, installation, distribution and service network relating to our products and services. We also experienced
reductions in demand for our disposable products as our healthcare customers (physicians and hospitals) re-prioritized the treatment
of patients and diverted resources away from non-coronavirus areas, leading to the performance of fewer procedures in which our disposable
products are used. Significant decreases to our capital or recurring revenues could have a material adverse effect on our business, operating
results, and financial condition. While we cannot reliably estimate the ultimate duration of the impact or the severity of ongoing periodic
resurgences of pandemic-related issues, we continue to anticipate periodic disruptions to our manufacturing operations, supply chains,
procedures volumes, service activities, and capital system orders and placements, any of which could have a material adverse effect on
our business, financial condition, results of operations, or cash flows. The impact has varied widely over time by individual geography.
|
Concentration of Credit Risk |
Concentration
of Credit Risk
Financial
instruments that potentially subject the Company to concentration of credit risk consist of cash, cash equivalents and marketable securities.
Our investments may include, at any time, a diversified portfolio of cash equivalents and short- and long-term investments in a variety
of high-quality securities, including money market funds, U.S. treasury and U.S. government agency securities, corporate notes and bonds,
commercial paper, non-U.S. government agency securities, and municipal notes. The Company’s exposure to any individual corporate
entity is limited by policy. Deposits may exceed federally insured limits, and the Company is exposed to credit risk on deposits in the
event of default by the financial institutions to the extent account balances exceed the amount insured by the Federal Deposit Insurance
Corporation (FDIC). The Company closely monitors events involving limited liquidity, defaults, non-performance or other adverse developments
that affect financial institutions or other companies in the financial services industry or the financial services industry generally,
including Silicon Valley Bank. On March 10, 2023, Silicon Valley Bank (“SVB”), where the Company maintained accounts with
a cash balance of less than 6% of the Company’s total cash, cash equivalents and marketable securities, was closed by the California
Department of Financial Protection and Innovation and the FDIC was appointed as receiver. On March 12, 2023, the U.S. Department of the
Treasury, Federal Reserve Board, and FDIC released a joint statement announcing that the FDIC would complete its resolution of SVB in
a manner that fully protected all depositors at SVB and that depositors would have access to all of their money starting March 13, 2023.
On March 26, 2023, it was announced that First-Citizens Bank & Trust Company would assume all of SVB’s deposits and loans as
of March 27, 2023. During the periods presented, the Company has not experienced any losses on its deposits of cash, cash equivalents
or marketable securities.
|
Cash and Cash Equivalents |
Cash
and Cash Equivalents
Cash
and cash equivalents include cash on hand, money market instruments, and other highly liquid investments with original maturities of
three months or less from the date of purchase. Accrued interest receivable on money market instruments, included in other current assets,
was less than $0.1 million as of June 30, 2024, and December 31, 2023.
|
Restricted Cash |
Restricted
Cash
Restricted
cash primarily consists of cash that the Company is obligated to maintain in accordance with contractual obligations. The Company’s
restricted cash was $0.5 million and $0.7 million as of June 30, 2024, and December 31, 2023, respectively.
|
Investments |
Investments
Our
investments may include, at any time, a diversified portfolio of cash equivalents and short-and long-term investments in a variety of
high-quality securities, including money market funds, U.S. treasury and U.S. government agency securities, corporate notes and bonds,
commercial paper, non-U.S. government agency securities, and municipal notes. As of June 30, 2024, and December 31, 2023, the Company
had no short-term investments.
Amortized
cost of U.S. treasury securities and marketable debt securities are based on the Company’s purchase price adjusted for accrual
of discount, or amortization of premium, and recognition of impairment charges, if any. The amortized cost of securities the Company
purchases at a discount or premium will equal the face or par value at maturity or the call date, if applicable. Stated interest on investments
is reported as income when earned and is adjusted for amortization or accretion of any premium or discount.
The
Company segments its portfolio based on the underlying risk profiles of the securities and has a zero-loss expectation for U.S. treasury
and U.S. government agency securities. The Company regularly reviews the securities using the probability of default method and analyzes
the unrealized loss positions and evaluates the current expected credit loss by considering factors such as credit ratings, issuer-specific
factors, current economic conditions, and reasonable and supportable forecasts. The Company did not have any material expected credit
losses on investments or material expected credit losses on accrued interest related to investments during the six months ended June
30, 2024, or year ended December 31, 2023.
|
Fair Value Measurements |
Fair
Value Measurements
Financial
instruments consist of cash and cash equivalents, restricted cash, investments, accounts receivable, and accounts payable.
The
Company measures certain financial assets and liabilities at fair value on a recurring basis. General accounting principles for fair
value measurement establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value.
The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level
1”) and the lowest priority to unobservable inputs (“Level 3”). The three levels of the fair value hierarchy are described
below:
Level
1: |
|
Values
are based on unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets
or liabilities. |
|
|
|
Level
2: |
|
Values
are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets
that are not active, or other model-based valuation techniques for which all significant assumptions are observable in the market. |
|
|
|
Level
3: |
|
Values
are generated from model-based techniques that use significant assumptions not observable in the market. |
As
of June 30, 2024, and December 31, 2023, financial assets classified as Level 2 consisted of money market funds. The Company reviews
trading activity and pricing for these investments as of the measurement date. When sufficient quoted pricing for identical securities
is not available, the Company uses market pricing and other observable market inputs for similar securities. These inputs either represent
quoted prices for similar assets in active markets or have been derived from observable market data. This approach results in the Level
2 classification of these securities within the fair value hierarchy.
|
Accounts Receivable, Contract Assets, and Allowance for Credit Losses |
Accounts
Receivable, Contract Assets, and Allowance for Credit Losses
Accounts
receivable primarily include amounts due from hospitals and distributors for acquisition of magnetic systems, associated disposable device
sales and service contracts, net of allowances for expected credit losses. Credit is granted on a limited basis, with balances due generally
within 30 days of billing. Contract assets primarily represent the difference between the revenue that was earned but not billed on service
contracts and revenue from system contracts that was recognized based on the relative selling price of the related performance obligations
and the contractual billing terms in the arrangements. The Company reports accounts receivable and contract assets net of an allowance
for expected credit losses in accordance with Accounting Standards Codification Topic 326, Financial Instruments – Credit Losses
(“ASC 326”). The provision for credit loss is based upon management’s assessment of historical and expected net collections
considering business and economic conditions and other collection indicators. We assess collectability by reviewing the accounts receivable
aging schedule on an aggregated basis where similar characteristics exist and on an individual basis when we identify specific customers
with known disputes or collectability issues. Amounts deemed uncollectible are recorded as an allowance for expected credit losses.
|
Revenue and Costs of Revenue |
Revenue
and Costs of Revenue
The
Company accounts for revenue in accordance with Accounting Standards Codification Topic 606 (“ASC 606”), Revenue from
Contracts with Customers.
We
generate revenue from the initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices,
from royalties paid to the Company on the sale of various devices as provided by co-development and co-placement arrangements, and from
other recurring revenue including ongoing software updates and service contracts.
We
account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights
of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We
record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that
are remitted to government authorities.
For
contracts containing multiple products and services, the Company accounts for individual products and services as separate performance
obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package,
and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes
revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.
For
arrangements with multiple performance obligations, revenue is allocated to each performance obligation based on its relative standalone
selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services.
If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market
conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market
conditions. The Company regularly reviews standalone selling prices and updates these estimates if necessary.
Our
revenue recognition policy affects the following revenue streams in our business as follows:
Systems:
Contracts
related to the sale of systems typically contain separate obligations for the delivery of system(s), installation, service-type
warranty, and an implied obligation to provide software enhancements if and when available for one year following installation.
Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs
that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from
service-type warranties and the implied obligation to deliver software enhancements if and when available is included in Other
Recurring Revenue and is recognized ratably typically over the first year following installation of the system as the customer
receives the service-type warranty and right to software updates throughout the period. The Company’s system contracts
generally do not provide a right of return. Systems may be covered by a one-year assurance-type warranty in lieu of a service-type
warranty. Assurance-type warranty costs were less than $0.1
million for the six months ended June 30, 2024, and 2023. Revenue from system delivery and installation represented 25%
and 36%
of revenue for the six months ended June 30, 2024, and 2023, respectively.
Disposables:
Revenue
from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment,
but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type
warranty that provides for the return of defective products. Warranty costs were not material for the six months ended June 30, 2024,
and 2023. Disposable revenue represented 28% and 22% of revenue for the six months ended June 30, 2024, and 2023, respectively.
Royalty:
The
Company receives royalties on the sale of various devices as provided by co-development and co-placement arrangements with various manufacturers.
Royalty revenue represented less than 1% of revenue for the six months ended June 30, 2024, and 2023.
Other
Recurring Revenue:
Other
recurring revenue includes revenue from product maintenance plans, service-type warranties, other post warranty maintenance, and the
implied obligation to provide software enhancements if and when available for a specified period, typically one year following installation
of our systems. Revenue from services and software enhancements, service-type warranties, and the implied obligation to provide software
enhancements are deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed
on a time-and-materials basis is recognized when performed. Other recurring revenue represented 47% and 41% of revenue for the six months
ended June 30, 2024, and 2023, respectively.
The
following table summarizes the Company’s revenue for systems, disposables, and service and accessories for the six months ended
June 30, 2024, and 2023 (in thousands):
Schedule of Revenue Disaggregated by Type
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
Systems | |
$ | 240 | | |
$ | 3,313 | | |
$ | 2,852 | | |
$ | 5,134 | |
Disposables, service and accessories | |
| 4,262 | | |
| 4,546 | | |
| 8,530 | | |
| 9,273 | |
Total revenue | |
$ | 4,502 | | |
$ | 7,859 | | |
$ | 11,382 | | |
$ | 14,407 | |
Transaction
price allocated to remaining performance obligations relates to amounts allocated to products and services for which the revenue has
not yet been recognized. A significant portion of this amount relates to the Company’s systems contracts and obligations that will
be recognized as revenue in future periods. These obligations are generally satisfied within two years after contract inception but may
occasionally extend longer. Transaction price representing revenue to be earned on remaining performance obligations on system contracts
was approximately $15.3 million as of June 30, 2024. Performance obligations arising from contracts for disposables and service are generally
expected to be satisfied within one year after entering into the contract.
The
following table summarizes the Company’s contract assets and liabilities (in thousands):
Summary of Contract Assets and Liabilities
| |
June 30, 2024 | | |
December 31, 2023 | |
Contract Assets - unbilled receivables | |
$ | 116 | | |
$ | 72 | |
| |
| | | |
| | |
Customer deposits | |
$ | 1,845 | | |
$ | 2,105 | |
Product shipped, revenue deferred | |
| 1,371 | | |
| 1,413 | |
Deferred service and license fees | |
| 3,855 | | |
| 4,776 | |
Total deferred revenue | |
$ | 7,071 | | |
$ | 8,294 | |
Less: Long-term deferred revenue | |
| (2,121 | ) | |
| (1,637 | ) |
Total current deferred revenue | |
$ | 4,950 | | |
$ | 6,657 | |
The
Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference
between the revenue that was earned but not billed on service contracts and revenue from system contracts that was recognized based on
the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Customer deposits
primarily relate to future system sales but can also include deposits on disposable sales. Deferred revenue is primarily related to service
contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system
contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally
recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance
obligations are satisfied. The Company did not have any impairment losses on its contract assets for the periods presented.
Revenue
recognized for the six months ended June 30, 2024, and 2023, that was included in the deferred revenue balance at the beginning of each
reporting period was $4.3 million.
|
Assets Recognized from the Costs to Obtain a Contract with a Customer |
Assets
Recognized from the Costs to Obtain a Contract with a Customer
The
Company has determined that sales incentive programs for the Company’s sales team meet the requirements to be capitalized as the
Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction.
The costs capitalized as contract acquisition costs included in prepaid expenses and other assets, in the Company’s balance sheet
were $0.1 million as of June 30, 2024, and December 31, 2023. The Company did not incur any impairment losses during any of the periods
presented.
Costs
of systems revenue include direct product costs, installation labor and other costs including estimated assurance-type warranty costs,
and initial training costs, when applicable. These costs are recognized at the time of sale. Costs of disposable revenue include direct
product costs and estimated warranty costs and are recognized at the time of sale. Cost of revenue from services and license fees are
recognized when incurred.
|
Leasing Arrangements |
Leasing
Arrangements
A
lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or equipment
for a period of time in exchange for consideration. The Company accounts for leases in accordance with Accounting Standards Update No.
2016-02 “Leases” (Topic 842) and all subsequent ASUs that modified Topic 842 (“ASC 842”). The Company determines
if an arrangement contains a lease at inception.
The
Company leases its facilities under operating leases. In accordance with ASC 842, operating lease agreements are recognized on the balance
sheet as a right-of-use (“ROU”) asset and a corresponding lease liability. These leases generally do not have significant
rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. Further, the leases do not contain
contingent rent provisions. Many of our leases include both lease (i.e., fixed payments including rent, taxes, and insurance costs) and
non-lease components (i.e., common-area or other maintenance costs) which are accounted for as a single lease component as we have elected
the practical expedient to group lease and non-lease components for all leases.
The
Company’s lease agreements often include one or more options to renew at the Company’s discretion. If at lease inception,
the Company considers the exercising of a renewal option to be reasonably certain, the Company will include the extended term in the
calculation of the ROU asset and lease liability. The Company elected not to include short-term leases (i.e., leases with initial terms
of twelve months or less) on the balance sheet.
The
calculated amounts of the ROU assets and lease liabilities are impacted by the length of the lease term and the discount rate used to
calculate the present value of the minimum lease payments. ASC 842 requires the use of the discount rate implicit in the lease whenever
this rate is readily determinable. As this rate is rarely determinable, the Company utilizes its incremental borrowing rate at lease
inception.
|
Stock-Based Compensation |
Stock-Based
Compensation
The
Company accounts for its grants of stock options, non-qualified stock options, stock appreciation rights, restricted shares, restricted
stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based
payments. These accounting principles require the determination of the fair value of the stock-based compensation at the grant date and
the recognition of the related expense over the period in which the stock-based compensation vests.
For
time-based awards, the Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation
rights at the date of grant. The weighted average assumptions and fair value for options granted during the six months ended June 30,
2024, were 1) expected dividend rate of 0%; 2) expected volatility of 76% based on the Company’s historical volatility; 3) risk-free
interest rate based on the Treasury yield on the date of grant; and 4) expected term of 6.25 years. The resulting compensation expense
is recognized over the requisite service period, which is generally four years. Restricted shares and units granted to employees and
non-employee directors are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense
over the service period, which is generally four years except for grants to directors which are generally earned over a period of six
months. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting
period and is subject to adjustment based on the actual achievement of objectives.
For
market-based awards, stock-based compensation expense is recognized over the minimum service period regardless of whether or not the
market target is probable of being achieved. The fair value of such awards is estimated on the grant date using Monte Carlo simulations.
Shares
purchased by employees under the 2022 Employee Stock Purchase Plans are considered to be non-compensatory.
|
Net Loss per Common Share |
Net
Loss per Common Share
Basic
earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common
shares outstanding during the period. In periods where there is net income, we apply the two-class method to calculate basic and diluted
net income (loss) per share of common stock, as our convertible preferred stock is a participating security. The two-class method is
an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available
to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as
our convertible preferred stock does not contractually participate in our losses. We compute diluted net income (loss) per common share
using net income (loss) as the “control number” in determining whether potential common shares are dilutive, after giving
consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding
during the period and potential issuance of stock upon the conversion of our convertible preferred stock issued and outstanding during
the period, except where the effect of such securities would be antidilutive.
The
following table sets forth the computation of basic and diluted EPS (in thousands except for share and per share amounts):
Schedule of Computation of Basic and Diluted Earnings Per Share
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
Net loss | |
$ | (5,833 | ) | |
$ | (4,957 | ) | |
$ | (10,340 | ) | |
$ | (10,304 | ) |
Cumulative dividend on convertible preferred stock | |
| (325 | ) | |
| (335 | ) | |
| (656 | ) | |
| (666 | ) |
Net loss attributable to common stockholders | |
$ | (6,158 | ) | |
$ | (5,292 | ) | |
$ | (10,996 | ) | |
$ | (10,970 | ) |
| |
| | | |
| | | |
| | | |
| | |
Weighted average number of common shares and equivalents: | |
| 84,570,738 | | |
| 81,049,211 | | |
| 84,025,335 | | |
| 78,787,652 | |
Basic EPS | |
$ | (0.07 | ) | |
$ | (0.07 | ) | |
$ | (0.13 | ) | |
$ | (0.14 | ) |
Diluted EPS | |
$ | (0.07 | ) | |
$ | (0.07 | ) | |
$ | (0.13 | ) | |
$ | (0.14 | ) |
The
Company did not include any portion of unearned restricted shares, outstanding options, stock appreciation rights, warrants or convertible
preferred stock in the calculation of diluted loss per common share because all such securities are anti-dilutive for all periods presented.
The application of the two-class method of computing earnings per share under general accounting principles for participating securities
is not applicable during these periods because those securities do not contractually participate in its losses.
As
of June 30, 2024, the Company had 4,103,847 shares of common stock issuable upon the exercise of outstanding options and stock appreciation
rights at a weighted average exercise price of $3.77 per share, 48,882,491 shares of our common stock issuable upon conversion of our
Series A Convertible Preferred Stock and 1,399,157 shares of unvested restricted share units. The Company had no unearned restricted
shares outstanding as of June 30, 2024.
|
Recently Issued Accounting Pronouncements |
Recently
Issued Accounting Pronouncements
In
June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial
Instruments” and also issued subsequent amendments to the initial guidance under ASU 2018-19, ASU 2019-04 and ASU 2019-05. The
standard modifies the measurement approach for credit losses on financial instruments, including trade receivables, from an incurred
loss method to a current expected credit loss method, otherwise known as “CECL.” The standard requires the measurement of
expected credit losses to be based on relevant information, including historical experience, current conditions and a forecast that is
supportable. The Company adopted the standard in the first quarter of 2023. The impact to the Company’s financial results was immaterial.
In
December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”),
which requires enhanced income tax disclosures, primarily related to the effective tax rate reconciliation and income taxes paid. The
Company does not expect a significant impact on its income tax disclosures upon adoption of the ASU which will be effective in the Company’s
year ending December 31, 2025.
|
X |
- DefinitionRisks and uncertainties [Policy Text Block]
+ References
+ Details
Name: |
STXS_RisksAndUncertaintiesPolicyTextBlock |
Namespace Prefix: |
STXS_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_AccountingPoliciesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
+ Details
Name: |
us-gaap_BasisOfAccountingPolicyPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1
+ Details
Name: |
us-gaap_CashAndCashEquivalentsPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionEntity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(1)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1
+ Details
Name: |
us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for credit risk.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 942 -SubTopic 825 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -SubTopic 10 -Topic 275 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1
+ Details
Name: |
us-gaap_ConcentrationRiskCreditRisk |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2
+ Details
Name: |
us-gaap_EarningsPerSharePolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.
+ References
+ Details
Name: |
us-gaap_FairValueMeasurementPolicyPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for investment in financial asset.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(3)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(f)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(f)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(f)(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 12 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-12
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 19 -Subparagraph (2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19
+ Details
Name: |
us-gaap_InvestmentPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for leasing arrangement entered into by lessee.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1
+ Details
Name: |
us-gaap_LesseeLeasesPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
+ Details
Name: |
us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for revenue from contract with customer.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 17 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 19 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 20 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 20 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 20 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 20 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20
Reference 9: http://www.xbrl.org/2003/role/exampleRef -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (e) -SubTopic 10 -Topic 235 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Topic 606 -Publisher FASB -URI https://asc.fasb.org/606/tableOfContent
+ Details
Name: |
us-gaap_RevenueFromContractWithCustomerPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4
Reference 3: http://www.xbrl.org/2003/role/exampleRef -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (e) -SubTopic 10 -Topic 235 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4
+ Details
Name: |
us-gaap_RevenueRecognitionPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(v) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.C.Q3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.D.1.Q5) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.D.3.Q2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.D.2.Q6) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for accounts receivable.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481962/310-10-50-6
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2
Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 310 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1
Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481962/310-10-50-15
Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11B -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B
+ Details
Name: |
us-gaap_TradeAndOtherAccountsReceivablePolicy |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Summary of Significant Accounting Policies (Tables)
|
6 Months Ended |
Jun. 30, 2024 |
Accounting Policies [Abstract] |
|
Schedule of Revenue Disaggregated by Type |
The
following table summarizes the Company’s revenue for systems, disposables, and service and accessories for the six months ended
June 30, 2024, and 2023 (in thousands):
Schedule of Revenue Disaggregated by Type
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
Systems | |
$ | 240 | | |
$ | 3,313 | | |
$ | 2,852 | | |
$ | 5,134 | |
Disposables, service and accessories | |
| 4,262 | | |
| 4,546 | | |
| 8,530 | | |
| 9,273 | |
Total revenue | |
$ | 4,502 | | |
$ | 7,859 | | |
$ | 11,382 | | |
$ | 14,407 | |
|
Summary of Contract Assets and Liabilities |
The
following table summarizes the Company’s contract assets and liabilities (in thousands):
Summary of Contract Assets and Liabilities
| |
June 30, 2024 | | |
December 31, 2023 | |
Contract Assets - unbilled receivables | |
$ | 116 | | |
$ | 72 | |
| |
| | | |
| | |
Customer deposits | |
$ | 1,845 | | |
$ | 2,105 | |
Product shipped, revenue deferred | |
| 1,371 | | |
| 1,413 | |
Deferred service and license fees | |
| 3,855 | | |
| 4,776 | |
Total deferred revenue | |
$ | 7,071 | | |
$ | 8,294 | |
Less: Long-term deferred revenue | |
| (2,121 | ) | |
| (1,637 | ) |
Total current deferred revenue | |
$ | 4,950 | | |
$ | 6,657 | |
|
Schedule of Computation of Basic and Diluted Earnings Per Share |
The
following table sets forth the computation of basic and diluted EPS (in thousands except for share and per share amounts):
Schedule of Computation of Basic and Diluted Earnings Per Share
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
Net loss | |
$ | (5,833 | ) | |
$ | (4,957 | ) | |
$ | (10,340 | ) | |
$ | (10,304 | ) |
Cumulative dividend on convertible preferred stock | |
| (325 | ) | |
| (335 | ) | |
| (656 | ) | |
| (666 | ) |
Net loss attributable to common stockholders | |
$ | (6,158 | ) | |
$ | (5,292 | ) | |
$ | (10,996 | ) | |
$ | (10,970 | ) |
| |
| | | |
| | | |
| | | |
| | |
Weighted average number of common shares and equivalents: | |
| 84,570,738 | | |
| 81,049,211 | | |
| 84,025,335 | | |
| 78,787,652 | |
Basic EPS | |
$ | (0.07 | ) | |
$ | (0.07 | ) | |
$ | (0.13 | ) | |
$ | (0.14 | ) |
Diluted EPS | |
$ | (0.07 | ) | |
$ | (0.07 | ) | |
$ | (0.13 | ) | |
$ | (0.14 | ) |
|
X |
- References
+ Details
Name: |
us-gaap_AccountingPoliciesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10
+ Details
Name: |
us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5
+ Details
Name: |
us-gaap_DisaggregationOfRevenueTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1
+ Details
Name: |
us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Financial Instruments (Tables)
|
6 Months Ended |
Jun. 30, 2024 |
Investments, All Other Investments [Abstract] |
|
Schedule of Cash and Cash Equivalents, Restricted Cash and Investments |
The
following tables summarize the Company’s cash and fair value by significant category reported as cash and cash equivalents and
restricted cash as of June 30, 2024, and December 31, 2023:
Schedule of Cash and Cash Equivalents, Restricted Cash and Investments
| |
June 30, 2024 | |
| |
Valuation | | |
Reported as: | |
(in thousands) | |
Amortized Cost | | |
Gross Unrealized Gains | | |
Gross Unrealized Losses | | |
Fair Value | | |
Cash and Cash Equivalents | | |
Restricted Cash- current | | |
Short-term Investments | | |
Restricted Cash | |
Cash | |
$ | 1,726 | | |
$ | - | | |
$ | - | | |
$ | 1,726 | | |
$ | 1,726 | | |
$ | - | | |
$ | - | | |
$ | - | |
Level 2 | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Money market funds | |
| 13,438 | | |
| - | | |
| - | | |
| 13,438 | | |
| 12,957 | | |
| 481 | | |
| - | | |
| - | |
Subtotal | |
| 13,438 | | |
| - | | |
| - | | |
| 13,438 | | |
| 12,957 | | |
| 481 | | |
| - | | |
| - | |
Total assets measured at fair value | |
$ | 15,164 | | |
$ | - | | |
$ | - | | |
$ | 15,164 | | |
$ | 14,683 | | |
$ | 481 | | |
$ | - | | |
$ | - | |
| |
December 31, 2023 | |
| |
Valuation | | |
Reported as: | |
(in thousands) | |
Amortized Cost | | |
Gross Unrealized Gains | | |
Gross Unrealized Losses | | |
Fair Value | | |
Cash and Cash Equivalents | | |
Restricted Cash- current | | |
Short-term Investments | | |
Restricted Cash | |
Cash | |
$ | 2,122 | | |
$ | - | | |
$ | - | | |
$ | 2,122 | | |
$ | 2,122 | | |
$ | - | | |
$ | - | | |
$ | - | |
Level 2 | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Money market funds | |
| 18,440 | | |
| - | | |
| - | | |
| 18,440 | | |
| 17,696 | | |
| 525 | | |
| - | | |
| 219 | |
Subtotal | |
| 18,440 | | |
| - | | |
| - | | |
| 18,440 | | |
| 17,696 | | |
| 525 | | |
| - | | |
| 219 | |
Total assets measured at fair value | |
$ | 20,562 | | |
$ | - | | |
$ | - | | |
$ | 20,562 | | |
$ | 19,818 | | |
$ | 525 | | |
$ | - | | |
$ | 219 | |
|
X |
- References
+ Details
Name: |
us-gaap_InvestmentsAllOtherInvestmentsAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of the components of cash, cash equivalents, and investments.
+ References
+ Details
Name: |
us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Inventories (Tables)
|
6 Months Ended |
Jun. 30, 2024 |
Inventory Disclosure [Abstract] |
|
Schedule of Inventories |
Inventories
consist of the following (in thousands):
Schedule
of Inventories
| |
June 30, 2024 | | |
December 31, 2023 | |
Raw materials | |
$ | 6,064 | | |
$ | 5,918 | |
Work in process | |
| 1,112 | | |
| 1,034 | |
Finished goods | |
| 4,111 | | |
| 3,413 | |
Reserve for excess and obsolescence | |
| (2,003 | ) | |
| (1,939 | ) |
Total inventory | |
$ | 9,284 | | |
$ | 8,426 | |
|
X |
- References
+ Details
Name: |
us-gaap_InventoryDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(c)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1
+ Details
Name: |
us-gaap_ScheduleOfInventoryCurrentTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Prepaid Expenses and Other Assets (Tables)
|
6 Months Ended |
Jun. 30, 2024 |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] |
|
Schedule of Prepaid Expenses and Other Assets |
Prepaid
expenses and other assets consist of the following (in thousands):
Schedule
of Prepaid Expenses and Other Assets
| |
June 30, 2024 | | |
December 31, 2023 | |
Prepaid expenses | |
$ | 297 | | |
$ | 181 | |
Prepaid commissions | |
| 97 | | |
| 110 | |
Deposits | |
| 467 | | |
| 424 | |
Other assets | |
| 97 | | |
| 98 | |
Total prepaid expenses and other assets | |
| 958 | | |
| 813 | |
Less: Noncurrent prepaid expenses and other assets | |
| (116 | ) | |
| (137 | ) |
Total current prepaid expenses and other assets | |
$ | 842 | | |
$ | 676 | |
|
X |
- References
+ Details
Name: |
us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.
+ References
+ Details
Name: |
us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Property and Equipment (Tables)
|
6 Months Ended |
Jun. 30, 2024 |
Property, Plant and Equipment [Abstract] |
|
Schedule of Property and Equipment |
Property
and Equipment consist of the following (in thousands):
Schedule
of Property and Equipment
| |
June 30, 2024 | | |
December 31, 2023 | |
Equipment | |
$ | 4,288 | | |
$ | 4,269 | |
Leasehold improvements | |
| 2,911 | | |
| 2,911 | |
Gross property and equipment | |
| 7,199 | | |
| 7,180 | |
Less: Accumulated depreciation | |
| (4,140 | ) | |
| (3,876 | ) |
Net property and equipment | |
$ | 3,059 | | |
$ | 3,304 | |
|
X |
- References
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 360 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Leases (Tables)
|
6 Months Ended |
Jun. 30, 2024 |
Leases |
|
Schedule of Lease Costs and Other Lease Information |
The
following table represents lease costs and other lease information (in thousands):
Schedule
of Lease Costs and Other Lease Information
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
Operating lease cost | |
$ | 227 | | |
$ | 227 | | |
$ | 454 | | |
$ | 454 | |
Short-term lease cost | |
| 5 | | |
| 4 | | |
| 8 | | |
| 8 | |
Total net lease cost | |
$ | 232 | | |
$ | 231 | | |
$ | 462 | | |
$ | 462 | |
| |
| | | |
| | | |
| | | |
| | |
Cash paid within operating cash flows | |
$ | 253 | | |
$ | 245 | | |
$ | 510 | | |
$ | 486 | |
|
Schedule of Future Minimum Operating Lease Payments |
Future
minimum payments for operating leases with initial or remaining terms of one year or more as of June 30, 2024, were as follows (in thousands):
Schedule
of Future Minimum Operating Lease Payments
| | |
June 30, 2024 | |
2024 | | |
$ | 449 | |
2025 | | |
| 919 | |
2026 | | |
| 935 | |
2027 | | |
| 956 | |
2028 | | |
| 976 | |
2029 and thereafter | | |
| 3,054 | |
Total lease payments | | |
| 7,289 | |
Less: Interest | | |
| (2,008 | ) |
Present value of lease liabilities | | |
$ | 5,281 | |
|
X |
- References
+ Details
Name: |
STXS_DisclosureLeasesAbstract |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4
+ Details
Name: |
us-gaap_LeaseCostTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6
+ Details
Name: |
us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Accrued Liabilities (Tables)
|
6 Months Ended |
Jun. 30, 2024 |
Payables and Accruals [Abstract] |
|
Schedule of Accrued Liabilities |
Accrued
liabilities consist of the following (in thousands):
Schedule
of Accrued Liabilities
| |
June 30, 2024 | | |
December 31, 2023 | |
Accrued salaries, bonus, and benefits | |
$ | 1,230 | | |
$ | 1,222 | |
Accrued licenses and maintenance fees | |
| - | | |
| 484 | |
Accrued warranties | |
| 83 | | |
| 107 | |
Accrued professional services | |
| 176 | | |
| 138 | |
Accrued investigational sites | |
| 101 | | |
| - | |
Deferred contract obligation | |
| 1,045 | | |
| 1,045 | |
Other | |
| 117 | | |
| 19 | |
Total accrued liabilities | |
| 2,752 | | |
| 3,015 | |
Less: Long term accrued liabilities | |
| (54 | ) | |
| (43 | ) |
Total current accrued liabilities | |
$ | 2,698 | | |
$ | 2,972 | |
The
Company reversed an aged accrued regulatory fee of approximately $0.5 million during the three-month period ended June 30, 2024. The
release was recognized as a reduction of research and development expenses within the Statement of Operations.
|
X |
- References
+ Details
Name: |
us-gaap_PayablesAndAccrualsAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of the components of accrued liabilities.
+ References
+ Details
Name: |
us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Convertible Preferred Stock and Stockholders’ Equity (Tables)
|
6 Months Ended |
Jun. 30, 2024 |
Equity [Abstract] |
|
Summary of Performance Award And Market Capitalization Milestones |
Summary
of Performance Award And Market Capitalization Milestones
Tranche # | | |
No. of Shares Subject to PSU | | |
Market Capitalization Milestones(1) | |
1 | | |
| 1,000,000 | | |
$ | 1,000,000,000 | |
2 | | |
| 1,500,000 | | |
$ | 1,500,000,000 | |
3 | | |
| 1,500,000 | | |
$ | 2,000,000,000 | |
4 | | |
| 2,000,000 | | |
$ | 2,500,000,000 | |
5 | | |
| 1,000,000 | | |
$ | 3,000,000,000 | |
6 | | |
| 1,000,000 | | |
$ | 3,500,000,000 | |
7 | | |
| 1,000,000 | | |
$ | 4,000,000,000 | |
8 | | |
| 2,000,000 | | |
$ | 4,500,000,000 | |
9 | | |
| 1,000,000 | | |
$ | 5,000,000,000 | |
10 | | |
| 1,000,000 | | |
$ | 5,500,000,000 | |
Total: | | |
| 13,000,000 | | |
| | |
|
Summary of Option and Stock Appreciation Rights Activity |
A
summary of the option and stock appreciation rights activity for the six-month period ended June 30, 2024, is as follows:
Summary
of Option and Stock Appreciation Rights Activity
| |
Number of Options/SARs | | |
Range of Exercise Price | | |
Weighted Average Exercise Price per Share | |
Outstanding, December 31, 2023 | |
| 3,650,115 | | |
| $0.74 - $9.87 | | |
$ | 3.93 | |
Granted | |
| 716,500 | | |
| $2.45 - $3.01 | | |
$ | 3.00 | |
Exercised | |
| (11,763 | ) | |
| $0.74 - $2.57 | | |
$ | 1.02 | |
Forfeited | |
| (251,005 | ) | |
| $0.74 - $9.20 | | |
$ | 3.99 | |
Outstanding, June 30, 2024 | |
| 4,103,847 | | |
| $0.74 - $9.87 | | |
$ | 3.77 | |
|
Schedule of Restricted Stock Unit Activity |
A
summary of the restricted stock unit activity for the six-month period ended June 30, 2024, is as follows:
Schedule
of Restricted Stock Unit Activity
| |
Number of Restricted Stock Units | | |
Weighted Average Grant Date Fair Value per Unit | |
Outstanding, December 31, 2023 | |
| 1,502,131 | | |
$ | 3.94 | |
Granted | |
| 389,610 | | |
$ | 1.54 | |
Vested | |
| (492,584 | ) | |
$ | 3.03 | |
Outstanding, June 30, 2024 | |
| 1,399,157 | | |
$ | 3.60 | |
|
X |
- DefinitionSummary of performance award and market capitalization milestones [Table Text Block]
+ References
+ Details
Name: |
STXS_SummaryofPerformanceAwardAndMarketCapitalizationMilestonesTableTextBlock |
Namespace Prefix: |
STXS_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_EquityAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Product Warranty Provisions (Tables)
|
6 Months Ended |
Jun. 30, 2024 |
Guarantees and Product Warranties [Abstract] |
|
Schedule of Accrued Warranty |
Accrued
assurance-type warranty, which is included in other accrued liabilities, consists of the following (in thousands):
Schedule
of Accrued Warranty
| |
June 30, 2024 | | |
December 31, 2023 | |
Warranty accrual, beginning of the fiscal period | |
$ | 107 | | |
$ | 163 | |
Accrual adjustment for product warranty | |
| (8 | ) | |
| 547 | |
Payments made | |
| (16 | ) | |
| (603 | ) |
Warranty accrual, end of the fiscal period | |
$ | 83 | | |
$ | 107 | |
|
X |
- References
+ Details
Name: |
us-gaap_GuaranteesAndProductWarrantiesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8
+ Details
Name: |
us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Schedule of Revenue Disaggregated by Type (Details) - USD ($) $ in Thousands |
3 Months Ended |
6 Months Ended |
Jun. 30, 2024 |
Jun. 30, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
Product Information [Line Items] |
|
|
|
|
Total revenue |
$ 4,502
|
$ 7,859
|
$ 11,382
|
$ 14,407
|
Systems [Member] |
|
|
|
|
Product Information [Line Items] |
|
|
|
|
Total revenue |
240
|
3,313
|
2,852
|
5,134
|
Disposables Service and Accessories [Member] |
|
|
|
|
Product Information [Line Items] |
|
|
|
|
Total revenue |
$ 4,262
|
$ 4,546
|
$ 8,530
|
$ 9,273
|
X |
- DefinitionAmount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32
Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32
Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 924 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4
+ Details
Name: |
us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- Details
Name: |
srt_ProductOrServiceAxis=STXS_SystemsMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_ProductOrServiceAxis=STXS_DisposablesServiceAndAccessoriesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.24.2.u1
Summary of Contract Assets and Liabilities (Details) - USD ($) $ in Thousands |
Jun. 30, 2024 |
Dec. 31, 2023 |
Product Information [Line Items] |
|
|
Contract Assets - unbilled receivables |
$ 116
|
$ 72
|
Total deferred revenue |
7,071
|
8,294
|
Less: Long-term deferred revenue |
(2,121)
|
(1,637)
|
Total current deferred revenue |
4,950
|
6,657
|
Customer Deposits [Member] |
|
|
Product Information [Line Items] |
|
|
Total deferred revenue |
1,845
|
2,105
|
Product Shipped Revenue Deferred [Member] |
|
|
Product Information [Line Items] |
|
|
Total deferred revenue |
1,371
|
1,413
|
Deferred Service and License Fees [Member] |
|
|
Product Information [Line Items] |
|
|
Total deferred revenue |
$ 3,855
|
$ 4,776
|
X |
- DefinitionAmount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8
+ Details
Name: |
us-gaap_ContractWithCustomerAssetNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of obligation to transfer good or service to customer for which consideration has been received or is receivable.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2
+ Details
Name: |
us-gaap_ContractWithCustomerLiability |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2
+ Details
Name: |
us-gaap_ContractWithCustomerLiabilityCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2
+ Details
Name: |
us-gaap_ContractWithCustomerLiabilityNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- Details
Name: |
srt_ProductOrServiceAxis=STXS_CustomerDepositsMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_ProductOrServiceAxis=STXS_ProductShippedRevenueDeferredMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_ProductOrServiceAxis=STXS_DeferredServiceAndLicenseFeesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.24.2.u1
Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended |
6 Months Ended |
Jun. 30, 2024 |
Jun. 30, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
Accounting Policies [Abstract] |
|
|
|
|
Net loss |
$ (5,833)
|
$ (4,957)
|
$ (10,340)
|
$ (10,304)
|
Cumulative dividend on convertible preferred stock |
(325)
|
(335)
|
(656)
|
(666)
|
Net loss attributable to common stockholders |
$ (6,158)
|
$ (5,292)
|
$ (10,996)
|
$ (10,970)
|
Weighted average number of common shares and equivalents, basic |
84,570,738
|
81,049,211
|
84,025,335
|
78,787,652
|
Weighted average number of common shares and equivalents, diluted |
84,570,738
|
81,049,211
|
84,025,335
|
78,787,652
|
Basic EPS |
$ (0.07)
|
$ (0.07)
|
$ (0.13)
|
$ (0.14)
|
Diluted EPS |
$ (0.07)
|
$ (0.07)
|
$ (0.13)
|
$ (0.14)
|
X |
- References
+ Details
Name: |
us-gaap_AccountingPoliciesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 52 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (e)(4) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(25)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(27)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(23)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7
+ Details
Name: |
us-gaap_EarningsPerShareBasic |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 52 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (e)(4) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(25)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(27)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(23)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7
+ Details
Name: |
us-gaap_EarningsPerShareDiluted |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4
Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A
Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B
Reference 32: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B
Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7
Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28
Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A
Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B
Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1
+ Details
Name: |
us-gaap_NetIncomeLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 5 -Subparagraph (SAB Topic 6.B) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B
+ Details
Name: |
us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.
+ References
+ Details
Name: |
us-gaap_PreferredStockDividendsIncomeStatementImpact |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 16 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16
+ Details
Name: |
us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionNumber of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10
+ Details
Name: |
us-gaap_WeightedAverageNumberOfSharesOutstandingBasic |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Summary of Significant Accounting Policies (Details Narrative) - USD ($) $ / shares in Units, $ in Millions |
6 Months Ended |
12 Months Ended |
Jun. 30, 2024 |
Jun. 30, 2023 |
Dec. 31, 2023 |
Product Information [Line Items] |
|
|
|
Restricted cash |
$ 0.5
|
|
$ 0.7
|
Short-term investments |
|
|
|
Expected credit loss on investments or accrued interest, description |
The Company did not have any material expected credit
losses on investments or material expected credit losses on accrued interest related to investments during the six months ended June
30, 2024, or year ended December 31, 2023.
|
|
The Company did not have any material expected credit
losses on investments or material expected credit losses on accrued interest related to investments during the six months ended June
30, 2024, or year ended December 31, 2023.
|
Remaining performance obligations |
$ 15.3
|
|
|
Contract with customer liability revenue recognized |
4.3
|
$ 4.3
|
|
Capitalized contract cost |
$ 0.1
|
|
$ 0.1
|
Expected dividend rate |
0.00%
|
|
|
Expected volatility |
76.00%
|
|
|
Expected term |
6 years 3 months
|
|
|
Series A Convertible Preferred Stock [Member] |
|
|
|
Product Information [Line Items] |
|
|
|
Potential common shares excluded from diluted earnings per share |
48,882,491
|
|
|
Stock Options and Stock Appreciation Rights [Member] |
|
|
|
Product Information [Line Items] |
|
|
|
Potential common shares excluded from diluted earnings per share |
4,103,847
|
|
|
Weighted average exercise price |
$ 3.77
|
|
|
Restricted Stock [Member] |
|
|
|
Product Information [Line Items] |
|
|
|
Potential common shares excluded from diluted earnings per share |
1,399,157
|
|
|
Unearned Restricted Shares [Member] |
|
|
|
Product Information [Line Items] |
|
|
|
Potential common shares excluded from diluted earnings per share |
0
|
|
|
Revenue From System Delivery and Installation [Member] | Product Concentration Risk [Member] |
|
|
|
Product Information [Line Items] |
|
|
|
Concentration risk percentage |
25.00%
|
36.00%
|
|
Disposable Revenue [Member] | Product Concentration Risk [Member] |
|
|
|
Product Information [Line Items] |
|
|
|
Concentration risk percentage |
28.00%
|
22.00%
|
|
Royalty Revenue [Member] | Product Concentration Risk [Member] |
|
|
|
Product Information [Line Items] |
|
|
|
Concentration risk percentage |
1.00%
|
1.00%
|
|
Other Recurring Revenue [Member] | Product Concentration Risk [Member] |
|
|
|
Product Information [Line Items] |
|
|
|
Concentration risk percentage |
47.00%
|
41.00%
|
|
Systems [Member] |
|
|
|
Product Information [Line Items] |
|
|
|
Warranty costs |
$ 0.1
|
$ 0.1
|
|
Other Current Assets [Member] | Maximum [Member] |
|
|
|
Product Information [Line Items] |
|
|
|
Accrued interest receivable |
$ 0.1
|
|
$ 0.1
|
X |
- DefinitionAccrued interest receivable on investment.
+ References
+ Details
Name: |
STXS_AccruedInterestReceivableOnInvestment |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionConcentration Risk Threshold Percentage.
+ References
+ Details
Name: |
STXS_ConcentrationRiskThresholdPercentage |
Namespace Prefix: |
STXS_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionExpected credit loss on investments and accrued interest description.
+ References
+ Details
Name: |
STXS_ExpectedCreditLossOnInvestmentsAndAccruedInterestDescription |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionSecurities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1
+ Details
Name: |
us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 340 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479483/340-40-50-3
+ Details
Name: |
us-gaap_CapitalizedContractCostNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8
+ Details
Name: |
us-gaap_ContractWithCustomerLiabilityRevenueRecognized |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe expense charged against earnings for the period pertaining to standard and extended warranties on the entity's goods and services granted to customers.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8
+ Details
Name: |
us-gaap_ProductWarrantyExpense |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8
Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(1)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1
+ Details
Name: |
us-gaap_RestrictedCash |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of transaction price allocated to performance obligation that has not been recognized as revenue.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -SubTopic 10 -Topic 606 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13
+ Details
Name: |
us-gaap_RevenueRemainingPerformanceObligation |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionThe estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionWeighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionExpected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:durationItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(8)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_ShortTermInvestments |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- Details
Name: |
us-gaap_StatementEquityComponentsAxis=STXS_SeriesAConvertiblePreferredStockMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_AwardTypeAxis=STXS_StockOptionsandStockAppreciationRightsMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_AwardTypeAxis=STXS_UnearnedRestrictedSharesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_ConcentrationRiskByBenchmarkAxis=STXS_RevenueFromSystemDeliveryAndInstallationMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_ConcentrationRiskByBenchmarkAxis=STXS_DisposableRevenueMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_ConcentrationRiskByBenchmarkAxis=STXS_RoyaltyRevenueMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_ConcentrationRiskByBenchmarkAxis=STXS_OtherRecurringRevenueMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_ProductOrServiceAxis=STXS_SystemsMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_RangeAxis=srt_MaximumMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.24.2.u1
Schedule of Cash and Cash Equivalents, Restricted Cash and Investments (Details) - USD ($) $ in Thousands |
Jun. 30, 2024 |
Dec. 31, 2023 |
Jun. 30, 2023 |
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] |
|
|
|
Cash and Cash Equivalents |
$ 14,683
|
$ 19,818
|
$ 22,877
|
Restricted Cash- current |
481
|
525
|
569
|
Short-term Investments |
|
|
|
Restricted Cash |
|
219
|
$ 481
|
Total assets measured at fair value, Amortized Cost |
15,164
|
20,562
|
|
Total assets measured at fair value, Gross Unrealized Gains |
|
|
|
Total assets measured at fair value, Gross Unrealized Losses |
|
|
|
Total assets measured at fair value, Fair value |
15,164
|
20,562
|
|
Fair Value, Inputs, Level 2 [Member] |
|
|
|
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] |
|
|
|
Cash and Cash Equivalents |
12,957
|
17,696
|
|
Restricted Cash- current |
481
|
525
|
|
Short-term Investments |
|
|
|
Restricted Cash |
|
219
|
|
Cash and Held to maturity securities, Amortized Cost |
13,438
|
18,440
|
|
Cash and Held to maturity securities, Gross Unrealized Gains |
|
|
|
Cash and Held to maturity securities, Gross Unrealized Losses |
|
|
|
Cash and Held to maturity securities, Fair Value |
13,438
|
18,440
|
|
Cash [Member] |
|
|
|
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] |
|
|
|
Cash, Amortized Cost |
1,726
|
2,122
|
|
Cash, Gross Unrealized Gains |
|
|
|
Cash, Gross Unrealized Losses |
|
|
|
Cash, Fair Value |
1,726
|
2,122
|
|
Cash and Cash Equivalents |
1,726
|
2,122
|
|
Restricted Cash- current |
|
|
|
Short-term Investments |
|
|
|
Restricted Cash |
|
|
|
Money Market Funds [Member] | Fair Value, Inputs, Level 2 [Member] |
|
|
|
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] |
|
|
|
Cash, Amortized Cost |
13,438
|
18,440
|
|
Cash, Gross Unrealized Gains |
|
|
|
Cash, Gross Unrealized Losses |
|
|
|
Cash, Fair Value |
13,438
|
18,440
|
|
Cash and Cash Equivalents |
12,957
|
17,696
|
|
Restricted Cash- current |
481
|
525
|
|
Short-term Investments |
|
|
|
Restricted Cash |
|
$ 219
|
|
X |
- DefinitionCash and cash equivalents, gross unrealized gains.
+ References
+ Details
Name: |
STXS_CashAndCashEquivalentsAtCarryingValueGrossUnrealizedGains |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionCash and cash equivalents, gross unrealized losses.
+ References
+ Details
Name: |
STXS_CashAndCashEquivalentsAtCarryingValueGrossUnrealizedLosses |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionTotal debt securities held to maturity inclusive of cash, amortized costs.
+ References
+ Details
Name: |
STXS_DebtSecuritiesHeldToMaturityInclusiveOfCashAndCashEquivalentsAtCarryingValueAmortizedCosts |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionTotal debt securities held to maturity inclusive of cash, gross unrealized gains.
+ References
+ Details
Name: |
STXS_DebtSecuritiesHeldToMaturityInclusiveOfCashAndCashEquivalentsAtCarryingValueGrossUnrealizedGains |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionTotal debt securities held to maturity inclusive of cash, gross unrealized losses.
+ References
+ Details
Name: |
STXS_DebtSecuritiesHeldToMaturityInclusiveOfCashAndCashEquivalentsAtCarryingValueGrossUnrealizedLosses |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionTotal debt securities held to maturity inclusive of cash, fair value.
+ References
+ Details
Name: |
STXS_DebtSecuritiesHeldToMaturityInclusiveOfCashAndCashEquivalentsFairValueDisclosure |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 45 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21
Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 45 -Paragraph 20 -SubTopic 210 -Topic 946 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20
+ Details
Name: |
us-gaap_Cash |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4
+ Details
Name: |
us-gaap_CashAndCashEquivalentsAtCarryingValue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionFair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2
+ Details
Name: |
us-gaap_CashAndCashEquivalentsFairValueDisclosure |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13
+ Details
Name: |
us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7A -Publisher FASB -URI https://asc.fasb.org/1943274/2147481962/310-10-50-7A
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479319/326-20-50-14
+ Details
Name: |
us-gaap_HeldToMaturitySecurities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5A -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5A
+ Details
Name: |
us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5A -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5A
+ Details
Name: |
us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionFair value of investment in debt security measured at amortized cost (held-to-maturity).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2E -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E
Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (aa) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5A
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1
+ Details
Name: |
us-gaap_HeldToMaturitySecuritiesFairValue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8
+ Details
Name: |
us-gaap_RestrictedCashCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(17)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 45 -Paragraph 5 -SubTopic 210 -Topic 954 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8
+ Details
Name: |
us-gaap_RestrictedCashNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(8)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_ShortTermInvestments |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- Details
Name: |
us-gaap_FinancialInstrumentAxis=us-gaap_CashMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.24.2.u1
X |
- DefinitionAmount of interest income (expense) classified as operating.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(10)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1
+ Details
Name: |
us-gaap_InterestIncomeExpenseNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_InvestmentsAllOtherInvestmentsAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Schedule of Inventories (Details) - USD ($) $ in Thousands |
Jun. 30, 2024 |
Dec. 31, 2023 |
Inventory Disclosure [Abstract] |
|
|
Raw materials |
$ 6,064
|
$ 5,918
|
Work in process |
1,112
|
1,034
|
Finished goods |
4,111
|
3,413
|
Reserve for excess and obsolescence |
(2,003)
|
(1,939)
|
Total inventory |
$ 9,284
|
$ 8,426
|
X |
- References
+ Details
Name: |
us-gaap_InventoryDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(a)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_InventoryFinishedGoods |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_InventoryNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(a)(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_InventoryRawMaterials |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of valuation reserve for inventory.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 330 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.BB) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_InventoryValuationReserves |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(a)(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_InventoryWorkInProcess |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
v3.24.2.u1
X |
- DefinitionPrepaid commissions current and noncurrent.
+ References
+ Details
Name: |
STXS_PrepaidCommissionsCurrentAndNoncurrent |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCarrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(17)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_DepositsAssets |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of assets classified as other.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 49 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(10)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1
Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(10)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(17)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_OtherAssets |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.
+ References
+ Details
Name: |
us-gaap_PrepaidExpenseAndOtherAssets |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_PrepaidExpenseAndOtherAssetsCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(10)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(18)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionCarrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(10)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(10)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(7)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_PrepaidExpenseCurrentAndNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
v3.24.2.u1
Schedule of Property and Equipment (Details) - USD ($) $ in Thousands |
Jun. 30, 2024 |
Dec. 31, 2023 |
Property, Plant and Equipment [Line Items] |
|
|
Gross property and equipment |
$ 7,199
|
$ 7,180
|
Less: Accumulated depreciation |
(4,140)
|
(3,876)
|
Net property and equipment |
3,059
|
3,304
|
Equipment [Member] |
|
|
Property, Plant and Equipment [Line Items] |
|
|
Gross property and equipment |
4,288
|
4,269
|
Leasehold Improvements [Member] |
|
|
Property, Plant and Equipment [Line Items] |
|
|
Gross property and equipment |
$ 2,911
|
$ 2,911
|
X |
- DefinitionAmount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(8)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(14)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1
+ Details
Name: |
us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(8)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(13)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 360 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentGross |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 360 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A
Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(8)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 360 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- Details
Name: |
us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.24.2.u1
X |
- References
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.
+ References
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentAdditions |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
v3.24.2.u1
X |
- References
+ Details
Name: |
STXS_DisclosureLeasesAbstract |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of lease cost recognized by lessee for lease contract.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 53 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4
+ Details
Name: |
us-gaap_LeaseCost |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 53 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4
+ Details
Name: |
us-gaap_OperatingLeaseCost |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 5 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (g)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4
+ Details
Name: |
us-gaap_OperatingLeasePayments |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of short-term lease cost, excluding expense for lease with term of one month or less.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 53 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4
+ Details
Name: |
us-gaap_ShortTermLeaseCost |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
v3.24.2.u1
X |
- References
+ Details
Name: |
STXS_DisclosureLeasesAbstract |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLessee operating lease liability payments due year five and thereafter.
+ References
+ Details
Name: |
STXS_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereafter |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payment for operating lease.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6
+ Details
Name: |
us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6
+ Details
Name: |
us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6
+ Details
Name: |
us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6
+ Details
Name: |
us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6
+ Details
Name: |
us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6
+ Details
Name: |
us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6
+ Details
Name: |
us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionPresent value of lessee's discounted obligation for lease payments from operating lease.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1
+ Details
Name: |
us-gaap_OperatingLeaseLiability |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
v3.24.2.u1
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1
+ Details
Name: |
us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDescription of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3
+ Details
Name: |
us-gaap_LesseeOperatingLeaseOptionToExtend |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTerm of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3
+ Details
Name: |
us-gaap_LesseeOperatingLeaseRenewalTerm |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:durationItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionTerm of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3
+ Details
Name: |
us-gaap_LesseeOperatingLeaseTermOfContract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:durationItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionWeighted average discount rate for operating lease calculated at point in time.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 53 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (g)(4) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4
+ Details
Name: |
us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionWeighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 53 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (g)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4
+ Details
Name: |
us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1 |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:durationItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionCash payments to lessor's for use of assets under operating leases.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (g) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25
+ Details
Name: |
us-gaap_PaymentsForRent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_TypeOfArrangementAxis=STXS_OfficeLeaseAgreementMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
dei_LegalEntityAxis=STXS_GlobeBuildingCompanyMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_AwardDateAxis=STXS_TwoThousandTwentyTwoMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_AwardDateAxis=STXS_TwoThousandThirtyOneMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.24.2.u1
Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands |
Jun. 30, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Payables and Accruals [Abstract] |
|
|
|
Accrued salaries, bonus, and benefits |
$ 1,230
|
$ 1,222
|
|
Accrued licenses and maintenance fees |
|
484
|
|
Accrued warranties |
83
|
107
|
$ 163
|
Accrued professional services |
176
|
138
|
|
Accrued investigational sites |
101
|
|
|
Deferred contract obligation |
1,045
|
1,045
|
|
Other |
117
|
19
|
|
Total accrued liabilities |
2,752
|
3,015
|
|
Less: Long term accrued liabilities |
(54)
|
(43)
|
|
Total current accrued liabilities |
$ 2,698
|
$ 2,972
|
|
X |
- DefinitionAccrued investigational sites.
+ References
+ Details
Name: |
STXS_AccruedInvestigationalSites |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAccrued licenses and maintenance fees current and noncurrent.
+ References
+ Details
Name: |
STXS_AccruedLicensesAndMaintenanceFeesCurrentAndNoncurrent |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionCarrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_AccruedLiabilitiesCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionCarrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(15)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1
+ Details
Name: |
us-gaap_AccruedLiabilitiesCurrentAndNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionCarrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_AccruedProfessionalFeesCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3
+ Details
Name: |
us-gaap_ContractualObligation |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of expenses incurred but not yet paid classified as other.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(15)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1
+ Details
Name: |
us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(24)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_OtherLiabilitiesNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_PayablesAndAccrualsAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCarrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (c)(5) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8
+ Details
Name: |
us-gaap_ProductWarrantyAccrualClassifiedCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
v3.24.2.u1
X |
- Definition
+ References
+ Details
Name: |
STXS_AccruedRegulatoryFee |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_PayablesAndAccrualsAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.2.u1
Summary of Performance Award And Market Capitalization Milestones (Details) - PSU Agreement [Member] - Mr. Fischel [Member]
|
Feb. 23, 2021
USD ($)
shares
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
Number of shares subject to PSU | shares |
13,000,000
|
Market capitalization milestone, amount | $ |
$ 1,000,000,000.0
|
Share-Based Payment Arrangement, Tranche One [Member] |
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
Number of shares subject to PSU | shares |
1,000,000
|
Market capitalization milestone, amount | $ |
$ 1,000,000,000
|
Share-Based Payment Arrangement, Tranche Two [Member] |
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
Number of shares subject to PSU | shares |
1,500,000
|
Market capitalization milestone, amount | $ |
$ 1,500,000,000
|
Share-Based Payment Arrangement, Tranche Three [Member] |
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
Number of shares subject to PSU | shares |
1,500,000
|
Market capitalization milestone, amount | $ |
$ 2,000,000,000
|
ShareBased Compensation Award Tranche Four [Member] |
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
Number of shares subject to PSU | shares |
2,000,000
|
Market capitalization milestone, amount | $ |
$ 2,500,000,000
|
ShareBased Compensation Award Tranche Five [Member] |
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
Number of shares subject to PSU | shares |
1,000,000
|
Market capitalization milestone, amount | $ |
$ 3,000,000,000
|
ShareBased Compensation Award Tranche Six [Member] |
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
Number of shares subject to PSU | shares |
1,000,000
|
Market capitalization milestone, amount | $ |
$ 3,500,000,000
|
ShareBased Compensation Award Tranche Seven [Member] |
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
Number of shares subject to PSU | shares |
1,000,000
|
Market capitalization milestone, amount | $ |
$ 4,000,000,000
|
ShareBased Compensation Award Tranche Eight [Member] |
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
Number of shares subject to PSU | shares |
2,000,000
|
Market capitalization milestone, amount | $ |
$ 4,500,000,000
|
ShareBased Compensation Award Tranche Nine [Member] |
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
Number of shares subject to PSU | shares |
1,000,000
|
Market capitalization milestone, amount | $ |
$ 5,000,000,000
|
ShareBased Compensation Award Tranche Ten [Member] |
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
Number of shares subject to PSU | shares |
1,000,000
|
Market capitalization milestone, amount | $ |
$ 5,500,000,000
|
X |
- DefinitionMarket capitalization milestone.
+ References
+ Details
Name: |
STXS_MarketCapitalizationMilestone |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1
+ Details
Name: |
us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(01) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
srt_TitleOfIndividualAxis=STXS_Mr.FischelMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_VestingAxis=STXS_ShareBasedCompensationAwardTrancheFourMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_VestingAxis=STXS_ShareBasedCompensationAwardTrancheFiveMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_VestingAxis=STXS_ShareBasedCompensationAwardTrancheSixMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_VestingAxis=STXS_ShareBasedCompensationAwardTrancheSevenMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_VestingAxis=STXS_ShareBasedCompensationAwardTrancheEightMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_VestingAxis=STXS_ShareBasedCompensationAwardTrancheNineMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_VestingAxis=STXS_ShareBasedCompensationAwardTrancheTenMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.24.2.u1
Summary of Option and Stock Appreciation Rights Activity (Details) - Equity Option [Member] - Stock Appreciation Rights (SARs) [Member]
|
6 Months Ended |
Jun. 30, 2024
$ / shares
shares
|
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] |
|
Number of Options/SARs, Outstanding, Beginning | shares |
3,650,115
|
Weighted Average Exercise Price per Share, Outstanding, Beginning |
$ 3.93
|
Number of Options/SARs, Granted | shares |
716,500
|
Weighted Average Exercise Price per Share, Granted |
$ 3.00
|
Number of Options/SARs, Exercised | shares |
(11,763)
|
Weighted Average Exercise Price per Share, Exercised |
$ 1.02
|
Number of Options/SARs, Forfeited | shares |
(251,005)
|
Weighted Average Exercise Price per Share, Forfeited |
$ 3.99
|
Number of Options/SARs, Outstanding, Ending | shares |
4,103,847
|
Weighted Average Exercise Price per Share, Outstanding, Ending |
$ 3.77
|
Minimum [Member] |
|
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] |
|
Range of Exercise Price, Outstanding |
0.74
|
Range of Exercise Price, Granted |
2.45
|
Range of Exercise Price, Exercised |
0.74
|
Range of Exercise Price, Forfeited |
0.74
|
Range of Exercise Price, Outstanding, Ending |
0.74
|
Maximum [Member] |
|
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] |
|
Range of Exercise Price, Outstanding |
9.87
|
Range of Exercise Price, Granted |
3.01
|
Range of Exercise Price, Exercised |
2.57
|
Range of Exercise Price, Forfeited |
9.20
|
Range of Exercise Price, Outstanding, Ending |
$ 9.87
|
X |
- DefinitionSharebased compensation shares authorized under stock option plans exercise price range outstanding options weighted average exercise price exercised.
+ References
+ Details
Name: |
STXS_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceExercised |
Namespace Prefix: |
STXS_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionSharebased compensation shares authorized under stock option plans exercise price range outstanding options weighted average exercise price forfeited.
+ References
+ Details
Name: |
STXS_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceForfeited |
Namespace Prefix: |
STXS_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionShare based compensation shares authorized under stock option plans exercise price range outstanding options weighted average exercise price granted.
+ References
+ Details
Name: |
STXS_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceGranted |
Namespace Prefix: |
STXS_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13
+ Details
Name: |
us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(03) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionGross number of share options (or share units) granted during the period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(01) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionNumber of options outstanding, including both vested and non-vested options.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionWeighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionWeighted average price at which option holders acquired shares when converting their stock options into shares.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(02) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionWeighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(03) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionWeighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(01) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionNumber of share options (or share units) exercised during the current period.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(02) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_RangeAxis=srt_MinimumMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_RangeAxis=srt_MaximumMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.24.2.u1
Schedule of Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs) [Member]
|
6 Months Ended |
Jun. 30, 2024
$ / shares
shares
|
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
Number of Restricted Stock Units, Outstanding, Beginning | shares |
1,502,131
|
Weighted Average Grant Date Fair Value per Unit, Outstanding, Beginning | $ / shares |
$ 3.94
|
Number of Restricted Stock Units, Outstanding, Granted | shares |
389,610
|
Weighted Average Grant Date Fair Value per Unit, Granted | $ / shares |
$ 1.54
|
Number of Restricted Stock Units, Outstanding, Vested | shares |
(492,584)
|
Weighted Average Grant Date Fair Value per Unit, Vested | $ / shares |
$ 3.03
|
Number of Restricted Stock Units, Outstanding, Ending | shares |
1,399,157
|
Weighted Average Grant Date Fair Value per Unit, Outstanding, Ending | $ / shares |
$ 3.60
|
X |
- DefinitionThe number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(01) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(01) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionPer share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionThe number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(02) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(02) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 35 -Paragraph 1D -Publisher FASB -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 35 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(01) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(02) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(03) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(01) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(02) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(03) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iv) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(v) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.24.2.u1
Convertible Preferred Stock and Stockholders’ Equity (Details Narrative) - USD ($)
|
|
1 Months Ended |
6 Months Ended |
Feb. 23, 2021 |
Sep. 30, 2016 |
Jun. 30, 2024 |
Jun. 30, 2023 |
Class of Stock [Line Items] |
|
|
|
|
Common stock, voting rights |
|
|
The
holders of common stock are entitled to one vote for each share held
|
|
Payments of dividends common stock |
|
|
$ 0
|
|
Stock-based compensation expense |
|
|
5,127,000
|
$ 5,314,000
|
Unrecognized stock-based compensation expense |
|
|
$ 3,600,000
|
|
Share based payment arrangement, cost not yet recognized, period |
|
|
4 years
|
|
2012 Stock Incentive Plan [Member] |
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
Stock plan expiration date |
|
|
May 19, 2022
|
|
Stock Award Plans [Member] |
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
Common stock, shares reserved for future grants |
|
|
5,633,730
|
|
PSU Agreement [Member] | Mr. Fischel [Member] |
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
Performance award term |
10 years
|
|
|
|
Number of shares granted |
13,000,000
|
|
|
|
Maximum market capitalization milestone, amount |
$ 1,000,000,000.0
|
|
|
|
Increase in market capitalization milestone, amount |
$ 500,000,000
|
|
|
|
Award vesting rights, description |
Each
tranche represents a portion of the PSUs covering the number of shares outlined in the table above. Each tranche vests upon (i) satisfaction
of the market capitalization milestones and (ii) continued employment as CEO of the Company from the grant date through December 31,
2030. Absent an earlier termination, the PSUs will expire on December 31, 2030. If our CEO ceases employment as CEO of the Company for
any reason including death, disability, termination for cause or without cause (as defined in the award agreement), or if he voluntary
terminates after service as CEO for at least five years, the remaining service period will be waived and he will retain any PSUs that
have vested through the date of termination
|
|
|
|
Stock-based compensation expense |
|
|
$ 3,600,000
|
3,500,000
|
Unrecognized stock-based compensation expense |
|
|
$ 33,400,000
|
$ 40,600,000
|
PSU Agreement [Member] | Mr. Fischel [Member] | Maximum [Member] |
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
Maximum market capitalization milestone, amount |
$ 5,500,000,000
|
|
|
|
Series A Convertible Preferred Stock [Member] |
|
|
|
|
Class of Stock [Line Items] |
|
|
|
|
Sale of stock, number of shares sold |
|
24,000
|
|
|
Preferred stock, par value |
|
$ 0.001
|
|
|
Preferred stock, stated value |
|
1,000
|
|
|
Redemption price per share |
|
$ 0.65
|
|
|
Common stock issuable from warrants |
|
36,923,078
|
|
|
Preferred stock dividend rate |
|
6.00%
|
|
|
Preferred stock redemption, triggering event, percent of common stock sold threshold |
|
50.00%
|
|
|
X |
- DefinitionIncrease in market capitalization milestone, amount.
+ References
+ Details
Name: |
STXS_IncreaseInMarketCapitalizationMilestone |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionMarket capitalization milestone.
+ References
+ Details
Name: |
STXS_MarketCapitalizationMilestone |
Namespace Prefix: |
STXS_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionPreferred stock redemption triggering event percent of common stock sold threshold.
+ References
+ Details
Name: |
STXS_PreferredStockRedemptionTriggeringEventPercentOfCommonStockSoldThreshold |
Namespace Prefix: |
STXS_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionPreferred stock, stated value
+ References
+ Details
Name: |
STXS_PreferredStockStatedValuePerShare |
Namespace Prefix: |
STXS_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13
Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Topic 272 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 272 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1
Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(27)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(2)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(2)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3
+ Details
Name: |
us-gaap_ClassOfStockLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionNumber of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3
+ Details
Name: |
us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionAggregate number of common shares reserved for future issuance.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_CommonStockCapitalSharesReservedForFutureIssuance |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionDescription of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3
+ Details
Name: |
us-gaap_CommonStockVotingRights |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of cost not yet recognized for nonvested award under share-based payment arrangement.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionWeighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:durationItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 15 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15
+ Details
Name: |
us-gaap_PaymentsOfDividendsCommonStock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe percentage rate used to calculate dividend payments on preferred stock.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6
+ Details
Name: |
us-gaap_PreferredStockDividendRatePercentage |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFace amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13
+ Details
Name: |
us-gaap_PreferredStockParOrStatedValuePerShare |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionThe price per share at which the preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity is redeemed or may be called at. The redemption features of this preferred stock are solely within the control of the issuer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 5 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-5
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-11
+ Details
Name: |
us-gaap_PreferredStockRedemptionPricePerShare |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionThe number of shares issued or sold by the subsidiary or equity method investee per stock transaction.
+ References
+ Details
Name: |
us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of noncash expense for share-based payment arrangement.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_ShareBasedCompensation |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionDescription of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(01) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionWeighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (e)(1) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:durationItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDate the equity-based award expires, in YYYY-MM-DD format.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_PlanNameAxis=STXS_TwoThousandTwelveStockIncentivePlanMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_PlanNameAxis=STXS_StockAwardPlansMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_TitleOfIndividualAxis=STXS_Mr.FischelMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_RangeAxis=srt_MaximumMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=STXS_SeriesAConvertiblePreferredStockMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.24.2.u1
X |
- References
+ Details
Name: |
us-gaap_GuaranteesAndProductWarrantiesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCarrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (c)(5) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8
+ Details
Name: |
us-gaap_ProductWarrantyAccrualClassifiedCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8
+ Details
Name: |
us-gaap_ProductWarrantyAccrualPayments |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of increase (decrease) in the standard and extended product warranty accrual from changes in estimates attributable to preexisting product warranties.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (c)(4) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8
+ Details
Name: |
us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
v3.24.2.u1
X |
- DefinitionThe carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)) -SubTopic 10 -Topic 210 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(16)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(16)(a)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1
+ Details
Name: |
us-gaap_LineOfCredit |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(f)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1
+ Details
Name: |
us-gaap_LineOfCreditFacilityLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe value (monetary amount) of the award the plaintiff seeks in the legal matter.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9
+ Details
Name: |
us-gaap_LossContingencyDamagesSoughtValue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.24.2.u1
X |
- DefinitionNumber of new stock issued during the period.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3
Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodSharesNewIssues |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDetail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 855 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2
+ Details
Name: |
us-gaap_SubsequentEventLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_TypeOfArrangementAxis=STXS_SharePurchaseAgreementMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
Stereotaxis (AMEX:STXS)
Historical Stock Chart
From Oct 2024 to Nov 2024
Stereotaxis (AMEX:STXS)
Historical Stock Chart
From Nov 2023 to Nov 2024